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'BRAIN ATTACK'
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Peter James Hand





This thesis proposes that patients with features of focal neurological dysfunction, of
abrupt onset, should be considered as suffering a brain attack. Brain attack is a neurological
emergency, requiring a prompt and accurate diagnosis before treatment can be commenced.
The hypothesis underlying this work was that key reliable and useful parts of the bedside
clinical assessment, and currently available brain imaging techniques, could be identified to
improve the assessment of patients with suspected acute stroke.
The thesis is divided into three sections. Section I reviews the history of stroke and
its terminology. A review of the pathophysiology of the ischaemic penumbra demonstrates
that 'time is brain' and supports a more urgent approach to stroke. The term brain attack is
introduced, its history and applications are traced, and a definition is proposed. A systematic
review of previous work examines the accuracy of the clinical diagnosis of stroke and the
nature of stroke mimics. The clinical features of stroke in the first few hours are explored
using data from the International Stroke Trial. The current contribution and potential of
brain imaging — computed tomography (CT), structural and advanced magnetic resonance
imaging (MRI) - in the assessment and management of brain attack is reviewed, with
particular emphasis on identifying where new information is needed.
Section II explores the clinical features of brain attack. A prospective study of 350
hospital presentations with brain attack is described to determine: 1) the conditions that
cause brain attack; 2) if the clinician could distinguish between stroke and mimic; 3) the
accuracy of the clinical diagnosis of the cause of brain attack; 4) the reasons for
disagreement between the clinical diagnosis and the final diagnosis, and 5) whether the
clinical features of patients presenting within the first six hours differed from those
presenting later. Univariate analyses identified several key items of history and examination
that differentiated between stroke and mimic. An interrater study, involving 98 patients and
four clinicians, was performed to determine the items of history and physical examination
that were reliable even when the observer had limited neurological training. A series of
diagnostic models (of varying simplicity) are developed using multivariable logistic
regression analysis, with strict attention to methodological details. The potential use of the
models to differentiate between stroke and mimic at the bedside is discussed.
Section III explores the influence of the CT scan on the diagnosis of brain attack for
the 350 patients in the cohort. Routine imaging was frequently normal - particularly in
patients where the clinical diagnosis was uncertain - and its sensitivity in the first few hours
was highly dependent on the skills of the radiologist. MR may provide more information.
The feasibility of scanning acute stroke patients with MR was tested prospectively in 138
MR-eligible patient presentations. The reasons for not scanning patients, and the difficulties
and possible risks encountered during scanning are described. The information from MR
was explored in 96 patients who underwent diffusion-weighted (DWI) and perfusion
imaging (PI), with outcome assessment at three months. The importance of DWI lesion
volume and the presence of a DWI-PI 'mismatch' are considered. The current clinical utility
of MR, in comparison with CT, is discussed in detail.
Results from this original research should help guide clinicians with an evidence-
based, streamlined approach to the emergency assessment of patients with brain attack.
Note: The scans reproduced in this thesis have had identifiers removed (including
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SECTION I
BRAIN ATTACK - A TERM FOR THE 21st CENTURY
Chapter 1 : The history of stroke terminology
1.1 Introduction
"Stroke - a sudden attack of weakness, numbness or
hemiplegia caused by cerebral haemorrhage or ischaemia.
Also called apoplexy" New Shorter Oxford English
Dictionary, 1993
The word 'stroke' was first used in a medical sense in the late 16th century.
The full term was a 'stroke of apoplexy': a combination of ancient Greek, apoplexia
- to be struck with violence (McHenry, 1969), and Middle English - implying an
unexpected, severe and traumatic event. Throughout time, various terms were used
to describe what we now know as stroke. The art of diagnosis changed from seeking
to group together conditions with a similar outcome, to attempting to define the
underlying pathological process. In this chapter, I will trace the historical
developments in classification and diagnosis of stroke and transient ischaemic attack.
This chapter serves as the historical rationale for embracing the term brain attack.
1.2 Apoplexy - from Hippocrates to the 19th century
1.2.1 The earliest records
The first record of apoplexy was in Hippocratic times (5th century BC). It
was defined as a sudden onset of generalised (not focal) brain disturbance, and was
invariably fatal. As the aim of the ancient Greek physician was to predict prognosis,
diseases as disparate as pulmonary embolism, myocardial infarction and stroke -
which may all have a sudden onset and result in coma - were considered to be
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'apoplexy'. Despite this, the Hippocratic Writings and Aphorisms gave a remarkably
clear description of the apoplexy we now consider as stroke (Clarke, 1963):
"Apoplexy...occurs most commonly between the ages of
forty and sixty...in some cases prodromal symptoms warn of
an impending attack.. .during the spasms the loss of speech
for a long time is unfortunate; if present for a short time it
proclaims a paralysis of the tongue, of the arm, or of parts
situated on the right side."
The Hippocratic physician was aware that apoplexy was a disorder of the
brain, and that the paralysis occurred on the side opposite the lesion. Understanding
of the function of the brain, or the reason for strokes, was limited because dissection
of the human body was precluded by its divine connotations (van Gijn, 2001). At the
time, the brain was seen as a gland that cooled the blood and secreted mucous that
flowed from the nose (Singer and Underwood, 1962). Apoplexy was explained as an
accumulation of black bile in the arteries of the brain, which obstructed the passage
of animated spirits from the ventricles.
Following Hippocratic times, there were more refinements in the clinical
description of apoplexy. Aretaeus of Cappadocia [81-138 AD] distinguished
between paraplegia (a loss of movement and sensation) and paresis (a loss of
movement only. Soranus of Ephesus [98-138 AD] distinguished apoplexy (an acute
seizure) from paralysis (the long-term sequelae of an episode of apoplexy) (Singer
and Underwood, 1962). Paul of Aegina (AD 625 - 690) introduced the term
hemiplegia (McHenry, 1969).
1.2.2 17th century -the era of the autopsy
A major advance occurred in the mid 17th century, with the new practice of
post mortem examinations. The detailed anatomy of the brain was discovered,
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including the vascular network. Willis described the interconnections between the
arteries at the base of the brain - later known as the 'circle of Willis' - in 1664
(Singer and Underwood, 1962). Basic pathology was described. Wepfer (Figure
1.1) was the first person to associate apoplexy with cerebral haemorrhage. He
distinguished between extravasation of blood into the brain and ventricles, and
arterial obstruction that prevented the flow of blood (van Gijn, 2001).
Figure 1.1 Johann Jakob Wepfer (1620 - 1695)
Swiss physician and contemporary of Thomas Willis.
Studied medicine in Basel, served as army surgeon
and physician to Duke Leopold of Wirtenberg. Also
known for his early recognition of toxicity from so-
called medicinal uses of hemlock, arsenic, and
mercury. Image courtesy of the National Library of
Medicine.
Clinical description continued to improve. Wepfer noted that those most at
risk of apoplexy were "the obese, those whose face and hands are livid, and those
whose pulse is constantly unequal", and also observed several patients who
recovered (van Gijn, 2001). In 1761 Morgagni, a pioneer of clinico-pathological
correlation, demonstrated that the pathological lesion was on the opposite side of the
brain to the clinical signs (McHenry, 1969).
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1.2.3 19th century
By the early 19th century, clinical diagnosis aimed to identify conditions with
common clinical features and causes. Clinical classifications of apoplexy were
proposed by Serres in 1819, Abercrombie in 1828, and Hope and Bennett in 1840.
Serres divided apoplexy into two types: in the majority (those with paralysis) the
brain was involved, and in those without paralysis, the meninges were affected
(possibly referring to patients without focal findings). Abercrombie of Edinburgh
(Figure 1.2) distinguished three classes of apoplexy: primary, where the patient was
suddenly struck down, developed convulsions and coma, and if recovery occurred,
the patient was often left with paralysis; secondary, which began with headache and
vomiting, and if recovery occurred, the patient was less likely to have paralysis; and
tertiary, which occurred without coma, but with loss of speech and power on one side
of the body, and often with recovery (McHenry, 1969). These classes can be
recognised as cerebral haemorrhage, subarachnoid haemorrhage, and vascular
occlusion. Hope and Bennett distinguished four forms of apoplexy: transient
apoplexy (symptoms last less than a day), primary apoplexy with death or slow
recovery, ingravescent apoplexy with partial recovery and relapse, and paraplexic
apoplexy (which was apoplexy complicated by paralysis, which they believed was
due to raised intracranial pressure) (McHenry, 1969).
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Obtained an MD from University of Edinburgh in
1803, and subsequently practised as a physician in
Nicholson Street, Edinburgh. In 1828 he became
physician to the king in Scotland, and in 1835
received an honorary degree from Oxford University.
Image courtesy of the National Library ofMedicine
Figure 1.2 John Abercrombie (1780 - 1844).
1.3 The diagnosis of cerebral infarction and haemorrhage
1.3.1 Cerebral haemorrhage
Extravasation of blood into brain parenchyma was recognised by Wepfer and
Morgagni, but the cause of this was obscure until the 19th century. In 1825 Baillie
associated haemorrhage with hardening of the arteries, which he noted was "a bony
or earthy matter deposited in the coat of the arteries" (Schiller, 1970). In 1868,
Charcot and Bouchard discovered minute outpouchings of small vessels in the basal
ganglia in patients with fatal haemorrhages (Iragui, 1986). They proposed that
rupture of these aneurysms resulted in intracerebral haemorrhage, but their view was
not uniformly accepted. Debate continued into the 20th century, and was only settled
in the 1960s.
It was recognised by Portal in 1781 that it was impossible to distinguish
between haemorrhagic and non-haemorrhagic apoplexy in life. This remained true
until the invention of computed tomography by Hounsfield in the 1970s.
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1.3.2 Cerebral infarction
In 1730, Boerhaave observed that apoplexy could result from interruption of
cerebral blood flow by compression of the neck (Schiller, 1970). Rostan [1790-
1866] noted that "softening of the brain" (or ramollissement) was a separate
pathological process to haemorrhage - it was more common than haemorrhage, and
its clinical features were often heralded by minor disturbances in limb function, or
speech or vision (van Gijn, 2001). Around the same time, Abercrombie (Figure 1.2)
recognised that brain softening was due to a failure of cerebral circulation as a result
of ossification of arteries.
Virchow [1821-1902] firmly established modern thinking about vascular
disease. In the mid 19th century, Virchow demonstrated that vascular occlusion
produced cerebral infarction, observed that thrombosis was caused by arteriosclerosis
(a term he used to describe the process occurring in the vessel wall), and coined the
term embolism to describe vessel occlusion where there was no local vessel wall
abnormality (McHenry, 1969). Virchow's pupil Cohnheim introduced the word
infarction in 1871 (but reserved this for haemorrhagic necrosis, rather than ischaemic
necrosis) (van Gijn, 2001). Finally, in 1873 Duret, whilst working in Charcot's
laboratory, mapped the areas of distribution of the major intracerebral vessels, and
the lesions caused by vascular occlusions (McHenry, 1969).
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1.4 Stroke in the twentieth century
1.4.1 Gowers and early 20th century neurology
By the turn of the 20th century, there were two London hospitals devoted to
apoplexy and other neurological illnesses (Critchley, 1960). Neurology had acquired
a "disease-based approach", with classification of disorders into the now familiar
categories of infectious, traumatic, vascular, nutritional, degenerative, demyelinating
and hereditary causes (McHenry, 1969). The major elements of stroke - its
classification, aetiology, pathology, clinical features and prognosis - had been
recognised and recorded.
The leading London neurologist of the time was Gowers (Figure 1.3)
(Critchley, 1960). Gowers devoted many pages of his Manual of the Diseases of the
Nervous System to stroke, which he recognised was "one of the most frequent
diseases of the brain" (Gowers, 1893). The clinical features were a result of either
sudden interference with the functions of the brain (e.g. loss of consciousness), or the
destruction of the nerve elements in the affected area. The commonest cause was
vascular occlusion (Gowers, 1893).
Figure 1.3 Sir William Gowers (1845 - 1915)
Neurologist at the National Hospital, Queen Square.
In addition to neurology and neuroanatomy, he had
varied interests, including etching and painting (he
illustrated all his books), the use ofshorthand, and the
study of mosses and wild flowers. Image courtesy of
the National Library ofMedicine.
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1.4.2 Birth of the term 'CVA'
At the turn of the 20th century, the common terms were 'stroke' and
'apoplexy' (Gowers, 1893). In the 1930s, a new term - 'cerebrovascular accident' -
came into existence. Why another term? Schiller (1970), a medical historian,
proposed the following rationale:
"That rather blurry and pompous piece of nomenclature must
have issued from the well-meant tendency to soften the blow
to patients and their relatives, also from a desire to replace
"stroke", a pithy term that may sound unscientific and lacking
gentility. 'Cerebrovascular accident (CVA)' can be traced to
the early 1930s - between 1932, to be exact, when it was still
absent from the 15th edition of Dorland's Medical
Dictionary, and the following edition of 1936 where it first
appeared."
By the mid 1950s, the plethora of terms for stroke was hampering research
and understanding - a plea was made for more specific terminology at the first
Princeton conference on cerebrovascular diseases (Wright, 1955). A major theme of
the second Princeton conference was 'problems of nomenclature', in which the
leading stroke clinicians of the day - amongst them Millikan, Fisher, Adams, Merritt
and Brain - tried to reach consensus (Millikan, 1958). The meeting's result was the
publication of 'A classification and outline of cerebrovascular diseases' (Anon.,
1958) which attempted to lay out a clear and simple framework.
Despite its banishment from official usage, cerebrovascular accident
remained (and remains) popular. On both sides of the continent, physicians with an
interest in the area disliked the term. Mulley (1985) stated that it "irritates the stroke
physician", Furlan (2000) described its real meaning as a "confused vascular
analysis", and van Gijn (2001) eloquently stated:
"One problem was that sometimes it was used as
synonymous with cerebral infarction, at other times as
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denoting stroke in general. In this day and age, the term is a
highly specific sign ofwoolly thinking."
The reader will find no further reference to 'CVA" in this work.
1.4.3 The 1950s - stroke might be a treatable disease
The Framingham study, which commenced in 1949, demonstrated that risk
factors such as hypertension, diabetes mellitus, cholesterol, obesity, cigarette
smoking and physical activity were clearly associated with premature coronary heart
disease. This changed the prevailing view that atherosclerosis was simply an
inevitable consequence of ageing. It appeared possible to prevent (and maybe even
treat) atheroma of the coronary arteries (Dawber, 1980). Stroke became the next
target.
In 1956, Dyken and White (1956) performed the first randomised study of
cortisone for acute stroke. Heparin, first used in 1941 (Fraser et al., 1999), attracted
much attention in the 1950s and beyond. Some believed that the difficulties of
distinguishing between haemorrhage and infarct precluded its safe use (Fields and
Lemak, 1989), however reports of its success appeared, and heparin use became
widespread. Aspirin was first used in stroke prevention by Craven, but the study's
results were not widely disseminated (and it was not until 1971 that interest was
rekindled) (Fields & Lemak, 1989).
Other methods of treating strokes, common in the 1950s, were: stellate
ganglion block (thought to abolish vasospasm thus increase blood flow to the
infarct), carbon dioxide inhalation (to increase blood flow), hypotensive agents and
surgery (Rankin, 1957a; Meyer, 1961). There was even mention of pilot studies of
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the use of thrombolytic agents for progressing cerebral thrombosis (Millikan et al.,
1961)
1.4.4 The difficulty of the clinical diagnosis
For many experts of the day, the need for a more active approach was clear.
"It is regrettable that the policy of labelling such patients
'cerebrovascular accidents' and committing them to bed
without benefit of accurate diagnosis or treatment has been so
prevalent in past years" (Meyer, 1961)
However, one of the major problems was that diagnosis was difficult, in the
absence of investigations such as brain imaging. Rankin (1957b) noted that:
"At the onset, when treatment is likely to be of most value,
accurate diagnosis is often difficult and sometimes
impossible. Later, when the diagnosis is perhaps obvious,
permanent damage has already occurred... Diagnosis at the
bedside shortly after the onset of symptoms may be
exceedingly difficult."
An accurate clinical diagnosis was usually made after several days of careful
observation. Cerebral haemorrhage was diagnosed by an onset over minutes,
accompanying headache, reduced consciousness, absence of rapid improvement, and
bloody CSF (Fisher, 1961a). Cerebral embolism was diagnosed by an abrupt onset,
absence of premonitory transient ischaemic attacks (TIAs), rapid improvement, and
demonstration of a cardiac source of emboli (Fisher, 1961b). Cerebral thrombosis
was diagnosed by the presence of TIAs, older age, evolving onset, and rapid
improvement (Fisher, 1961b), and was further divided into 'threatening', 'stroke-in-
evolution' (a subacute or progressing stroke, often with slow onset), 'completed
stroke' (onset often during sleep, deficit maximal on wakening) and 'chronic cerebral
infarction' (which may imitate a space occupying lesion) (Carter, 1972).
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Treatments were prescribed for a particular type of stroke (e.g. anticoagulants
for evolving strokes) (Carter, 1961). Thus the clinical diagnosis - most accurate
after several days of observation - formed the basis for the decision to treat a patient
immediately (and often with risky medications). It was little wonder that some
clinicians preferred to do nothing.
1.4.5 Simplification of the clinical approach
By the 1970s, it was realised that a cerebral infarct, embolism, or
haemorrhage could result in a clinical 'evolving' or 'completed' stroke (Marshall,
1976). Treatment of a completed stroke was deemed not possible, but treatment of
progressing or evolving strokes could be attempted with steroids (to reduce oedema),
dextran-40 (to aid blood flow) or anticoagulants (Marshall, 1976). There was also
growing awareness that the clinical definitions were ambiguous (e.g. 'completed
stroke' - some thought it meant that the stroke had stopped worsening, others that the
neurological impairment had reached its maximum (Whisnant, 1990)).
The first step towards simplification was the World Health Organisation
(WHO) clinical definition of stroke ["rapidly developing clinical signs of focal (at
times global) disturbance of cerebral function, lasting more than 24 hours or leading
to death, with no apparent cause other than that of vascular origin" (Hatano, 1976)].
One can speculate that this definition was more useful for epidemiological studies
than for the busy clinician. As the clinical features, investigation, treatment and
prognosis of subarachnoid haemorrhage are different to other forms of stroke, the
clinical utility of the WHO definition was questioned (Bamford, 2001). A sensible
modification was to separate SAH and define a stroke as "a clinical syndrome
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characterised by an acute loss of focal cerebral function with symptoms lasting more
than 24 hours or leading to death, and which is thought to be due to either...
haemorrhage or infarction." (Bamford, 2001). This alteration became widely
accepted (Mulley, 1985; Rangel, 1986), and has carried through into modem
textbooks of stroke (Bamett et al., 1998; Warlow et al., 2001; Bogousslavsky and
Caplan, 2001), and will be used in this thesis.
The greatest advance of the 20th century for stroke medicine was the
discovery of computerised tomography (CT). Before the era of CT, studies achieved
an accurate pathological diagnosis in only about 30% of cases (Marquardsen, 1976).
When CT brain scans became available in the 1980s, it was possible to accurately
distinguish between haemorrhage and infarct. CT scanning demonstrated that
previously held ideas about clinical features were often wrong, leading to a general
abandonment of the confusing sub-classifications seen in the previous decades
(Toole et al., 1988). With CT, diagnosis and management were aided by an accurate
knowledge ofwhat was occurring "inside the head" (McDowell, 2001).
1.5 Defining the transient ischaemic attack (TIA)
References to premonitory symptoms were made by many of the early
pioneering physicians (e.g. Hippocrates, Wepfer, Willis, Hope & Bennett). These
minor symptoms attracted little interest, as the primary focus for physicians of the
time was on apoplexy, with its grave prognosis (Loeb, 1980). Additionally, very
early reports did not always differentiate between focal symptoms and general
symptoms such as fainting (van Gijn, 2001). Around the end of the 19th century,
descriptions of transient stroke-like episodes were common, and in 1914 Ramsay
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Hunt called the events "cerebral intermittent claudication" (Hankey and Warlow,
1994). Over the next 40 years, however, little attention was paid to transient
episodes of cerebral dysfunction.
Stimulated by the experience of a patient who developed visual loss in the
right eye followed by hemiparesis, Fisher (Figure 1.4) recognised the importance of
transient events as a marker of increased risk of cerebral infarction (Fisher, 1951).
Fisher first proposed the term transient ischaemic attack (TIA) in 1957. Other terms
used at that time included 'intermittent vascular insufficiency', 'ischaemic recurrent
attacks', 'transient cerebral ischaemia' and 'transient ischaemic cerebrovascular
attacks'. Fisher's term did not gain widespread acceptance until the fourth Princeton
conference of 1965 (Hankey and Warlow, 1994).
Figure 1.4 C. Miller Fisher (1913 -).
Imprisoned in a German prisoner of war camp for
three and a halfyears during the Second World War.
Later, neurologist at the Massachusetts General
Hospital, Boston. Major contributions to knowledge
of transient ischaemic attacks, lacunar syndromes,
also described the Miller-Fisher variant of Guillain-
Barre syndrome. Reproduced from Stroke. A
practical guide to management, 2nd edition; CP
Warlow, MS Dennis, J van Gijn, GJ Hankey, PAG
Sandercock, JM Bamford, JM Wardlaw, eds. Oxford:
Blackwell Science 2001 with permission.
The accepted duration of TIAs varied greatly over the years: in 1958, it was 1
hour (Committee of the National Institutes of Neurological Diseases and Blindness,
1958), and in 1975, it was 2-30 minutes (Millikan, 1975). In 1978, the World Health
Organisation proposed an upper limit of 24 hours (World Health Organisation,
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1978). Despite the fact that most cerebral TIAs resolve in less than 60 minutes, this
arbitrary definition of symptom duration achieved widespread acceptance (Hankey
and Warlow, 1994). In their monograph, Hankey and Warlow (1994) define the
transient ischaemic attack as:
"an acute loss of focal cerebral or monocular function with
symptoms lasting less than 24 hours and which is thought to
be due to inadequate cerebral or ocular blood supply as a
result of arterial thrombosis or embolism associated with
arterial, cardiac or haematological disease."
1.5.1 The 'RIND' and other variants
There is a spectrum of symptom duration in cerebrovascular disorders.
Symptoms may last from minutes to hours, days, weeks or months (Hankey and
Warlow, 1994). Some transient episodes of cerebral ischaemia lasted longer than 24
hours yet still eventually resolved, so terms such as reversible ischaemic neurological
deficit ('RIND'), minor ischaemic stroke and 'protracted TIA' were introduced
(Hankey and Warlow, 1994). These terms were popular in the 1980s. In the 1990s,
they were largely abandoned (Hankey and Warlow, 1994), after considerable debate
as to whether there was any point in distinguishing between a TIA and minor
ischaemic stroke (Whisnant, 1990)
1.6 The 'decade of the brain'
In 1990 the US Congress signed a resolution declaring the forthcoming ten
years to be the 'Decade of the Brain' (Rosenberg and Rowland, 1990). At the
commencement of the decade, there was enthusiasm for what could be achieved in
stroke:
15
"There is a new excitement in stroke research - new
technology, new findings, renewed promise of stroke
prevention, intervention at the time of stroke to limit
destruction, new clinical therapies, and hope that new
approaches to restoration after stroke will improve the long-
term outlook for patients" (Goldstein, 1990).
The decade of the brain achieved many advances. Sound epidemiological
studies in the late 80s and early 90s improved knowledge of the incidence, risk
factors and natural history of cerebral infarction and haemorrhage. The Oxfordshire
Community Stroke Project developed a simple clinical classification of infarcts that
was used in large-scale trials such as the International Stroke Trial (Bamford et al.,
1991). Stroke severity scales such as the National Institute of Health Stroke Scale
(NIHSS) - the "common language" of acute stroke (Furlan, 2000) - were used in
many trials, allowing easier comparisons both within and between trials. Clinical
trial methodology improved substantially (Bath et al., 1998), and rigorous studies of
neuroprotectants, antiplatelet agents, heparin, oral anticoagulants, and carotid
endarterectomy were performed. Evidence-based medicine, aided by systematic
reviews and meta-analysis of all available trial results, was introduced (Sandercock,
2001).
1.6.1 Thrombolysis for acute ischaemic stroke
The 1990s can also be seen as the decade of thrombolysis (Starkman &
Saver, 1997). Clot dissolution became a theoretical possibility in the early 1950s,
after the discovery of the clotting pathway, and streptokinase, a substance produced
by bacteria that was capable of accelerating clot lysis. Early studies had an
unacceptable risk of complications (Heiss, 1988), prompting a 1980 recommendation
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that thrombolysis for acute cerebrovascular disorders is contraindicated
(Anonymous, 1980).
In the 1980s, progress was made on several fronts. Understanding of the
concept of the ischaemic penumbra increased, which formed the theoretical rationale
for reperfusion (Heiss, 1988). Tests in animal models showed that the efficacy of
thrombolysis was maximal if given early (within 90 minutes of onset) (Zivin, 1999).
The success of trials of thrombolysis in acute myocardial infarction provided a
framework for clinical trials of thrombolysis in acute stroke (Baron et al., 1995). But
the prevailing attitude of stroke physicians was that treatment of stroke victims
within 48 hours of symptom onset was essentially impossible (Sterman et al., 1987).
The decade of the brain changed that attitude. In 1995, the National Institute
of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study reported that
recombinant tissue-plasminogen activator (rt-PA) uniformly improved all measures
of outcome when given within three hours of onset (The National Institute of
Neurological Disorders and Stroke rt-PA Stroke Study Group, 1995). rt-PA was
subsequently licensed for commercial use in the USA and Canada.
By the end of 1999, over 5,000 patients had been enrolled in 17 randomised-
controlled trials of thrombolysis. A Cochrane systematic review of the data showed
that treatment with rt-PA up to six hours after onset resulted in 57 fewer dead or
disabled patients for every 1000 treated (Wardlaw et al., 2001a). Leading US
clinicians had little doubt that rt-PA should be given to any suitable patient
presenting within three hours of symptom onset (Grotta, 1997; Zivin, 1999).
However, disappointingly few patients were actually treated (Horowitz, 1998), and
many issues remained unresolved, such as whether thrombolysis could safely be
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given up to six hours after onset, and the interaction between stroke severity and CT
appearances and the risks of treatment (Wardlaw et al., 2001a).
By the end of the 1990s, there was little doubt that: (1) there was a treatment
for acute stroke that was effective for selected patients, and (2) for treatment to be
successful, it had to be started as soon as possible. A new era in acute stroke
assessment and treatment had begun.
18
Chapter 2 : The ischaemic penumbra
2.1 Introduction
The recent progress in treating acute ischaemic stroke has been underpinned
by advances in knowledge of stroke pathophysiology (Carter, 1961; Marshall, 1976).
Infarction is not an all or nothing episode, instantaneous in onset, and irreversibly
complete (Hankey, 2001). Instead, occlusion of a blood vessel initiates a series of
pathophysiological cascades, involving the vascular system (platelets, coagulation
factors, vessel wall, thrombi) and brain tissue, ultimately resulting in neuronal death.
In this chapter, I will briefly review the mechanisms that lead to cell death after a
vessel is occluded. The major focus will be on the ischaemic penumbra, and how
this influences modem management of stroke.
2.2 Cerebral metabolism, blood flow and autoregulation
2.2.1 Cerebral metabolism
The working brain consumes one-third of its energy for maintenance of
synaptic transmission, one-third for transporting sodium and potassium ions across
the membrane (thus maintaining ionic homeostasis), and one-third for preserving
structural integrity (Back et al., 1998). Glucose is the only source of energy, and
oxygen is required to convert glucose to ATP with maximal efficiency. The brain is
incapable of storing glucose, thus it requires a constant supply of glucose and oxygen
(Paczynski et al., 1995; Hankey, 2001).
19
2.2.2 Cerebral blood flow (CBF)
Resting blood flow to the brain is 50-55ml/100g brain tissue/minute. Total
blood flow to the brain constitutes 20% of cardiac output (despite the brain being
only 2% of body weight). In the resting brain, metabolism and blood flow are tightly
coupled (by unknown mechanisms). The fraction of oxygen extracted from the
blood (oxygen extraction fraction, OEF) is also coupled to CBF. Normally, OEF is
about 33%, but it can increase significantly ifnecessary (Hankey, 2001).
2.2.3 Autoregulation
Under normal conditions, CBF is maintained by autoregulation: flow is kept
constant despite changes in cerebral perfusion pressure. As flow = pressure /
resistance, maintaining flow in the face of changes in pressure can be achieved by
altering vascular resistance (by dilation or constriction of intracerebral and pial
arterioles). Systemic arterial oxygen content, carbon dioxide tension, local pH, and
degree of local functional activation of neurones also influence CBF (Paczynski et
al., 1995).
Autoregulation functions within the usual blood pressure ranges (higher for
those with long-standing hypertension), but when mean arterial blood pressure falls
to 50mmHg and below, further dilation of arterioles is not possible and
autoregulation fails. Then CBF parallels perfusion pressure, and brain tissue must
increase its OEF to sustain aerobic metabolism. In disease states such as stroke,
autoregulation is lost (Olsen et al., 1983). CBF becomes 'pressure passive', and
sudden drops in blood pressure can predispose to, or worsen, stroke (Hankey, 2001).
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2.3 Pathophysiology of ischaemia
2.3.1 Effect of vessel occlusion
Complete arrest of the cerebral circulation leads to irreversible neuronal
damage within minutes. Stroke, however is a focal disorder, commencing with
occlusion of a single cerebral vessel, and its outcome is far less predictable (Astrup et
al., 1981). The presence of collateral blood vessels means that an occlusion will
reduce, but not abolish, the delivery of oxygen and glucose to an area of brain tissue.
Cells closest to the occluded vessel will infarct after five minutes of severe focal
ischaemia. Cells nearest to the collateral vessels are less severely affected than areas
close to the occlusion (Pulsinelli, 1992; Siesjo, 1992a).
2.3.2 Critical thresholds of blood flow
The development of infarction is critically dependent on blood flow (Astrup
et al., 1981). With initial reductions in CBF (see Figure 2.1), cerebral oligaemia
occurs: OEF increases to maximal, but oxygen metabolism remains normal. This
tissue is not ischaemic, and is not at risk of infarction (Baron, 1999). When CBF
reduces to around 50% of normal (20ml/100g brain tissue/minute), electrical failure
occurs: cells shut down activities such as synaptic transmission to preserve
homeostasis. Electroencephalogram recordings are characteristically suppressed, and
evoked potentials attenuated. At this point, a focal neurological deficit will be
present (Fisher, 1999). With reduction of CBF to lOml/lOOg brain tissue/minute,
membrane failure occurs: the cell no longer has enough energy to maintain
membrane ion pumps, so sodium and water enter the cell leading to cytotoxic
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oedema, and calcium enters the cells leading to failure of mitochondria. This tissue






















Figure 2.1 Critical bloodflow thresholds
Ischaemic brain injury passes through several thresholds, which relate decrements in
cerebral blood flow (CBF) to pathological events. In the normal range, CBF is maintained
by autoregulation. In oligaemia, there are modest reductions in CBF, but brain tissue
maintains normal metabolism by increasing the oxygen extraction fraction. At a CBF of
20ml/100g brain tissue/minute, the threshold of electrical failure is met, the EEG is
suppressed, and the tissue is ischaemic. At a CBF of 10ml/l OOg/minute, the threshold of
membranefailure is met, and the cells become infarcted. (Adaptedfrom Hossmann (1988))
Time is also a vital factor in the development of infarction (Baron, 1999).
The CBF threshold for membrane failure (infarction) depends on the time elapsed
since vessel occlusion - tissue with CBF 15ml/100g/min may withstand three hours
of occlusion, but tissue with CBF lOml/lOOg/min may withstand only two hours.
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2.3.3 Phases and mediators of cell death
With prolonged severe reductions in CBF, infarction occurs. There are
believed to be four sequential but overlapping cascades that give rise to cell necrosis
(Pulsinelli, 1992; Siesjo, 1992b; Paczynski et al., 1995; Hakim, 1998; Garcia et al.,
1999; Fisher & Schaebitz, 2000; Hankey, 2001):
1. Excitotoxicity. This occurs within minutes, and is a result of uncontrolled
release of the neurotransmitter glutamate. High extracellular concentrations of
glutamate cause overstimulation of glutamate receptors, allowing even more sodium
and calcium to enter the cell. Elevated levels of intracellular calcium activate
destructive enzyme systems and generate free radicals.
2. Peri-infarct depolarisation. This mechanism occurs minutes to hours after
ischaemia. Glutamate and potassium are released into the extracellular space by the
ischaemic neurones, and trigger off repetitive depolarisations of adjacent cells. The
neurones around the ischaemic area must then consume precious energy in
repolarisation, which eventually exhausts, recruiting more cells into the expanding
ischaemic lesion.
3. Inflammation. This occurs hours to days after the insult. As a result of the
influx of calcium into the cell, there is expression of inflammatory cytokines, causing
secondary neuronal injury.
4. Apoptosis. This mechanism results in further cell death over several days.
Ischaemia causes an induction of genes that regulate programmed cell death (through
the action of caspases, which destroy cytoskeletal proteins and enzymes essential for
cell repair).
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2.4 The concept of the ischaemic penumbra
The demonstration of critical thresholds of blood flow to support synaptic
transmission and ion homeostasis, and an orderly sequence of events as neuronal
blood flow diminishes, led to the concept of the ischaemic penumbra (Astrup et al.,
1981). Tissue that loses its electrical function, but maintains its membrane function,
is 'between life and death' - if blood flow is restored, it can regain its function
(Baron, 1999). Hence tissue in the ischaemic penumbra is destined for infarction,
but is still viable - and it can be rescued by appropriate treatment (Ginsberg &
Pulsinelli, 1994; Hossmann, 1994; Hakim, 1998; Fisher, 1999).
The term "penumbra" is an analogy to the shaded zone around the centre of a
complete solar eclipse (Astrup et al., 1981). In its idealised form the penumbra is a
ring of ischaemic but viable tissue surrounding a core of infarcted tissue (see Figure
^>.Core
Figure 2.2 The ischaemic penumbra
Idealised diagram showing the topography of the central ischaemic core (in dark grey), the
penumbra (light stippled) and the zone of oligaemia (dark stippled). Based on a baboon




2.4.1 Does the penumbra exist in humans?
Initial observations were in animal models - rats, cats, dogs, gerbils and
primates - which demonstrated similar blood flow thresholds and response to
reperfusion (Hossmann, 1994). However, there are difficulties in translating results
of animal studies to humans (Scheinberg, 1991; Furlan et ai, 1996). Positron
emission tomography (PET) allowed the study of the ischaemic penumbra in
humans. The penumbra does exist, and - surprisingly - for much longer than the
penumbra seen in animal models (Baron, 1999).
PET has not become a widely used technique (due to limited availability and
long scanning times) (Fisher, 1999). Another promising imaging modality for the
study of the penumbra in humans is diffusion and perfusion magnetic resonance
imaging (MRI). The advantages include its greater availability, shorter scanning
times, and ability to be used within minutes of stroke onset. Diffusion weighted
imaging (DWI) is sensitive to the movement of water molecules into brain tissue. It
is thought that a lesion seen on DWI represents membrane pump failure - the core of
an infarct (Warach, 1998). Perfusion imaging detects relative reductions of blood
flow to areas of brain. The penumbra is thought to be the region of abnormal
perfusion that is larger than the region of abnormal diffusion (Warach, 1998). As
shall be discussed in Chapter 6, there remains much work to be done before this
theory can be considered proven.
2.4.2 Evolution of the penumbra
After focal ischaemia, there is a critical reduction of blood flow to an area of
brain tissue, but collateral blood flow from adjacent vascular territories maintains
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near normal CBF to much of the periphery of the area (Paczynski et cil., 1995). For
example, in the primate model, occlusion of the middle cerebral artery (MCA) causes
maximal reduction in CBF to the sylvian region and anterior basal ganglia. Outside
this densely ischaemic region are zones of less severe CBF reduction, ranging from
40-80% of normal, depending on the distance from the ischaemic core and local
collateral supply (Paczynski et al., 1995).
Thus, the ischaemic penumbra is a dynamic process. Brain regions outside
the zones of severe ischaemia are eventually recruited into the developing infarct.
The infarct grows with time at the expense of the surrounding penumbra, which is
initially large but then shrinks (Figure 2.3). If blood flow can be restored, tissue will
be saved, but as time goes by, the volume of salvageable tissue gets smaller (Baron,
1999).
Figure 2.3 The dynamic penumbra.
The grey area represents the penumbra, the white area is the core of the infarct, the mottled
grey area is tissue oligaemia, and the black area is normal brain. As time progresses, the
core grows into the penumbra - by three hours, there is a large infarct and only a small rim
ofpenumbra. Adaptedfrom Baron (1999)
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2.5 The 'therapeutic time window'
The development of effective therapies for acute ischaemic stroke depend on
defining: (1) the tissue that is the therapeutic target, and (2) how long the tissue is
likely to respond to any treatment (Fisher, 1999). The therapeutic target tissue is the
ischaemic penumbra: thrombolysis and neuroprotective agents aim to restore
perfusion or attack the mechanisms that lead to cellular necrosis, hence salvage
potentially reversible ischaemic tissue (Fisher, 1999).
The time that the therapeutic target is likely to respond to a treatment - the
'therapeutic time window' - is the time that the ischaemic penumbra exists. Work in
animal models suggested that the duration of the time window was perhaps as little
as 2 hours (Ginsberg & Pulsinelli, 1994). However, PET studies have documented
that in some patients, substantial volumes of viable ischaemic tissue exists for up to
16 hours after onset (Furlan et al., 1996). It is not possible to detect whether a
patient has potentially salvageable ischaemic tissue by clinical methods (Fisher,
1997). Perhaps MR will be able to identify the ischaemic penumbra and so guide
individual treatment in the future.
It seems likely that the time window is not rigid and universal, but is a highly
dynamic process that also depends on interactions with factors such as adequacy of
collateral blood flow, temperature, blood pressure and systemic metabolic
disturbances (Baron et al., 1995; Fisher, 1997). The time window also varies for
individual treatments (Baron et al., 1995). An additional factor for thrombolysis is
reperfusion injury, whereby restoration of blood flow (beyond a critical time point)
may exacerbate ischaemic damage (by increased oedema or free radical production)
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(Siesjo, 1992a; Paczynski et al., 1995; Hankey, 2001). It is not known precisely at
what time reperfusion injury occurs.
2.6 Summary
• The identification of critical thresholds of blood flow, and the tissue
response to reduced blood flow, led to the concept of an ischaemic
penumbra
• Current strategies for treatment of acute ischaemic stroke are based on
rescuing tissue within the ischaemic penumbra
• The duration of time during which the penumbra exists is likely to be
influenced by many factors. An important consideration in thrombolysis
is that late treatment may actually increase injury
• Current clinical methods cannot determine if tissue is likely to respond to
treatment. It may be possible in the future to determine the state of the
penumbra by using advanced imaging
• Until then, the best way of ensuring that there is potentially viable tissue
to rescue is for the patient with a stroke to present to hospital as soon as
possible after symptom onset
• Time is brain!
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Chapter 3 : Brain attack
3.1 Introduction
The limitation of the terms stroke and transient ischaemic attack (TIA) is that
they are time-based definitions: an accurate label cannot be applied to a patient until
24 hours have elapsed. Yet increasingly, patients present for assessment within
hours or even minutes of symptom onset. What should we call these events in the
initial few hours? In this chapter, I will present the case for using the term 'brain
attack' to describe this clinical state.
3.2 Why another change in terminology?
3.2.1 Pathophysiological rationale
Infarction is not an inevitable and immediate consequence of vessel
occlusion, as was previously believed. There is a progression of events, from near
normal tissue function, to electrical failure, and finally membrane failure and cell
death, that occur both in time and in space. Around a core of tissue destined for
infarction is the ischaemic penumbra, which is potentially salvageable. The key
factor in these processes is time.
The concept that 'time is brain' has major implications for the clinical
approach to acute stroke. For treatment to be given within the therapeutic time
window, patients need to present to hospital urgently, the clinical assessment needs
to be rapid, and the diagnosis of ischaemic stroke needs to be made accurately.
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The terms stroke and transient ischaemic attack offer little assistance to the
clinician seeing a patient with focal neurological signs in the first few hours after
symptom onset. These diagnoses that can only be made after 24 hours (and it is
hoped that successful treatment would convert a 'stroke' to a 'TIA'), but to wait 24
hours ignores the ischaemic penumbra, and may prevent effective treatment.
3.2.2 Historical rationale
The terminology of stroke was developed at a time when our understanding
of the pathophysiology of ischaemia was minimal, and treatments were often started
72 hours or more after the onset of symptoms. It was routine practice to observe the
patient for a period of time, so the cut-off point of 24 hours to distinguish between
stroke and transient ischaemic attack was reasonable. The definitions were helpful
for epidemiological studies, and for the therapeutic nihilist.
In the 21st century, patients are assessed - and in some cases treated with
potentially dangerous drugs - within a few hours of the onset of symptoms.
Traditional time-based definitions of stroke and TIA are now less useful. The
problem is: what to label the patient with symptoms of stroke when seen within 24
hours? As Bamford stated (2001):
"Looked at from the perspective of physicians seeing patients
acutely (i.e. within 24 hours from onset of symptoms), there
are basically two groups of patients; those whose symptoms
have resolved at the time of assessment and therefore can be
correctly referred to as TIAs, and those who still have
symptoms with or without relevant physical signs. It would
seem inappropriate (and potentially confusing) to use the
term stroke in this situation and we can see that there may be
value in using a new term such as 'brain attack'."
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Before embracing the term brain attack, it is important to leam the lessons of
recent history. One of the major problems encountered in the early study of stroke
treatments was the difficulty in classification. Clinicians attempted to predict the
underlying pathology by often quite complex clinical classifications (evolving stroke,
threatened stroke, completed stroke, chronic stroke etc.). These terms proved to be
unwieldy, with a return to simpler terminology once haemorrhage could be reliably
identified with CT scanning. It is clear that for a new term to be of benefit, it needs
to be simple, clearly defined, and must serve a useful clinical purpose.
3.3 Early use of the term 'brain attack'
Hachinski (see Figure 3.1) first coined the term 'brain attack' in 1974. At his
inaugural lecture as a faculty member of the University of Toronto, he concluded
with the statement [quoted in Starkman & Saver (1997)]:
"the day will come when brain attacks will be treated with the
same alacrity as heart attacks"
The first printed reference to brain attack appeared in al986 monograph that
examined the relationship between heart disease and brain disease (particularly
stroke) (Furlan, 1987). In a chapter titled 'Are heart attacks really brain attacks?'
(Levine et al., 1987), the authors postulated that sudden cardiac death (and other
arrhythmias) could be induced by cerebral reactions to psychosocial stressors or
acute intracranial events such as a stroke. Activation of a neural neural pathway
arising in the orbital frontal cortex and projecting to brainstem cardioregulatory
centres was believed to cause sudden cardiac death.
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Trained in Toronto and Montreal, Canada.
Pioneered early acute stroke units, and is credited
with coining the terms multi-infarct dementia,
leukoaraiosis and brain attack. Currently Editor-in-
Chiefo/Stroke. Image courtesy ofStroke.
Figure 3.1 Vladimir Hachinski
The term remained dormant until 1991, when once again Hachinski used it
publicly at a press conference to announce the results of the North American
Symptomatic Carotid Endarterectomy Trial. This was reported in the San Francisco
Chronicle (Petit, 1991), and thereafter widespread usage followed (Camarata et al.,
1994; Hachinski, 1996; Starkman & Saver, 1997; Ellis & Matthews, 1999). The US
National Stroke Association began to champion the term in the early 1990s "because
it characterises the medical condition and communicates the actual event more
clearly to the public than does the word 'stroke'" [NSA website http://www.stroke.org/],
3.4 How is brain attack defined?
Brain attack, as a substitute for the word stroke, has become popular in the
lay press and on many patient information websites (and even hospital websites that
advertise their own 'brain attack teams'). Despite this public attention, there has
been little discussion of the term in the medical literature. No formal definition has
ever been given. There are four general ways in which 'brain attack' has been used:
(1) As a synonym for the word stroke. Some authors suggest that brain attack
encompasses all conditions previously defined by the World Health Organisation
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(infarction, primary intracerebral haemorrhage, and subarachnoid haemorrhage)
(Heros et al., 1997), whilst others, including patient support groups such as the NSA,
have excluded subarachnoid haemorrhage (National Stroke Association, 1994; Ellis
& Matthews, 1999; Wehrmacher et al., 2000). The term is meant to raise awareness
of the urgency of the situation for patients, and also to counter the nihilism of
paramedic and hospital staff towards stroke that is still prevalent (Wehrmacher et al.,
2000).
(2) To refer to brain ischaemia only (Starkman & Saver, 1997; Selman et al.,
1997). This is a direct analogy to myocardial ischaemia - the same therapy
(thrombolysis) is most effictive if given as soon as possible after symptom onset.
Although advocating the use of brain attack, Ellis & Matthews (1999) are highly
critical of analogies with myocardial infarction:
"Those interested in the management of 'stroke' were lulled
into intellectual complacency by an uncritical acceptance of
analogies with myocardial infarction. Cerebral infarction is a
much more complex process and requires a more
sophisticated approach; a preliminary and necessary step is
the discarding of simplistic terminology (i.e. stroke)"
(3) To refer to a US campaign to recognise stroke as a more urgent condition
(Heros et al., 1997). A group of professional, voluntary and governmental entities
'dedicated to reducing the occurrence, disabilities and death associated with stroke'
called the 'Brain Attack Coalition' [http://www.stroke-site.org/] aim to increase public
knowledge of the early symptoms of stroke. Along with the term brain attack, the
Brain Attack Coalition has also introduced 'the three Rs of stroke': Reduce the risk,
Recognize the symptoms, and Respond to the symptoms by calling an ambulance
[NSA website, http://www.stroke.org/].
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(4) As a more specific term to describe the patient who presents with
symptoms (or signs) of focal cerebral dysfunction within 24 hours of onset. Rather
than a definitive diagnosis, brain attack is a description of a clinical state that awaits
further clarification (Ellis & Matthews, 1999). For Bamford (2001), the term
highlights the fact that there is a differential diagnosis for the patient's presenting
complaint.
In all uses of the term, the need for rapid presentation and assessment is
implicit. A brain attack is an emergency, just like a heart attack. Unfortunately, the
term suffers from a lack of a clear definition. I favour the fourth use of the term: it
serves a useful clinical purpose (describing the patient who cannot presently be
classified), highlights the instability of the clinical situation, and alerts the physician
to the possibility of masquerading conditions, whilst also embracing the public
educational aspects. Brain attack does not pretend to be a diagnosis, which in the
hyper-acute situation is an advantage. I see the term as a description, to be applied
for a short time until a definitive diagnosis is reached.
3.5 Advantages of using the term 'brain attack'
It should be noted that the following sections refer to potential advantages, as
no studies have actually assessed the effects of this change in terminology.
3.5.1 Improved public awareness
Stroke is the poor cousin of myocardial infarction. In contrast to heart attack
victims, stroke patients do not perceive their symptoms as serious or requiring
immediate attention, and often arrive at hospital late (Williams et al., 1997). Just
half of the general public can identify one of five warning signs of stroke (Pancioli et
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al., 1998), whilst 90% can name at least one major sign of myocardial infarction
(Heros et al., 1997). Only 29% of the general public - and 50% of stroke patients -
know that a stroke is due to an injury of the brain (Wellwood et al., 1994; Heros et
al., 1997; Kothari et al., 1997). 'Brain attack' states simply that the problem affects
the brain, is sudden and serious, and is a medical emergency (National Stroke
Association, 1994).
3.5.2 Counter medical nihilism
There is still widespread nihilism amongst paramedical and medical staff
(Heros et al., 1997). Stroke is considered a low priority in emergency transport
system protocols and emergency department triage (Heros et al., 1997). The medical
assessment of patients with stroke can be painfully slow (Johnston et al., 1999). In
the UK, most patients with stroke first contact their general practitioner, but the
primary reason general practitioners refer patients to hospital is for nursing care,
rather than for treatment (Ebrahim & Harwood, 1999a). 'Brain attack' is devoid of
the nihilistic connotations of 'stroke', emphasises that this is a treatable condition,
and may help to promote a change in physician attitude (Starkman & Saver, 1997).
3.5.3 Benefits beyond thrombolysis
The main purpose of brain attack has been to increase the number of patients
who might receive thrombolysis. However, an aggressive approach to the
assessment of all patients is likely to be beneficial (Hachinski, 1996). All patients
can benefit from stroke unit care (Stroke Unit Trialists' Collaboration, 2001). Blood
pressure needs to be maintained, hyperglycaemia controlled, and hyperthermia
treated (Hachinski, 1996). Although trials of neuroprotectants have been
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disappointing to date, there may be a role for combined treatment with thrombolysis
(Grotta, 1999). Other promising treatments include hypothermia, haemodilution,
emergency carotid endarterectomy, middle cerebral artery embolectomy or
hemicraniectomy (Heros et al., 1997). Primary intracerebral haemorrhage may
benefit from early clot removal (Heros et al., 1997). Where evidence is currently
lacking for new treatments, trials may become feasible if large numbers of patients
can be randomised within minutes or hours of symptom onset. Prompt intervention
holds the best hope for benefit (Hachinski, 1996).
3.5.4 The risks of using brain attack
There may be potential risks of using brain attack. Patients with stroke
mimics (e.g. seizure, migrainous aura) could be drawn into fast-track systems and
exposed to the risks of acute treatment, if they are diagnosed as brain attack. It is
important that brain attack is seen as an interim label rather than a definitive
diagnosis.
3.6 Summary
• I propose that 'brain attack' is a useful description of a clinical state in the
early stages of suspected cerebrovascular disease
• There has not been a clear definition of brain attack the term. Its use has
primarily been to champion a public (and professional) education
campaign in the United States
• There are advantages for stroke patients from the change in attitude that
using this term would engender
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Chapter 4 : A systematic revi ew of the accuracy of the
clinical diagnosis of stroke
4.1 Introduction
The clinical assessment is the key process that determines whether the patient
with brain attack will receive treatment. In the past, when little was done acutely, an
accurate clinical diagnosis within the first few hours was not so important.
Thrombolysis has changed that. Yet, as noted by Hachinski (1996), clinical
assessment of the patient can be difficult:
"In contrast to myocardial infarction, which manifests with
pain or a limited repertoire of symptoms and signs, stroke can
present with bewildering variety, as can its mimics. Inexpert
diagnosticians could unintentionally subject some of their
patients to the serious risk of thrombolysis without any hope
of benefit."
This review is written from the perspective of a hospital-based stroke
physician. Typically, a referral to the stroke team or unit is made after a non-
specialist doctor (such as an emergency physician or general practitioner, without
access to brain imaging) has assessed the patient. This chapter will examine the
accuracy of the bedside diagnosis of stroke (using the final diagnosis, determined by
the stroke physician after observation and completion of investigations, as the gold
standard). The causes and frequencies of conditions that mimic stroke will be




This review sought to systematically search the literature for data to address
the following aims:
(1) To determine the accuracy of the initial bedside diagnosis of stroke versus
non-stroke by non-specialist medical practitioners blind to results of
investigations
(2) To determine if the misdiagnosis rate was greater in the hyperacute phase
of brain attack (within six hours of symptom onset), compared to later
stages
(3) To describe the conditions that mimic stroke, and their frequencies
(4) To determine the proportion of mimics that were positively identified by
brain imaging
4.3 Methods
4.3.1 Selection of studies
A systematic review of the literature was undertaken to identify appropriate
observational studies of the accuracy of the clinical diagnosis of stroke. Included
were any studies in which an initial, bedside diagnosis of stroke was made by a
medical practitioner with no specific training in neurology or stroke, and later
validated by a stroke expert. I used the Cochrane Database of Systematic Reviews
methodology to perform an electronic search (Cochrane Stroke Group, 2001).
Although this methodology was developed for reviews of randomised controlled
treatment trials, the same principles apply to reviews of observational studies (Keir
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and Wardlaw, 2000). I used a broad search strategy that consisted of the Cochrane
search strategy for stroke, combined with a strategy to detect diagnostic studies and
errors/false diagnoses, expanded to maximise the number of hits (see Appendix 1).
Reference lists of studies obtained were hand-searched, as were abstract books from
recent major stroke meetings.
I limited the search to English language studies in Medline, as I had
insufficient time to search other databases (e.g. Embase) or translate non-English
articles. The search was performed from 1980 to July 2001, to obtain studies where
CT scanning had been performed routinely (this was critical for the final diagnosis,
see below). Case reports, and studies published in abstract form only were excluded.
4.3.2 Assessment of study quality
An important component of a systematic review is to assess the quality of the
studies identified (Deeks, 2001). It has been shown that studies with methodological
shortcomings overestimate a test's diagnostic accuracy (Lijmer et al., 1999). The
initial clinical assessment of a patient with possible stroke by a non-specialist may be
viewed as a diagnostic test. However, the stated purpose of the majority of the
studies identified was not to assess the accuracy of the clinical assessment. It would
be unreasonable to rigidly apply the criteria suggested by Jaeschke and co-workers
(1994a; 1994b) to the studies of this review.
I therefore developed my own measures of study quality (see Table 4.1),
which were based on several sources (Sackett et al., 1985a; Jaeschke et al., 1994a;
Jaeschke et al., 1994b; Holloway & Feasby, 1999; Lijmer et al., 1999; Deeks, 2001).
Ideally, the study was prospective. The patient sample should have been consecutive
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and selected without restrictive exclusion criteria (it is essential that the sample in the
study closely resemble clinical practice (Jaeschke et al., 1994a; Holloway & Feasby,
1999)). To ensure that comparisons were uniform, the initial clinical assessment
should have been made prior to investigations (particularly brain imaging). The gold
standard diagnosis was the final diagnosis, ideally based on both independent expert
clinical assessment and all investigation results (rather than just brain imaging, which
may be normal). The final diagnosis should have been made after a reasonable
period of time had elapsed, although it was difficult to define a 'reasonable' period of
time (in some situations only a day may be required, in others, one or more weeks).
Finally, a reasonable number (arbitrarily set at 50%) of the patient sample should
have had either a brain scan or autopsy. It was not necessary for all patients to
undergo brain scanning or autopsy, as many conditions that mimic stroke will not be
discovered by a brain scan.
I used these quality measures to comment on the probable reliability of this
review, rather than to exclude individual studies.
4.3.3 Data extraction and analysis
I extracted relevant data from the studies. The measure of accuracy used in
this review was determined by the fact that in most studies, only patients with an
initial diagnosis of stroke were likely to be further evaluated. This allowed the
determination of positive predictive value (PPV, = true positives/[true positives +
false positives]) but not other accuracy parameters such as specificity or sensitivity.
Only those with a final diagnosis of stroke were classed as true positives, not patients
with a final diagnosis of transient ischaemic attack or possible stroke. Details of
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stroke mimics were tabulated. Frequencies, and their 95% confidence intervals (95%
CI), were calculated. Analyses were performed with Microsoft Excel (version 97
(6)
SR-2, Microsoft Corporation 1997) and Confidence Interval Analysis software
(version 2.0.0, ®Trevor Bryant 2000).
4.4 Results
4.4.1 Study selection
The systematic search strategy identified 38 potentially relevant studies, from
a total of 4,982 titles. 13 studies were excluded. Nine of these studies were
concerned with paramedic diagnosis of stroke (Bratina et al., 1995; Kothari et al.,
1995a; Kidwell et al., 1998; Zweifler et al., 1998a; Smith et al., 1998a; Harbison et
al., 1999; Smith et al., 1999; Kidwell et al., 2000; Harbison et al., 2001). Two early
studies (Weisberg & Nice, 1977; Britton et al., 1984) were excluded as their primary
aim was an evaluation of the usefulness of CT scanning, and the patient sample was
therefore biased. An epidemiological study (Lauria et al., 1995) was excluded as
notifications to the research team were from neurologists or other consultant
physicians once the patient had been hospitalised. One study (Mielke and Hennerici,
2001) was excluded as it was presented in abstract form only - there were
insufficient details provided to draw conclusions.
The 25 studies selected (Table 4.2) were divided into three categories,
according to the source and type of referral. In the first two categories, patients were
initially assessed by an emergency physician. Patients were then admitted directly to
a stroke unit or (in the United States) referred to a stroke team in nine studies (von
Arbin et al., 1979; von Arbin et al., 1981; Norris and Hachinski, 1982; Chambers et
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al., 1983b; Morris et al., 1993b; Weir et al., 1996b; The members of the Lille Stroke
Program, 1997c; Zweifler et al., 1997e; Zweifler et al., 1998c). In eight studies,
patients with suspected stroke were admitted to either general medical, geriatric or
neurology wards, and a study investigator followed up on these admissions (Allen,
1983a; O'Brien et al., 1987b; Lindley, 1993a; Kothari et al., 1995a; Libman et al.,
1995b; Besson et al., 1996a; Ferro et al., 1998a; Allder et al., 1999a).
The remaining nine studies were community-based. The diagnosis of
suspected stroke was made by the general practitioner, who then referred the patient
to a study investigator or neurovascular clinic (Sandercock et al., 1985a; Ricci et al.,
1991; Anderson et al., 1993c; Ellekjaer et al., 1997a; Horn et al., 1997b; Martin et
al., 1997d; Ferro et al., 1998a; Kolominsky-Rabas et al., 1998b; Vemmos et al.,
1999b). One study (Ferro et al., 1998a) accepted referrals from both general
practitioners and emergency room physicians, and presented results from both
settings, thus has been treated in this review as two separate studies.
4.4.2 Study quality
Only two studies (Anderson et al., 1993c; Vemmos et al., 1999b) met all
quality criteria for this review (see Table 4.1). In most studies the patient sample
was consecutive (although the community-based part of Ferro et al's study (1998a)
received 172 notifications from general practitioners, but only 52 patients were
actually referred to be seen by the study neurologists).
Eligibility criteria
Many studies had restrictive eligibility criteria: Ricci et al (1991) included
only patients with a definite first ever in a lifetime stroke; Allen (1983a) excluded
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patients older than 76 years; O'Brien et al (1987b) required admissions to have had a
stable deficit for 24 hours; Besson et al (1996a) required a stable deficit for 72 hours;
Horn et al (1997b) excluded patients with reduced consciousness, prior stroke,
headache or absence of hemiparesis; Allder et al (1999a) selected only anterior
circulation ischaemia; Kolominsky-Rabas et al (1998b) included patients only after
several neurological examinations, and Morris et al's (1993b) consecutive series
excluded 'those with known non-vascular conditions'.
Timing of brain imaging
The initial (or bedside) diagnosis was made before imaging was performed in
most UK studies (although this was not clearly stated in one report - probably
because of space restrictions (Weir et al., 1996b)). In some settings, emergency
physicians had immediate access to brain imaging (Kothari et al., 1995a; Ferro et al.,
1998a), and in others patients were scanned immediately on admission (The
members of the Lille Stroke Program, 1997c; Kolominsky-Rabas et al., 1998b).
Definitions of the diagnosis
14/25 studies provided definitions for the diagnosis of stroke (which was
usually the World Health Organisation definition (Hatano, 1976)). Few studies
provided criteria for deciding that a patient's condition was caused by a non-vascular
condition. Four studies presented figures for a final diagnosis of 'possible stroke'.
This was defined differently - in one study, patients who lacked laboratory evidence
of infarct or haemorrhage were classed as possible stroke (von Arbin et al., 1981),
and another study provided a list of conditions that were considered possible stroke
(e.g. migraine aura). Two studies provided no definition for possible stroke.
43
Many studies did not provide adequate details of how the final (or gold
standard) diagnosis was reached. One study based the final diagnosis purely on the
CT (Besson et al., 1996a), and a further study was heavily influenced by results of
advanced MR imaging (i.e. infarct only diagnosed if lesion seen on diffusion-
weighted imaging) (Allder et al., 1999a). Two studies used a single neurologist's
opinion for the final diagnosis (Zweifler et al., 1997e; Zweifler et al., 1998c), and
one study determined the diagnosis by retrospective case notes review (Kothari et al.,
1995a).
Were any strokes missed?
The community-based epidemiological studies went to great lengths to ensure
that case ascertainment was complete. Only three hospital-based studies examined
the issue of patients with true stroke whose initial bedside diagnosis was non-stroke.
In two, the proportion of false negative diagnoses was around 1% (von Arbin et al.,
1980; Kothari et al., 1995a). However, Zweifler et al's (1998c) study of referrals to
a mobile stroke team, set up to provide thrombolysis, found that 60 patients with
stroke were not notified to the code stroke team (there were 185 notifications).
4.4.3 Accuracy of the bedside clinical diagnosis
There was wide variation in the accuracy of the bedside clinical diagnosis of
stroke (figure 4.1). Accuracy was higher for stroke unit admissions or referrals to a
stroke team (PPV 88.8%, 95% CI 87.9 - 89.7), and general or neurology ward
admissions (PPV 88.9%, 95% CI 87.5 - 90.4), than for community-based studies
(PPV 72.4%, 95% CI 71.2 - 73.7). Mean positive predictive value for all 25 studies
was 81.9% (95% CI 81.1-82.6%).
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Stroke unit admission/stroke team referral
Von Arbin et al, 1980
Von Arbin et al, 1981
Norris & Hachinski, 1982
Chambers et al, 1983
Morris et al, 1993
Weir et al, 1996
Lille Stroke Program, 1997
Zweifler et al, 1997




O'Brien et al, 1987
Lindley et al, 1993
Kothari et al, 1995
Libman et al, 1995
Besson et al, 1996
Ferro et al, 1998




Sandercock et al, 1985
Ricci et al, 1991
Anderson et al, 1994
Martin et al, 1997
Horn et al, 1997
Ellekjaer et al, 1997
Ferro et al, 1998
Kolominsky-Rabas et al, 1998
Vemmos et al, 1999
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Accuracy of clinical diagnosis
Figure 4.1 Accuracy ofthe initial diagnosis ofstroke
Dotted vertical line is the mean positive predictive valuefor all studies (80.9%). Each study
is represented by a square box, with 95% confidence intervals provided. Size of the box is
proportional to the number ofpatients within each study. Subtotals (diamonds) are given for
each of the three settings.
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Seven studies provided figures for transient ischaemic attacks, which
accounted for between 10% (Allder et al., 1999a) and 18% (Kolominsky-Rabas et
al., 1998b) of the total in these studies.
Studies that reported the highest accuracy of referrals to a stroke unit (Morris
et al., 1993b; Weir et al., 1996b) accepted patients 'in whom known non-vascular
conditions had been excluded'. Although the patient sample was consecutive, it is
not clear how much selection had occurred before referral to the stroke unit.
Similarly, accuracy for general/neurology ward admissions was highest in those
studies with restrictive entry criteria (Allen, 1983a; O'Brien et al., 1987b; Besson et
al., 1996a). Kothari et al's study (1995a), often cited as evidence that the emergency
physician's diagnosis of stroke is highly accurate, reported that the initial diagnosis
was correct in 322/341 admissions (94%). However, patients received a CT scan in
the emergency department, a phone consultation with a neurologist could be
obtained, and the emergency physician had to present the case to the emergency
department faculty before the decision was made to admit the patient (Kothari,
1996).
Community studies had lower accuracy than hospital-based studies. In the
studies of Ellekjaer et al (1997a) and Anderson et al (1993c), general practitioners
were encouraged to refer as many patients as possible, even if the symptoms were
dubious. Conversely, Ricci et al (1991), found only four mimics amongst 379
patients, an accuracy of 99%. This study registered only those with first-ever-in-a-
lifetime-stroke, and it was unclear how many patients were screened (and thus
excluded) to obtain the final 379 registered patients.
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4.4.4 Stroke mimics
The final diagnosis was definite stroke in 9,113 / 11,259 patients in total.
Thus 2,146 patients had a final diagnosis other than stroke: there were 1,265 mimics,
and the remainder were TIAs, possible strokes, or patients excluded from the study
for various reasons. Seven of 25 studies (28%) provided no details of stroke mimics
and 12 studies provided an incomplete list of mimics.
The frequencies (and their 95% confidence intervals) of stroke mimics are
presented in Figure 4.2. The five major causes were: seizures (14.2% of mimics),
toxic/metabolic disturbances (11.2%), sequelae of prior stroke (11.2%), space
occupying lesions (11.2%), and syncope/presyncope (10.4%). The miscellaneous
category accounted for 16% of all mimics (see Table 4.3). These included diverse
conditions such as cardiac disorders, spinal cord lesions, multiple sclerosis, and rare
neurological problems.
Clinical factors that increased the likelihood of an incorrect initial diagnosis
included: inability to obtain a good history (Allen, 1983a; Sandercock et al., 1985a;
Ferro et al., 1998a), absence of vascular risk factors (Ferro et al., 1998a), reduced
level of consciousness (Libman et al., 1995b) and younger age of patient (Kothari et
al., 1995a). Physicians with better clinical skills made fewer errors than junior
physicians (Norris and Hachinski, 1982).
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4.4.5 The initial diagnosis in studies where a brain scan was available
In four studies, the initial clinical diagnosis was made after a CT brain scan
had been performed (Kothari et al., 1995a; The members of the Lille Stroke
Program, 1997c; Ferro et al., 1998a; Kolominsky-Rabas et al., 1998b). The mean
PPV for the studies in which the initial diagnosis was made after scanning was
86.4% (95% CI 84.9-87.7%). For the studies where the clinical diagnosis was made
before the CT scan, the mean PPV was 79.5% (95% CI 78.7-80.3%). The difference
in means was significant (6.9% difference, 95% CI 5.2-8.4%).
4.4.6 'Hyperacute stroke'
Only 729/11,053 (6.6%) patients were recruited in the hyperacute phase of
stroke (symptom onset less than six hours). Horn et al (1997b) recruited all 229
patients within six hours of onset to a community-based study. Despite rigid
selection criteria, general practitioners achieved only 69% accuracy (but 96% if
possible strokes were included). Allder et al's (1999a) hospital-based study recruited
70 patients with symptoms of anterior circulation ischaemia within six hours of
onset. 57 / 70 (81%) had a final diagnosis of stroke. Five other studies (Morris et
al., 1993b; Libman et al., 1995b; Zweifler et al., 1997e; Ferro et al., 1998a; Zweifler
et al., 1998c) reported the proportion of hyperacute stroke patients seen (which
ranged from 25% to 57%), but did not provide figures for the accuracy of the initial
diagnosis in those seen early. Ferro et al (1998a) found that time was not a
significant influence on the accuracy of the initial assessment by emergency
physicians, but numbers were small (46 seen within six hours/185).
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4.5 Discussion
There is consistent evidence that large numbers of patients arrive at hospital
within the first few hours of symptom onset (Harper et al., 1992; Barsan et al., 1994;
Johnston et al., 1999; Lacy et al., 2001). Despite this, few patients receive time-
critical treatments such as thrombolysis. The major barrier appears to be the long
delay for the patient to be assessed in the emergency department (Evenson et al.,
2001; Barber et al., 2001a).
A confident clinical diagnosis allows the clinician to rapidly arrange further
investigations and treatment. The present delays are probably due to the uncertainty
of junior doctors (the first contact point in emergency rooms) who are not
comfortable dealing with acute neurological patients (Johnston et al., 1999). For the
experienced stroke clinician the diagnosis may seem easy, but is it so for the non-
specialist doctor seeing a patient within minutes or hours of symptom onset?
An earlier review of the clinical assessment of stroke (Goldstein & Matchar,
1994) identified only two studies of the accuracy of the clinical diagnosis. The
present review identified twenty-five. The accuracy of the bedside diagnosis of
stroke by a non-specialist varied between 51% and 99%, depending on the source of
referral, the presence of restrictive entry criteria, and the availability (to the referring
doctor) of specialised tests. It is important to note that the community-based studies
attempted to capture all strokes, thus GPs were encouraged to refer all possible
strokes. These studies may have overestimated the number of mimics, but they do
provide useful information (as an 'upper limit' of what the hospital-based doctor
might expect). Overall, almost 20% of patients referred to a stroke physician were
incorrectly diagnosed.
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Methodological limitations of the included studies
I aimed to include many studies to provide a broad picture of what stroke
clinicians can expect to be referred. There was considerable variation in the quality
of the studies - few met all of the criteria developed for this review. In accordance
with others (Lijmer et al., 1999), we observed that studies with outlying results often
contained sources of bias. Identifying these biases - patient exclusions, scan before
the bedside diagnosis, etc. - allows a better understanding of the data.
I was surprised that only four studies included possible stroke as a final
diagnosis. In one, 28% of all referrals were classed as possible stroke (Horn et al.,
2001). It is a fact of clinical life that there is uncertainty: as Sackett and colleagues
state (1985b), "certainty is a delusion". How were all the other studies able to be so
precise (particularly when few described how they determined what was a non-
stroke)?
4.5.1 Limitations of the present review
The search strategy of the present review was limited to Medline and English
language articles, which may have introduced bias. Although a recent study found
that systematic reviews restricted to one language did not yield biased conclusions
(Moher et al., 2000), ideally all studies should be included in a systematic review. It
is said that Medline lacks comprehensive references in the fields of psychology,
medical sociology and non-clinical pharmacology (Greenhalgh, 1997). Other
databases that can be searched include Embase, which focuses on drugs and
pharmacology, and CINAHL, which covers nursing and allied health fields. Embase
is more time consuming and less accessible than Medline (Woods & Trewheellar,
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1998). However, using multiple databases identifies more studies, and is ideal for a
comprehensive review (Woods & Trewheellar, 1998; Topfer et al., 1999; Minozzi et
al., 2000).
The measure of accuracy used in this review was the positive predictive value
(PPV). PPV depends on the prevalence of the disease being studied, so is not an
ideal measure of test performance (Sackett et al., 1985b; Ebrahim & Harwood,
1999a). Unfortunately, insufficient data were provided to determine sensitivity,
specificity and likelihood ratios for the individual studies. Most studies did not
follow patients admitted with a non-stroke diagnosis (i.e. true and false negatives).
However, the aim of this review was to identify studies in a variety of settings (thus
different prevalence of stroke mimics) to provide a robust overall estimate of the
nature and proportion of mimics that a stroke physician will encounter.
4.5.2 Implications of the review
Stroke physicians should encourage referrals
It is possible to increase the accuracy of referrals by stipulating rigid criteria
(such as a definite hemiparesis). However, this would come at the expense of
missing patients with true stroke, as was observed (Zweifler et al., 1998c). To
ensure that patients might receive the benefit of acute care, stroke physicians should
actively encourage the referral of all patients with possible stroke (no matter how
vague the symptoms). We must be prepared for a high rate of diagnostic error.
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Improved clinical skills
In addition, stroke physicians need to provide better training to junior doctors.
Many stroke mimics (e.g. sudden onset multiple sclerosis or encephalitis) are
neurological disorders that are rarely seen by a non-specialist. As was shown by
Norris & Hachinski (1982), greater experience and clinical skill resulted in better
accuracy. However, only one study (Libman et al., 1995b) examined the clinical
clues that suggested a mimic.
An alternative approach would be to involve the stroke specialist at an earlier
stage (Hachinski, 1996; Adams, Jr., 1998). Recent evidence suggests that US
hospitals that have a stroke neurologist are more likely to treat acute stroke patients
with thrombolysis (Reed et al., 2001). However, this is impractical for the many
smaller centres that do not have the resources to provide a mobile stroke team.
Improved methods of clinical diagnosis are still required.
The CT brain scan is normal in most mimics
The present review found that studies with access to immediate brain
scanning were significantly more accurate that those in which the scan was
performed later. There were other sources of bias in these studies that may also have
influenced accuracy, such as early assessment by a stroke specialist. It may be
optimistic to believe that improved imaging - though desirable - is the answer. In
the 11.2% with a space-occupying lesion, and the few with subarachnoid
haemorrhage, and possibly dementia, the scan may be helpful. The scan may also be
misleading (e.g. if the patient has suffered a previous stroke).
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More research is needed
Patients with symptoms that eventually resolve (i.e. transient ischaemic
attacks) are a particular problem in the clinical assessment of hyperacute stroke.
This review suggests that up to 18% of patients turn out to have had a TIA. Ideally,
the clinician could identify such patients before commencing treatment. In addition,
few studies have examined patients in the hyperacute phase of stroke. One might
anticipate that the diagnosis in the first few hours would be difficult, but the available
data from the present review cannot be extrapolated to routine clinical practice.
More clinical research is required. Studies should try to avoid the biases
identified in this report - in particular, the patient sample should reflect routine
practice, and the definitions and methods of reaching the final diagnosis should be
specified. There is a need for further research into the features that suggest a mimic
is likely, and the features of hyperacute stroke that are most reliable.
4.6 Summary
• Accuracy of the non-specialist clinical diagnosis of stroke is around 81%,
but may be as low as 51% or as high as 99% depending on the setting,
selection criteria, and investigations available
• Few of the studies identified aimed to address the issue of accuracy, and
thus contained major biases
• There are a large number of stroke mimics. There is a need for better
training of junior doctors in the clinical skills required to diagnose brain
attack
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• Brain imaging, though helpful, should not be relied on excessively as
imaging will be normal for most stroke mimics
• Further methodologically sound clinical studies are required
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Table 4.1: Quality measures ofincluded studies
Number clearly
Quality measure specified (n=26)
■ Prospective study design 22 (85%)
■ Consecutive patient sample 25 (96%)
■ Patient sample lacked restrictive exclusions 18 (69%)
■ Initial clinical assessment was made before investigations 20 (77%)
■ Final (or gold standard) diagnosis based on both an independent
expert's clinical assessment and all investigation results
17 (65%)
■ Final diagnosis made after a reasonable period of time had elapsed 15 (58%)
■ A reasonable number of patients had a brain scan or autopsy 16 (62%)
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Table 4.3: The 'miscellaneous' causes ofstroke mimics
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Vertebral artery dissection 1
Friedreich's ataxia 1
Multiple systems atrophy 1
Cerebral sarcoidosis 1
Normal pressure hydrocephalus 1
Sleep apnoea 1
Perforated duodenal ulcer 1
Weakness of unknown cause 1
Arm stiffness of unknown cause 1
Arm pain of unknown cause 1
Sudden death 13
No details provided 76
Total 193
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Chapter 5 : The clinical features of hyperacute stroke - an
analysis of the International Stroke Trial
5.1 Introduction
Stroke is a medical emergency, but the diagnosis of hyperacute ischaemic
stroke can be difficult for the inexperienced doctor. Better understanding of the
clinical features common to patients presenting very early is required, as there is no
good reason to assume that patients presenting early are the same as those presenting
later.
I used data from the International Stroke Trial (1ST) to explore the clinical
features of patients with hyperacute stroke, compared to patients presenting later.
The 1ST was used for this analysis as it enrolled large numbers of patients assessed
within the first few hours, as well as those who reached hospital at later times (up to
48 hours after onset), and in different countries where different health resources
might influence time to presentation.
5.2 Aims
The aim of this analysis was to assess the frequency of different clinical
features among patients recruited into the 1ST at different times after stroke onset.
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5.3 Methods
Methodology of the 1ST
The 1ST was the largest available dataset that contained details of patients
with acute, presumed ischaemic stroke assessed up to 48 hours after symptom onset.
The trial sought to evaluate the efficacy of antithrombotic therapy, started as soon as
possible after onset of ischaemic stroke. Full details of the protocol have been
published elsewhere (International Stroke Trial Pilot Study Collaborative Group,
1996; International Stroke Trial Collaborative Group, 1997). Data collected at
assessment included: age, gender, time since symptom onset, whether symptoms
were first noted on waking from sleep, conscious level, systolic blood pressure,
presence of atrial fibrillation, seven key neurological signs, and stroke subtype (after
Bamford et al (1991)). I applied a validated model (Slattery & Sandercock, 1996)
which used the neurological deficit at assessment to calculate a baseline stroke
severity score. The greater the number of deficits (aphasia, hemiparesis etc), the
higher the baseline severity score. Outcome was measured by (1) the proportion of
patients dead at 14 days (early deaths were notified to the trial office), and (2) the
proportion dead or dependent in daily activities at six months (functional outcome
was assessed by postal questionnaire (International Stroke Trial Pilot Study
Collaborative Group, 1996)).
Computed tomography (CT) or Magnetic resonance (MR) brain imaging was
to be performed where possible before randomisation (and was mandatory for
patients in coma). If brain imaging were not immediately available, and the clinician
felt that haemorrhagic stroke was unlikely, the patient could be randomised in the
study (with imaging to be performed as soon as possible after enrolment). This was
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allowed on the basis that the benefit of antithrombotic therapy might be time-
dependent and hence early randomisation would offer scope for greater benefit.
The final diagnosis of the event that led to the patient's inclusion in the trial
was based on all of the available clinical, radiological (and autopsy) data. As
anticipated, a small proportion of patients (5%) proved to have a non-stroke
condition or intracranial haemorrhage as the final diagnosis. The primary analysis of
the 1ST was an intention-to-treat analysis, so these patients were retained in the
database. In this report, I have combined data from the treatment and control
patients, and the findings therefore do not describe variation between the groups in
the efficacy of aspirin or heparin
Methodology of the present analysis
I compared the baseline clinical features, stroke subtype classification, stroke
severity, final diagnosis, early deaths and six-month outcome of patients assessed
within three hours, four to six hours and seven to 48 hours. I plotted median severity
(and interquartile range) of patients assessed and randomised into the 1ST at three
hourly intervals for the first 12 hours, and six hourly thereafter, to explore the
relationship between severity and time to randomisation (as stroke severity was not
normally distributed). I analysed the relationship between severity and time by linear
regression (using time from onset to assessment as a continuous variable).
Comparisons between countries
I hypothesised that there would be no major differences in the features of
patients assessed early between countries, despite differences in healthcare systems.
I examined measures of severity for each country that randomised over 500 patients
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to give a reasonable sample. By excluding countries that recruited fewer patients, I
wished to avoid the extreme variability that can occur with small sample sizes (Weir
et al., 2001).
Statistical analyses
Data analyses were performed using Microsoft Excel (version 97 SR-2,
®Microsoft Corporation 1997) and SPSS for Windows (version 10.0.5, ®SPSS Inc.
1999).
5.4 Results
5.4.1 Baseline characteristics and outcome
The 1ST enrolled 19,435 patients in 36 countries, of whom 3,165 (19%) were
assessed and treated within six hours, and 843 (4.3%) within three hours. Almost all
of the clinical features assessed among patients randomised within three hours, and
between four and six hours, were significantly different to those randomised between
seven and 48 hours (y test for trend) (see Table 5.1). The most important
differences were that patients assessed within three hours were more likely to have
cortical signs, reduced consciousness and total anterior circulation syndrome (TACS)
than patients assessed later.
Patients assessed early had worse baseline stroke severity. Figure 5.1 shows
a trend for severity to decrease as time to assessment increased, particularly over the
first 12 hours. When analysed by linear regression, the trend was significant but the
strength of the association was weak (r2=0.015, p<0.0001).
66
n=843 n=2322 n=1933 n=2181 n=2243 n=3325 n=2538 n=1883 n=1054 n=1113
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Time (hrs) from symptom onset to assessment
Figure 5.1 Baseline stroke severity score in the 1ST, subdivided by time to randomisation.
Severity score (expressed as the % likelihood of a poor outcome) was determined by the
neurological deficit at baseline. The boxes represent the inter-quartile range and the thick
black line the median severity scoreforpatients within each time interval.
5.4.2 Final diagnosis and outcome
Patients were randomised into the 1ST if the clinical diagnosis were acute
ischaemic stroke. In two thirds, the clinical diagnosis had been confirmed as definite
ischaemic stroke by neuroimaging prior to randomisation. If the patient were
conscious, enrolment was permitted whilst the scan was being arranged. 403/843
(48%) of patients recruited within three hours had a CT scan before randomisation,
compared with 1,279/2,322 (55%) recruited between four and six hours, and
11,342/16,270 (70%) recruited between seven and 48 hours (p<0.0001, y2 test for
trend).
Among those not scanned until after randomisation, as expected, there were
some patients with haemorrhagic stroke (n=538). 51/440 (12%) of patients recruited
within three hours, 110/1,043 (11%) of patients recruited four to six hours, and
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377/4,928 (7.7%) of patients recruited after six hours (in all cases before the CT
scan) had an intracerebral haemorrhage, (p=0.0004, x test for trend) (Table 5.2).
More patients assessed within three hours died within 14 days of stroke or
were either dead or dependent at six months (Table 5.2).
5.4.3 Comparisons between countries
There were nine countries that individually recruited more than 500 patients
in the 1ST. Table 5.3 shows the proportions of patients randomised within six hours,
which varied between seven and 25% of all patients recruited by each country.
Patients randomised early had worse baseline severity scores than those recruited
later in all countries; although this finding was not significant in Norway, Sweden
and Argentina (Mann-Whitney U test). These three countries recruited only a few
early patients, thus there is the possibility of type II error explaining the lack of
statistical significance. Clinical evidence of an extensive cortical infarction (TACS)
was more frequently observed in patients randomised within six hours in all
countries except Norway and Sweden (p<0.001, x2 tests).
5.5 Discussion
The 1ST enrolled 3165 patients within six hours (and 843 patients within
three hours) of onset, the largest group of prospectively recruited hyperacute stroke
patients ever reported. The data were systematically collected, came from a variety
of settings, and follow-up was 99% complete. Although there are limitations to the
1ST data, the clear finding of the present analysis is that patients with features of
severe stroke arrived at hospital and were assessed earlier. This was seen in seven of
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the nine major recruiting countries, and is therefore likely to be independent of
regional variations in healthcare provision.
Comparison with other studies
These findings in 19,435 patients confirm previous smaller single centre
(Jorgensen et al., 1996; Goldstein et al., 2001) and multicentre (Davalos et al., 1995;
Barber et al., 2001a) studies which showed that the clinical features of patients with
suspected hyperacute stroke were different to those presenting later. In addition, the
present study clarifies the results of other earlier studies, which did not measure
severity directly (Kay et al., 1992; Anderson et al., 1995; Wang et al., 1997; Smith et
al., 1998b; Lacy et al., 2001). This analysis refutes the findings of two moderate-
sized studies which found that severity was not a significant factor in early
presentation (Harper et al., 1992; Barsan et al., 1994).
5.5.1 Limitations of the present study
The limitations of the data presented here are that they were collected in a
randomised-controlled trial, rather than an epidemiological study, and were
purposefully kept brief, as there is evidence that one barrier to recruitment is
excessive data collection (Ross et al., 1999). The exact time of admission to hospital
(and other details of pre- or in-hospital delays) was not known. One of the now
standard stroke severity scales (such as the National Institute of Health Stroke Scale)
was not used in the 1ST. Therefore we approached the assessment of stroke severity
from several angles: we used a validated model to assign a baseline 'severity score'
to each patient, we looked at individual clinical variables such as coma, stroke
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subtype and cortical neurological signs, and we looked at outcome. All pointed to
the same conclusion.
Given the large sample size of the 1ST, even small differences between
groups were found to be statistically significant. For example, the linear regression
... 9
analysis of baseline severity score and time found an r value of 0.015, suggesting
that although significant, the strength of the relationship observed was small. In this
report, changes that were clinically significant have been highlighted.
5.5.2 Implications of the present study
Training
Clinicians should be aware that the features of patients who present early are
likely to be different to 'average' stroke, and that bedside diagnosis may be more
difficult. Clinical algorithms to aid early diagnosis are needed, which could be used
to educate non-specialist staff as well as stroke physicians and neurologists. Most
acute stroke patients are cared for by non-specialist staff (Mitchell et al., 1996), who
may not be familiar with the clinical features of the hyperacute syndrome.
Organisation of stroke services
In the 1ST, there was a strong tendency for patients who later turned out to
have haemorrhagic stroke to be (inadvertently) randomised earlier. Since such
patients may be 'fast-tracked' for thrombolysis (until the CT scan is performed),
hyperacute stroke services will need to be designed to cope with increased numbers
of patients with acute intracerebral haemorrhage. Care must be taken to ensure that
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these patients are not neglected in the rush to thrombolyse the ischaemic stroke
patient.
The impact of stroke severity on time to presentation is relevant to audit of
stroke service performance and observational cohort studies. Audits that assess the
performance of different acute stroke services must allow for the fact that patients
presenting earlier are likely to be more severe (otherwise, stroke units that manage a
larger proportion of early-presenting patients will appear to perform worse than units
that manage more late-presenting patients) (Weir and Dennis, 2001).
Design of clinical trials
For randomised controlled trials, these data emphasise the importance of
employing both time and stroke severity as stratification (or minimisation) variables.
For example, in the National Institute ofNeurological Disorders and Stroke (NINDS)
rt-PA Stroke Study, there was substantial imbalance in stroke severity among those
recruited between 91 and 180 minutes, which could potentially have biased the
estimate of treatment effect (Marler et al., 2000). Such imbalance will not
necessarily be corrected by standard statistical covariate adjustment techniques
(Mann, 2002).
5.6 Summary
• The 1ST data have significant limitations that permit only cautious
conclusions to be drawn
• This report highlights the differences in patients assessed within hours of
onset, compared to patients assessed later. The finding of greater stroke
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severity in those assessed early was consistent across several different
clinical measures, and in patients enrolled throughout the world.
• The findings have important implications for the provision of stroke
services, training of staff, and the design and interpretation of
observational studies and randomised-controlled trials.
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Table 5.3: Measures of severity in patients recruited early among nine countries that
contributed over 500patients to the 1ST
Proportion of patients Median severity scoref
randomised 0-6 hours among patients randomised:
Country n/N (%) 0-6hrs 7-48hrs
Argentina 49/545 (9.0) 65 56
Australia 102/597 (17) 76 58
Italy 739/3437 (22) 67 59
Netherlands 176/728 (24) 66 57
Norway 52/526 (10) 68 65
Poland 157/759 (21) 73 61
Sweden 46/636 (7.2) 68 60
Switzerland 407/1631 (25) 77 72
UK 888/6257 (14) 78 68
Total 2616/15116 (17) 72 64
f Severity score predicted the likelihood of a poor outcome (death or dependence) for each
patient based on initial neurological deficits (expressed as percentage likelihood of a poor
outcome). The difference between groups was significantfor all countries except Argentina,
Norway and Sweden (Mann-Whitney U test, difference between mean severity scores).
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Chapter 6 : The potential of imaging in hyperacute stroke
6.1 Introduction
Imaging is fundamental to the assessment and management of acute stroke.
In the past, the main purpose of imaging was to differentiate haemorrhage from
infarct. Whilst this remains vital, recent research using computed tomography (CT)
and magnetic resonance (MR) has suggested that imaging can confirm the diagnosis
of infarction within hours (or even minutes) of symptom onset, and possibly assist in
the selection of treatment for acute ischaemic stroke.
In this chapter, I will review the use of CT, structural MR (T2, gradient echo
sequences etc) and advanced MR (diffusion and perfusion sequences) to diagnose
acute stroke. This thesis is not concerned with the complex technical details of
different imaging techniques, but rather how best to apply them to solve common
clinical problems. Hence each section will provide the clinician with brief — but
essential - technical background.
6.2 Brain imaging is required to differentiate haemorrhage from
infarction
The initial step in the diagnosis of brain attack is to determine whether the
event is a result of a vascular process (Bamford, 2001). The second step is to
distinguish between ischaemic stroke and primary intracerebral haemorrhage (PICH).
This is an important distinction, as the causes, prognosis and management of PICH is
vastly different to ischaemic stroke (Qureshi et al., 2001). The gold standard for
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making the distinction is brain imaging (either CT or MR) (Mohr & Donnan, 1998;
Wardlaw, 2001).
6.2.1 Clinical scoring methods
Our early knowledge of the clinical features of PICH came from the post¬
mortem examination, which emphasised that PICH was a catastrophic event. CT
scanning revolutionised the approach to PICH (Caplan, 1994). It allowed precise
clinico-pathological correlation of the whole spectrum of disease, including the
milder clinical syndromes (usually due to capsular haemorrhages) which were
difficult to distinguish from infarcts (Kinkel & Jacobs, 1976; Harrison, 1980).
Several scoring methods, based on clinical features, were developed to differentiate
PICH from infarction when CT scanning was unavailable. These are the Guy's
Hospital score (Allen, 1983a), the Siriraj stroke score (Poungvarin et al., 1991) and a
simpler scale proposed by Besson et al (1995). The score was determined by
combining clinical features that increase the likelihood of PICH (e.g. elevated
diastolic blood pressure) with features that reduce the likelihood of the event being
haemorrhagic (e.g. markers of atheroma elsewhere).
When tested in prospective validation studies, the results were less impressive
than the original studies (Sandercock et al., 1985b; Celani et al., 1992; Weir et al.,
1994; Hawkins et al., 1995). The scoring systems were unwieldy and difficult to
perform at the bedside, even for the experienced stroke clinician (Weir et al., 1994;
Ebrahim & Harwood, 1999a; Wardlaw, 2001). For those with a low pre-test
probability of haemorrhage, clinical scoring systems will misclassify small
haemorrhages as infarcts in up to 10% of patients (Wardlaw, 2001). The level of
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accuracy achieved by scoring methods is unacceptable for high-risk decisions such as
thrombolysis - brain imaging is mandatory (Mohr & Donnan, 1998).
6.2.2 CSF examination
Before routine CT scanning, lumbar puncture was usually performed to
diagnose cerebral haemorrhage (particularly when anticoagulation was
contemplated) (Fishman, 1992). Following PICFI, the typical changes in CSF are:
blood-stained fluid (which may be obvious to the naked eye), raised white cell count
(due to blood-induced meningeal irritation), raised protein and low glucose. Similar
changes may be seen after cerebral infarcts, though less commonly (Fishman, 1992).
Clear CSF does not exclude a small PICH (up to 20% of patients with
haemorrhage have normal CSF (Harrison, 1980)), nor does bloody CSF exclude an
infarct (up to 10% of infarcts will have xanthochromic or slightly bloody CSF)
(Fishman, 1992). A traumatic tap can simulate a haemorrhage, and it can be
dangerous to perform lumbar puncture when there is raised intracranial pressure.
CSF examination is thus a useless method of distinguishing between haemorrhage
and infarction (Harrison, 1980; Fishman, 1992; Mohr & Donnan, 1998).
6.2.3 CT evidence of haemorrhage
Technical details
The basic principle of the x-ray image is that a beam of radiation is attenuated
to some degree as it passes through body tissues. Dense tissues such as bone
attenuate more x-rays than less dense tissue such as brain. The intensity of the
exiting radiation is measured with sensitive photographic film. In computed
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tomography (CT), thin beams of x-rays are emitted from multiple different
directions, and the intensity of the exiting radiation is measured by detectors (rather
than on film). A computer integrates the information to construct images in cross-
section (Hounsfield, 1973; New et al., 1974; Ketonen & Berg, 1997; Gilman, 1998).
The attenuation of a body tissue is determined by the density and atomic
number of that tissue, and is measured in Hounsfield units (HU) (Dul & Drayer,
1994). In a CT scan of the brain, bone (or metal) has the highest density [1000 HU],
then blood [80-85 HU], gray matter [35-40 HU], white matter [25-30 HU],
cerebrospinal fluid [0 HU] and finally fat [-100 HU] (Dul & Drayer, 1994; Ketonen
& Berg, 1997).
On CT, an intracerebral haematoma appears hyperdense (white, see Figure
6.1). Increased density on CT is a result of both the haemoglobin content and the
protein matrix of the clotted blood. Haemorrhages are visible in patients with
anaemia, thrombocytopenia or abnormal clotting syndromes (Pierce et al., 1994). In
the first few hours, an ICH appears slightly less dense than it will ultimately appear
on CT, as blood has extravasated but not yet clotted (Dul & Drayer, 1994). Over the
next few hours to days, the process of clot retraction produces a well-defined,
homogeneous, hyperdense mass (Savoiardo & Grisoli, 1998). After three or four
days, as haemoglobin is broken down, the density of the haematoma decreases
(initially at the periphery and later in the centre) (Savoiardo & Grisoli, 1998). After
a few weeks - depending on the size of the haematoma - it can appear identical to an
infarct of the same age (Dennis et al., 1987) (Figure 6.2).
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Figure 6.1 An acute intracerebral haematoma on CT
There is extension ofblood into the lateral ventricles
Figure 6.2 An old PICH appears identical to an old infarct
Patient presented with a right hemiparesis six months earlier, arrow points to the remains of
the old bleed. Although old haemorrhages tend to be more slit-like than old infarcts, the
reliability ofthis sign is unknown.
How often is the CT positive?
Early reports suggested that a CT diagnosis of PICH was highly accurate and
correlated with autopsy findings (Paxton & Ambrose, 1974; Scott et al., 1974;
Kinkel & Jacobs, 1976; Weisberg, 1979; Tohgi et al., 1981). As far as we know, all
haemorrhages large enough to cause symptoms will be seen on CT when imaged in
the first few days (Savoiardo & Grisoli, 1998; von Kummer & Patel, 1999; Wardlaw,
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2001). The haematoma will be visible on CT immediately [as seen in patients who
have had an ICH whilst being scanned (Franke et al., 1990)].
There are a few pitfalls in the CT diagnosis of haemorrhage. CT appearances
that can be confused with haemorrhage include calcification (both physiological and
pathological), high-density tumours or colloid cysts. However, the clinical details of
a patient with a tumour or colloid cyst will usually be different. Careful analysis of
the attenuation coefficient of the lesion may be required to distinguish calcium from
blood (Dul & Drayer, 1994).
6.3 CT for acute ischaemic stroke
CT is now widely available - 92% of consultants caring for patients with
stroke in the UK have access to a CT scanner (Ebrahim & Redfem, 1999) - and
relatively cheap. An unenhanced CT scan of the brain (5-mm slices through the
posterior fossa, 10-mm slices throughout the rest of the brain) takes only five
minutes. Fast CT provides diagnostic information even in restless, uncooperative
patients, and allows access to critically ill patients during scanning.
6.3.1 Limitations of the CT
The main limitations of CT are:
(1) Beam-hardening artefact - this produces alternating dark and bright lines
on the CT film. It arises when soft tissue is adjacent to bone, as the computer is
unable to compensate for the sudden marked change in densities. Beam hardening
particularly affects the posterior fossa, reducing the sensitivity to lesions of the
cerebellum and brainstem.
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(2) Small lesions are less visible than larger infarcts on CT. Between 35 to
49% of patients with lacunar infarcts have a lesion on CT (Bamford et al., 1987;
Norrving & Cronqvist, 1989; Arboix et al., 1990a; Chamorro et al., 1991). In the
International Stroke Trial (1ST), 41% of patients with lacunar syndromes had a
relevant lesion when scanned within 48 hours of onset (compared with 61% of
patients with total anterior circulation syndromes) (Hand & Wardlaw, 2001).
(3) 'Fogging' of an infarct - this occurs in the second week, when the density
of the infarct gradually increases to become isodense with normal brain tissue, and
after swelling has subsided. The infarct may be impossible to see on CT, or its size
may be underestimated (Savoiardo & Grisoli, 1998; Wardlaw, 2001). The frequency
of 'fogging' varies from 100% (Becker et al., 1979) to 54% (Skriver & Olsen, 1981)
depending on the study. Eventually, when the process of tissue breakdown is
completed, the infarct is replaced by fluid-filled cystic spaces (Savoiardo & Grisoli,
1998).
6.3.2 What influences the likelihood of seeing an infarct on CT?
Early reports indicated that abnormalities on CT could be seen with cerebral
infarcts as well as bleeds (Paxton & Ambrose, 1974; Kinkel & Jacobs, 1976). The
quality of scans was poor, which limited the ability to visualise small infarcts and the
subtle abnormalities of early infarcts (Wardlaw, 2001). Despite this, it was
recognised that infarcts resulted in reduced density of the involved brain tissue, often
with surrounding oedema.
In the past, CT was thought to be insensitive to ischaemic changes in the first
24 hours (Wardlaw et al., 1999). Even now, an infarct may never be seen in up to
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50% of patients (Wardlaw, 2001). Signs of infarction on CT within the first six
hours of stroke are often subtle but become more obvious and better demarcated over
the first few days (Figure 6.3).
Figure 6.3 subtle early signs of ischaemia evolving into an obvious infarct
Early CT on left (4hrs from onset) shows loss of the insular ribbon (large black arrow, white
arrows show normal insular ribbon) and early effacement ofsulci (thin arrows show limits
of effacement, arrow heads show obscured sulci). CT six days later (right) reveals obvious
hypodensity in the left middle cerebral artery territory (thin arrows) and compression of the
lateral ventricle by swelling (large arrow) in addition to the sulci.
Established infarction
When visible, an established infarct (i.e. one that is a day or so old) appears
as a wedge-shaped or rounded hypodensity within a recognised vascular territory
(Figure 6.3). Swelling may be seen within the lesion, reaching its peak around the
third to fifth day. The likelihood of seeing a relevant infarct depends on time to
scanning, and stroke severity. The later a patient is scanned, and the more extensive
the clinical syndrome, the greater the chance of seeing an infarct. In the International
Stroke Trial (1ST), an infarct was seen in 33% of patients scanned within six hours,
and in 58% of those scanned 24-48 hours after onset. 61% with a total anterior
circulation infarct had a visible infarct, compared with 41% of those with a lacunar
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syndrome (see Figure 6.4) (Hand & Wardlaw, 2001). There is a weak independent
association of visible infarction with poor outcome - a patient with a visible infarct
has a slightly worse prognosis than an otherwise identical patient with no visible
infarct (Wardlaw et al., 1998).
80% i
70% -
0-6hrs 7-12hrs 13-24hrs 25-48hrs
Time from stroke onset to randomisation
Figure 6.4 The effect of time and stroke severity in determining the presence of a visible
infarct, amongst 12,802 patients randomised into the International Stroke Trial
immediatelyfollowing CT
Vertical bars represent the proportion ofpatients with a visible infarct in each time interval,
subdivided by stroke subtype (used here as a measure of stroke severity). TACS - total
anterior circulation syndrome; PACS - partial anterior circulation syndrome, LACS -
lacunar syndrome; POCS -posterior circulation syndrome.
Early CT signs of infarction
With advances in modern CT technology, and more patients presenting for
early assessment, signs of ischaemia may be seen on a scan within hours of stroke
onset. The characteristic changes are a loss of tissue density, resulting in loss of
distinction between grey and white matter, and swelling. The pathological process
that explains the CT signs is an influx of water into affected ischaemic cells. The
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grey matter is affected first, as neuronal cell bodies are more sensitive to ischaemia
than axons or other cells in white matter tracts (Beauchamp & Bryan, 1997).
The 'Hyperdense Middle Cerebral Artery Sign' (HMCAS)
This is not strictly a sign of early infarction, but reflects occlusion of the
middle cerebral artery (MCA) by acute thrombus or embolism (von Kummer et al.,
1995). The CT appearance (Figure 6.5) is an increased density of part of the MCA
compared with other parts of the vessel or its contralateral counterpart (and not
attributable to calcification). Although most frequent in the MCA, any artery may
appear hyperdense when it contains fresh thrombus (even the lenticulostriate arteries
(Wardlaw et al., 2001b)). In the distal MCA, it has been called the hyperdense
sylvian fissure 'dot' sign (Barber et al., 2001b) (Figure 6.6).
Figure 6.5 Hyperdense middle cerebral artery
A 79 year old man with right sided weakness, aphasia and right hemianopia. CT scan at
5.25 hrs shows a left HMCAS (arrow).
Basal Ganglia
Loss of definition of grey matter is most obvious at the interface of grey and
white matter in the basal ganglia. The distinction between caudate nucleus and
anterior limb of internal capsule, globus pallidus and genu of internal capsule, and
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putamen and external capsule, is blurred or lost (Figure 6.6). Within the first few
hours, the ischaemic grey matter becomes a similar density to the adjacent white
matter. Later, the grey and white matter become even more hypodense, so that the
whole area is darker than surrounding brain tissue. Swelling is seen as compression
of the adjacent ventricle (Figures 6.3 & 6.7).
Figure 6.6 Hyperdense sylvian fissure dot sign and loss of the outline of the basal ganglia.
A 69 year old man fell out ofbed, and was found to have right sided weakness and aphasia.
CT at 4hrs shows a hyperdense sylvian fissure dot sign (large arrow), and loss of the outline
of the basal ganglia (thin black arrows, normal outline of contralateral basal ganglia
marked by white arrows). The patient made a full recovery and was discharged four days
later (follow-up CTshowed a small hypodensity of the left insular cortex).
Cortical surface
Swelling of the cortex results in effacement (loss of visibility) of the sulci in
the territory of the involved artery, most easily seen by comparing sulci in
corresponding parts of each hemisphere (Figures 6.3 & 6.7). Loss of definition
between grey and white matter may be seen at the boundary between cortex and
white matter, in particular involving the insular cortex between the sylvian fissure
and external capsule. Loss of definition of the insular cortex results in 'loss of the
insular ribbon' (Figure 6.3). Subsequently both grey and white matter become more
hypodense than normal white matter, so more obviously abnormal.
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Figure 6.7 An 80 year old woman developed mild right sided weakness, then deteriorated
2.5 hours later with dense weakness and aphasia.
CT on left (3.3 hrs after onset) shows very subtle loss of grey-white differentiation in the
anterior division of left middle cerebral artery (black arrow). CT 48 hours later (on right)
shows an established infarct (thin arrows) with compression of the lateral ventricle and
haemorrhagic transformation (thick arrow) within a larger island of surviving tissue. Tim
patient died three months later.
6.3.3 Making a positive diagnosis: how often do early changes occur?
Early studies reported that hypodensity and/or swelling were seen in 82% of
patients with hemispheric stroke scanned within six hours (von Kummer et al.,
1996). 46% of patients had parenchymal hypodensity, and 21% had focal swelling
on the initial scan in the European Cooperative Acute Stroke Study (ECASS) (in the
opinion of the expert CT reading panel, who were not blind to the follow-up scans)
(von Kummer et al., 1995). Conversely, the NINDS rt-PA trial, which enrolled
patients within three hours, had a 5.7% frequency of clear-cut early CT findings (von
Kummer & Patel, 1999).
The frequency of the HMCAS varies from 50% in some series of anterior
circulation infarcts (Bastianello et al., 1991; von Kummer et al., 1994), to 5% in a
recent Canadian study (Barber et al., 2001b). An equal number of patients may not
demonstrate the HMCAS despite angiographically proven MCA occlusion (Leys et
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al., 1992; von Kummer et al., 1994). A hyperdense distal MCA is reported to occur
in 16% of thrombolysis-eligible patients (Barber et al., 2001b). When studied
serially, the HMCAS usually disappears in a few days (Bastianello et al., 1991).
It is difficult to be certain of the true frequency of early signs of infarction. It
all depends on the severity of stroke in the particular patient group, the size and
position of the infarct, how quickly patients are scanned, the expertise of the
radiologist, the quality of the scanner, and so on. A study that reports high
frequencies probably reflects the interests of the research group and the mix of
patients admitted to its service, and may not be easily extrapolated to the rest of the
world. Early signs of infarction, and the presence of visible clot in a large cerebral
vessel, are helpful to confirm the clinical diagnosis when present.
6.3.4 Unresolved issues of early CT signs of infarction
Enthusiasm for making an early positive diagnosis on CT needs to be
balanced by an understanding of the problems involved. Confusion has arisen
through the use of multiple terms for early infarct signs that describe two basic
pathological processes, ischaemia and swelling (Table 6.1) (Wardlaw, 2001). In one
study, 5/15 doctors even observed an invented sign ('dense cortical sulci') on CT,
suggesting that knowledge of early infarct signs was poor (Wardlaw et al., 1999).
There needs to be simplification, as well as clear and universally agreed definitions
for early CT signs of infarction.
How reliable are early signs of infarction?
Even amongst neuroradiologists with an interest in stroke, agreement for
early signs is moderate at best (Marks et al., 1999; Kalafut et al., 2000). There are
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not- and will probably never be - enough neuroradiologists to provide timely reports
to clinicians (Brillman et al., 1997). Unfortunately, the reliability amongst general
radiologists, stroke clinicians and emergency physicians in detecting early signs of
infarction is poor, barely better than would be achieved by chance alone(Wardlaw et
al., 1999; Grotta et al., 1999; Kalafut et al., 2000; Barber et al., 2000).
There have been some recent attempts to improve reliability of early scan
interpretation. One study formalised the interpretation of the 1/3 rule (by applying a
series of imagined templates) (Silver et al., 2001), and another developed a
systematic quantitative scoring system for ischaemic changes in the MCA territory
('ASPECTS') (Barber et al., 2000). Both studies report impressive interobserver
reliability, but are based on small numbers of patients treated with intravenous
thrombolysis. Neither scale can be used for the many infarcts that occur outside
MCA territory.
What does it all mean?
When seen in the proximal vessel, the HMCAS is associated with severe
brain ischaemia and poor outcome, but has no independent prognostic significance
(Manelfe et al., 1999). A distal HMCAS may be associated with small volumes of
infarcted tissue and a better prognosis than the proximal sign (Barber et al., 2001b).
Several studies have shown that early infarct signs have a strong univariate
association with stroke severity and outcome (Moulin et al., 1996; von Kummer et
al., 2001), but do not independently predict outcome in multivariate analyses
(Mendizabal et al., 2001). It is likely that early infarct signs, as with established
infarct signs, probably have weak independent prognostic significance. However
this, and the magnitude of any independent association, is still to be determined.
89
Current thinking is that these early CT changes reflect the pathophysiology of
the infarct (von Kummer & Weber, 1997; Buchan, 2001). Early evidence of
infarction involving a large part of the cerebral hemisphere is thought to represent
major, irreversible ischaemic damage, where reperfusion is unlikely to be helpful.
When the CT changes are more subtle, evidence from positron emission tomography
studies (albeit of very small sample size) have suggested that there is a small core of
tissue destined to infarct, surrounded by a larger area of critically hypoperfused (yet
still viable) brain tissue (Grond et al., 1997). The current thinking is that reperfusion
is likely to be of benefit in this situation, and that those with normal CT scans may
recover rapidly, or develop delayed infarction (von Kummer & Hacke, 2000).
However, despite strongly polarised opinions of some experts, all of this conjecture
remains to be proven.
6.4 Structural MR for acute stroke
In this section, I will summarise the technical principles underlying MR, and
discuss the potential of specific sequences that examine the structure of the brain
('structural' MR). There has been huge enthusiasm for the (relatively) new imaging
modality of MR. However, this enthusiasm has not yet been matched by appropriate
availability. In the UK 93% of consultants who care for stroke have access to an MR
scanner, but 85% of consultants scan fewer than 10% of their patients, and only 10%
of consultants are able to scan patients within the same or next day (Ebrahim &
Redfem, 1999).
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6.4.1 Technical details of MR in general
The theory underlying MR imaging is extremely complex, and beyond the
scope of this thesis. The following is a brief summary of the basic principles and
techniques ofMR (to help discuss stroke imaging for the clinician).
How does it work?
When the human body is placed in a strong constant magnetic field, the
protons within the tissues align. If a radiofrequency pulse is applied, the protons
become excited. When the pulse is turned off, the protons relax to their previous
state over milliseconds, giving off energy that is detected as the MR signal (and is
called the 'spin echo'). The signal is converted into digital images through
computerised Fourier transformation. For images of the brain, a coil is placed over
the head, which provides the radiofrequency pulses and detects the resultant MR
signal (Moseley, 1988; Ketonen & Berg, 1997; Gilman, 1998; DeLaPaz & Mohr,
1998).
The T1 and T2 time constants
In general, tissues with the highest proton content (fat and water) produce
more signal than tissues with low proton content (bone). Simplistically, a
conventional MR image is a measure of the amount of fat and water within different
regions (Ketonen & Berg, 1997). The radiofrequency pulse sequences can be varied
to produce images with different tissue contrast. The parameters altered are the
repetition time of the radiofrequency pulses (TR) and the time after these pulses that
a spin echo returns (TE). T1 and T2 are time constants that describe the rate of
proton relaxation after a radiofrequency pulse; varying the TR and/or the TE
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'weights' images to show mainly the T1 or T2 tissue property (see Figure 6.8 and
Table 6.2) (Ketonen & Berg, 1997; DeLaPaz & Mohr, 1998).
Figure 6.8 Saggital views ofa normal (the author's!) brain
T1 weighted image on left (note CSF black), T2 image in middle (note CSF white), and
proton density on the right.
Magnetic susceptibility
Tissues placed within a magnetic field generate their own magnetic field,
which may enhance or reduce the effect of the externally applied field (Dul &
Drayer, 1994). Paramagnetic substances such as gadolinium, calcium and blood
products (iron in haemosiderin, deoxyhaemoglobin, or methaemoglobin) disrupt the
local magnetic field, resulting in low signal on T1-weighted images. Intravenous
gadolinium, a common MR contrast agent, can be used to enhance the arterial signal
in the acute stages of infarction, to define areas of blood-brain barrier breakdown,
and to image the regional perfusion of the brain (DeLaPaz & Mohr, 1998).
MR artefacts and limitations
Although MR provides outstanding tissue definition (Dul & Drayer, 1994),
there are several technical limitations with which to be familiar. MR is insensitive to
bone or densely calcified tissues (which contain little fat or water) (Ketonen & Berg,
1997). Artefacts occur at interfaces between tissues with different magnetic
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properties, and may result in focal distortion or bright bands being seen on the MR
image. Chemical shift artefact is common at water-fat interfaces (e.g. the orbit), and
susceptibility artefact is seen in the paranasal sinus region, the skull base and
pituitary gland (Ketonen & Berg, 1997).
MR is extremely sensitive, but not very specific (Hommel, 1995). Normal
anatomy can easily be mistaken for pathology (e.g. enlarged Virchow-Robin spaces),
and non-vascular pathology may be mistaken for infarcts (e.g. gliosis, myelin loss,
'unidentified bright objects') (Ketonen & Berg, 1997) (Kertesz et al., 1987; Hommel,
1995).
6.4.2 Structural MR imaging sequences
A routine MR brain imaging sequence consists of some combination of a
midline saggital localising view of the brain, a T1 weighted axial image, a T2 axial
image and a proton density or fluid attenuated inversion recovery (FLAIR) image
covering the whole brain (DeLaPaz & Mohr, 1998; Wardlaw, 2001). The exact
sequence performed depends on the preference of the neuroradiologist. The images
obtained with routine sequences provide information about the structure of the brain,
and will be referred to as structural MR.
The evolution of an infarct on structural MR
The earliest change of ischaemia is absence of the normal flow void in the
affected artery (the equivalent of the hyperdense middle cerebral artery sign). Within
hours there may be subtle swelling of cortical gyri seen on T1-weighted images. T2
signal changes are quite unusual before eight hours, but are usually seen by 24 hours.
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T1 signal changes take longer to develop, and are more difficult to see (dark as
opposed to bright) so are less commonly observed (see Table 6.3).
Following the acute changes, the infarct gradually enlarges (in up to 1/3) and
swelling becomes pronounced. The CT equivalent of fogging, an increase in the T1
signal, and reduction in the T2 hyperintensity, may be seen by two to three weeks —
which can make the infarct difficult to identify (Pereira et al., 1997). This fact has
probably been under recognised. Later, the infarct shrinks as the affected tissue
atrophies. This is accompanied by ex-vacuo dilatation of the ipsilateral ventricle and
adjacent sulci, and often Wallerian degeneration of the corticospinal tracts (seen as
increased signal on T2-weighted images of the brainstem) (Yuh et al., 1991;
DeLaPaz & Mohr, 1998; Wardlaw, 2001).
The appearance of haemorrhage
Acute haemorrhage may be difficult to detect with structural MR (Tl, T2 or
proton density images) (Dul & Drayer, 1994). When imaged within the first few
hours, PICH has a characteristic appearance on T2 images: a centre of isointense
signal, a periphery of hypointensity and a rim of oedema (see Figure 6.9)
(Schellinger et al., 1999; Linfante et al., 1999). This is because the main constituent
of the bleed is oxygenated haemoglobin, which has a signal intensity equivalent or
slightly reduced relative to normal brain tissue, but over hours to days, the
oxygenated haemoglobin is converted to de-oxygenated haemoglobin (starting at the
periphery). Deoxyhaemoglobin is paramagnetic, so results in signal loss on T2
images (Dul & Drayer, 1994).
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Figure 6.9 Acute haemorrhage on T2
MR at 12 hours after onset. There are some darker lines at the periphery of the bleed
(deoxyhaemoglobin, large arrow), and surrounding oedema (thin arrow).
After a few days, and up to a few weeks, deoxyhaemoglobin is converted into
methaemoglobin, which has different MR characteristics. Thus the subacute PICH
will appear as marked hyperintense signal on T1-weighted images (and dark on T2-
weighted images). After several weeks, the methaemoglobin is converted to
haemosiderin, and appearances are changed once again - this time signal is low on
Tl, and very low on T2 images (Dul & Drayer, 1994).
The gradient echo sequence (GRE)
A more recent sequence called gradient echo (also known as susceptibility-
weighted, or 'Flash2D'T2) is exquisitely sensitive to breakdown products of blood.
In this sequence, gradient shifts rather than radiofrequency pulses are used to
generate the spin echo; consequently the sequence is more sensitive to tissue
magnetic field inhomogeneities. It is capable of detecting prior ICH more reliably
than spin echo or fast spin echo T2 images (Wardlaw, 2001), is very sensitive to
acute haemorrhage (Patel et al., 1996) and may also show old petechial haemorrhage
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in infarcts (Keir, 2002) or in apparently unaffected tissue ('microbleeds) (Roob et al.,
1999). It adds an extra five minutes to the scanning time (Wardlaw, 2001).
The 'FLAIR' sequence
The FLAIR (fluid attenuated inversion recovery) sequence suppresses the
signal from CSF, so lesions near the brain surface stand out more clearly from CSF
in adjacent ventricles or sulci. FLAIR appears to detect ischaemic abnormalities
better than T2-weighted images (Lansberg et al., 2000a; Oppenheim et al., 2000a),
and shows small cortical and periventricular infarcts well. However, it may miss
lesions in the posterior fossa, cannot distinguish between acute and subacute infarcts,
and may be oversensitive (particularly for asymptomatic white matter lesions)
(DeLaPaz & Mohr, 1998; Wardlaw, 2001).
Magnetic resonance angiography
Magnetic resonance angiography (MRA) is an attractive alternative to digital
subtraction angiography (DSA), as it is non-invasive, and when combined with
structural MRI provides more information than DSA alone (Ketonen & Berg, 1997).
The principles underlying MRA techniques are complex. In general, arteries are
imaged using time of flight techniques (whilst veins are imaged with the phase
contrast technique). MRA can be used to demonstrate extracranial carotid stenosis,
intracranial stenosis of the vessels at the base of the brain, and venous sinus
thrombosis (Lee, 1998). Of greatest potential in acute stroke is the sequence that
examines the cerebral vessels. Demonstration of an occluded major cerebral vessel
confirms the diagnosis, and could help to select treatment (Schellinger et al., 2001).
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When compared with DSA, MRA has accuracy of 80-90% for detection of stenoses
of the circle of Willis (Lee, 1998).
Important limitations of the MRA technique are (1) lower resolution than
conventional DSA - the resolution becomes progressively worse as the vessel lumen
size decreases, so vessels smaller than the second segment of the anterior, middle and
posterior cerebral artery will not be seen reliably (Beauchamp, Jr. et al., 1999); (2)
sensitivity to patient movement, and (3) slow flow or turbulent flow causes loss of
signal, which results in overestimation of the degree of stenosis or failure to visualise
a vessel (Lee, 1998).
6.4.3 The clinical utility of structural MR
Structural imaging may point to an unusual cause of ischaemic stroke
MRI is recommended for young patients with ischaemic stroke (Brown,
2001), or older patients without clear risk factors for vascular disease (Warlow,
2001). In these situations, an unusual (i.e. non-atheromatous) cause of stroke
becomes much more likely. Many of the rare causes of stroke can be readily
identified with MR imaging (see Table 6.4); additional sequences may be performed
at the same time (such as non-invasive angiography), and MR may be able to localise
the site of the lesion better than CT (which may be important).
Is structural MR better than CT in detecting ischaemic stroke lesions?
Like CT, MR may remain normal after cerebral infarction. Kertesz and co¬
workers (1987) found that the MR was normal in 16/87 patients (18%) imaged
within one week of stroke, and Alberts et al (1992) identified seven patients over a
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two year period with normal scans. The cases were a mix of small and large vessel
disease, brainstem and hemispheric location. It is highly likely that even more
patients with true stroke and normal MR were missed, as the result of the scan
strongly influences the final clinical diagnosis of stroke.
There have been several studies that compared the visibility of lesions on
structural MR imaging with CT. Kertesz et al (1987) (time to scanning, t<72hrs,
sample size, n=39) found that the MR was positive in 74%, whilst the CT was
positive in 44%. For those scanned after 48 hours, CT and MR performed equally.
Bryan et al (1991) (t<24hrs, n=31) found a visible infarct in 82% of patients on MR,
and 58% on CT. Mean time to CT was eight hours, and mean time to MR was 12
hours. Mohr et al (1995) (t<6hrs, n=80) found that CT and MR were equal in their
ability to demonstrate infarcts, although CT correlated better with outcome. CT was
usually performed first, and median time to second scan was 72 minutes (range eight
minutes to 11 hours). In the latter two studies there was bias against CT, as MR was
performed later, and was thus more likely to show an abnormality.
For the detection of lacunar infarcts, studies have shown that MR was
positive in 74-98%, compared with a positive imaging rate of 15-58% with CT
(Salgado et al., 1986; Rothrock et al., 1987; Brown et al., 1988; Arboix et al.,
1990b). Overall, it would seem that MR is better at identifying lacunar and
brainstem lesions, but CT may be as good at showing early changes in cortical
strokes (Wardlaw, 2001).
How does MR compare with CT for the detection of haemorrhage?
The complex pattern of changes seen on MR contrasts with the much more
obvious hyperdensity seen immediately on CT. Despite the fact that until recently,
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the main indication for brain imaging in stroke was to rule out haemorrhage, there
have been few reports of direct comparisons between CT and MR in detection of
acute haemorrhage. Schellinger et al's (1999) series of nine patients underwent MR
on average two hours after CT. All cases of ICH were 'unambiguously identified' on
MR; however the same clinician who interpreted the initial CT scan also interpreted
the MR several hours later (the degree of blinding - if any - was unclear). Patel et
al's (1996) six patients were evaluated within six hours of ICH. The haematoma on
MR was 'easily identified when compared with the baseline CT'. Mohr et al's
(1995) study - the only blinded study - recruited five acute haematomas, which were
identified equally well by both imaging techniques. The paucity of data seems rather
extraordinary given the importance of differentiating between haemorrhage and
infarct (Tong et al., 1999).
6.5 The promise of advanced imaging techniques for hyperacute
cerebral ischaemia
Advancements in MR technology over the last decade have brought new
imaging sequences that hold great promise for acute ischaemic stroke. The following
sections deal with 'advanced' MR: diffusion-weighted (DWI) and perfusion imaging
(PI). [Functional MR and MR spectroscopy will not be considered in this thesis],
6.5.1 Technical details of diffusion and perfusion imaging
Diffusion-weighted imaging (DWI)
The DWI sequence detects the random movements of water molecule
protons. Water molecules can diffuse freely in the extracellular space and into cells,
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although the degree of movement depends on the immediate environment (Fisher et
al., 1992; Beaulieu & Moseley, 1999). Natural barriers limit free diffusion of water
molecules in different directions, giving rise to anisotropic diffusion. For example,
water diffuses readily down and up white matter tracts, but diffusion perpendicular to
the fibre is restricted by its myelin sheath (Baird & Warach, 1998).
Diffusion weighted images are obtained by adding two strong, rapidly
switched gradient pulses to the standard T2-weighted spin echo sequence. Regions
of fast diffusion (e.g. CSF) appear darker than normal brain tissue because
movement of water results in signal loss (Baird & Warach, 1998). The rate of
diffusion can be quantified, and is expressed as the apparent diffusion coefficient
(ADC). Where diffusion is free, the ADC will be high; where diffusion is restricted,
the ADC will be low.
A major early problem with DWI was that image acquisition was slow, and
images were very sensitive to movement artefact. The new method of echoplanar
imaging (EPI) has allowed ultrafast acquisition of DWI images, thus less sensitivity
to movement and shorter scanning time. However, EPI is limited by air/bone edge
susceptibility artefact causing image distortion in the posterior fossa, base of skull
and frontal lobes (Baird & Warach, 1998).
DWI in ischaemia
In ischaemic brain tissue, inadequate supply of glucose and oxygen
eventually results in failure of the cell's membrane pumps, leading to influx of
sodium and water into the cell (see Chapter 2). Water passes from the interstitial
(extracellular) space, where it can diffuse freely, to the intracellular space, where it is
trapped (Beauchamp, Jr. et al., 1999). It is generally accepted that high intensity
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signal on DWI (and low ADC) is a reflection of early cytotoxic oedema due to
failure of the membrane pump (see Figure 6.10) (Fisher et ai, 1992; Albers, 1998;
Baird & Warach, 1998; Provenzale & Sorensen, 1999; Beauchamp, Jr. et al., 1999;
Beaulieu & Moseley, 1999).
Perfusion deficit
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Figure 6.10 Chain ofevents thought to result in an observable lesion on DWI
Adaptedfrom Beaulieu & Moseley (1999)
The ischaemic lesion appears hyperintense (white) on DWI (see figure 6.11),
in contrast to the more subtle changes seen on CT. DWI is capable of detecting
cerebral ischaemia very early: within minutes of arterial occlusion in animal models
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(Moseley et al., 1990), within the first few hours in human stroke (Warach et al.,
1995).
Figure 6.11 DWI appearance ofacute ischaemia
A 42 year old man with a left hemiparesis (TACS). DWI scan at 24 hours showed extensive
signal alteration in the right middle and anterior cerebral artery territories. The patient
died 80 hours after onset due to 'malignant' middle cerebral artery infarction.
Both animal models and human studies have demonstrated a time course of
the ADC following stroke. ADC values decrease after stroke onset, then normalise
(after one to two days in rodent models, but longer in humans), before becoming
high in the chronic phase (Baird & Warach, 1998). A decrease in ADC always
precedes the development of infarction, but it is unclear whether decreased ADC
values imply that the tissue is irreversibly bound for infarction. There is no
consensus on the threshold of cerebral perfusion that results in a diffusion
abnormality: some believe it is as low as 15-20ml/100g brain tissue/min (DeLaPaz &
Mohr, 1998), whilst others believe it could be 30-40 m/lOOg brain tissue/min
(Latchaw, 1999; Yuh et al., 1999). Animal studies suggest that DWI lesions can
recover, but this appears to be uncommon in humans (Baird & Warach, 1998;
Provenzale & Sorensen, 1999).
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Perfusion imaging (PI)
Magnetic resonance perfusion imaging (PI) measures the passage of blood
through the brain's vascular network (Petrella & Provenzale, 2000). PI evaluates
blood volume, blood transit times and blood flow as relative measures. The most
popular method of PI is dynamic contrast bolus tracking. Gadolinium is given by
rapid intravenous injection, and serial scans performed every one to two seconds for
one to two minutes measure the concentration of gadolinium as it passes through the
brain (Baird & Warach, 1998; Petrella & Provenzale, 2000). Gadolinium induces a
strong local magnetic field change in the perfused area, hence there is a loss of signal
intensity on T2 images. When the contrast leaves the area, the signal intensity
returns to normal (Fisher et al., 1992). The change in signal intensity is
approximately proportional to the amount of gadolinium and hence 'flow'. By using
the theory of tracer kinetics, signal-time course data can be converted to
concentration-time course data. Tracer (i.e. gadolinium) concentration curves can
then be analysed to determine various haemodynamic parameters.
The best measure ofperfusion
There is as yet no consensus for the optimal method of measuring abnormal
perfusion. Cerebral blood volume (CBV) is the easiest to measure, as the amount of
signal loss is proportional to blood volume (Baird & Warach, 1998). However,
studies have demonstrated that CBV can be decreased in the area of interest (Rother
et al., 1996), both increased and decreased (Kim et al., 1999), or increased
(Beauchamp, Jr. et al., 1999). The distribution of reduced CBV in an ischaemic
lesion may be heterogeneous (Wu et al., 1998).
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Relative time-to-peak maps (TTP, i.e. the time from injection of contrast until
the highest concentration of contrast agent) are also easily calculated. Because of its
simplicity, many investigators have favoured this method (Tong et al., 1998; Thijs et
al., 2001). However, TTP maps can be non-specific because delayed arrival time
may be due to vessel occlusion, or due to slow or indirect flow (Beauchamp, Jr. et
al., 1999).
Further calculations require an internal reference or 'arterial input function'
and are more difficult. Mean transit time (MTT) is the average time it takes blood to
pass through a given region of brain tissue. From this, cerebral blood flow (CBF)
can be calculated according to the central volume principle (CBF=CBV/MTT)
(DeLaPaz & Mohr, 1998; Beaulieu & Moseley, 1999; Petrella & Provenzale, 2000).
MTT and CBF appear to be most widely used, and are favoured by our laboratory.
After vessel occlusion, CBF maps will show hypointensity whilst the MTT map will
show hyperintensity in the ischaemic area (see Figure 6.12).
Figure 6.12 PI lesion
The DWI scan on the left shows a large left MCA hyperintensity, and the CBV map on the
right shows a matchedperfusion lesion (reduced cerebral blood volume is blue).




The main clinical limitations of PI are: (1) the requirement for intravenous
access with a large bore catheter; (2) the need to give contrast (complete safety of
gadolinium in acute stroke has not been established (Wardlaw, 2001)); (3)
susceptibility artefacts, and (4) the extensive amount of postprocessing required
(Baird & Warach, 1998; Petrella & Provenzale, 2000).
It should also be noted that as the complexity of the processing methods
increase, the results become less reliable (Latchaw, 1999; Calamante et ai, 2002).
The PI maps generated are relative to another area of brain (which in itself may not
be normal), although many attempts are being made to make them absolute
(Beauchamp, Jr. et al., 1999; Petrella & Provenzale, 2000).
DWI-PI 'mismatch'
Many clinicians believe that combining PI with DWI may define 'tissue-at-
risk', which could be rescued with appropriate treatment (Prichard & Grossman,
1999; Fisher & Albers, 1999; Beaulieu & Moseley, 1999). This stems from the
observation that the initial perfusion deficit can be much larger than the initial DWI
lesion (so-called 'mismatch', see Figure 6.12). With time, the DWI lesion increases
in size to match the initial perfusion deficit (Fisher & Albers, 1999) (although others
believe that initial perfusion deficit overestimates the final infarct area (Beauchamp,
Jr. et al., 1999;Baird & Warach, 1998; Latchaw, 1999). The PI/DWI mismatch
theory is based on two major assumptions: (1) that the DWI lesion represents
irreversibly ischaemic tissue (Prichard & Grossman, 1999), and (2) the perfusion
lesion represents salvageable brain tissue - the ischaemic penumbra (Baird &
Warach, 1998; Beaulieu & Moseley, 1999).
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Four patterns of diffusion-perfusion abnormalities have been described: (1)
perfusion volume > DWI volume, suggesting the presence of a penumbra; (2)
perfusion volume = DWI volume, which suggests that there is no penumbra - but the
lesion will not enlarge; (3) perfusion volume < DWI volume, suggesting reperfusion
has occurred, and (4) normal perfusion with abnormal DWI, which also suggests
reperfusion has occurred (Baird & Warach, 1998). These concepts are yet to be
established as true.
6.5.2 The usefulness of advanced imaging for the stroke clinician
There has been tremendous enthusiasm expressed for advanced MR. Many
experts argue passionately for it (Prichard & Grossman, 1999; Hacke & Warach,
2000), but others are not so convinced (Powers & Zivin, 1998; Yuh et al., 1999;
Powers, 2000). In the following sections, I will review the large number of clinical
studies of DWI, PI and their combination.
Methodological flaws of many imaging studies
Powers (2000) pointed out that there was insufficient good quality evidence
to support the use of DWI in the routine care ofpatients with acute ischaemic stroke.
A recent systematic highlighted the problems common to many studies of advanced
imaging (Keir & Wardlaw, 2000). These included small sample size, absence of
blinding, inadequate information about inclusions /exclusions /failures /tolerability,
comparing different imaging techniques performed at different time points
(invariably favouring the newer technique), and retrospective study design. Often
the imaging was performed in non-consecutive series of patients who were different
to everyday practice {selection and referral bias), and the results of the MR study
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were included among criteria to establish the final diagnosis, or outcome event
0incorporation bias) (Powers, 2000; Keir & Wardlaw, 2000). Publication bias is
another problem, as the current enthusiasm of expert referees may lead to negative or
disappointing MR studies being rejected. Thus, studies of the usefulness of
advanced imaging need to be interpreted with caution.
Are advanced imaging techniques a diagnostic aid?
D WI compared with structural MR
Most studies report that DWI has very high sensitivity, specificity and
accuracy for the diagnosis of ischaemia, and is superior to standard structural MR
(Hacke & Warach, 2000; Keir & Wardlaw, 2000). For example, Lansberg et al
(2000a) (time to scanning, t<48hrs, sample size, n=49) showed that 46 patients
(94%) had a positive DWI, whilst 34 (71%) had a lesion on T2. FLAIR may be just
as sensitive: Oppenheim et al (2000a) (t<48 hrs, n=59) found DWI positive in 56
(95%), and FLAIR positive in 58 (98%)patients.
DWI compared with CT
There have been fewer studies of DWI in comparison with CT (Keir &
Wardlaw, 2000). Typically, DWI identified an acute lesion in all patients (100%
sensitivity), but sensitivity of CT varied from less than 33% (Sorensen et al., 1996;
Gonzalez et al., 1999), to around 50% (Urbach et al., 2000; Lansberg et al., 2000b)
to as high as 75% (Barber et al., 1999a; Fiebach et al., 2001). In all studies the CT
was performed first, and the MR done 60 to 150 minutes later. The one dissenting
study so far - in which the MR was still two hours after the CT - suggested that a
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careful, systematic review of the CT (using the ASPECTS score) was as useful as
DWI (Barber et al, 2001c).
DWI is probably superior to CT and conventional MR in detecting acute
infarcts (see Figure 6.13). Several studies showed that identification of DWI lesions
was more reliable (Urbach et al., 2000; Fiebach et al., 2001), and that the image
interpreter felt lesions were more conspicuous with DWI and so had greater
confidence in reporting (Lansberg et al., 2000a). Is this clinically useful? Albers et
al (2000a) found that DWI provided "potentially clinically relevant findings" in up to
76% of patients, whilst it was only 10% of cases in another series (Lutsep et al.,
1997). The usefulness is likely to be strongly influenced by casemix.
Figure 6.13 The DWI scan shows the relevant lesion
A 46 year old man, with a previous stroke causing right sided sensory disturbance,
developed further right sided symptoms. CT (left) showed several low densities consistent
with old lacunar infarcts (one marked by arrow). T2 image showed many more lesions in the
white matter (arrows). DWI scan (right) showed a high attenuation lesion (arrow),
suggesting this to be the infarct responsiblefor the recent clinical event.
Clinical situations in which DWI is particularly helpful
DWI appears to be superior to structural MR and CT for the imaging of
lacunar infarcts, particularly when imaged close to symptom onset and when the
lesion is in the brainstem (Figure 6.13) (Noguchi et al., 1998; Singer et al., 1998;
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Schonewille et al., 1999). DWI readily distinguishes recent lesions from old, which
may be helpful in clinical management (Singer et al., 1998; Fitzek et al., 1998;
Altieri et al., 1999). In 16% of patients with a clinical lacunar syndrome, DWI
showed multiple lesions suggesting the possibility of an embolic source (Ay et al.,
1999a). The finding of acute multiple brain infarcts (which is only possible with
DWI) in any clinical presentation suggests the possibility an unusual mechanism or a
proximal embolic source (Altieri et al., 1999; Roh et al., 2000; Baird et al., 2000a).
Perfusion imaging
Few studies have looked at PI as a diagnostic aid (most have been technical
in nature, or have focussed on DWI-PI mismatch) (Keir & Wardlaw, 2000).
Perfusion abnormalities precede the development of DWI lesions (Baird & Warach,
1998), and occur within minutes of stroke onset (Fisher & Albers, 1999), so PI maps
may be abnormal even before DWI shows a lesion. Sunshine et al (2001) (t<6 hours,
n=62) found that seven patients had no lesion on DWI, yet had an abnormality on
mean transit time (MTT) maps. In a further nine patients, the MTT lesion was the
best evidence of disease distribution (the DWI showing a smaller lesion). Several
other studies, all of small sample size, have shown that the volume of the lesion seen
on PI correlates strongly with initial neurological deficit (Barber et al., 1998;
Neumann-FIaefelin et al., 1999; Beaulieu et al., 1999).
However, studies have also shown that perfusion imaging might be normal in
10-20% of patients with acute stroke, even when scanned within six or seven hours
of onset (Rother et al., 1996; Beaulieu et al., 1999; Kim et al., 1999).
109
Can advanced imaging predict outcome?
DWI lesion volume
Many studies have demonstrated that early DWI lesion volume is correlated
with outcome [e.g., Beaulieu et al (1999) (time to scanning, t<7hrs, sample size,
n=21), Tong et al (1998)(t<6.5hrs, n=10), and Barber et al (1998)(t<24hrs, n=18)].
Lovblad et al (1997)(t<24hrs, n=50) showed that the correlation was less robust for
lesions smaller than 5mL. van Everdingen et al (1998)(t<60hrs, n=42) found that
lesion volume greater than 22mL was associated with a significantly worse outcome
on univariate analysis. Thijs et al (2000)(t<48hrs, n=63) performed a logistic
regression analysis which showed that DWI lesion volume was an independent
predictor of outcome, but patients with no DWI lesion were excluded.
A recent study by Baird et al (2001)(t<48hrs, n=66) proposed a prognostic
model for the prediction of outcome after stroke that incorporated the initial DWI
lesion volume (as well as time to scanning and the NIHSS score). DWI lesion
volume greater than 14.1mL was the radiological determinant of poor outcome. The
many methodological flaws within the study seriously limits its potential clinical use
(Hand et al., 2001; Counsell et al., 2001).
Schellinger et al (2001)(t<6hrs, n=51), in the largest prospective study of
patients scanned within six hours, demonstrated weak correlation between baseline
DWI lesion volume and stroke severity, and only moderate correlation between
baseline lesion volume and outcome. There was strong correlation between day five
DWI lesion volume and outcome, leading the authors to conclude that the early scan
reflected a 'dynamic' infarct whose fate had not been decided. Studies that
examined patients later than six hours (i.e. the vast majority) showed infarcts whose
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fate had already been sealed, hence the observed correlation with outcome in many
earlier studies.
Perfusion Imaging
There are many conflicting studies. Some investigators found a weak
correlation between PI lesion volume and outcome (Beaulieu et al., 1999)(t<7hrs,
n=21)(Barber et al., 1998)(t<24hrs, n=18)(Neumann-Haefelin et al., 1999)(t<24hrs,
n=20); others found a strong correlation (Tong et al., 1998)(t<6.5hrs, n=10)(Karonen
et al., 1999)(t<24hrs, n=49)(Rohl et al., 2001a)(t<6hrs, n=22).
There is also disagreement about the most accurate PI method. Several
studies showed that abnormalities of cerebral blood volume (CBV) best correlated
with final infarct size (Ueda et al., 1999)(t<72 hrs, n=18),(Sorensen et al.,
1999)(t<12 hrs, n=23)(Karonen et al., 2000)(t<24 hrs, n=49), although another study
found rCBV unhelpful (Tong et al., 1998). Parsons et al (2001)(t<6hrs, n=30) found
that relative cerebral blood flow (CBF) lesion volume best correlated with outcome,
and commented that it was not possible to rely on one single measure of PI - maps of
relative CBV underestimated, and maps of relative mean transit time (MTT)
overestimated tissue at risk. Yet Thijs et al (2001) were unable to replicate these
findings.
D WI/PI mismatch
Although the mismatch theory is logical and attractive, it remains
controversial Schellinger et al (2001). Central to the theory is the belief that the
DWI lesion seen acutely represents the ischaemic core (tissue irreversibly destined
for infarction). In support of this, many studies report that the DWI lesion increases
or remains the same in all patients (e.g., Schlaug et al (1999) (t<24hrs, n=25),
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Karonen et al (2000) (t<24hrs, n=49)). Conversely, some studies found that the final
infarct volume was actually smaller than the initial or maximum DWI lesion; in 9%
(Sorensen et al., 1996), 40% (Neumann-Haefelin et al., 1999), 55% (Baird et al.,
1997), and 86% of patients (Schwamm et al., 1998). It seems unlikely, therefore,
that the DWI lesion reliably represents tissue destined for infarction in every patient.
Most believe that the ischaemic penumbra is represented by the area of
perfusion abnormality unaccompanied by DWI abnormality (i.e. PI>DWI). In the
absence of treatment, where PI>DWI, the expected behaviour of the infarct on
follow-up imaging is to grow to near the size of the PI lesion. This occurred in 100%
of patients in some studies (Sorensen et al., 1999; Karonen et al., 2000), but was as
few as 63% (Grandin et al., 2001) or 56% (Neumann-Haefelin et al., 1999).
Schlaug et al (1999) attempted to define the penumbra by measuring ADC
and CBF values in the core and the mismatch. Similar figures were obtained by Rohl
et al (2001b) (who further divided the penumbra into areas destined for infarction
and return to normal state). A simpler method was proposed by Neumann-Haefelin
et al (1999), who noted that a relative TTP delay of more than six seconds was
associated with lesion growth, but stated that "large parts of the PWI-DWI mismatch
are not 'at risk' on haemodynamic grounds."
Most studies have shown that the presence of a mismatch correlates with poor
outcome (Barber et al., 1998; Karonen et al., 1999). Many studies have used infarct
volume as a measure of outcome, but it has often been measured too early (e.g. day
four, when swelling is at its peak (Oppenheim et al., 2001) or at one week, when
fogging can be a problem (Karonen et al., 2000)), or there has been failure to account
for tissue distortion when assessing change in lesion size.
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Magnetic resonance angiography (MRA) and mismatch
Studies that combined MRA with PI and DWI showed that mismatch was
associated with major vessel occlusion (Rordorf et al., 1998; Jansen et al., 1999;
Barber et al., 1999b; Schellinger et al., 2001; Staroselskaya et al., 2001). However,
mismatch was also seen in patients without vessel occlusion (Staroselskaya et al.,
2001), and in only 70% of those with an occluded vessel in one study (Rordorf et al.,
1998). Schellinger et al (2001) found a weak correlation between initial lesion
volume and outcome, and no correlation between the mismatch ratio and outcome;
vessel occlusion was the key prognostic indicator. The key question is whether PI
and DWI adds anything beyond the MRA (or arguably simpler methods of vascular
assessment such as transcranial doppler ultrasound, or CT-angiography).
False positives and negatives of DWI
False negative DWI
In contrast to what most believe, DWI can provide false-negative information
(Yuh et al., 1999). There have been case reports of patients with negative DWI
when performed in the hyperacute phase who progress to complete stroke (Lefkowitz
et al., 1999). Several retrospective reviews found negative DWI in 17/772 (2%) (Ay
et al., 1999b), 8/139 (6%) (Oppenheim et al., 2000b), 7/62 (11%) scanned within six
hours of onset (Sunshine et al., 2001), and 18/151 (12%) patients (Lovblad et al.,
1998). False negative DWI was more common in brainstem strokes, very small
lesions, and those imaged early.
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False positive DWI
Conditions that mimic stroke may result in a hyperintense DWI lesion. False
positive DWI has been reported in partial status epilepticus (Lansberg et al., 1999),
hypoglycaemia (Hasegawa et al., 1996), cerebral venous thrombosis (Doege et al.,
2001) and transient global amnesia (Strupp et al., 1998). As there has not been a
study that has prospectively evaluated patients presenting with brain attack, the DWI
findings of other non-stroke conditions are simply not known (Keir & Wardlaw,
2000).
Transient ischaemic attacks
Ideally, imaging should tell the clinician whether symptoms are likely to
resolve (i.e., the patient will have a TIA). This is not possible with CT (Koudstaal et
al., 1992). Ueda et al (1999), Kidwell et al (1999) and Engelter et al (1999) have
demonstrated that patients with TIA can have an abnormal DWI. The latter two
studies were prospective, and most patients' symptoms had resolved at time of
scanning. Nonetheless, up to 48% of patients demonstrated typical infarct lesions on
DWI (Kidwell et al., 1999), particularly if symptoms were of longer duration.
6.5.3 Practical issues/difficulties of imaging
Patients must remain motionless in a confined and noisy environment for up
to 40 minutes to obtain good MR images. This can be a challenge for some stroke
patients. Although often recommended MR as the ideal radiological examination
(Prichard &Grossman, 1999), there is relatively little attention given to the
practicalities of MR imaging of the acute stroke patient. This section will address the




There are important hazards to MR scanning that need to be considered in
every patient. The presence of aneurysm clips, cardiac pacemakers, intravascular
wires, shrapnel or intraocular foreign bodies are absolute contraindications to
scanning, as the magnetic field may cause displacement or malfunction of the object
(Moseley, 1988). Dental prostheses containing metal need to be removed.
Radiofrequency waves can heat body tissues, which may cause symptoms in those
with large metallic prostheses such as hip replacements. How best to determine
whether an aphasic or confused patient could have an intraocular metallic foreign
body has been completely omitted from these prior enthusiastic studies. The bottom
line is that one might have to x-ray all aphasic patients, so further delaying time to
treatment (and increasing the risk of scanning).
Patient monitoring
Reliable and accurate monitoring is an essential component of the safe
examination of unwell patients (Peden et al., 1992). However, once within the
scanner, the patient is inaccessible to direct observation and monitoring (Moseley,
1988). Therefore, indirect monitoring (ECG, and pulse oximetry) is required.
Careful attention to lead placement is required to avoid burns (due to current
induction by radiofrequency waves in the monitoring leads) (Peden et al., 1992).
Monitors can generate noise that results in image degradation (Jorgensen et al.,
1994). In addition, the MR can interfere with the function of the monitor.
Asymptomatic T wave and ST segment changes on ECG (particularly leads I, II, V]
and V2) are commonly seen. Pulsing of gradients may appear as spikes on the ECG
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monitor large enough to produce an artificially elevated heart rate (Peden et al.,
1992). The pulse oximeter is the most difficult monitor to use within a magnetic
field. The signal is often degraded because of induced currents in the cable, and poor
signal/noise ratios (Peden et al., 1992).
Medical emergencies
Life-threatening emergencies are a challenge. It is impossible to manage
cardiopulmonary resuscitation in the scanner. The patient must immediately be
removed from the bore and out of the magnetic field - resuscitation trolleys and
equipment cannot be brought into the scanner (Moseley, 1988; Peden et al., 1992).
Claustrophobia
An American study of ambulant outpatients found that four percent were too
distressed to complete the procedure (Flaherty & Hoskinson, 1989). Patients
reported a variety of anxiety symptoms, which they attributed to the physical
conditions of the scanner (rather than fear of what the MR might discover). Other
studies reported frequencies of around one percent (Avrahami, 1990; Dantendorfer et
al., 1991; Sarji et al., 1998). A Malaysian study suggested that claustrophobia was
more common in the educated or those from a higher socio-economic group (Saiji et
al., 1998).
There is little doubt that the procedure is uncomfortable, and at times,
distressing for patients (Smith, 1990; Sheldon, 1996). Perhaps the best description of
the actual experience of an MR examination came from a GP who wrote in the
'Personal view' section of the BMJ:
"The bed glided slowly into the scanner, like a pizza into an
oven, foreshadowing the imagery that has haunted me since.
Despite earplugs, the knocking sounds were overwhelming.
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Time seemed endless. The roof of the tunnel was so close to
my nose that I could not move... The cheerful image of the
pizza oven soon metamorphosed into Auschwitz gas
chambers." (Rosenthal, 1996)
Other colourful reports from medically qualified colleagues have likened MR
scanning to "burial at sea" (personal communication, R. Tallis) and "being in a coffin
on a train" (personal communication, A. Walker).
Stroke patient considerations
During MR scanning, particularly where many prolonged sequences are
performed, the patient is required to lie motionless on his/her back. It is important
for the success of the scan that clear instructions are provided to (and understood by)
the patient (Moseley, 1988; Smith, 1990; Sheldon, 1996). There are certain features
of stroke patients that may place them at increased risk from MR, and/or reduce the
quality of the scan.
Impaired conscious state
This reduces the ability to explain the procedure to the patient and may
increase the patient's risk of aspiration. The International Stroke Trial (1ST)
(International Stroke Trial Collaborative Group, 1997) recruited 19,435 hospitalised
patients with a clinical diagnosis of acute ischaemic stroke within 48 hours of onset.
Overall, 23% of patients had a reduced conscious state at randomisation, but amongst
patients randomised within six hours, the frequency was 31%. When patients with
intracerebral haemorrhage are included in the cohort, the figure is higher: 41% of
patients (and 62% of those with ICH) in the Stroke Data Bank had a reduced
Glasgow Coma Scale (GCS) (Foulkes et al., 1988). Community-based stroke studies
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show similar figures - 50% in the Perth Community Stroke Study had GCS below 15
(Hankey et al., 2000).
Acute confusion (delirium)
Safety could be threatened by patient confusion, as it may not be clear that
there are contraindications to scanning, and explanation of the procedure may be
difficult. Confusion is common in stroke. Delirium may be the sole presenting
symptom of acute (often right hemispheric) stroke (Brust & Caplan, 2001). Agitated
hyperactive states may be seen after a variety of lesions (in both hemispheres) that
involve the limbic system (Brust & Caplan, 2001). 48% of patients were acutely
confused on admission, or developed an acute confusional state during the first week,
in a prospective study of 150 stroke patients with a focal neurological deficit
(Gustafson et al., 1991). The major predictors of confusion were older age, pre-
stroke dementia, previous episodes of confusion, or treatment with drugs possessing
anticholinergic effects.
Aphasia
Aphasia also interferes with the ability to explain, and understand, a complex
procedure such as MR. In the Stroke Data Bank, 31% of patients with cerebral
infarction or ICH had abnormal language (Foulkes et al., 1988). In the 1ST, aphasia
was observed in 45% of patients overall, and 54% of patients randomised within six
hours. The recovery from aphasia is often dramatic, and may occur surprisingly
quickly (Kertesz, 2001), so it is possible that studies which examine patients days




Dysphagia and aspiration are significant complications of a variety of stroke
syndromes, and predispose to chest infection and dehydration. Presumably, lying
patients flat for an MR would increase the risk of aspiration (as sitting upright whilst
eating seems to reduce the risk of aspiration (Horner et al., 1988)). Several studies
have shown that the problem of aspiration is common after stroke. Barer (1989)
found dysphagia in 29% of acute stroke patients (within 48 hours of onset),
particularly those who were drowsy or had a severe neurological deficit. In two
recent prospective studies, bedside clinical assessment identified dysphagia in 51%,
and video fluoroscopy identified aspiration in 22% of patients. Dysphagia was
associated with chest infections, and poor outcome after stroke (Smithard et al.,
1996; Mann et al., 1999).
Oxygen desaturation
Rowat and colleagues (2000) found that stroke patients have a small but
significant difference in resting oxygen saturation when compared with elderly
hospitalised patients and young healthy controls (and up to 25% had episodes where
the saturation dropped to less than 90%). In a further study, Rowat et al (2001)
demonstrated that positioning influenced the saturation - episodes of hypoxia were
seen in 10% of patients when lying flat. MR, with its long scanning times, may place
patients at risk of hypoxia.
How many stroke patients can be scanned?
It is instructive to search the many published studies for details of inclusions
and exclusions and failed scans to determine whether MR is feasible for most
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patients with acute stroke. Unfortunately, this is not revealing. A systematic review
of 84 studies of advanced MR in human stroke (up to Dec 1999) revealed that only
6/47 studies of DWI gave details of patient inclusions and exclusions, and nine gave
details of the number (and reasons for) inadequate scans (Keir & Wardlaw, 2000).
None of the 84 studies provided details of patient tolerability of MR.
Highly selectedpatients
Most studies of advanced imaging techniques recruit small numbers of
patients - a median of 34 patients for studies of DWI alone, 21 for DWI and PI (Keir
& Wardlaw, 2000). It would appear that these patients are highly selected, and may
not be representative of 'typical' acute stroke patients. For example, Baird et al's
(2000b) study of the correlation between outcome and DWI /PI lesion volume
included 18 patients from a potential 254, and a later study included only 66 patients
out of a possible 347 scanned over a five year period (Baird et al., 2001). A study of
the 'feasibility and practicality of MR imaging' (Schellinger et al., 2000) recruited
64 patients within 12 hrs of symptom onset over 2 years. During this time, the
authors estimated that 1200 patients were seen per year (i.e. <3% were scanned).
Exclusion criteria included age over 85, symptoms too mild to warrant aggressive
intervention, or obvious CT changes (which meant that the authors did not feel MR
was appropriate). Selection bias such as this limits the generalisability of many
studies reported to date.
MR failures
The failure rate of MR is crucial to determine how widely applicable the
investigation could be, but is not widely reported. It is likely that patients with poor
quality scans were excluded from analysis in many studies (Keir & Wardlaw, 2000).
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One study reported that 5/47 (11%) could not be scanned (van Everdingen et al.,
1998), and another excluded 11/57 (19%) because the images obtained were
unsatisfactory (Karonen et al., 2001). Both studies specified that they selected only
patients who they felt were stable enough to undergo imaging safely. Despite this,
patients were uncooperative or medically unstable.
Failure rates for recurrent scans are more frequently reported. For example,
Beaulieu et al (1999) completed the full scanning protocol in 13 of 21 patients, and
Parsons et al (2000) in 12 of 19 patients. Perhaps it is more difficult to recruit
patients to research studies, which may have a longer protocol, than imaging for
clinical purposes only. However, it is clear that MR scanning is difficult for many
patients, and impossible in a proportion. There has been substantial selection bias in
the studies reported, which has probably led to over-optimism about the applicability
of MR imaging.
6.6 Conclusion to Section I: Aims of Sections II and III
In section I, I have proposed brain attack as a specific term to describe the
patient who presents with symptoms of focal cerebral dysfunction within 24 hours of
onset. Current understanding of the ischaemic penumbra has driven our approach to
treating the patient as early as possible, and is the scientific rationale for the term.
The history of stroke medicine suggests that complex or redundant terminology may
be detrimental to patient care; however, brain attack fulfils a clinical need, is simple
and is now clearly defined.
A systematic review demonstrated that the bedside (clinical) diagnosis of
brain attack could be inaccurate. Conditions that mimic stroke are varied, and many
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are rarely observed in non-specialist practice. There has been little research into the
clinical clues that can help the clinician distinguish between stroke and mimic. In
addition, evidence from the International Stroke Trial suggests that the clinical
features of stroke patients who are assessed in the first few hours may be different to
the 'average' patient.
Brain imaging is an essential part of patient assessment. At the very least, a
scan is required to determine the pathological type of stroke. Evidence is emerging
that CT may be able to positively diagnose ischaemia within hours of onset, but the
signs seen are subtle, and current reliability is poor. MR has great potential to
expand our understanding of the pathophysiology of ischaemia, and may be helpful
for diagnosis and management. However, MR is not widely available, is impossible
in some patients, and substantial biases in the literature may have given an over-
optimistic impression of its value.
In the next sections I will present the results of several prospective studies
that aimed to identify the best elements of clinical assessment and brain imaging for
the diagnosis and management of patients with brain attack.
Section II: Clinical assessment ofbrain attack
Issues in the clinical assessment that I hope to address include:
• Can an observational study avoid bias and produce good quality data?
• What are the conditions that mimic stroke and how frequently do they occur?
• How accurate (i.e. sensitivity and specificity, not just positive predictive value) is
the bedside diagnosis compared with the gold standard?
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What clinical features can distinguish between stroke and mimic? Are these
features independently predictive of the diagnosis? Could a simple, streamlined
model assist the non-specialist?
What elements of the clinical assessment are most reliable?
Section III: Imaging to improve diagnosis and management ofbrain attack
Imaging issues that I hope to address include:
What are the limitations of CT in the assessment ofbrain attack?
How feasible and safe is MR in acute stroke patients?
Can a methodologically sound study produce useful data?
What is the added value of MR and should it replace CT? In particular,
- How well does MR identify mimics and haemorrhages?
- How accurately does MR diagnose ischaemia in a diverse sample of
patients?
- In what specific clinical situations should advanced MR be used?
- Does the initial MR predict outcome, and could it guide treatment?
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Table 6.1 CT signs ofearly infarction - why the confusion?
hemispheric sulcal effacement
loss of the insular ribbon
obscuration of the lentiform nucleus
midline shift
mass effect
loss of the grey-white matter junction
attenuated cortico-medullary contrast
'early infarction'
hyperdense middle cerebral artery
effacement of the cortex
hypodensity:
■ parenchymal hypodensity
■ hypodensity in <50%, 50-90%,
>90% of the middle cerebral artery
territory
■ hypodensity in <33%, >33% of the
middle cerebral artery territory
early infarct oedema (does this mean
swelling or low density?)
cortical hypodensity
local swelling
A list ofsome of the names for signs ofearly infarction cited in the literature. Most of these
signs actually describe one of two basic processes - loss of tissue density and tissue
swelling. The subject is thus further confused by the use ofmultiple poorly defined terms.
Table 6.2 Standard MR images
MR image Pulse sequence Characteristics
T1-weighted image Short TR, short TE Fat has high signal, CSF low
signal




Long TR, short TE CSF has low signal (both T1 and
T2 properties are minimised)
TR - repetition timefor radiofrequency pulses
TE - time taken for a spin echo to return
CSF - cerebrospinalfluid
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Tl-weighted images T2-weighted images Other
Normal Normal
Subtle swelling of Normal
structures








May show reduction in
signal (fogging)
High signal
Absent flow void in
affected artery
FLAIR may identify
infarcts at ~ 4 hours










FLAIR -fluid attenuated inversion recovery sequence (suppresses CSF signal)
Adapted from (Ketonen and Berg, 1997; DeLaPaz and Mohr, 1998; Yuh et al., 1999;
Wardlaw, 2001).
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Table 6.4 MR can assist in the diagnosis of rare causes ofstroke
MR appearances
'Rare' cause Specific sequence Notes





















Readily demonstrates sinus thrombosis
Infarct does not correspond to known vascular
territory, and is often haemorrhagic
May display mural haematoma
Demonstrates the distribution of the pathology
('rat's tail' stenosis)
Cortical and subcortical ischaemic lesions
commonly in the occipital regions but not confined
to PCA territory
Focal, diffuse and confluent lesions in
periventricular white matter, basal ganglia and
pons. Cortical lesions are exceptional.
Meningeal enhancement may be seen, marked
subcortical lesions with evidence of haemorrhage as
well as infarction
Lesions affect grey and white matter, not confined
to vascular territory, meningeal enhancement may
be seen (particularly in sarcoidosis)
Demonstrates collateral vessels and absence of flow
in major vessels
Demonstrates basal ganglia collateral vessels
Multiple cortical infarcts in various territories
suggests a cardiac source (although the diagnosis is
made by clinical examination and
echocardiography)
MELAS - mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes
PCA - posterior cerebral artery
CADASIL - cerebral autosomal dominant arteriopathy with subcortical infarcts and
leukoencephalopathy
Based on (Farrugia et al., 1997; Barnett et al., 1998; Warlow, 2001; Brown, 2001)
126
SECTION II
CLINICAL ASSESSMENT OF BRAIN ATTACK:
THE SCIENTIFIC BASIS OF THE ART'
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Chapter 7 : The Brain Attack study
7.1 Introduction
In this chapter, I will describe the Brain Attack study, an observational study
of a cohort of consecutive patients admitted to the Western General Hospital with
brain attack. The intention of the project was to enhance understanding of the
diagnostic process, and to produce tools which may aid the clinical (or bedside)
diagnosis and lead to its improvement. The patients who presented within the first
few hours of symptom onset will be described in more detail in Chapter 8. The
results of brain imaging, and their impact on the diagnostic process, will be described
in Section III.
7.2 Aims
The specific aims of the Brain Attack study were:
(1) To determine the conditions that caused brain attack
(2) To determine if the clinician could distinguish (at the bedside) between
stroke and mimic
(3) To examine the accuracy of the bedside diagnosis of the cause of brain
attack.
(4) To explore the reasons for disagreement between the clinical diagnosis
and the final diagnosis.
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7.3 Methods
7.3.1 Study design - methodological issues
The brain attack study was an observational study of a cohort of patients with
brain attack. As discussed in Chapter 4.3.2, observational studies of the accuracy of
the clinical (or bedside) diagnosis of stroke are prone to bias - and seven indicators
of quality were proposed (see Table 4.1). In the brain attack study, I attempted to
avoid bias by the following measures:
• Prospective study design
• Consecutive patient sample
• Avoiding restrictive exclusions
• The initial clinical assessment was made by the stroke research fellow
before the results of investigations were known
• The final diagnosis was based on the consensus opinion of a panel of
experts, who were aware of the clinical data, investigation results and
short-term patient follow-up
• The panel meetings were convened at least one week after admission
• It was anticipated that most of the patient sample would have a brain scan
7.3.2 Inclusion criteria
Defining 'brain attack'
The sole entry criterion was that the patient was admitted to hospital with a
brain attack. I defined a brain attack as:
"Apparently focal brain dysfunction ofapparently abrupt onset"
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The word apparently was chosen to prevent a rigid interpretation of the key
terms focal brain dysfunction and abrupt onset. Focal brain dysfunction could be a
symptom or a sign. The aim was to assess as many patients as possible, rather than
restrict numbers to patients who could provide a good account of their symptoms
(which would not reflect clinical reality).
Patients are often sent in to hospital, or admitted to the ward, with a diagnosis
of "?Stroke", which may be the principal diagnosis, or one of a long list of
differential diagnoses. Unless these patients had symptoms of a brain attack, they
were not included in the study. For example, a patient with reduced mobility and
difficulty coping at home - a common "?stroke" referral - was not considered a brain
attack. This ensured that patients were selected on the basis of clear, pre-specified
criteria, rather than depending on the referring clinician's skill (or lack thereof). In
turn, this could make the results of the study applicable to other centres.
There were no other exclusion or inclusion criteria; in particular, the patient
did not need to have a neurological deficit when first seen, there were no age limits,
and a patient could be included more than once (if he/she represented with a further
brain attack). In this thesis, subarachnoid haemorrhage was not considered to be a
brain attack or a stroke and will not be discussed further.
Time limits
I did not set time limits for patient recruitment, although I tried to see them as
soon as possible. Although the concept of 'brain attack' applies best to patients
presenting within hours of symptom onset, around half present to the Western
General Hospital later than six hours (Johnston et al., 1999). By taking all patients, I
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hoped to study the full spectrum of stroke and its mimics, and determine if time was
a factor in the ease of diagnosis.
7.3.3 Case ascertainment
Source of patients
There were five potential areas to which eligible patients could be admitted.
(1) Acute Receiving Unit (ARU)
Most patients with brain attack are admitted to the Western General Hospital
through the ARU. This department assesses patients with acute emergencies that are
not trauma (e.g. myocardial infarcts). Patients can be referred to ARU by their
General Practitioner (GP) or by ambulance (if the GP practice the patient is
registered with is in the northern zone of Edinburgh). The main emergency
department that accepts all patients (trauma, self-presentation, and GP referrals from
the southern zone of Edinburgh) is located at the Edinburgh Royal Infirmary.
(2) Acute Stroke Unit
After assessment by ARU medical and nursing staff, a patient with brain
attack could be admitted directly to the 10-bed Acute Stroke Unit (later enlarged to
16 beds at the end of patient recruitment) during working hours. One of two stroke
consultants (Drs Dennis or Lindley) reviewed each new admission during daily ward
rounds.
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(3) Acute Medical Assessment Unit (ward 26)
If outwith working hours, or if no beds were available on the stroke unit,
patients were admitted to ward 26. Patients were then transferred to the acute stroke
unit after review by a stroke research fellow or stroke consultant.
(4) Department ofClinical Neurosciences (DCN)
The Western General Hospital is the site of Edinburgh's regional
neuroscience service (DCN). Patients could be admitted directly to DCN, thus
bypassing ARU. Typically, these were patients who presented to another hospital
and were found to have had an intracerebral haemorrhage (admitted to
neurosurgery), or were young stroke patients (admitted under neurology).
(5) Other medical/surgical specialty units
Patients known to another specialty could be admitted directly to their parent
unit (e.g. a patient with known malignancy may be referred by the GP directly to
oncology), or could have a brain attack whilst in hospital for another reason.
Identification of study patients
Direct referral
Multiple overlapping sources were used to ensure that all patients with brain
attack were identified. ARU medical and nursing staff were encouraged to refer any
potential patients upon their arrival. We carried a hospital bleep, placed posters in
ARU, and maintained daily contact with medical and nursing staff to remind them of
the project. Referrals were aided by the fact that (1) there was no NHS stroke
registrar, and (2) we were able to assess the patient, take bloods, order brain imaging
and arrange a bed, thus providing a strong incentive to the NHS ARU staff to refer
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all possibly eligible patients. Consequently, during working hours, we saw most
patients with brain attack.
Patients admitted outwith working hours
Patients admitted on weekends or outwith working hours were identified the
following working day by inspection of the ARU admission register each morning.
The ARU admission register contained a brief description of the patient's complaint
(e.g. left arm weakness). We retrieved the filed medical notes for patients of interest
- all those with a description that suggested brain attack, and all non-specific
descriptions ('off legs', 'confused', 'unwell', 'decreased mobility' etc). The stroke
research fellow read through the medical notes searching for features suggesting a
brain attack. Doubts about the suitability of the patient were resolved by discussion
at the time (but in general we aimed to see as many patients as possible). Patients
identified in this manner were then assessed on the ward.
Overlapping sources
The admission registers of the Acute Medical Assessment Unit and the Acute
Stroke Unit were also inspected daily to ensure that no patients were missed.
Medical staff from other wards were encouraged to refer patients to the stroke
research fellows. The stroke consultants (Drs Dennis and Lindley) notified us of any
patients referred directly to them. One stroke research fellow attended the morning
DCN x-ray meeting (during which all brain imaging from the previous day is
reviewed), thus covering direct admissions to DCN.
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7.3.4 Stroke research fellows
Four research fellows participated in this study. The majority of assessments
were to be performed by the author (PJH) and Dr J Kwan (who was recruiting
patients for his own study - data collected were shared). Dr S Keir assessed patients
in the early part, and Dr B Lamont assessed patients in the latter part of the study.
When this study commenced, PJH and BL were fully trained neurologists
undertaking sub-specialty training in stroke medicine. PJH trained in Australia and
UK, BL trained in Belgium. JK and SLK were UK trainees in general internal
medicine / care of the elderly, who had both performed stroke research for two years.
JK was five years post registration, SLK was nine years post registration.
7.3.5 Patient assessment and data collection
Bedside clinical assessment of the patient with brain attack
The stroke research fellow performed a detailed patient assessment, and
completed an acute assessment data form (see Appendix 2). The important elements
of the bedside clinical assessment were:
Past medical history - included standard vascular risk factors, prior stroke or
TIA, and risk factors I suspected would increase the likelihood of a stroke mimic
(cognitive impairment, migraine, epilepsy, malignancy and psychological
disturbance).
History of the present event - included the nature of the neurological
symptoms, and any accompanying symptoms (such as loss of consciousness, or
vomiting, which increase the likelihood of haemorrhage). There was particular
emphasis on timing. I wanted to determine how often the exact time of onset was
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known (and why it was not known). I wanted to validate a popular clinical rule of
stroke diagnosis [that if the patient cannot recall exactly what he/she was doing at the
time symptoms came on, then the cause is unlikely to be vascular (Warlow et al.,
1987)]. I reasoned that patients were more likely to have a mimic if they had been
unwell in the week before symptom onset.
General examination - this assessed vascular risk factors (atrial fibrillation,
cervical bruits), as well as signs in other systems. I assessed conscious level with the
Glasgow Coma Scale (GCS) and the Reaction Level Scale (Starmark et al., 1988)
(see Appendix 3). Two scales were used as the verbal component of the GCS may
be difficult to determine in the presence of aphasia (Johnstone et al., 1993; Prasad &
Menon, 1998). In patients who were alert and not aphasic, I assessed for acute
confusion by testing orientation and attention (days of the week backwards), as
suggested by Hodges (1994).
Neurological examination - included the National Institutes of Health Stroke
Scale (NIHSS, see Appendix 2, pp6-7) and additional elements of the neurological
examination not covered by the NIHSS (e.g. plantar response). The NIHSS was
downloaded from the Internet Stroke Centre (http://www.strokecenter.org/trials/scales/)
and modified to fit onto two sides of paper.
Diagnostic formulation - the examiner made a bedside diagnosis before
assessing the patient (the 'end of bed assessment'), after taking the history, and at the
end of the clinical assessment. The examiner assigned the Oxfordshire Community
Stroke Project (OCSP) sub-classification at the end of the assessment (after Bamford
et al (1991), see Appendix 3). I also collected information about tests that could bias
the examiner, and details that could suggest a non-stroke diagnosis (e.g. if the signs
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did not conform to vascular territory, or if there was discrepancy between symptoms
and signs).
Difficulty in obtaining the history - the source of the history, any
corroborating sources, and inconsistencies between sources was noted, as I felt these
factors could result in an incorrect bedside diagnosis.
Form design and modification
The data collection form was designed to record the data obtained by the
bedside clinical assessment. The forms were discussed at a research group seminar,
and then piloted for several weeks before the study commenced. Further form
modifications were required approximately one month into the study (see results).
7.3.6 The final diagnosis
Determining a gold standard for the diagnosis of stroke is difficult
(D'Olhaberriague et al., 1996). Whilst autopsy would be ideal, only 20% of patients
actually die from the acute effects of a stroke, and it is increasingly difficult to obtain
consent for autopsy (post Alder Hey scandal). Computerised tomography (CT) brain
scans can be performed in almost all stroke patients, but are normal in around 50% of
definite strokes (Hand & Wardlaw, 2001). Magnetic resonance (MR) brain scans
cannot be used in all patients with stroke.
In the brain attack study, a panel of stroke experts determined the gold
standard diagnosis by consensus. The research fellow gave the panel the clinical
details, anonymised so that the clinician could not be influenced by any memory they
might have of caring for that patient. Then the brain imaging was reviewed, and
results of any further relevant investigations were discussed (all anonymised). If
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there was still no consensus, the patient's identity was revealed so that the panel
could receive detail of the patient's progress in hospital, and corroboration of the
clinical details by the stroke consultant who had seen the patient.
'Expert panel' meetings
The panel met weekly to discuss the cases (see Figure 7,1). A minimum
number of panel members was arbitrarily set at two consultant geriatricians (Drs
Lindley, Dennis or Mead), one consultant neurologist (Professors Sandercock and
Warlow), one consultant neuroradiologist (Professor Wardlaw), and two research
fellows (PJH, JK, BL, SLK, Dr Sudlow). It was important to have several clinicians
present as the final diagnosis was determined by consensus.
Figure 7.1 Some ofthe experts at a panel meeting
Meetings were held every Wednesday afternoon, and proved to be both educational and
entertaining. From left to right: PJH, Dr C Sudlow, Prof. C Warlow, Dr M Dennis, Dr R
Lindley, Dr S Keir. Photographed by JK.
The panel was asked to make a diagnosis after the history, then the
examination, then the imaging, and then a final diagnosis (when all clinical details
and investigation results were known). The brain imaging findings were recorded on
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a standard form (Appendix 4). The diagnoses, plus any detail on the subtype of
stroke (e.g., lacunar, striatocapsular or lobar haemorrhage), were recorded on the
final diagnosis form (Appendix 5).
Definitions for the panel diagnoses
A definite non-stroke was diagnosed when the clinical details did not suggest
a vascular aetiology, and another convincing explanation for the symptoms was
discovered (often requiring supportive investigations, e.g. a brain tumour). A
definite stroke was diagnosed when the history and examination were considered to
be completely typical of a stroke; often imaging revealed an infarct or haemorrhage,
but this was not essential. A probable stroke was defined as clinical features
consistent with a vascular aetiology, with no better alternative explanation. A
possible stroke was defined as clinical features that could be consistent with a
vascular cause. An alternative explanation for the clinical syndrome may have been
present, and may have been more likely than stroke, but there was no definite proof
of a non-stroke. A definite transient ischaemic attack was defined as an appropriate
clinical syndrome with full resolution of symptoms within 24 hours. A possible
transient ischaemic attack was a less convincing clinical syndrome that resolved
within 24 hours, with no definite proof of another cause for the patient's symptoms.
These diagnostic categories were somewhat arbitrary, and probably differed
between clinicians. However, consistency was achieved by maintaining a similar
number and type of clinician at each meeting, and by resolving differences by
discussion so that a consensus was obtained.
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7.3.7 Sample size
An approximate sample size for this study was determined by several factors.
The systematic review of stroke mimics (Chapter 4.2) suggested that a mimic rate of
around 20% could be anticipated. The confidence intervals (CI) for a 20% mimic
rate are determined by the number of patients seen. If 100 patients are seen, the 95%
CI ranges from 12.7% to 29.2% mimic rate; if 300 patients are seen, the 95% CI is
15.5-24.5%, and if 400 patients are seen, the 95% CI is 16.1-23.9%.
There are approximately 250 admissions to the acute stroke unit per year
(personal communication, Dr Martin Dennis). I aimed to recruit patients into the
brain attack study for 12-18 months, thus 300 patients was judged to be a practical
number. [This number would also be suitable for logistic regression analyses, which
will be discussed in Chapter 10.]
7.3.8 Ethics and consent
The chairman of the local ethics committee of the Western General Hospital
approved the study. Where possible, consent to participate in the study was obtained
from the patient or a close relative. Where obtaining consent was impossible (i.e. a
small number of patients who were confused or unconscious), the patient was seen
and the data obtained was handled in accordance with the Scottish Data Protection
Act (2000).
7.3.9 Data management
Data collected and recorded by the research fellow at the bedside were
entered into a database (designed and developed in-house by Neurosciences Trials
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Unit Senior Programmer, Ms Vera Soosay). Every entry was double-checked to
minimise inaccuracies. Any errors identified were remedied by referring to the
original paper data forms, hospital case notes, or discussion with the relevant
research fellow. Changes to the data were made prior to analysis.
Once patient recruitment and data checking were complete, the data were
anonymised and transferred to a Microsoft Excel spreadsheet (version 97 SR-2,
©Microsoft Corporation 1997). The original paper files (with no patient identifiable
details on the cover) were kept in locked, fireproof cabinets.
7.3.10 Statistical analyses
'Patient-episodes' and 'patients'
The same patient could be recruited into the study several times. Each
hospital admission was defined as an episode (i.e. the episode commenced when the
patient was admitted, and ended when the patient was discharged). Multiple
presentations by the same patient has implications for the analysis of the data. In the
results, I refer to 'patient episodes' as the recruiting event or brain attack, and
'patients' as the true number of patients. I restricted analysis of demographic data
and past medical history to the number of patients, as these items are constant (whilst
the features of the event that led to recruitment - history of the complaint,
examination findings - are unique, no matter how many times that patient presents).
'Collapsing' the final diagnostic categories
The six final diagnostic categories were dichotomised to allow easier analysis
of the data, and to ensure adequate numbers in each category. However, it was not
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possible at the panel meetings to be definitive about every event, which made
dichotomising difficult. The major difficulties were (a) what to do with possible
events, and (b) how to treat transient ischaemic attacks (TIA).
Definition of 'thrombolysis-eligible' brain attack
A clinically sensible solution was to define the 'target' population as brain
attacks that would be 'thrombolysis-eligible'. I have used this term purely to denote
the level of diagnostic certainty that a clinician would require before considering
treating a patient with thrombolysis. Only if the clinician were sure that the
diagnosis was definite or probable stroke would a risky treatment then be
contemplated. In this study, definite or probable strokes were considered
'thrombolysis-eligible.'
Naturally, all other conditions would have to be favourable (timing, severity
of deficit etc) for that patient to actually receive treatment; but the starting point in
the decision process is that the clinician is reasonably certain that the diagnosis is
stroke. In the present study, it is used to denote the diagnostic certainty, thus a
patient labelled as 'thrombolysis-eligible' may not be once other factors were
considered.
The clinician would wish to avoid thrombolysis for brain attacks due to a
non-stroke, or possible strokes. This group, therefore, constituted the "mimic"
group. I treated patients with a final diagnosis of TIA as if they were strokes (i.e.
definite TIA became "thrombolysis-eligible", possible TIA became "mimic").
Patients with a definite TIA would presumably be 'thrombolysis-eligible' if they
presented early enough and were still symptomatic.
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The other possible way of analysing the data was to dichotomise the groups
into definite non-stroke and all other stroke. This may be acceptable if the purpose
of separating the two groups was to provide a relatively safe intervention (such as
admission to a stroke unit, or scanning within 24 hours). However, thrombolysis can
be hazardous, so one would only wish to treat patients one was reasonably certain
had a stroke. As an underlying aim of this research was to increase the proportion of
patients receiving thrombolysis, I elected to divide patients into 'thrombolysis-
eligible brain attacks' and 'stroke mimics'.
Statistical packages
Data analyses were performed using Microsoft Excel (version 97 SR-2,
^Microsoft Corporation 1997), SPSS for Windows (version 10.0.5, @SPSS Inc.
1999), Review Manager (version 4.1, ®Wintertree Software Inc. 1997) and
(6)
Confidence Interval Analysis (version 1.0, Martin J Gardner and British Medical
Journal, 1989) statistical programs.
Statistical tests
To determine if the data were normally distributed, histograms were plotted
and inspected visually, and the Kolmogorov-Smirnov test of normality was
performed. If normally distributed, the continuous data were presented using the
mean, standard error of the mean, and the range. If the distribution was not normal,
then data were presented as median and interquartile range. Standard parametric and
non-parametric tests of significance were performed on the data (as appropriate).
The odds ratio (OR) [with 95% confidence intervals (95% CI)] was calculated for
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dichotomised data. More detailed statistical methods will be discussed in the
relevant sections.
7.4 Results
Patient recruitment commenced on 24/7/00, and was completed on 30/4/01.
During this time, there was a break in recruitment from 14/11/00 - 7/1/01 (for
conferences and holidays). Total duration of patient recruitment was 33 weeks (754
months). During the study period, there were 350 presentations of brain attack by
336 patients. Eight patients presented twice, and three patients presented three times.
7.4.1 General characteristics
General Description
The general characteristics of the patient-episodes are detailed in Table 7.1.
321/350 (92%) entered hospital through ARU, and a small number had in-hospital
brain attacks (n=14, 4%) or were admitted directly to another ward (n=15, 4%). The
median time of admission was 4.7 hours, with 187 patient-episodes (57%) admitted
within six hours of onset (see Figure 7.2). 209 (62%) of ARU admissions were in
working hours, yet the median time between symptom onset and evaluation by the
research fellow was 25.8 hours. Only 56 patient-episodes were assessed by the
research fellow within six hours of symptom onset (see Figure 7.3). 213 (61%)
patient-episodes of brain attack were initially admitted to a general ward (many were
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Figure 7.2 Time to presentation at hospital in the brain attack study (n=330)
15 episodes were inpatient brain attacks, details of onset unknown in four, details ofARU
arrival unknown in one.
Table 7.2 shows the demographic details of the patients recruited into the
brain attack study (n=336). I used the data from the first presentation for the 11
patients recruited more than once. 297/336 (88%) of patients had one or more
vascular risk factor. 129/323 (40%) of patients had a previous brain attack, and in
69/129 (53%) symptoms had completely resolved before the current admission.
Despite this, only 7% of patients were unable to walk independently prior to
admission. A small number of patients had a proposed risk factor (migraine,
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Time from onset to assessment
Figure 7.3 Timefrom onset to assessment by the stroke research fellow
Onset details unknown forfourpatients
For all patient-episodes of brain attack (see Table 7.3), an exact onset of
symptoms could be determined in 247/350 (71%) patients. Almost 1/3 first noticed
symptoms on waking from sleep. 112 (32%) presentations had blood pressure
greater than 150/90 mmHg, and 72 (21%) were found to be in atrial fibrillation on
admission. When examined by the stroke research fellow, 92/256 (36%) were
confused (either because of errors in orientation or attention), but 236/350 (67%)
were documented to have a normal GCS. 47/350 (13%) presentations had no
neurological signs at the time of examination by the stroke research fellow.
There were a small number of patients in whom presence or absence of each
variable was unknown. These were patients who were confused, or aphasic and
other reliable sources of history were unavailable.
At the time of assessment by the research fellow, results of investigations
were available in 287/350 (82%) patient-episodes [blood sugar level alone (n=87),
ECG alone (n=33) both tests (n=166), or the MSU result (n=1)]. These were tests
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performed immediately in ARU by nursing staff as part of their 'suspected stroke'
protocol.
I did not record whether the research fellow was aware of the brain imaging
result, as I anticipated that almost all patients would be seen either before scanning,
or before a report was available. I estimate that fewer than 15 patients were assessed
in knowledge of the brain imaging. The proportion of the sample that underwent
brain imaging was 302/350 (86%), and two additional patients had imaging of the
spine, which was diagnostic. [The imaging findings, and reasons patients were not
scanned, will be discussed in Chapter 11].
Expert panel meetings were held at a median of 20 days after admission
(interquartile range (IQR): 14-43 days), with a median seven doctors present at
each meeting (IQR: 6-8 doctors).
Data form modifications
Three revisions were made to the initial data collection form, with the last
revision made on 30/8/00. Approximately 40 patients were enrolled prior to the final
alteration to the data form. The major changes were:
• Additional diagnostic categories (expanded to include definite, probable
and possible stroke and non-stroke).
• An approximate time and date of onset (when exact time could not be
determined).
• Clarification of whether there were any focal neurological symptoms, and
which side they affected.
• Describing the neurological signs for both sides of the body (I had hoped
to keep this simple by referring only to the symptomatic side, however
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this proved unworkable as some patients had bilateral signs, or old signs
on the unaffected side).
• Clarification of whether there were no signs present at the time of
examination
The data form was densely packed and initially not easy to use. For the first
75 or so patients, several questions were continually unanswered due to poor form
layout (e.g., 'Can patient or relative recall time of onset?'; 'Does the patient have an
overwhelming comorbid condition (making assessment difficult)?'; 'If so, can the
patient be engaged (follow your face)?'). However, these data were easily extracted
from other sources. Two questions were discarded: (1) 'Evolution to maximal deficit
took:' was left blank 113 times and given a time of zero minutes 167 times,
reflecting the difficulty in answering this question. I asked the research fellow to
record the number of minutes it took to reach maximal deficit, but in retrospect if
would have been simpler to use categories (e.g. 'maximal at onset', 'evolved over
minutes' and so on). (2) 'Visuospatial dysfunction' had too many alternatives, and
was confusing and unreliable (the NIHSS 'neglect' section was used instead).
7.4.2 What conditions cause brain attack?
350 presentations with brain attack were studied. The final diagnoses, as
determined by the expert panel, for the 350 brain attacks are detailed in Table 7.4.
In Figure 7.4, the six diagnostic categories were collapsed into vascular, non¬
vascular and uncertain causes. The majority of brain attacks were almost certainly













Vascular cause Uncertain cause Stroke mimic
Final diagnosis of cause of brain attack
Figure 7.4 Final diagnosis of the
causes ofbrain attack
Definite non-strokes
A definite non-stroke accounted for 65 brain attacks (18.6%) in 61 patients
(see Table 7.5). The most common mimic was seizure (n=13); 7/13 patients had
known epilepsy, whilst 2/13 had prior stroke and 2/13 had known dementia. 10
patients were found to have a space-occupying lesion: seven primary brain tumours
(glioblastoma multiforme in five patients, meningioma in two); two patients with
cerebral metastases, and one patient with a subdural haematoma. Eight brain attacks
were due to sepsis, with chest infection the most common site (n=4). 2/8 patients
had a prior history of stroke, and 2/8 were known to have dementia. Toxic/metabolic
disturbance accounted for eight brain attacks, 4/8 due to hypoglycaemia, 1/8 due to
hyperglycaemia. There were three presentations with acute facial nerve palsy, and
one presentation with sciatic nerve palsy. Three brain attacks were labelled as acute
confusional state as there was no more definitive diagnosis. In two of these patients,
there was a clear history of dementia, and in the remaining patient, dementia was
suspected but had not been formally confirmed. The spinal cord lesions were
metastatic cord compression (n=2), and infection resulting in deterioration of cervical
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myelopathy. The five miscellaneous causes were Parkinsonian syndrome (n=l),
migrainous aura (n=l), subarachnoid haemorrhage (n=l), transient global amnesia
(n=l) and dementia (n=l). Overall, 20/61 (32.7%) patients with a mimic had
suffered an earlier stroke (with symptoms completely resolved in 11/20), and 12/61
(19.7%) were known to have cognitive impairment.
'Stroke mimics'
There were 48 presentations of brain attack where the expert panel could not
determine the definitive cause of the symptoms. As these patients may have had a
stroke, they were labelled as possible stroke (or TIA). However, in all but four
episodes, there was an alternate, plausible non-stroke diagnosis. If these patient-
episodes are combined with the definite non-strokes, there were 109/350 (31.1%)
brain attacks that were probably NOT due to a vascular cause. The combined list of
stroke mimics is detailed in Table 7.6. The major difference between this table and
Table 7.5 is the seven patients with vestibular dysfunction — the expert panel were
unable to make a definitive diagnosis of a non-vascular aetiology in any of these
patients.
Overall, there were 109 presentations with brain attack by 106 patients whose
current medical problem was not cerebrovascular disease. 44/106 patients (41.5%)
had suffered an earlier stroke (with symptoms completely resolved in 19/44), and
27/106 patients (25.5%) were known to have cognitive impairment. 62/109 (56.9%)
mimics were neurological conditions, and in a further 20 mimics (syncope,
confusional state, dementia), neurological conditions were amongst the differential
diagnoses.
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7.4.3 Can the clinician distinguish between stroke and mimic at the
bedside?
In this section, the aim was to determine the clinical features that could allow
the clinician to distinguish between a 'thrombolysis-eligible' brain attack and a
mimic at the bedside. The category of 'thrombolysis-eligible' brain attack made the
assumption that all other conditions - timing, severity, absence of contraindications,
etc. - were favourable. The possible stroke events with no alternate, plausible non-
stroke diagnosis were included in the 'thrombolysis-eligible' group.
General features
There were 241 presentations with a thrombolysis-eligible brain attack from
237 patients, and 109 presentations with a stroke mimic from 106 patients. Seven
patients had at least one thrombolysis-eligible brain attack and a stroke mimic. I
have compared the characteristics of the two groups to identify factors/variables that
might help distinguish them on first assessment. In the following sections I present
the results of the univariate analyses (multivariate logistic regression will be
discussed in Chapter 10).
The two groups had similar age, gender, and time from onset to presentation
(see Table 7.6). Each research fellow examined a similar proportion of patients in
each group. The main differences related to stroke severity. Patients with
thrombolysis-eligible brain attacks had a higher NIHSS score (p<0.01, Mann-
Whitney U), and were more likely to present with signs that could be classified by
the OCSP classification [particularly total anterior circulation syndrome (TACS) or
lacunar syndrome (LACS)] (p<0.01, Mann-Whitney U). Fewer patient-episodes of
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stroke mimic received a brain scan (72/109, 66%) than thrombolysis-eligible brain
attacks (232/241, 96%, p<0.01, Mann-Whitney U).
History items
The history component of the clinical assessment was divided into past
history and history of the presenting complaint. For past history, patients' details
were included only once (n=343 patients). Three items reached significance
(p<0.05) (see Figure 7.5): known cognitive impairment favoured a mimic (Odds
Ratio (OR) 0.4, 95% confidence intervals (95% CI) 0.2-0.7); ischaemic heart disease
(OR 1.8, 95% CI 1.0-3.1) and peripheral vascular disease (OR 3.5, 95% CI 1.2-10.3)
favoured a thrombolysis-eligible brain attack. Confidence intervals for peripheral
vascular disease were wide, reflecting its low frequency (only 29/218 (13%)
thrombolysis-eligible events). The other vascular risk factors - hypertension,
diabetes, smoking and atrial fibrillation - did not distinguish mimic from stroke. The
conditions thought likely to predispose to a mimic - migraine, epilepsy, known
malignancy and psychological disturbance - did not prove to be helpful (due to low
frequency; there was a trend for these factors to favour a mimic). Similarly, there
was a trend for previous stroke to favour the possibility that the current event was a
mimic, but this did not reach significance (OR 0.6, 95%CI 0.4-1.0). Patients with
walking difficulties before the event might be at higher risk of a stroke mimic (e.g.,
sepsis leading to further deterioration in gait may simulate a stroke), however this
was observed infrequently (5.5% of strokes, 9.5% of mimics) and so was not a useful
distinguishing factor.
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TPA-eligible event Mimic OR OR
n/H n/N (95%CI Fixed) (95%CI Fixed)
1+ mig, ep, mlg, psy 51 /237 32/106 0,63[0.38,1.06]
cognitive impairment 28 / 230 27 /103 0.39(0.22,0.70]
walking problems 13/234 10/105 0.56[0.24,1.32]
Ever smoked 123 / 213 51 / 96 1.21 [0.74,1.96]
IHD 79/231 22/98 1.80[1.04,3.10]
Hypertension 121 / 233 45/99 1.30[0.81,2.08]
Diabetes mellitus 26/233 15/101 0.72[0.36,1.43]
Hx of AF 47/229 18/99 1.16[0.64,2.12]
PVD 29/218 4/96 -.3 53[1 nn 1 n 341
Focal neurol deficit 87 / 231 48/99 0.64(0.40,1.03]
.1 .2 1 5 10
Favours mimic Favours TPA-eligible
Figure 7.5 Past medical history: features that distinguished 'thrombolysis-eligible' brain
attack from stroke mimic
TPA-eligible - 'thrombolysis-eligible' assuming all other conditions werefavourable
1+ mig, ep, mlg, psy - one or more of migraine, epilepsy, malignancy or psychological
disturbance
IHD - ischaemic heart disease
Hx ofAF - history ofatrialfibrillation
PVD - peripheral vascular disease
Data for the history of the presenting complaint were available for all 350
brain attacks. I have broken this down into general or associated symptoms (Figure
7.6) and the specific neurological symptoms (Figure 7.7). General symptoms that
favoured a 'thrombolysis-eligible' brain attack included (Figure 7.6): the patient
complained of definite focal symptoms (OR 16.5, 95% CI 7.0-38.6); an exact time of
onset could be determined (OR 2.5, 95% CI 1.6-4.1); the patient could recall exactly
what he/she was doing at the time of onset (OR 2.2, 95% CI 1.4-3.6), and the patient
was well in the week before symptom onset (OR 2.5, 95% CI 1.6-4.0). General
symptoms that favoured a mimic were: loss of consciousness (OR 0.3, 95% CI 0.2-
0.5); seizure (OR 0.3, 95% CI 0.1-0.6), and still being able to walk after symptom
onset (OR 0.5, 95% CI 0.3-0.8). Headache proved to be more common in those with
a stroke (78/216, 36%) than those with a mimic (22/95, 23%), and actually favoured
the diagnosis of stroke (OR 1.9, 95% CI 1.1-3.3).
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TPA-eligible euent Stroke mimic OR OR
n.'H n/tl (95%CI Fixed) (95%CI Fixed)
Exact time be detd 185/241 62/109 2.50[1.55,4.06]
wake from sleep 64/192 14/62 1.71 [0.38,3.34]
recall what doing 152 / 237 48 /108 2.24[1.41,3.55]
well last week 163 / 241 48 /106 2.53[1.58,4.031
definite focal sx 234/241 73 /109 —►16.49[7.04,38.62]
can walk now 84/238 56/108 0.51 [0.32,0.80]
LOC 25/234 28/94 0.28[0.15,0.52]
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Figure 7.6 History of the presenting complaint: features that distinguished 'thrombolysis-
eligible' brain attack from stroke mimic
TPA-eligible - 'thrombolysis-eligible' assuming all other conditions werefavourable
detd - determined
sx — symptoms
LOC - loss ofconsciousness
Focal neurological symptoms favoured a thrombolysis-eligible event (figure
7.7). In particular, visual loss, loss of speech/language, abnormal facial sensation,
arm weakness and/or abnormal sensation, hand weakness and/or abnormal sensation,
and leg weakness and/or abnormal sensation were all significant (p<0.05). A mimic
was strongly suggested if the symptoms could not be lateralised to one side of the
body (OR 0.18, 95% CI 0.11 -0.30).
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TPA-eligible euents Stroke mimic OR OR
n/N n/N (95H.CI Fixed) <95%CI Fixed)
visual loss 28/241 2/109 7.03[1.64,30.08]
diplopia 7/241 2/109 1,60[0.33,7.83]
loss speech/lang 131 / 241 30/109 3.14[1.92,5.12]
loss balance 33 / 241 12/109 1,28[0.63,2.59]
vertigo 10/241 9/109 0.48[0.19,1.22]
face weakness 57 / 241 16/109 1.80[0.98,3.31]
face sens abN 25/241 2/109 6.19[1.44,26.63]
arm weakness 156/241 24/109 6.50[3.85,10.98]
arm sens abN 44 / 241 10/109 2.21 [1.07,4.58]
hand weakness 148/241 17/109 8.61[4.83,15.36]
hand sens abN 56 / 241 10/109 3.00[1.46,6.13]
leg weakness 135/241 29/109 3.51 [2.14,5.76]
leg sens abN 37 / 241 8/109 2.29(1.03,5.10]
no lateralising sx 37 / 241 55/109
1
0.18[0.11,0.30]
.01 .1 1 10 100
Favours mimic Favours TPA-eligible
Figure 7.7 Focal neurological symptoms: features that distinguished 'thrombolysis-
eligible' brain attack from stroke mimic
Note - scale 0.01 -100 (ten times larger than otherfigures)
TPA-eligible - 'thrombolysis-eligible' assuming all other conditions werefavourable
Sens abN- sensory abnormality
sx - symptoms
Examination items
General examination findings were available for all 350 patient episodes (see
Figure 7.8). The finding of hypertension (systolic blood pressure greater than 150
mmHg, or diastolic blood pressure greater than 90 mmHg) was associated with
stroke (OR 1.7, 95% CI 1.1-2.7 and OR 2.0, 95% CI 1.2-3.2, respectively), as was
valvular heart disease (OR 2.7, 95% CI 1.2-5.9), although this was observed
infrequently. Abnormal physical findings in other systems (OR 0.5, 95% CI 0.3-0.8)
or confusion (OR 0.5, 95% CI 0.3-0.8) favoured a mimic.
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Figure 7.8 General examination: features that distinguished 'thrombolysis-eligible' brain
attackfrom stroke mimic
TPA-eligible - 'thrombolysis-eligible'
SBP - systolic blood pressure; DBP - diastolic bloodpressure; 02 sat - oxygen saturation
Cx bruit - cervical bruit
Valv hrt dis - valvular heart disease
CCF - congestive cardiacfailure
Absent PPs - absent peripheralpulses
AbN signs other syst - abnormal signs in other (non-neurological or vascular) systems
Decreased LOC - decreased level ofconsciousness
On neurological examination (see Figure 7.9), impaired comprehension,
oculomotor cranial nerve palsy, nystagmus, lower limb ataxia and reflex asymmetry
were not statistically significant distinguishing factors. All other neurological signs
strongly suggested a thrombolysis-eligible brain attack. The most common findings
were arm weakness (162/237, 68%), hand weakness (158/237, 67%), abnormal
verbal output (146/241, 61%) and leg weakness (128/238, 54%). A unilateral
extensor plantar response was a common finding (117/235, 50%) and a useful sign
suggesting a thrombolysis-eligible stroke (OR 2.6, 95% CI 1.6-4.3). Even
uncommon findings such as visual inattention (39/223, 17%) or eye deviation
(23/239, 10%), proved to be useful discriminators as they were rarely seen in the
mimics (4/101, 4% and 1/109, 1%, respectively).
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TPA-eligible euents Stroke mimic OR OR
nit n/N (95%CI Fixed) (95%CI Fixed)
Impaired comprhsn 45 / 239 17/106 1.21 [0.66,2.24]
AbN verbal ouput 146 / 241 45 /109 «— 2.19[1.38,3.46]
Slurred speech 75 1241 11 /109 4.03[2 04,7 .95]
Hemianopia 64 / 227 5/105 7.85(3.06,20.17]
Visual inattention 39 1223 4/101 5.14(1.78,14.81]
Eye deviation 23/239 1 /109 11 50(1 53 86 3fll
III, IV, VI palsy 10/235 1 /108 4 7fir0 60 37 631i . f U[U .UU ' 1 .UJJ
Facial asymmetry 110/234 26 /106 2.73(1.64,4.55]
Arm weakness 162/237 28 /106 6.02(3.61,10.03]
Hand weakness 158/218 31 /100 5.86(3.49,9.84]
Leg weakness 128 / 236 28/105 - 3.26(1.97,5.39]
Sensory loss 80 / 224 17/100 -• - 2.71(1.51,4.89]
Visuospatial dysfn 95 / 241 18/109 3.29(1.86,5.80]
Nystagmus 18 / 236 5/107 1.68(0.61,4.66]
UL ataxia 25 /196 4/90 3.14(1.06,9.32]
LL ataxia 24 /191 5/88 2.39(0.88,6.48]
Reflex asymmetry 46 / 240 13/109 1.75(0.90,3.40]
Extensor plantar 117/235 30/109 -• 2.61 [1.60,4.27]
1 1
.01 .1 10 100
Favours mimic Favours TPA-eligible
Figure 7.9 Neurological signs that distinguished 'thrombolysis-eligible' brain attack from
stroke mimic
Note - scale 0.01 -100 (ten times larger than otherfigures)
TPA-eligible - 'thrombolysis-eligible'
AbN verbal output - abnormal verbal output
III, IV, VIpalsy - oculomotor, trochlear or abducens cranial nerve palsy
dysfn - dysfunction
UL - upper limb, II - lower limb
Diagnostic Formulation
Strong pointers towards a mimic were the absence of neurological signs (OR
0.04, 95% CI 0.01-0.10) and the inability to lateralise the signs (OR 0.3, 95% CI 0.1-
0.6) (see Figure 7.10). When the signs could be lateralised to the right or left side of
the brain, a stroke was more likely. The research fellow was asked to record whether
the signs were consistent with the symptoms, and whether the neurological signs
conformed to a known vascular territory. A negative response to either question
strongly favoured a mimic (OR 0.2, 95% CI 0.1-0.5, and OR 0.1, 95% CI 0.05-0.2,
respectively). A thrombolysis-eligible brain attack was highly likely when the
research fellow classified the clinical syndrome as lacunar or total anterior
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circulation syndrome (OR 7.1, 95% CI 2.2-23.5, and OR 3.9, 95% CI 1.5-10.1,
respectively). Mimics were more likely if the clinical classification could not be
determined (OR 0.2, 95% CI 0.1-0.4).
TPA-eligible euent Stroke mimic OR OR
n/N n/N (95%CI Fixed) (95%CI Fixed)
No signs 5/241 39/109 0.04[0.01,0.10]
No lat signs 10/241 16/109 0.25(0.11,0.57]
L brain lesion 108 / 241 24/109 —•— 2.88(1.71,4.83]
R brain lesion 96/241 14/109 —»— 4.49(2.42,8.33]
Signs inconsistent 22/229 22/70 0.23(0.12,0.45]
Signs not conform 13/229 26/71 0.10(0.05,0.22]
Clin class TACS 57/236 3/70 7.11(2.15,23.48]
Clin class PACS 77/236 31 / 70 0.61(0.35,1.05]
Clin class LACS 54 / 236 5/70 3.86(1.48,10.06]
Clin class POCS 31 /236 11 /70 0.81(0.38,1.71]
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Figure 7.10 Diagnostic formulation: features that distinguished 'thrombolysis-eligible'
brain attack from stroke mimic
Note - scale 0.01 -100
TPA-eligible - 'thrombolysis-eligible'
No lat signs - no lateralising signs
L - left, R - right
Signs inconsistent - with the symptoms reported in the history
Signs not conform - to known vascular territory
Clin class - OCSP clinical classification
7.4.4 The accuracy of the clinical diagnosis of brain attack
The sensitivity, specificity, positive predictive value (PPV), negative
predictive value (NPV), accuracy and likelihood ratio (LR) for the bedside clinical
diagnosis was determined by comparing it to the final consensus panel diagnosis (the
gold standard) (see Table 7.8 for description of terminology). Up to five bedside
diagnoses could be given to each patient: the general practitioner (GP) diagnosis,
ARU staff member (nurse or doctor) diagnosis, 'end of bed' diagnosis by stroke
research fellow, research fellow diagnosis after the history, and stroke research
fellow's final bedside diagnosis (see below). In this section, I have again divided the
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GPs referred 239/350 patient-episodes (97 brain attacks presented directly via
ambulance and 14 occurred in hospital). No specific diagnosis was provided in 24
GP referral letters. GPs thus made 215 diagnoses: 16 were non-stroke and 199
stroke. Of the 24 events with no GP diagnosis, 12 turned out to be mimics; and of
the 97 events with no GP letter, 32 events (33%) were mimics. The raw data (in 2x2
tables) are provided in Appendix 6, and the summary data in Table 7.9. Whilst
sensitivity of the GP diagnosis of stroke was excellent (95.4%), specificity was poor
(14.5%); overall, the GP diagnosis of stroke increased the likelihood of stroke by
only a small amount (likelihood ratio 1.12).
Acute Receiving Unit
The Acute Receiving Unit (ARU) was the entry point to the hospital for 321
brain attacks (there were 14 inpatient events, and 15 events admitted directly to other
wards). The ARU diagnosis was 'stroke' (n=244), 'non-stroke' (n=46) or 'unsure'
(n=31). I have grouped the non-stroke and unsure categories together, as a patient in
either category would not be a suitable candidate for thrombolysis. The diagnoses of
ARU staff had higher specificity, better positive predictive value, better negative
predictive value, and greater accuracy than the GPs' diagnoses (Table 7.9). The
likelihood ratio was 1.71. A medical senior house officer provided a diagnosis for
271/321 (84%) events, and a nurse provided a diagnosis for 50/321 (16%) events.
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The accuracy (i.e. total number of correct diagnoses / all diagnoses made, see Table
7.8) of the medical staff was 205/271 (75.6%), and 36/50 (72.0%) for the nursing
staff.
The research fellow's assessment
'End ofbed assessment'
At the beginning of the assessment, the stroke research fellow was asked to
record his/her 'end of bed assessment', which was based on a brief clinical history
(from the ARU medic or nurse) and inspection of the patient. 278/350 (79%) end of
bed diagnoses were stroke, 31/350 (9%) were non-stroke, and 41/350 (12%) were
unsure. I grouped unsure diagnoses with non-strokes in these analyses. The
accuracy of the stroke research fellow's end of bed assessment was almost identical
to the ARU staff (see Table 7.9). Accuracy did not differ significantly depending on
the clinician - PJH assessed 181 events, accuracy 77.3%, JK assessed 136 patients,
accuracy 73.5% (confidence intervals for difference in proportions overlap).
Diagnosis after taking the history
It is often claimed that the clinical diagnosis is based predominantly on the
history (Warlow, 1991). By asking the clinician to record his/her diagnosis after
taking the history (but before performing a physical examination), I hoped to explore
the relative impact of the history and examination on the diagnostic process. There
was a modest improvement in overall accuracy (80.0% after history, compared with
75.1% for end of bed assessment, p=0.15, y2), however the likelihood ratio was only
1.94 (Table 7.9).
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Research fellow'sfinal bedside diagnosis
At the completion of the clinical assessment, the research fellow recorded
his/her final diagnosis based on all the available clinical data. The diagnoses were
definite stroke (n=151), probable stroke (n=74), possible stroke (n=68), and non-
stroke (n=57). These were collapsed into 'thrombolysis-eligible' brain attacks
(definite and probable stroke, n=225), and stroke mimics (possible stroke and non-
stroke, n=125). The accuracy of the research fellow was 84.6%, and both specificity
and sensitivity were greater than 80% (Table 7.9, see Appendix 6 for raw data in
2x2 tables). The likelihood ratio was 4.9. Assuming a prevalence of stroke of
around 70% (the pre-test probability in unselected patients with brain attack), a LR
of 5 raises the possibility of stroke to 95% after the bedside assessment (Sackett et
al., 1985b).
The difference in accuracy between the research fellow's end of bed
assessment and the research fellow's final diagnosis was significant (9.4%
difference, 95% CI 3.5 - 15.3%, p<0.01, x2)- The accuracy of each clinician also
increased after the full clinical assessment (77.3% to 86.7% for PJH, 73.5% to 81.6%
for JK).
7.4.5 Reasons for disagreement between research fellow bedside diagnosis
and the gold standard diagnosis
This section explores the reasons for an inaccurate bedside diagnosis. I
compared the stroke research fellow's final bedside diagnosis (the bedside diagnosis)
with the gold standard expert panel diagnosis (made in knowledge of the brain
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imaging and early progress), and divided patients into those with a correct bedside
diagnosis, and those with an incorrect bedside diagnosis.
There were 296 correct bedside diagnoses: 90 were mimic and 206 were
'thrombolysis-eligible' brain attack. 54 incorrect bedside diagnoses were made by
the research fellows: 35 (65%) events initially diagnosed as mimic received a panel
diagnosis of thrombolysis-eligible stroke, and 19 (35%) events diagnosed as stroke
received a final diagnosis of mimic. The 19 mimics initially diagnosed as stroke
were space occupying lesion (n=5), sepsis (n=4), vestibular disturbance (n=3),
seizure (n=2), functional (n=l), migraine (n=l), toxic/metabolic (n=l), dementia
(n=l), and syncope (n=l).
The general features of patient-episodes, divided into correct and incorrect
bedside diagnosis, are detailed in Table 7.10. The two groups were similar in age,
gender, research fellow examiner, and baseline stroke severity. The main difference
was that incorrect bedside diagnoses were more frequent in patients who presented
after six hours: 61% of incorrect diagnoses were made in patients who presented
after six hours, compared with 41% of correct diagnoses (p=0.01, x2 test for trend).
Patients with an incorrect bedside diagnosis were seen by the research fellow later
than patients with a correct bedside diagnosis (p=0.03, Mann-Whitney U).
History items
The only significant variable was that patients who re-presented (i.e. had been
recruited into the study earlier) were more likely to be given an incorrect diagnosis
(OR 3.3, 95% CI 1.1 - 10.1) (see Figure 7.11). Inability to obtain the history from
the patient or a relative, absence of a second source of history, and inconsistencies in
the details provided by different sources (all postulated to cause difficulties bedside
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diagnosis) did not reach significance. There were trends for vertigo or past history of
stroke (particularly with incomplete recovery) to increase the likelihood of an






Primary source hx 13/54 77/296
Secondary source hx 2/54 42 / 296
Inconsistencies 8/54 58/296
Re-presentation 5/54 9/296
Cant walk before 5/54 19/292
Cog impairment 6/53 51 /287
1 of m/e/hi/jo 15/54 70 / 296
PHx stroke 27/53 114/284
PHx incomplete recov 14/27 41 /114
Exact time 35/54 212 / 296
Onset unassess/uncl 17/54 76 / 296
Unwell in last week 19/53 117/294
Sx not lateralised 13/54 79 / 296
Sx unstable 5/54 27 / 296
Isolated speech prob 0/54 21 / 296
Vertigo 6/54 13/296
Headache 17/50 83 / 261
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Favours correct dx Favours incorrect dx
Figure 7.11 History items thatfavoured an incorrect bedside diagnosis
Dx - diagnosis
Primary source hx -primary source ofhistory was not patient or relative
Secondary source hx - no secondary source ofhistory available
Cog impairment - cognitive impairment
1 ofm/e/m/p - one ofmigraine, epilepsy, malignancy orpsychological disorder
PHx — past history; Sx —symptoms
Examination items
Factors such as altered level of consciousness, confusion, aphasia, or the
presence of a comorbid condition that made examination difficult, did not
significantly increase the likelihood of an incorrect bedside diagnosis (see Figure
7.12). Patients with right hemisphere cortical lesions may exhibit anosognosia
(Ghika-Schmid & Bogousslavsky, 2001), which might result in difficulties with the
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10
Figure 7.12 Examination and diagnostic formulation items that favoured an incorrect
bedside diagnosis
Dx - diagnosis
No signs - no neurological signs
Signs inconsistent - neurological signs inconsistent with the symptoms
Signs no conform - neurological signs did not conform to known vascular territory
Clin class unsure - OCSP clinical classification could not be determined
I anticipated that an incorrect bedside diagnosis would be likely if the
neurological signs were inconsistent with the symptoms, or if the neurological signs
did not conform to known vascular territory. This proved to be the case for signs that
were inconsistent with the symptoms (OR 2.6, 95% CI 1.3 - 5.5). However, there
were differences in the way these questions were answered by the research fellows.
For examiner PJH, signs were consistent in 115/136 (85%) of correct diagnoses and
9/19 (47%) of incorrect diagnoses (p<0.01, y2); and signs conformed to vascular
territory in 113/136 (83%) of correct diagnoses and 14/19 (74%) of incorrect
diagnoses (p=0.497, y2). For examiner JK, signs were consistent in 86/94 (91%) of
correct diagnoses and 21/24 (88%) of incorrect diagnoses (p=0.836, y2); and signs
conformed to vascular territory in 88/95 (93%) of correct diagnoses and 20/24 (83%)
163
of incorrect diagnoses (p=0.312, %2). Thus, 'signs consistent with symptoms' was




Of 350 presentations, a definite non-stroke accounted for 65 (18.6%), and a
probable non-stroke accounted for 44 (12.6%). In my systematic review of the
accuracy of the clinical diagnosis of stroke, the overall frequency of mimics was
18.1% (see Figure 4.1 [Note that the measure of accuracy used was the positive
predictive value; the frequency of mimics is 1 - positive predictive value]). For
studies based in the hospital (rather than the community), mimics were a much
smaller proportion of admissions (11.2%). The present study identified a frequency
of 31.1%, although if only definite mimics are counted, the figure is 18.6%.
Why was the frequency higher in the present study?
In the Brain Attack study, I specifically aimed to identify all non-strokes in a
consecutive sample of patients. Many of the hospital-based studies that reported low
frequency of mimics [e.g. 1.2% for O'Brien et al (1987b), and 5.0% for Besson et al
(1996a)] were much more selective. Community-based studies were less selective,
and consequently the misdiagnosis rate was higher; but these studies are less relevant
to the hospital-based stroke physician. The study of Libman et al (1995b), although
retrospective, similarly aimed to identify all patients presenting with "sudden onset
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of a focal deficit" to a general hospital. 78/411 (19%) patients were found to have
mimics - an almost identical figure to the definite mimics of the present study.
Causes
The four leading causes of mimic were seizure (21% of mimics), sepsis
(13%), toxic / metabolic disturbance (11%), and space occupying lesion (9%). The
mimics identified, and their frequencies, were similar to earlier studies (see Figure
4.2). I did not use the category 'sequelae of old stroke' as this is a non-specific term,
and we were able to determine a precise cause in almost all cases. Nonetheless,
41.5% of mimics in this study had suffered a previous stroke. In both the present
study, and the review of 25 earlier studies, there was a long list of infrequently
observed stroke mimics - conditions such as transient global amnesia, meningitis,
multiple sclerosis (presenting acutely), spinal cord lesions, and so on.
Implications
The present study probably provides typical figures for doctors working in a
typical general hospital. Around 30% of patients presenting with brain attack will
have a stroke mimic. Some mimics will be definitively diagnosed (by brain imaging
or other laboratory tests), but many cannot be diagnosed with certainty. In the
present study, they were labelled as 'possible stroke'. Patients with possible stroke
would not be candidates for thrombolysis or other risky treatments.
82/109 (75%) mimics in the present study could be classed as a neurological
disorder. This highlights the need for neurologists - or stroke physicians with
adequate neurological training - to be involved in the assessment of patients with
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brain attack, as has been argued by others since the 1950s (Rankin, 1957b; Bratina et
al., 1995; Hachinski, 1996; Horowitz, 1998).
7.5.2 Transient ischaemic attacks
In the present study, the final diagnosis was TIA in 48/350 events (14%),
similar to the frequency identified by other studies (e.g., 10% (Allder et al., 1999a) to
18% (Kolominsky-Rabas et al., 1998b)). I simply treated those with a definite TIA
(n=35) as thrombolysis-eligible brain attacks, and those with possible TIA (n=13) as
mimics. It is not possible to distinguish, in the first few hours, those likely to recover
spontaneously (TIAs) from those who will not (strokes). Thus, patients with a TIA
who present early enough and are still symptomatic may receive unnecessary
treatment. Ideally, one would avoid treating patients with thrombolysis if there were
a reliable method of determining if their symptoms would resolve within 24 hours.
Unfortunately, numbers were too small in the present study to explore this issue
further.
7.5.3 Diagnostic certainty
In the present study, the expert panel had great difficulty in arriving at a
definitive diagnosis for all patients (e.g. the patient with vestibular disturbance and a
normal brain scan). This reflects clinical reality: the diagnosis is not always clear-
cut, and a gold-standard for the diagnosis of stroke is lacking (D'Olhaberriague et al.,
1996). Our category of possible stroke contained patients who could not be classed
as definite non-stroke, but a non-stroke explanation for their symptoms may actually
have been more likely than stroke. As this thesis is directed towards acute
interventions such as thrombolysis, which carries significant risks, I treated possible
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strokes as mimics. However, possible strokes may be treated differently in other
management scenarios (e.g. treating with aspirin).
The simple observation of the difficulty in arriving at a final consensus
diagnosis is not widely reported. Only four of 25 earlier studies identified possible
stroke as a category, yet the frequency ranged from 4% to 28% (von Arbin et al.,
1981; Ellekjaer et al., 1997a; Horn et al., 1997b; The members of the Lille Stroke
Program, 1997c). When some class up to one quarter of patients as uncertain, how
were the majority of studies able to be so definite? Absence of a possible category
makes interpretation of a study's results difficult, and limits their extrapolation to
other clinical settings.
7.5.4 Features that distinguish between stroke and mimic
Despite the importance of the clinical assessment, there have been few
studies that specifically examined how clinical assessment might be improved. The
largest previous study, by Libman and colleagues (1995b), identified six significant
clinical predictors on univariate analyses. Female gender, abnormal visual fields,
diastolic blood pressure > 90mmHg and atrial fibrillation increased the odds of
stroke; and normal eye movements and abnormal admission neurological
examination increased the odds of a mimic (Libman et al., 1995b). In the present
study, we also found that diastolic blood pressure > 90mmHg and abnormal visual
fields predicted stroke, but we did not find that female gender, atrial fibrillation or
normal eye movements were significant predictors. We found that an abnormal
neurological examination actually predicted a stroke (rather than a mimic)
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Several studies provided clinical pointers to distinguish stroke from mimic,
but did not systematically evaluate the clinical assessment. Ferro et al (1998a)
suggested that a mimic was more likely if the patient had no vascular risk factors; but
this was not confirmed by the present study (odds ratio for absence of vascular risk
factors to predict a mimic 1.7, 95% CI 0.8-3.3, p=0.20, y2). Allen (1983a) provided
clinical features that distinguished mass lesions from vascular lesions. The
significant features were that the symptoms had evolved over more than 24 hours,
and in a stuttering manner. Similarly, Weisberg & Nice (1977), in an early study on
the usefulness of CT in stroke, found that the temporal evolution of the deficit was
crucial in differentiating vascular from non-vascular aetiology. Unfortunately, in the
present study, these details could not be adequately established. However, an exact
time of onset, the patient being able to recall exactly what he/she was doing at
symptom onset, and being well in the last week were all strongly predictive of
('thrombolysis-eligible') stroke, and all point to an abrupt onset.
Implications
Table 7.11 lists the significant clinical factors that helped to distinguish
between stroke and mimic at the bedside. As patients with previous stroke were at
risk of both stroke and mimic, few elements of the past history can be relied on,
although cognitive impairment increases the likelihood of a mimic. A history of an
exact onset of symptoms, and no health problems in the last week suggest a stroke,
whilst seizures or loss of consciousness suggest a mimic. Focal neurological
symptoms, and almost any focal neurological signs (with five exceptions, see Table
7.11) suggest stroke, but absence of either, and the findings of confusion or
abnormalities in another body system suggest a mimic. If the features can be
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classified into an OCSP category, a stroke is likely, but if the signs are unclassifiable,
or do not conform to known vascular territory (or to the symptoms), suspect a mimic.
These data could be used to develop clinical algorithms to assist the non-
specialist. This, in turn, could increase clinician's confidence in the diagnosis of
brain attack, and improve the speed of assessment and referral for brain imaging, a
major current barrier to the implementation of time-sensitive treatments (Johnston et
al., 1999).
7.5.5 The bedside diagnosis
Accuracy
The accuracy of the bedside diagnosis increased progressively as the
experience of the assessor increased (see Table 7.12). The general practitioner's
diagnosis was least accurate overall, although the most sensitive. High sensitivity
suggests GPs are good at diagnosing stroke. A more clinically useful measure, for a
hospital doctor faced with a GP diagnosis of stroke, is the positive predictive value
(PPV), or the chance of a positive diagnosis being correct. For the present study, the
general practitioner PPV was 73%. This was similar to other studies that examined
GP accuracy [e.g. 85% for the patients referred to the stroke clinic in the study of
Ferro et al (1998a); 69% for the study of Horn et al (1997b; 2001)]. The GP's
positive assessment of stroke may be helpful, but is not satisfactory for difficult
management decisions.
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Importance of the elements of the clinical assessment
In the present study, the research fellows achieved the greatest accuracy,
reinforcing the finding of Norris & Hachinski (1982) that clinical skill improves
accuracy. However, we found that a quick, 'end of bed' assessment by an
experienced stroke research fellow was no more accurate than the assessment of the
ARU staff. Similarly, the research fellow's diagnosis after taking a history was less
accurate than at the completion of the history and examination. Our findings suggest
that the clinical assessment is a package, and all the individual components are
required for it to function optimally. Our findings would also suggest that there is
little point in having an experienced stroke expert stationed at the door of the
emergency department to 'triage' potential stroke patients for fast-tracking (by
asking a few brief questions).
Disagreements
I attempted to discover the features that made the diagnosis difficult in certain
patients. As the number of incorrect diagnoses was small, the present study lacked
power. Others (Allen, 1983a; Sandercock et al., 1985a) found that an inadequate
history predicted an incorrect diagnosis, but in the present study the source of the
history (whether direct from patient/relative or indirect from notes/ambulance
sheet/GP referral letter) was not a significant factor.
Only three significant factors were identified: re-presentation, late (>6 hours)
presentation, and signs inconsistent with symptoms suggested an incorrect bedside
diagnosis (see Table 7.13). The implications of time to presentation will be
discussed further in Chapter 8. An important cause of disagreement was when the
clinical symptoms did not correlate with the signs. However, the variation in the
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way this question was answered by the two examiners suggested that it had not been
fully understood. The question was part of the diagnostic formulation, a section of
data collection left open to the free thought processes of the clinician. For this to be
a useful factor in clinical practice, further training would be necessary.
7.5.6 Limitations of the study
There were several limitations to the present study. I shall discuss how these
may have impacted on the results obtained in the following sections.
Were cases missed?
I attempted to recruit all patients with brain attack who were admitted to the
Western General Hospital during the study period. It is possible that the definition of
brain attack was too restrictive, von Arbin et al (1980) used a similar definition to
select patients for entry to a stroke unit ("patients with acute onset of focal
neurological deficit...without trauma to the head"). Of 1865 patients who did not
fulfil entry criteria for the stroke unit, only 24 had a stroke (a 1.3% false negative
rate). Thus, it is probably unlikely that I missed many true strokes by using the
definition of brain attack (although I may not have seen all of the patients considered
by the referring doctor to have a possible stroke).
Despite using multiple overlapping sources of case ascertainment, it is
possible that suitable patients were missed. This was true of direct admissions to the
Department of Clinical Neurosciences, which were difficult to monitor. Many of
these patients were transferred from another hospital for neurosurgical evacuation of
an intracerebral haematoma. These patients did not present de-novo to the Western
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General Hospital, and could not be assessed without knowing the results of important
investigations.
During August 2000, I monitored the number of patients we were unable to
see. There were three patients missed (and 56 patients recruited): one was a brief
admission to neurology unit with transient global amnesia, the other two were
admitted with symptoms due to malignancy. I judged this to be an acceptable rate.
Was the spectrum of patients recruited 'typical'?
The patients recruited were consecutive, unselected admissions to the
Western General Hospital (WGH). The broad description of the cohort seems
similar to other published studies (International Stroke Trial Collaborative Group,
1997), although older than patients in the Lausanne Stroke Registry (Bogousslavsky
et al., 1988) and Stroke Data Bank (Foulkes et al., 1988). This age difference is very
important, as stroke can be difficult to diagnose when patients are frail or have co¬
morbidity. The age difference can be explained by the WGH stroke unit offering an
'all-age' service with active involvement of geriatricians.
Our patients had milder strokes than patients recruited to trials of
thrombolysis (The National Institute of Neurological Disorders and Stroke rt-PA
Stroke Study Group, 1995; Hacke et al., 1998). The admission policy of the stroke
unit is to accept all patients, no matter how severe. The vast majority of admissions
come through the Acute Receiving Unit, referred in by GP or by ambulance. Due to
the complexity of the zoning arrangements for the Edinburgh area, it is possible that
some of the severe patients were taken to the Royal Infirmary (particularly if there
were any trauma). This may explain the milder composition of our cohort.
However, more severe strokes are probably easier to diagnose clinically.
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Was the bedside assessment performed blind to results of brain imaging?
It was anticipated that all patients would be seen prior to brain imaging (and
no provisions were made for collection of this data). However, some patients had
already been scanned (particularly weekend patients) when seen by the research
fellow. The best available estimate is that fewer than 15 patients (4%) were assessed
when the scan result was available, and this is not likely to have caused significant
bias.
Problems with the gold standard diagnosis
Panel composition
Inevitably, the members of the panel were unable to attend every meeting.
As decisions were made by consensus, and certain members of the team were more
likely to dominate the meeting than others, the consistency of the diagnoses varied.
If the neuroradiologist was absent, clinicians had to interpret the scans themselves,
which may have diminished certainty.
There were several sources of additional bias. The history and examination at
the expert team meetings were provided by the research fellow who had seen the
patient. To allow errors to be avoided, if there was any uncertainty or dispute about
the history/examination, the name of the patient was revealed and the responsible
clinician invited to clarify the details. In attempting to reduce one source of bias,
another bias was introduced.
Definitions
The definitions provided were loose. Subtle interpretations changed from
week to week (e.g., a 'probable' stroke became a 'definite' stroke when the panel
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was 90% sure, but other times it was when 95% sure). The diagnoses applied were
more rigid than 'real life', which particularly impacted on the possible stroke
category. Even when the responsible clinician told us that the patient was treated as
(and behaved as) a non-stroke, unless there was laboratory or convincing clinical
evidence of an alternate diagnosis, the patient was diagnosed as a possible stroke.
Was it appropriate to split the diagnostic categories as I did, or was this
just a post-hoc analysis?
The large group of possible strokes presented a difficulty for data analysis.
Eligible patients should not be excluded from analysis, as this creates potentially
strong biases (Piantadosi, 1997). It seemed clinically sensible to group those with a
plausible alternative non-stroke diagnosis with the definite non-strokes, as these
patients are unlikely to be given thrombolysis. This was chosen as my primary
analysis because it was clinically relevant. Restricting the analysis to definite non-
strokes (n=65) compared with any stroke (n=285) produced broadly similar results. I
elected not to present both data sets to maintain clarity for the reader.
Were there any confounding factors?
The main sources of possible confounding in this study were:
• Differences in training and experience between examiners
• Improvements in clinical skills with time (i.e. our training in stroke
medicine)
• Inability to obtain key data in some situations (e.g. aphasic patient with
no relative)
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• Patients were assessed by the research fellow later than they presented
(median delay from presentation to assessment was 17 hours), and may
have fluctuated in this time. It would have been ideal to see patients
immediately on presentation, but this was not possible. This issue will be
considered further in Chapter 8.
Was the sample size adequate?
For the purposes of determining a reasonably precise point estimate of the
frequency of stroke mimics, and calculating odds ratios for clinical factors that
distinguish between stroke an mimic, the sample size was adequate. However, there
were relatively few situations in which there was disagreement between the clinical
and final diagnoses, so for these analyses confidence intervals were wide (and a type
II error could not be excluded).
7.6 Summary
• Although the present study has many limitations, the results add
substantial knowledge to a field of limited and variable quality studies
• In the thrombolysis era, a detailed clinical assessment needs to be
performed quickly and with confidence
• These results provide, for the first time, numerical scientific data to
support the 'art' of the clinical assessment of patients with brain attack.
• The value of the clinical assessment is cumulative: 'end of bed' accuracy
is improved by taking a history, which is improved by performing an
examination.
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• Around 30% of brain attacks are due to stroke mimics, and 75% of these
mimics are neurological disorders. Adequate training in neurology is
certainly required, and this study provides evidence that UK neurologists
should become more involved in acute stroke services.
• Important 'rule in' laws for the diagnosis of stroke include: definite time
of onset, definite focal neurological symptoms and signs, a classifiable
clinical syndrome
• Cautionary features that suggest a mimic include: dementia, confusion,
absence of focal neurological symptoms or signs, when the features 'don't
make sense'
• Much of what I have shown would be familiar to the experienced
clinician. Placing numerical values ('weights') on the diagnostic
discriminating ability of each feature means it can be taught to junior
doctors to help them gain experience and skill
Recommendations for further research
• The clinical factors suggested in this chapter should be tested for
reliability, and validated on an external, prospectively recruited dataset
• Clinical methods to distinguish TIA from stroke in the first few hours are
needed
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Table 7.1 General characteristics ofpatient recruitment in Brain Attack study
Feature Number (%)
Age (n=336 patients):
Median (IQR) 76.3 years (66.5-82.9)
Mean (standard deviation) 73.5 years (13.4)




Referred to research team by (n=350 episodes):
ARU 321 episodes (92%)
Other ward 15 episodes (4%)
Inpatient brain attacks 14 episodes (4%)
Source of referral to research team (n=350 episodes):
Doctor 299 (85%)
Nurse 51 (15%)
Median time from symptom onset to presentation (n=330
episodes) (IQR):* 4.7 hours (2.0-13.7)
Time of ARU admission (n=335 episodes):+
9.00am - 5.00pm 209 episodes (62%)
5.01pm - Midnight 90 episodes (27%)
Midnight - 8.59am 36 episodes (11%)
Median time from symptom onset to evaluation (n=345 episodes)
(IQR):1 25.8 hours (12.5-50.5)
Median Delay between presentation to hospital and evaluation by
research team (n=330 episodes) (IQR):* 17.0 hours (1.3-25.7)
Admission destination (n=350 episodes):
Stroke unit 126 (36%)
General ward 213 (61%)






IOR - interquartile range
*
- 14 episodes were inpatient brain attacks, in 5 episodes the time ofonset was unknown, in
one episode the time ofarrival in ARU was unknown
f - 14 inpatient brain attacks, 1 brain attack with unknown time ofarrival in ARU
/ - time ofonset could not be determined in 5 episodes ofbrain attack
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Table 7.2 Baseline demographic data ofpatients in brain attack study (n-336)
Feature n/total known (%)*
Patient could walk independently before admission: 309/332 (93%)
Vascular risk factors:
Hypertension 159/325 (49%)
Ischaemic heart disease 100/322 (31%)
Smoker (past or present) 172/326 (53%)
Atrial fibrillation 62/321 (19%)
Diabetes mellitus 40 / 327 (12%)
Peripheral vascular disease 33 /307 (11%)
Past history of stroke or TIA 129/323 (40%)
(Proposed) risk factors for stroke mimic:
Cognitive impairment 54 / 326 (17%)
Known history of migraine 16/336 (5%)
Known history of epilepsy 12/336 (4%)
Known malignancy 33 / 336 (10%)
Psychological disturbancet 28/336 (8%)
*
- In a small number ofpatients, the presence or absence ofan individual feature could not
be determined. Thus the denominator excludes those patients in whom the feature was
unknown
f - one or more episodes ofpsychological disturbance severe enough to warrant medication
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Table 7.3 Presentingfeatures and examination findings ofallpatient-episodes (n=350)
Feature n/total known (%)*
Presenting event:
Exact time of onset 247 / 350 (71%)
Woke from sleep with symptoms 78/253 (31%)
Patient was well in last week 211/347 (61%)
Focal neurological symptoms 307/350 (88%)
Loss of consciousness 53 /328 (16%)
Vomited 44/335 (13%)
Headache 100/311 (32%)
Patient could walk after symptom onset: 140/346 (40%)
Examination findings:
BP> 150/90 112/349 (32%)
Irregular pulse 72/350 (21%)
GCS = 15 236/350 (67%)
Confusion1 92 / 256 (36%)
No neurological signs 47 / 350 (13%)
*
- In a small number ofpatients, the presence or absence ofan individualfeature could not
be determined. Thus the denominator excludes those patients in whom the feature was
unknown
f - made one or more errors on tests for confusion (orientation and attention, see Appendix
2). Note the denominator was smaller than for GCS
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Table 7.4 Final diagnosis in the brain attack study (n=350)
Category Number (%) 95% Confidence Intervals
Definite stroke 186 (53%) 48%-58%
Probable stroke 34 (10%) 7%-13%
Definite TIA 17 (5%) 3%-8%
Possible stroke 35 (10%) 7%-13%
Possible TIA 13 (4%) 2%-6%
Stroke mimic 65 (19%) 15%-23%
Table 7.5 Definite non-strokes in the brain attack study
Condition Number (%)* 95% Confidence Intervals*
Seizure 13 (3.7%) 2.0%-6.3%
Space occupying lesion 10 (2.9%) 1.4%-5.2%
Sepsis 8 (2.3%) 1.0%-4.5%
Syncope/presyncope 8 (2.3%) 1.0%-4.5%
Toxic/metabolic 8 (2.3%) 1.0%-4.5%
Acute mononeuropathy 4 (1.1%) 0.3% -2.9%




Spinal cord lesion 3 (0.9%) 0.2%-2.5%
Other causes 5 (1.4%) 0.5%-3.3%
Total 65 (18.6%) 14.5%-22.6%
*
- expressed as the proportion ofall patient episodes in the brain attack study (n=350)
Table 7.6 All stroke mimics (definite non-stroke and possible stroke with a plausible




Toxic / metabolic 12 (11.0%)
Space occupying lesion 10 (9.2%)
Syncope / presyncope 10 (9.2%)
Acute confusional state 7 (6.4%)
Vestibular dysfunction 7 (6.4%)
Acute mononeuropathy 6 (5.5%)
Functional/medically unexplained symptoms 6 (5.5%)
Dementia 4 (3.7%)
Migraine 4 (3.7%)
Spinal cord lesion 3 (2.8%)
Other* 3 (2.8%)
Total 109 (100%)
* this includes the 65 brain attacks definitely due to a mimic, and the 44 brain attacks
labelled as possible stroke/TIA in which there was a highly plausible alternate diagnosis.
There were four presentations diagnosed as possible stroke/TIA with no plausible alternate
diagnosis (these patient-episodes have not been included),
f expressed as a proportion ofthe 109 mimics
t includes subarachnoid haemorrhage, transient global amnesia and Parkinsonian
syndrome
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Table 7.7 Generalfeatures of 'thrombolysis-eligible' brain attacks and stroke mimics
'Thrombolysis-eligible'
brain attacks Stroke mimics
n=241 episodes n=109 episodes
Feature n=237patients n=106 patients P-value*
Median age (years/ 76.27 76.95 .568
Male gender+ 118 (49.8%) 48 (45.3%) .441
Median time from onset to
presentation (hours): 4.47 4.67 .586
Number presenting .916
0-6 hours 129 (53.5%) 60 (55.0%)
6-12 hours 38 (15.8%) 13 (11.9%)
>12 hours 63 (26.1%) 33 (30.3%)
Examiner: .791
PJH 124 (51.5%) 57 (52.3%)





TACS 57 (23.7%) 3 (2.8%)
PACS 77 (32.0%) 31 (28.4%)
LACS 54 (22.4%) 5 (4.6%)
POCS 31 (12.9%) 11 (10.1%)
Unsure/No signs 22 (9.2%) 59 (54.1%)
Number with brain imaging 232 (96.3%) 72 (66.1%) <.001
*
- p value determined by Mann- Whitney U test (for continuous variables) and y test (for
categorical variables),
f - refers to the number ofpatients
/ - incomplete numbers, as inpatient strokes were not included
§ - OCSP clinical classification. TACS: total anterior circulation syndrome, PACS: partial
anterior circulation syndrome, LACS: lacunar syndrome, POCS: posterior circulation
syndrome
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Disease present Disease absent
Feature Question addressed Formula
Sensitivity How well the test diagnoses
those with the condition
a / (a+c)
Specificity How well the test excludes




If the test is positive, how





If the test is negative, how
likely is it that the patient
does not have the condition?
d / (c+d)
Accuracy The proportion of all
diagnoses that are correct
(a+d) / (a+b+c+d)
Likelihood ratio (LR)
(of a positive test)
The ratio of the proportion
with a true positive diagnosis




Adaptedfrom (Ebrahim & Harwood, 1999a; Greenhalgh, 2000)
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Table 7.10 Generalfeatures ofpatients with incorrect and correct bedside diagnosis by the
research fellow
Incorrect diagnosis Correct diagnosis
n=54 episodes, n=296 episodes,
Feature n=49 patients n=28 7patients P-value*
Median age (years)1 73.79 76.38 .270
Male gender+ 22 (44.9%) 141 (49.1%) .584
Median time from onset to
presentation (hours): 6.50 4.27 .064
Number presenting:* .014
0-6 hours 20 (37.0%) 169 (55.0%)
6-12 hours 11 (20.4%) 40 (11.9%)
>12 hours 20 (37.0%) 76 (30.3%)
Median time from onset to
assessment by research
fellow (hours): 30.58 25.12 .028
Examiner: .316
PJH 24 (44.4%) 157 (53.0%)





TACS 5 (9.3%) 55 (18.6%)
PACS 20 (37.0%) 88 (29.7%)
LACS 6 (11.1%) 53 (17.9%)
POCS 9 (16.7%) 33 (11.1%)
Unsure/No signs 14 (25.9%) 67 (22.6%)
*
- p value determined by Mann-Whitney U test (for continuous variables) andy2 test (for
categorical variables)
f - refers to the number ofpatients
/ - incomplete numbers, as inpatient strokes were not included
§ - OCSP clinical classification (Bamford et al., 1991). TACS - total anterior circulation
syndrome, PACS - partial anterior circulation syndrome, LACS- lacunar syndrome, POCS
-posterior circulation syndrome
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Table 7.11 Summary features that distinguish between stroke and mimic
Likely stroke if: Likely mimic if:
Past medical history - Peripheral vascular disease - Cognitive impairment
History ofpresenting
complaint
- Any focal neurological
symptoms
- No lateralising symptoms
- Exact time of onset - Loss of consciousness
- Well in the last week - Seizure
Examination - Hypertension - Confusion
- Valvular heart disease - Signs in other systems
- Any neurological sign* - No neurological signs
Diagnostic formulation - Lateralised to right/left brain - Signs not consistent with
symptoms
-TACS - Signs did not conform to
vascular territory
-LACS - Can't determine side of brain
- Signs unclassifiable
*
any sign except: (l)impaired comprehension; (2) III, IV, VI cranial nerve palsy; (3)
nystagmus;(4) lower limb ataxia, and (5) reflex asymmetry
Table 7.12 Summary accuracy ofthe clinical diagnosis ofbrain attack
Accuracy* (%) 95% CI
GP diagnosis 154/215 (72.1%) 65.7- 77.7%o
ARU diagnosis 241 /321 (75.1%) 70.1 - 79.5%
Research fellow - 'End of bed' diagnosis 263 / 350 (75.1%) 70.4- 79.4%
Research fellow after history 280/350 (80.0%) 75.5- 83.9%
Research fellow final clinical diagnosis 296/350 (84.6%) 80.4- 88.0%
* Accuracy = all correct diagnoses / total number diagnoses
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Table 7.13 Summary offactors that resulted in an incorrect clinical diagnosis
Incorrect diagnosis likely if:
History
- Re-presentation
- Later presentation (>6 hours)
Examination
- Signs inconsistent with symptoms
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Chapter 8 : The hyperacute brain attack
8.1 Introduction
The following chapter describes a sub-study of the Brain Attack study. The
features of patients who presented to hospital within six hours of symptom onset -
'hyperacute' brain attack - will be presented. These patients are the subject of a
separate chapter because: patients who arrive at hospital within three hours (and up
to six in clinical trials) are currently eligible for stroke treatments such as
thrombolysis; I have shown that patients assessed within six hours in the
International Stroke Trial were different to those assessed later, and I wanted to
discover if the findings of the last chapter - determined by analysis of all patients
with brain attack - are relevant to those presenting very early.
8.2 Aims
The present study will focus on patients recruited into the Brain Attack study
within six hours of onset to address the following aims.
(1) Are the clinical features of patients who present with brain attack in the
first few hours different to those who present later?
(2) Are the key clinical features of a 'thrombolysis-eligible' brain attack the
same in patients who present earlier compared to later?
(3) Is the clinical diagnosis more difficult in the first few hours?
(4) How often can an exact time of onset be determined, and what are the
reasons for difficulty in the hyperacute phase?
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(5) Can clinical tools, such as the OCSP classification and the NIHSS score,
help distinguish between mimic and stroke?
8.3 Methods
This is a sub-study of the patients recruited into the brain attack study within
six hours of symptom onset. Patient eligibility criteria, case ascertainment, data
collection forms, final diagnosis, and data management were all identical to the main
study, and are described in detail in Chapter 7.2. In this section, I will highlight the
methods that were of relevance to the present analyses.
8.3.1 Patients
Inclusion criteria
Patients with brain attack who presented within six hours of symptom onset
were studied. A six hour time limit was chosen because the Cochrane systematic
review of thrombolysis for acute ischaemic stroke suggests that treatment is
promising when given within six hours of onset (Wardlaw et al., 2001a).
Symptom onset was defined as the time that symptoms were first noted, even
if the patient woke from sleep with symptoms. Presentation was defined as the time
the patient arrived in acute receiving unit (ARU), or the time of evaluation by the
research team for those patients who had a brain attack whilst in hospital. Where
precise timing details were unknown, we estimated a time of onset from all available
sources (GP letter, ambulance note, friend or relative).
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Clinical assessment
The key components of the clinical assessment for the present chapter were
the National Institutes of Health Stroke Scale (NIHSS) and the Oxfordshire
Community Stroke Project (OCSP) classification. The NIHSS score (see Appendix
2) provides a global description of the patient's neurological deficit, and has been
shown to correlate with outcome (Muir et al., 1996; Adams, Jr. et al., 1999). Two
examiners (PJH & BL) had been officially certified as competent to administer the
NIHSS prior to the study commencing. JK and PJH successfully completed the re-
certification program during the study.
The OCSP classification (see Appendix 3) groups patients into one of four
categories that define the site and size of the stroke, and gives an indication of likely
outcome (Bamford et al., 1991). This classification applies to the patient's deficit at
its greatest. Where appropriate, the research fellow incorporated information about
the maximal deficit (obtained from the history) to determine the classification if there
had been a delay between presentation and assessment. There is no official training
program for the OCSP classification.
8.3.2 Statistics
Brain attacks were divided into those presenting within six hours, and those
presenting after six hours from symptom onset, for most of the analyses. Continuous
data (age, NIHSS, times) were not normally distributed, and were presented as
median (with interquartile range). Standard non-parametric tests of statistical
significance were performed. Categorical data were analysed by chi-squared (or
similar) tests, with presentation of a p-value or an odds ratio (with 95% confidence
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intervals [95% CI]). Significance was assumed when p<0.05 or the 95% CI did not
cross one. For clarity, I have rounded the p-value to two decimal places in the text.
The clinical features of brain attack in the hyperacute phase
In Chapter 5, I demonstrated that there were important differences in the
clinical features of patients recruited within the first few hours to the International
Stroke Trial (1ST). In the present study, I wished to determine if the findings from
the 1ST, an international multicentre trial, could be reproduced in a single Scottish
hospital. Similar analyses and data presentation styles were used to facilitate
comparisons between the present study and Chapter 5.
The key clinical features of a thrombolysis-eligible brain attack
The two primary diagnostic categories that were used in the Brain Attack
study were also used in the present chapter. 'Thrombolysis-eligible' brain attack
refers to a definite or probable stroke (and assumes that all other conditions
necessary for thrombolysis were favourable), and mimic refers to a definite non-
stroke or possible stroke with a plausible alternative explanation. The rationale
behind this division is detailed in Chapter 7.3.10,
In the previous chapter, it was shown that several clinical features could be
used to distinguish a thrombolysis-eligible brain attack from a mimic (see Table
7.11). I tested whether these features were present in 'thrombolysis-eligible' brain
attacks recruited within six hours. I compared the frequencies of the key items of
history, examination and diagnostic formulation for thrombolysis-eligible brain
attacks that presented within and after six hours. I limited the analysis to features
that identify thrombolysis-eligible brain attacks (rather than mimics), as I felt it was
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more useful in a clinical setting to be able to make a positive diagnosis of stroke. I
also limited the analysis to the predictive features that were reasonably frequent
(arbitrarily defined as around 50%) to minimise the possibility of spurious
associations.
Is the clinical diagnosis more difficult in the first few hours?
I determined the frequency and nature of mimics that presented in the first
few hours. I used accuracy and positive predictive value (PPV) to ascertain if
diagnostic accuracy was affected by early presentation. I determined if
disagreements between the clinical diagnosis and final diagnosis were more common
in those presenting within six hours.
Exact time of symptom onset
The decision to treat a patient with thrombolysis (or randomise the patient
into a trial of thrombolysis) is critically dependent on knowing the exact time of
symptom onset. As this is such an important factor, I wanted to explore how often
the time of onset could not be determined, and why. Brain attacks that presented
within six hours were divided into those with an exact time of onset and those with
an estimated time of onset. The clinical features of each group were compared for
significant differences.
The OCSP and NIHSS in brain attack
Both the OCSP classification and the NIHSS severity score are widely used
in the assessment of stroke patients. I aimed to determine if either scale could
usefully distinguish a mimic from a stroke. The NIHSS was arbitrarily divided into
five categories (on the basis of the author's clinical experience): NIHSS = 0, NIHSS
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1-4, NIHSS 5-10, and NIHSS > 10. The OCSP divides into four categories, with an
additional category for those who could not be classified ('unsure'). The proportions
of stroke and mimic in each category were determined. Analysis was limited to brain
attacks that presented in the hyperacute phase.
8.4 Results
8.4.1 The clinical features ofpatients who presented within the first few
hours of symptom onset.
Patient recruitment
192/350 patient-episodes presented to hospital within six hours (55%). The
research fellow saw three in-hospital brain attacks within six hours of onset. The
exact time of onset could not be determined for six events (although the day of
symptom onset was known - all presented greater than six hours). The histogram of
time to presentation (within six hours) is provided in Figure 8.1, and the histogram
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Figure 8.2 Histogram of time to assessment (hours) by research fellow for patients with
hyperacute brain attack (192 patient-episodes)
Note different scale on x-axis
The general features of patients who presented within six hours are compared
with those who presented after six hours in Table 8.1. For early presenters, the
median time from onset to presentation (at ARU) was 2.33 hours, whilst the median
time from onset to evaluation by a research fellow was 19.75 hours. Around a third
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of early presenters were seen by the research fellow within three hours of arrival at
ARU (as were late presenters).
Clinical features
The clinical characteristics of the patients who presented in the hyperacute
phase are detailed in Table 8.2 (set out identically to the table describing the features
of patients randomised into the International Stroke Trial within six hours [Section I,
Table 5.1]). Compared with patients who presented later, patients who presented
within six hours were more likely: to be aged 80 and over (42% within six hours vs.
28% after six hours, p=0.02); to have altered conscious level (29% vs. 16%, p<0.01);
to have signs of cortical involvement (61% vs. 43%, p<0.01), or to have a clinical
syndrome of total anterior circulation involvement (TACS). Patients who presented
early were less likely, when compared with patients who presented later, to be asleep
at symptom onset (23% vs. 43%, p<0.01), have a lacunar clinical syndrome (13% vs.
22%, p<0.01), or to have a clinical syndrome of brainstem involvement (8% vs. 17%,
pO.Ol).
Many of the baseline clinical features associated with patients who presented
early were a reflection of greater stroke severity. In the present study, the NIHSS
was used to characterise the patients' clinical deficits and thus stroke severity. The
median NIHSS (and interquartile range) for brain attacks that presented in each of
five time intervals is shown in Figure 8.2. There was a weak but significant inverse
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Time to presentation
Figure 8.3 Baseline severity (measured as NIHSS) in all patients recruited to the brain
attack study
The shaded box represents the interquartile range, and the horizontal bar represents the
median for each time category.
Final diagnosis
There was no significant difference in the frequency of mimics observed in
the two time intervals (Table 8.3). However, brain attacks that were later diagnosed
as definite transient ischaemic attacks (TIAs) were more frequent in the first six
hours (7.3% vs. 1.9%, p=0.02, Fisher's exact). Intracerebral haemorrhage accounted
for 10.8% of patients who presented within six hours, and 3.6% of patients who
presented after six hours (p=0.04, Fisher's exact). As there were fewer
haemorrhages, TIAs and possible strokes in the late group, a confirmed infarct was
the final diagnosis in 91% (compared with 78% of the early group, p=0.01, % ).
Patients assessed within six hours
The research fellow assessed 56/192 (29%) patients within six hours of onset.
46 of these patients arrived at hospital between 8am and 5pm. The clinical features
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of patients assessed within six hours are compared with patients who were assessed
later (but still presented within six hours) in Table 8.4. 'Static' items of the history
and examination (e.g. atrial fibrillation or whether patient woke from sleep with
deficit) were not significantly different between the two groups. However, items that
may change over time (e.g. conscious level or NIHSS) showed significant
differences between the groups: patients admitted and assessed within six hours
showed greater stroke severity than those admitted within six hours but not assessed
till later. There was no significant overall difference in OCSP classification, but a
trend for more TACS to be observed in patients assessed within six hours.
8.4.2 Are the key distinguishing clinical features for thrombolysis-eligible
brain attack the same in patients who present earlier?
130 thrombolysis-eligible brain attacks (from 126 patients) presented within
six hours, and 111 thrombolysis-eligible brain attacks (from 111 patients) presented
after six hours. In the present analysis, a history of arm, hand or leg weakness, and
signs of abnormal verbal output, facial asymmetry, sensory loss, extensor plantar, or
arm, hand or leg weakness were compared. Peripheral vascular disease and valvular
heart disease were not used in this analysis as their frequency was less than 50%.
History items
There was no major difference between early and later stroke events in any of
the history items except one: exact time of onset (see Figure 8.4). This factor was
more frequent in the thrombolysis-eligible brain attacks presenting within than after





















































Figure 8.4 Were the history items that can help diagnose a thrombolysis-eligible stroke
valid in the hyperacute patient?
OR=l indicates that the clinicalfactor was equally useful in predicting a stroke (whether the
patient presented within or later than six hours)
Examination items
There were no significant differences in the neurological examination of the
patients with a thrombolysis-eligible brain attack who presented within six hours


























































Figure 8.5 Were the examination items that can help diagnose a thrombolysis-eligible
stroke valid in the hyperacute patient?
OR=l indicates that the clinicalfactor was equally useful in predicting a stroke
SBP - systolic bloodpressure, DBF - diastolic bloodpressure, AbN- abnormal
Diagnostic formulation
Patients with signs that were classified as a total anterior circulation
syndrome (TACS) were more likely to present early (OR 2.6, 95% CI 1.3 - 5.3) (see
Figure 8.6). Patients whose signs could be lateralised to the left or right side of the
brain were also more likely to present early (OR 2.4, 95% CI 1.3 - 4.5). Patients
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with signs classed as a lacunar syndrome (LACS) were more likely to present later
(OR 0.4, 95% CI 0.2 - 0.8).
0-6 hour strokes >6 hour strokes OR OR
nfU niH (95%CI Fixed) (95%CI Fixed)
Signs lateralise 117/130 87/112 2,59[1.25,5.34]
TACS 40/121 17/99 ■ 2.38[1.25,4.54]
LACS 21 /121 33/99 . 0.42[0.22,0.79]
.1 .2 1 5 10
Favours >6hr stroke Favours 0-6hr stroke
Figure 8.6 Items of the diagnostic formulation that can assist in the diagnosis of a
thrombolysis-eligible stroke: are they valid in the hyperacute patient?
OR=l indicates that the clinicalfactor was equally useful in predicting a stroke (whether the
patient presented within or later than six hours)
Signs lateralise to left or right side of brain; TACS - total anterior circulation syndrome;
LACS — lacunar syndrome
8.4.3 Is the clinical diagnosis more difficult in the first few hours?
Are the mimics different in the first few hours?
Mimics accounted for slightly more brain attacks that presented within six
hours than brain attacks that presented later (32.3% vs. 29.7%, p not significant, x2)-
The nature of the mimics that present within and after six hours is provided in Table
8.5. The commonest condition overall, seizure, was most frequently observed within
six hours, but was the fourth leading cause beyond six hours (p=0.04, Fisher's exact).
Syncope/presyncope was the second most common mimic within six hours, but was
rarely observed beyond six hours (p=0.03, Fisher's exact). There was an overall
trend for conditions with an abrupt onset (such as acute mononeuropathy or
functional symptoms) to be more frequent early on, whilst conditions in which the
onset is often gradual (sepsis, toxic or metabolic disturbance, space occupying lesion,
confusional state) were more frequent in those who presented after six hours.
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Is diagnostic accuracy worse?
In Table 8.6 I have tabulated two measures of overall diagnostic accuracy
(accuracy [all correct diagnoses / total number of diagnoses]; and positive predictive
value [PPV, correct diagnosis of stroke / correct and incorrect stroke diagnoses]) for
the patients presenting within six hours, and compared these results to patients
presenting after six hours.
For the general practitioners and ARU staff, there were no significant
differences in accuracy or PPV for events that presented earlier. There was a trend
towards improved overall diagnostic accuracy for the research fellow's final bedside
diagnosis of brain attacks that presented within six hours (accuracy 89.6%, PPV
95.1%). This was significant for the measure of correct diagnoses / total diagnoses
(accuracy), but not for the PPV.
Exploring reasons for improved diagnostic accuracy early
Was the trend of better diagnostic accuracy for patients seen early after
symptom onset due to the act of being assessed promptly, or due to the nature of the
brain attacks? The research fellows saw 99 patients within three hours of their
arrival in ARU (irrespective of time from onset of symptoms). I therefore compared
accuracy and PPV for the patients assessed within 3 hours, and compared this to the
results for patients assessed after six hours, to determine if the act of assessing the
patient promptly was important. Accuracy was 85/99 (85.9%) for the patients seen
within three hours of arrival in ARU, and 192/227 (84.6%) for patients seen after six
hours (p=0.90, %2). PPV was 69/72 (95.8%) for the patients seen within three hours
of arrival in ARU, and 123/138 (89.1%) for patients seen after six hours (p=0.17, x2)-
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Overall diagnostic accuracy (for the research fellow) was no different for patients
assessed promptly or patients seen later (regardless of time to presentation).
The patients who presented within six hours and were assessed within six
hours (n=56) had features suggesting more severe strokes than patients who
presented within six hours but were assessed later (n=136). I compared accuracy and
PPV in these two groups to determine the impact of the timing of the research
fellow's assessment. Accuracy was 51/56 (91.1%) for patients assessed within six
hours of onset, and 121/136 (89.0%) for patients who presented within six hours but
were assessed later (p=0.86, x2)- PPV was 42/43 (97.7%) and 74/79 (93.7%)
respectively (p=0.59, x2)- Once again, the actual timing of the assessment was less
important than the time of presentation, suggesting that the improved diagnostic
accuracy was due to the more severe nature of the patients who presented early.
Are disagreements more frequent in patients presenting within 6 hours?
There were 20 incorrect diagnoses of events that presented within six hours
(37.0% of all incorrect diagnoses, yet events that presented within six hours
constituted 54.9% of all patient-episodes). Compared with patients presenting later,
clinical disagreements for patients presenting within six hours were more likely when
the signs were inconsistent with the symptoms (p<0.01, x )• There was a non¬
significant trend for disagreements to be more common when patients re-presented,
there was a past history of stroke, or the clinical classification was a partial anterior
circulation syndrome (PACS) (see Table 8.7).
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8.4.4 How often could an exact time of onset be determined, and what were
the reasons for difficulty in the hyperacute phase?
In the brain attack study, 192 events presented to hospital within six hours of
onset. An exact time of onset could be determined confidently in 115 events (60%).
35 patients (18%) first noticed their symptoms or deficit on waking from sleep. For
these patients, the median time from when they were last known to be normal to the
time they woke with symptoms was 8.25 hours (interquartile range 5.00 - 10.88
hours, time last known to be normal could not be determined for two patients). If
one defined onset as the last time the patient was known to be normal (as randomised
trials of thrombolysis have done), then only 3/35 patients who woke from sleep with
a brain attack presented to ARU within six hours.
Where the research fellow could not determine an exact time of onset, an
approximate time was estimated (from all available data sources). A comparison
between those in whom time of onset was estimated and those in whom exact time of
onset was known is presented in Table 8.8. When compared to patients with a
known time of onset, those without an exact time of onset were more likely to have
known cognitive impairment (34% vs. 15%, p=0.02, %2), be confused on examination
(70% vs 36%, p=0.01, %2), to have aphasia (55% vs. 37%, p=0.04, x2), or to receive a
final diagnosis of mimic (48% vs. 33%, p=0.02, x ). Where the patient or relative
was not the primary source of history, the time of symptom onset had to be estimated
more frequently. Overall stroke severity did not differ between the groups (median
NIHSS 4.5 for exact onset, 7.5 for estimated onset, p=0.58, Mann-Whitney U). A
right sided brain lesion was not more frequently observed in those without an exact
time of onset.
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8.4.5 Can the NIHSS severity score distinguish mimic from stroke?
Figure 8.7 shows that the proportion of mimics was greatest when the NIHSS
was zero. When brain attacks were divided into NIHSS zero and NIHSS one or
more, mimics accounted for 61 % of NIHSS=0, and 27% of NIHSS>0 (p<0.01, x).
However, even at high NIHSS scores, there was still a considerable proportion of
mimics. When brain attacks were divided into NIHSS 0-10 and NIHSS>10, mimics
accounted for 39% of NIHSS 0-10, and 19% of NIHSS>10 (p<0.01, x2).
□ Mimic □ Stroke
Overall n=62 | n=130
NIHSS>10 n=11 | n=49 |
NIHSS 5-10 n=9 | n=32
NIHSS 1-4 n-25 | n-38
NIHSS = 0 n=17 | n=11 |
0% 20% 40% 60% 80% 100%
Figure 8.7 The value of the NIHSS score to distinguish between mimic and stroke in brain
attacks thatpresented within six hours (n=192)
The OCSP classification was better able to distinguish between stroke and
mimic (see Figure 8.8). All those classified as total anterior circulation syndrome
(TACS) had a thrombolysis-eligible stroke, as did 88% of those classified as a
lacunar syndrome (LACS). Neither partial anterior circulation syndrome (PACS) nor
posterior circulation syndrome (POCS) classification was able to differentiate stroke
from mimic, and over half of those who could not be classified had a mimic. When
brain attacks were divided into those that could be assigned an OCSP classification
203







0% 20% 40% 60% 80% 100%
Figure 8.8 The value of the OCSP classification to distinguish between mimic and stroke
in brain attacks that presented within six hours
n=162, excludes 29 patients with no signs when examined
8.5 Discussion
8.5.1 Limitations of the present study
The limitations that were identified for the general Brain Attack study
(Chapter 7.5) also apply to the present sub-study of patients who presented within
the first six hours. Specific limitations will be addressed below.
The delay between presentation and evaluation
This was a major confounding factor. It would have been desirable for the
research fellow to see the majority of patients immediately after presentation. This
did not occur, for the following reasons:
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• Over 1/3 of admissions were between 5pm and 9am; and weekend or
holiday admissions were seen on the next working day (which comprised
a further 2/7 to 1/3 of admissions)
• Referrals within the hospital, although complete, were often received late
(as the perceived view was that all the stroke team had to offer was
'rehab')
• There was reluctance by ARU staff to refer possible strokes or clear non-
strokes (possibly a hangover effect from previous clinical trials and
observational studies at this hospital where only definite strokes were
recruited). Although we identified and saw most of these patients, it was
usually the next day
Impact ofthe delay to assessment
The majority of patients who presented within six hours were actually
assessed the following day. This may have had no impact on 'static' items of the
history and examination (e.g. past history, whether patient woke from sleep with
symptoms etc), which remain stable irrespective of the time of assessment. Some
items of the assessment can change considerably (e.g. conscious level, NIHSS), and
it must be remembered that the assessment was performed much later than the patient
was admitted.
I compared clinical features of the 56 patients who presented within six hours
and were assessed within six hours with the 136 patients who were assessed later
(see Table 8.4). All severity parameters were greater in the patients assessed within
six hours, which suggests that: (1) the patients assessed within six hours were
particularly severe - and not representative of all the patients who presented within
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six hours; and/or (2) stroke severity is milder when assessed the following day. The
static items of history and examination were not significantly different between the
two groups, and even the OCSP classification appeared reasonably stable (allowing
for the possibility that more TACS were assessed earlier).
It is unlikely that the delay between patient presentation and evaluation by the
research fellow resulted in major bias. The distribution of delay from presentation to
assessment was identical for patients who presented within six hours of onset and
patients who presented later (i.e. about 30% were assessed promptly, the rest were
assessed the next day, see Table 8.1). Although stroke severity measures were
probably underestimates of true severity at presentation, both groups were equally
affected - differences between groups are probably valid.
Was the cut-off time of six hours appropriate?
Six hours was chosen as the cut-off time because evidence suggests that this
is the extent of the critical therapeutic time window for thrombolysis. Patients who
present to hospital within six hours may be eligible for thrombolysis (intravenous or
intra-arterial, as part of a trial or open-label) provided they fulfil other criteria for
treatment. However, the time from patient presentation to actual treatment ('door to
needle' time) can be as low as 45 minutes (Grond et al., 1998) to as high as 90
minutes (Albers et al., 2000b). The National Institute of Neurological Disorders and
Stroke (NINDS) recommended that the door to needle time be less than sixty minutes
(Marler et al., 1997). Thus, the actual cut-off time for patient presentation may need
to be reduced to five hours to allow for brain imaging and patient consent. If so, then
the figures provided in the present study may be an overestimate.
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Stroke research fellow training
The clinical data were obtained by four research fellows with probably
greater than average previous exposure to stroke medicine and/or neurology. Three
of four research fellows had undergone specific training in the use of the NIHSS. All
received training in the OCSP classification (and other aspects of clinical
assessment) at the weekly team meetings. This level of training and supervision may
make generalisation of the results difficult; however it is likely that the data obtained
were accurate.
8.5.2 Implications of the study
The clinical features of patients who present with brain attack in the first
few hours differ to those who present later
The present study has demonstrated that patients who present to hospital
within six hours have more severe strokes. These findings support the analysis of the
International Stroke Trial (1ST), presented in Chapter 5. Although on a much
smaller scale than the 1ST, this study makes an important contribution. This is
because the cohort was unselected, and patients with mimics, TIAs or intracerebral
haemorrhages were all recruited. All three conditions were seen more frequently in
patients presenting within six hours. Patients who present to hospital with a brain
attack comprise a heterogeneous group of serious medical conditions and not all will
have a cerebral infarct (which seems to be the starting point of so many other
studies).
The present study has implications for acute treatments, such as thrombolysis.
Thrombolysis has rarely been tested in the older population (Wardlaw et al., 2001a),
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yet more patients aged 80 and over presented early in the present study (and in the
1ST). Previous studies did not find that older patients presented earlier than young
patients (Harper et al., 1992; Jorgensen et al., 1996). There is still much to be learnt
about the interplay between stroke severity, time, and the risks and benefits of
treatment (Lindley, 2001). Many of the clinical factors identified in this analysis,
and the 1ST analysis, may be important determinants of the success of thrombolysis -
but more data, ideally from large randomised trials, are required.
The key distinguishing clinical features for thrombolysis-eligible brain
attacks are similar regardless of time from symptom onset
In an earlier chapter, several clinical predictors that could positively identify
a thrombolysis-eligible brain attack were identified. As the clinical features of
patients presenting within six hours are different, it was reasonable to consider
whether the clinical predictors would still be of use in 'hyperacute brain attack'.
Overall, there were no major unexpected differences, suggesting that the clinical
predictors can be safely used in patients presenting within hours of symptom onset.
The clinical diagnosis appears to be no more difficult in the first few
hours than later
The general feeling of stroke clinicians, supported by some evidence [e.g.
(Allder et al., 1999a), the 1ST analysis], is that stroke is more difficult to diagnose in
the first few hours. There has been almost no research into this issue. The present
study, and the earlier study of Ferro et al (1998a), found that the clinical diagnosis
was no more difficult in patients who present within six hours. In fact, there was a
trend for hospital-based doctors to have greater diagnostic accuracy when assessing
208
patients in the first few hours after symptom onset. This may well be due to the
effect of severity: patients with more severe strokes present to hospital earlier, and
the diagnosis is more obvious.
An exact time of onset is often unavailable
Time of symptom onset is a critical issue for thrombolysis. Barber et al
(2001a) found that uncertain time of onset resulted in 33% of patients being excluded
from thrombolytic therapy. Most of these patients awoke with symptoms. Many
earlier studies have noted that time of onset is often difficult to obtain. In
retrospective studies, exact onset time may be missing from the case notes in around
30% of patients (Smith et al., 1998b; Kothari et al., 1999). Some prospective studies
excluded those with unknown exact time of onset (Jorgensen et al., 1996), whilst in
others, the proportion without an exact time ranged from 21% (Streifler et al., 1998)
to 45% (Salisbury et al., 1998). A recent retrospective review of 'the stroke patient
who woke up' found that 27% of patients woke from sleep with the deficit (Fink et
al., 2002). Although there were no statistically significant differences in clinical
features, those who woke from sleep were more likely to have a lacunar stroke,
compared with those with onset whilst awake.
In the present study, an exact time of onset could not be determined in 22%,
and a further 17% awoke from sleep with symptoms too late to be eligible for
thrombolysis. The clinical features of patients with unknown onset did not differ
greatly from those with known time of onset. I wondered if right cortical lesions
resulting in anosognosia or neglect could explain part of the difficulty in determining
time from onset. However, right sided brain lesions were not over-represented in the
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patients without an exact time of onset. Instead, factors such as aphasia, confusion
and dementia explained the difficulty in determining time of onset.
The implications of these findings are clear: almost 40% of patients who
present within six hours of onset are ineligible for treatment with thrombolysis. It is
difficult to see how clinical methods to improve the determination of onset time
could possibly overcome the difficulties of aphasia, confusion, and absence of a
reliable second source of history. Perhaps imaging will hold the key to discovering
whether patients with unclear time of onset, or waking from sleep with symptoms,
may be eligible for thrombolysis (Barber et al., 2001a). This shall be considered
further in Chapter 14.
The NIHSS score and OCSP classification may help discriminate
between stroke and mimic
The NIHSS was developed for use in clinical trials and has become part of
the routine assessment for many clinicians (Lyden & Hantson, 1998). The baseline
NIHSS strongly predicts outcome after stroke (Adams, Jr. et al., 1999). Although
not intended to discriminate between stroke and mimic, I wondered if this might be
possible. Most patients with a baseline NIHSS of zero were mimics, and most with a
severe brain attack (NIHSS>10) were strokes. However, at all NIHSS scores,
mimics constituted a small proportion. The NIHSS measures severity, but cannot
distinguish old lesions from new, which may explain why almost 20% of mimics had
a NIHSS score of greater than 10. Additionally, patients with dementia could score
up to 5 points without any focal neurological deficit, because of difficulty with
naming objects, naming the month and stating their age, or following commands.
210
The advantage of the OCSP classification [compared with other systems,
such as the 'TOAST' subtype (Adams, Jr. et al., 1993; Madden et al., 1995)] is that it
does not depend on investigations, so may be applied at the bedside. The OCSP
predicts site and size of cerebral infarction on CT (Wardlaw et al., 1996), as well as
outcome (Bamford et al., 1991). In the present study, an OCSP classification could
not be made in 10% of brain attacks, and over half of these patients proved to be
mimics. 100% of patients classified as total anterior circulation syndrome and 88%
classed as lacunar syndrome proved to be strokes. Thus, the OCSP can be useful in
discriminating between stroke and mimic, but only when the diagnosis is lacunar or
total anterior circulation syndrome (approximately 1 in 3 patients).
8.6 Summary
• This study has limitations, but the results are in general agreement with
those of the 1ST analysis, which demonstrated that patients who were
assessed earlier were different to those assessed later.
• Patients with brain attacks who present to hospital early are older, the
strokes are more severe, TIAs or intracerebral haemorrhages are more
likely, and the nature of the mimics differs.
• Despite the differences, patients who present earlier are no more difficult
to diagnose than those who present later - probably because severe
strokes are easier to diagnose.
• Patients who present within six hours are potentially eligible for
thrombolysis, but many will not qualify, as the time of onset cannot be
confidently established clinically.
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• Rules for the clinician: be wary of stroke mimics if the NIHSS is low, and
if it is difficult to classify the neurological deficit into an OCSP category.
Recommendations for further research
• The OCSP classification needs to be tested for reliability in the
hyperacute phase
• Further research on patients assessed very early is required to validate the
suggestion that the diagnosis is easier in the hyperacute phase
• We need to evaluate imaging (or other) methods to determine if patients
with unknown time of onset may be treatable with thrombolysis.
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Table 8.1 General characteristics ofpatient recruitment
Patient presenting:
Feature Within 6 hours After 6 hours p*
Median age (n=336 patients): 76.33 years 76.24 years .625
Median time from symptom onset to
presentation^ 2.33 hours 18.25 hours <.001
Time of ARU admission:*
9.00am-5.00pm 111 (58.7%) 95 (65.1%)
5.01pm- 12.00am 53 (28.0%) 40 (27.4%)
12.01am - 8.59am 25 (13.3%) 11 (7.5%)
Median time from symptom onset to
evaluation by research fellow:5 19.75 hours 40.00 hours <.001
Delay between presentation and
evaluation by research fellow:+ .696
0-3 hrs 58 (31%) 41 (29%)
3-6 hrs 3 (2%) 1 (1%)
> 6 hrs 128 (68%) 99 (70%)
Referred to research team by: .018
ARU 182 (95%) 139 (88%)
Other ward 7 (3.5%) 8 (5%)
Inpatient brain attacks 3 (1.5%) 11 (7%)
Examiner: .472
PJH 102 (53%) 79 (50%)
JK 74 (39%) 62 (39%)
Other 16 (8%) 17 (11%)
* P value determined by Mann Whitney U test for continuous variables, and y test for
categorical variables
f n=330 episodes: 14 were inpatient brain attacks, in 5 the time ofonset was unknown, and
in one episode the time ofarrival in ARU was unknown
/ n=335 episodes: 14 inpatient brain attacks, 1 brain attack with unknown tune ofarrival in
ARU
§ n=345 episodes: time ofonset could not be determined in 5 brain attacks
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Table 8.2 Clinical features at baseline in brain attack study, subdivided by time
Features among patients presenting:
Clinical Feature 0-6 hours (%) >6 hours (%) P*
Male 82/181 (45.3) 81 /155 (52.3) .124
Age 80 and over 76/181 (42.0) 44/155 (28.4) .015
Asleep at onset 35/152 (23.0) 43/101 (42.6) .001
Reduced consciousness 56/192 (29.2) 25/158 (15.8) .003
Systolic BP>185 31 / 192 (16.1) 20/158 (12.7) .370
In Atrial Fibrillation 38/192 (19.8) 34/158 (21.5) .691
Cortical Signs:
Aphasia 79/192 (41.1) 45/158 (28.5) .014
Neglect 74/192 (38.4) 39/158 (24.7) .006
Hemianopia 62/192 (32.3) 37/158 (23.4) .067
Any cortical sign 117/192 (60.9) 68/158 (43.0) .001
Stroke Subtype:1
TACS 40 / 146 (20.8) 20/123 (12.7) .043
PACS 67 / 146 (34.9) 41 / 123 (25.9) .071
LACS 24/146 (12.5) 35/123 (22.2) .016
POCS 15/146 (7.8) 27/123 (17.1) .008
* P value determined by % test
f Stroke subtype could not be determined in 81 patients
Table 8.3 Final diagnosis in brain attack study subdivided by time
Diagnosis among patients presenting:
Final diagnosis 0-6 hours (%) >6 hours (%) P*
Mimic 62/192 (32.3) 47/158 (29.7) .609
Possible stroke 1 / 192 (0.5) 3/158 (1.9) .283
TIA 14/192 (7.3) 3/158 (1.9) .019
Definite & probable stroke 115/192 (59.9) 105/158 (66.5) .206
ICH 14/130 (10.8) 4/111 (3.6) .036
Infarct 101 / 130 (77.7) 101 / 111 (91.0) .009
* P value determined by test and Fisher's exact test (where numbers were small)
f mimic defined as all definite non-strokes and possible strokes with a plausible non-stroke
explanation
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Table 8.4 A comparison of clinical features in those who presented and were seen by the
research fellow within six hours of onset, and those who presented within six hours but
were seen by the research fellow later
Patients who presented within six hours, but were
assessed by the research fellow:
Clinical Feature 0-6 hours (%) >6 hours (%) P*
Asleep at onset 13/50 (26.0) 22/102 (21.6) .542
Reduced consciousness 22/56 (39.3) 34/136 (25.0) .048
Median Systolic BP 155 mmHg 152 mmHg .098
In Atrial Fibrillation 9/56 (16.1) 29/136 (21.3) .406
Cortical Signs:
Aphasia 26/56 (46.4) 53/136 (39.0) .340
Neglect 32/56 (57.1) 42/158 (30.9) .001
Hemianopia 23/56 (41.1) 39/136 (28.7) .095
Any cortical sign 40/56 (71.4) 77/136 (56.6) .056
Median NIHSS 8.0 4.0 .005
Stroke Subtype:1 .083
TACS 17/50 (34.0) 23 /126 (18.3)
PACS 18/50 (36.0) 49/126 (38.9)
LACS 8/50 (16.0) 16/126 (12.7)
POCS 4/50 (8.0) 11/126 (8.7)
* P value determined by test and Mann- Whitney U test
f Stroke subtype could not be determined in 16 patients
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Table 8.5 Causes ofmimics subdivided by time
Mimics presenting:
Condition* Within 6 hrs (%) After 6 hrs (%>) P+
1. Seizure 18 (29.0%) 5 (10.6%) .035
2. Sepsis 6 (9.7%) 8 (17.0%) .276
3. Toxic / metabolic 6 (9.7%) 6 (12.8%) .568
4. Space occupying lesion 3 (4.8%) 7 (14.9%) .088
5. Syncope / presyncope 9 (14.5%) 1 (2.1%) .027
6. Acute confusional state 3 (4.8%) 4 (8.5%) .470
7. Vestibular dysfunction 3 (4.8%) 4 (8.5%) .470
8. Acute mononeuropathy 4 (6.5%) 2 (4.3%) .659
9. Functional/medically
unexplained symptoms
4 (6.5%) 2 (4.3%) .659
10. Dementia 2 (3.2%) 2 (4.3%) .793
11. Migraine 2 (3.2%) 2 (4.3%) .793
12. Spinal cord lesion - (0%) 3 (6.4%) .077
13. Other 2 (3.2%) 1 (2.1%) .784
* Conditions have been ranked according to theirpercentage overall (see Table 1.5)
f significance determined by Fisher's exact test
Table 8.6 The accuracy ofthe bedside diagnosis ofbrain attack in thefirst six hours
Patients presenting:







Research fellowfinal bedside diagnosis
Accuracy
Positive predictive value
* P value determined by £ test
f Accuracy = all correct diagnoses / total number diagnoses
/ Positive predictive value = correct diagnosis ofstroke / all diagnoses ofstroke
74/ 108 (68.5%) 81 / 108 (75.0%) .364
70 / 97 (72.2%) 76 / 112 (67.9%) .599
141 / 182 (77.5%) 100/ 139(71.9%) .315
111 / 141 (78.7%) 79 / 103 (76.7%) .826
172 / 192 (89.6%) 124 / 158 (78.5%) .007
116/ 122 (95.1%) 90/ 103 (87.4%) .067
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Table 8.7 Features of patients who presented within the first six hours incorrectly
diagnosed by the research fellow (compared with patients who presented later than six
hours)
Incorrect diagnosis:
Feature Within 6 hrs (n=20) After 6 hrs (n=34) P*
Median age (years)+ 68.12 76.11 .450
Male genderf 9/17 (52.9%) 13/32 (40.6%) .409
Number of representations: 3/20 (15.0%) 2/34 (5.9%) .316
Past history of stroke1 11 /17 (64.7%) 12/31 (38.7%) .155
Known cognitive impairment1 2/18 (11.1%) 3/30 (10.0%) .895
Confused on examination 5/13 (38.5%) 9/30 (30.0%) .603
Signs inconsistent with





TACS 2 (10.0%) 3 (8.8%) .619
PACS 10 (50.0%) 10 (29.4%) .111
LACS 2 (10.0%) 4 (11.8%) .609
POCS 1 (5.0%) 8 (23.5%) .078
Unsure/No signs 5 (25.0%) 9 (26.5%) .920
Final diagnosis: .541
Stroke 14/20 (70.0%) 21/34 (61.8%)
Mimic 6/20 (30.0%) 13/34 (38.2%)
*
- p value determined by £ test, and Fisher's exact test (for categorical variables), and
Mann- Whitney U test (for continuous variables)
f - denominator refers to the number ofpatients (not events)
/ - OCSP clinical classification. TACS - total anterior circulation syndrome, PACS -
partial anterior circulation syndrome, LACS - lacunar synrome, POCS -posterior
circulation syndrome
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Table 8.8 Brain attacks that presented within six hours - a comparison between those with
estimated and known time ofonset
Time of symptom onset:
Feature Estimated (n=42) Known (n=150) p*
Examiner: .425
PJH 19 (45.2%) 83 (55.3%)
JK 18 (42.9%) 56 (37.3%)
Other 5 (11.9%) 11 (7.3%)
Median agef 77.55 76.33 .415
Male gender+ 18/40 (45.0%) 64/141 (45.4%) .965
History details:
No patient/relative as primary
source of history 23/42 (54.8%) 29/150 (19.3%) <.001
No patient/relative as secondary
source history 13/23 (56.5%) 20/29 (69.0%) .525
Inconsistencies in history 8/42 (19.0%) 33/150 (22.0%) .842
Symptoms affected L body 9/30 (30.0%) 53/131 (40.4%) .393
Past history of stroke1 20/37 (54.1%) 57/137 (41.6%) .244
Known cognitive impairment1 13/38 (34.2%) 21 / 140 (15.0%) .015
Examination findings:
Confused 14/20 (70.0%) 38/105 (36.2%) .010
Altered conscious state 16/42 (38.1%) 40/150 (26.7%) .150
Aphasia 23/42 (54.8%) 56/150 (37.3%) .042
Neglect 14/42 (33.3%) 60/150 (40.0%) .433
Signs affect L body 8/30 (26.7%) 53/131 (40.5%) .232
Diagnostic formulation:
R brain affected 7/21 (33.3%) 43/101 (42.6%) .589
Cortex involved 24/42 (57.1%) 83/150 (55.3%) .974
Final diagnosis: .016
Stroke 22/42 (52.4%) 101 /150 (67.3%)
Mimic 20/42 (47.6%) 49/150 (32.7%)
Incorrect clinical diagnosis 3/42 (7.1%) 17/150 (11.3%) .461
*
- p value determined by test, and Fisher's exact test (for categorical variables), and
Mann- Whitney U test (for continuous variables)
f - denominator refers to the number ofpatients (not events)
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Chapter 9 : Interrater study of the clinical assessment
9.1 Introduction
"The need for reproducible, reliable clinical measurement
goes beyond the requirement for powerful diagnostic,
prognostic, and treatment data."(Sackett et al., 1985c)
Reliability {precision) is the assessment of agreement between different
observers. It complements accuracy {validity), as there is no point in determining
criteria that make a diagnosis with 100% accuracy if these criteria are unreliable.
The following chapter describes an inter-rater reliability study of the clinical
assessment of patients with brain attack. Real patients (rather than vignettes, or
videotaped observations) were examined in a routine manner by several observers
with varied levels of experience. The results are presented using the kappa statistic
(k), a measure of agreement that takes account of chance.
9.2 Aims
This study had two primary aims:
(1) To determine the reliability of the clinical assessment of patients with
brain attack.
(2) To explore if modifiable external factors (such as experience, time, or





The study was based in an urban teaching hospital with an acute stroke unit
and an academic interest in stroke medicine. Patients presenting with symptoms of
brain attack were studied prospectively. The time between assessments was kept to a
minimum to reduce the effect that fluctuations in patient state could have on
reliability.
Procedure
We aimed to recruit consecutive patients with brain attack to the interrater
study. Identification of patients was exactly the same as described for the Brain
Attack study. This study ran parallel with the Brain Attack study, so patients were
recruited into both studies. Allocation of examining pairs to patients was determined
by a random list (see below).
Once identified, a patient was assessed by the first examiner. Immediately
after this, the second examiner assessed the patient. Observers were given no
specific instructions as to how to elicit or score the assessment. Examiners were
permitted to read the one-page acute receiving unit (ARU) admission summary, but
were not able to inspect the rest of the patient's notes (the ARU sheet is kept loosely
and separately). Each examiner independently recorded his/her findings on a
standard data form (see Appendix 7) at the end of the assessment. On completion,
the examiner's data form was placed in a sealed envelope and collected by Ms J
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Haisma (a senior medical student who co-ordinated the study during a four-month
research elective). Discussions about the patient were only permitted once both
envelopes were sealed and collected.
Achieving balance in randomising pairs
To maintain an even number of pairings and an equal number of times that
each observer was the first or second examiner, a randomised and counterbalanced
list was generated [using random number tables, (Neave, 1978)]. The available
examining pair was allocated to each patient in the order of the list. Allocation was
performed by JH, who was unaware of any patient details.
9.3.2 Patient recruitment
Patient eligibility and case ascertainment for the reliability study was as
outlined in the brain attack study (Section II, Chapter 9). Every patient (or relative)
agreed to enter the study. Consent was obtained by the first examiner at the time that
the patient was invited to enter the brain attack study. The study had ethics
committee approval.
9.3.3 Observers
Three of four observers who performed the clinical assessments were
medically qualified physicians. PJH was in his ninth, JK was in his sixth, and BL
was in his fifth post-graduate year. BL had five years, and PJH four years of
neurology training; JK had no formal training in neurology. BL and PJH trained
overseas (English was not the primary language of BL). All were undergoing further
training in stroke medicine.
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The other examiner, JH, was in her fourth year of medical school in the
Netherlands. She was not proficient in neurological examination, or the assessment
of stroke patients. For the four weeks before the study commenced, she read
standard stroke and neurology examination textbooks, and received practical
demonstrations in examination and history taking when she accompanied PJH to see
patients.
9.3.4 Data collection
The data collection forms were designed to be brief, so that a clinical
assessment took 15 to 20 minutes. A long second assessment risked causing fatigue
to the patient. The key items from the brain attack data form (considered to be most
important in making a clinical diagnosis of stroke) were selected. The data form (see
Appendix 7) was divided into four areas: vascular risk factors, history of the
presenting complaint, examination (including neurological examination), and
diagnostic formulation (including the Oxfordshire Community Stroke Project
(OCSP) classification). Brief instructions were provided (primarily to aid the
medical student). An 'unknown' category was accepted, as there was confusion
amongst observers as to how to score items when information could not be elicited
from patients (e.g. due to aphasia).
An important component of the brain attack study, the National Institute of
Health Stroke Scale (NIHSS), was not assessed in the present study. This was to
keep the training of the medical student to a minimum, and because several other
studies have assessed the reliability of the NIHSS (Goldstein et al., 1989; Brott et al.,
1989a; Lyden et al., 1994; Dewey et al., 1999). The three medically qualified
222
examiners had completed the NIHSS training videotapes and were familiar with the
scale.
9.3.5 Data processing
The data were entered onto a Microsoft Excel spreadsheet (version 97 SR-2,
^Microsoft Corporation 1997). All data were double-checked to ensure accuracy.
Corrections were made before the analysis: omitted answers or typographical errors
were corrected by referring to the Brain Attack data form where this was available.
Analyses were performed in SPSS for Windows (version 10.0.5, ®SPSS Inc. 1999),
and confidence intervals for kappa values were calculated using Confidence Interval
Analysis (version 2.0.0, ®Trevor Bryant, 2000)
9.3.6 Statistical analysis
The kappa statistic
There are several ways to measure interobserver variability. The simplest is
the percentage of cases in which both observers agree on the presence or absence of
the item studied. This measure gives a misleadingly good impression of agreement,
as it does not account for agreement that is expected by chance (Rothwell, 2000).
The present study used Cohen's kappa statistic (k), a measure of the extent to which
agreement is greater than expected by chance alone (Cohen, 1960) (see Figure 9.1).
When the obtained agreement equals chance agreement, k = 0. Greater than chance
agreement leads to positive k values, to a maximum of+1.00, which indicates perfect
agreement between observers. Less than chance agreement leads to negative k
values, to a minimum of-1.00 (perfect disagreement).
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Kappa = actual agreement beyond chance
Dotential aareerrent bevond chance
Figure 9.1 The kappa statistic
Adaptedfrom Sackett et al (1985c)
k values between 0 and +1.00 are generally interpreted as suggesting
agreement that ranges from poor to excellent (see Table 9.1) (Brennan & Silman,
1992). The k statistic was developed for categorical, unranked data (e.g., yes/no,
present/absent), but has since been extended for observations with more than two
categories (e.g., yes/no/maybe) or ranked categories (e.g., 0-33%, 33-66%, 66-
100%). To adjust for the different levels of agreement that can occur when mulitple
categories are used, the k statistic can be weighted (Cohen, 1968). I have not used
weighted k in this analysis, as it is arbitrary, may not reflect clinical practice, and
often prevents meaningful comparisons between studies (Maclure & Willett, 1987;
Al Shahi et al., 2002).
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Subgroup analyses
This study aimed to assess the influence of several variables on the reliability
of the clinical assessment. Therefore, further analyses were performed on the poorly
performing items (identified by fair or moderate k values). Pre-specified subgroups
included:
• Observer experience: around half of the patients were assessed by a
medical student-physician pair, and the remainder were assessed by a
physician-physician pair (of similar experience), thus enabling an
assessment of the impact of experience on the assessment.
• Time from onset ofsymptoms to presentation: half of the patients studied
presented to hospital within six hours, and were assessed sooner than the
remainder of the patients who presented after six hours from symptom
onset. This allowed an assessment of the impact of time on the reliability
of the clinical assessment.
• Confidence of the examiners: each examiner was asked to rate his/her
confidence for the three components of the clinical assessment (history,
examination, and diagnostic formulation). A highly confident pair was
defined as where both examiners stated that they were highly confident; a
low confidence pair was defined as where one or both examiners stated
that their confidence was low. Comparing the two categories allowed the
impact of confidence to be assessed.
In addition, the impact on the reliability of the 'unknown' category was
analysed by re-classifying the data in a clearly specified manner. Results of
subgroup analyses were tabulated for qualitative comparisons. Significance tests
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were not available, as they have limited validity when applied to the k statistic
(Cohen, 1960; Maclure & Willett, 1987), and may prevent real differences between
groups from being recognised (personal communication, Dr S.Lewis, statistician).
9.4 Results
9.4.1 General features
The reliability study began recruiting patients on 9 February 2001, and
completed recruitment on 30 April 2001. 98 patients were seen (see Table 9.2). The
age, gender distribution, and time from onset to presentation were similar to the brain
attack study, although patients were seen slightly later (median 25.3 hours). 55% of
patients presented to hospital within six hours of symptom onset (but only 11 patients
were assessed within six hours of onset).
The median time from commencement of the first examination to
commencement of the second was 0.9 hours. The median time taken for completion
of the clinical assessment was 20 minutes, thus around 30 minutes elapsed between
evaluations. The research fellows performed an equal number of assessments as first
and second examiner, and an even number of pairings were achieved (except that the
author and JH saw more patients).
Difficulties in patient recruitment
Although we aimed to recruit consecutive patients with brain attack, this was
not possible. During the study period of time, 125 consecutive presentations with
brain attack were recruited into the Brain Attack study. Thus, 98/125 (78%) of all
brain attacks entered the reliability study. Patients were not recruited to the
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reliability study due to lack of consent (e.g. absent relative, or refusal) in a small
number of patients, and unavailability of an examination pair in the majority of
patients. It proved too difficult to have four clinicians available at all times of the
day to participate in the study. Consequently, most patients were identified and seen
the following morning - hence the median time between onset and assessment was
25 hours.
Difficulties encountered in data collection
During the course of the study, the data forms changed several times. Extra
questions were added: e.g., the presence of diabetes (somehow initially missed as a
vascular risk factor!), the time that the patient was last normal, whether the patient
could walk. Some questions were unintentionally left blank
One observer (BL) stated that an exact time of symptom onset could be
determined, but was unable to provide the time (instead providing the date and an
approximate time such as 'morning'). This occurred for five patients (four
physician-physician pairings, one student-physician pairing).
9.4.2 Reliability of the clinical assessment
Vascular risk factors
The summary kappa values are provided in Table 9.3, and the raw data are
available in Appendix 8. There was substantial agreement for the presence of the
vascular risk factors ischaemic heart disease (k: 0.64) and diabetes mellitus (k: 0.65),
and whether the patient was a current smoker (k: 0.69). Agreement was moderate for
all other items.
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History of the presenting complaint
Table 9.4 shows that there was substantial agreement for whether an exact
time of onset could be determined (k: 0.63). Good agreement was obtained for many
of the focal neurological symptoms, and the presence of headache. Agreement was
only fair for whether the patient could recall what he/she was doing at the time of
onset (k: 0.37), and if the patient was well in the last week (k: 0.40).
There was consensus that an exact time of onset could be determined for 46
patients, and both examiners provided the exact date and time for 42 patients. There
was complete agreement for date and time (hour and minute) in 19/42 (45%),
agreement for date and hour in 11/42 (26%), agreement for date only in 9/42 (21%),
and complete disagreement for date and time in 3/42 (7%). The median difference in
onset times for the 23 patients where there was disagreement was 30 minutes
(interquartile range 10-90 minutes). There were 34 patients in whom there was
agreement that it was not possible to determine time of onset.
In three patients where there was no consensus for date or time of onset, the
dispute arose over whether symptoms were first noted on waking, or the night before.
In these patients, symptoms had fluctuated, and the examiners could not determine
whether symptoms had resolved completely before the patient went to bed. None of
these patients presented within the time window for thrombolysis.
Examination findings
Many items achieved good or better kappa values, including perfect
agreement for patients who were unconscious (k: 1.00) (see Table 9.5). Neglect was
less reliable than other items of the neurological examination, with 'other forms of
neglect' achieving a fair rating (k: 0.34). There was poor agreement for determining
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if signs affected both sides of the body (k: 0.19). Inspection of the raw data
(Appendix 8) shows that both examiners agreed that the signs were bilateral in one
patient, and not bilateral for 90 patients. Hence, the crude agreement was 91/98
(93%).
Diagnostic formulation
The reliability of the diagnostic formulation was generally good (Table 9.6).
The initial classification - stroke or non-stroke - achieved k 0.77, and localisation to
the left or right side of the brain was extremely good (k: 0.90 and k: 0.81,
respectively). Agreement for brainstem localisation was moderate (k: 0.40), but - as
with bilateral signs - crude agreement was 70/75 (93%).
There was moderate reliability for the OCSP classification (overall k: 0.58).
There was consensus between observers for total anterior circulation syndrome
(TACS) 13 times, partial anterior circulation syndrome (PACS) 20 times, lacunar
syndrome (LACS) 13 times, and posterior circulation syndrome (POCS) seven times
(70% of all OCSP classifications were in agreement). Individual k values were good
for POCS (0.70), TACS (0.64) and LACS (0.64), but only moderate for PACS
(0.43). The disagreements were most frequently between TACS and PACS, and
LACS and PACS.
9.4.3 Exploring reasons for poor reliability
Selection of items for further analysis
Some items achieved only fair agreement, and several important components
of the history or examination achieved modest agreement. I have selected some of
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these items for further analysis, to determine if the reliability depends - in part - on
another factor (such as experience, or time). Variables selected were: peripheral
vascular disease and past history of a focal neurological deficit (moderate
agreement); patient could recall what he/she was doing at the time of onset, and
patient was well in the week before symptom onset (fair agreement only); items from
the neurological examination with moderate agreement, and the OCSP classification.
The impact of experience
A pair of physicians saw 45 patients, and a medical student-physician pairing
saw 48 patients. Table 9.7 demonstrates that the kappa was higher for the doctor-
doctor pairing across almost all components of the clinical assessment. The
difference was generally greatest for the neurological examination (e.g., k for visual
neglect was 0.23 for student-doctor and 0.64 for doctor-doctor), and the OCSP
classification (k 0.38 and 0.70, respectively); and least for the items of history (e.g.,
k for whether the patient was well in the last week was 0.37 and 0.44, respectively).
The impact of time
In the present study, 54 patients presented within six hours of symptom onset.
The median time of assessment was 21.3 hours (interquartile range 11.9 - 29.8
hours). 44 patients presented after six hours from onset, including four patients in
whom an onset time was unknown. Median time of assessment in the later
presenting group was 31.8 hours (interquartile range 25.0 - 56.2 hours). There was a
trend for the reliability of the clinical assessment to be better when patients who
presented in the first six hours were evaluated (see Table 9.8). However, this did not
hold true for the assessment of facial weakness, which was moderately reliable in the
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hyperacute patients, but attained good agreement later on (k 0.42 to 0.62,
respectively). The agreement for visuo-spatial dysfunction was modest to fair no
matter when patients were assessed.
Was clinician's confidence important?
Examiners recorded their level of confidence for the history, examination,
and diagnostic formulation. 47 pairs of examiners both reported high confidence for
the items of history. Table 9.9 shows that the kappa values were impressive for past
history of focal neurological deficit (k 0.71) and whether the patient woke from sleep
with the deficit (k 0.80) when both examiners were confident about the history
gathered. Yet agreement was only fair - and no different to that of the low
confidence pairs - for whether the patient could recall what he/she was doing at the
time of symptom onset (k 0.26), and whether the patient was well in the last week (k
0.33).
60 pairs of examiners both reported high confidence for the examination, and
there was greater agreement for neurological signs in this group (e.g., k 0.67 for face
weakness, compared with k 0.31 for the same sign when one or both examiners were
not confident). The agreement for confusion and other forms of neglect (i.e., not
visual or sensory neglect) actually improved when confidence was low. For the 42
pairs who were confident about the final diagnosis, the OCSP classification achieved
good agreement (k 0.68).
How to deal with the 'unknowns'
The 'unknown' category represented a difficulty for statistical analysis, as a
greater number of categories inevitably results in a lower k (Brennan & Silman,
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1992). We wanted to distinguish between whether an item was truly absent, or
unanswerable, hence we allowed the unknown category. But it could be argued that
if something is unknown it is of little clinical value - in the setting of thrombolysis,
decisions need to be made swiftly, so unknown items cannot be used to make a
decision. Hence, an alternative approach would be to class an item as absent unless
it was definitely known to be present.
To determine if some of the poor reliability was due to the extra category, the
data were re-analysed with unknown re-classified to no. The results are provided in
Table 9.10. There was no observable trend: some items improved (e.g. for 'patient
can recall what he/she was doing at time of onset', k improved from 0.37 to 0.55),
some remained the same, and some deteriorated (e.g. for visual neglect, k went from
0.41 to 0.13).
9.5 Discussion
9.5.1 Importance of the present study
The history and examination form the cornerstone of neurological diagnosis
(Goldstein & Matchar, 1994). Many studies of the reliability of the clinical
assessment of stroke have now been reported (Tomasello et al., 1982; Shinar et al.,
1985; Gelmers et al., 1988; Gordon et al., 1993; Lindley et al., 1993; Dewey et al.,
2001), particularly studies of the NIHSS (Goldstein et al., 1989; Brott et al., 1989a;
Lyden et al., 1994; Dewey et al., 1999). The present study adds important additional
information, for five main reasons. Firstly, real patients were used as subjects. This
is a clinically realistic method of assessment, arguably more so than clinical vignettes
(Gordon et al., 1993), or videotaped observations (Lyden et al., 1994). It has been
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suggested that the latter are more suited to studies of the acute phase of stroke, where
patient's signs may change rapidly (D'Olhaberriague et al., 1996). This is a valid
point, but we were able to minimise patient fluctuations by examining patients on
average 30 minutes apart [much sooner than other studies, e.g. (Shinar et al., 1985;
Lindley et al., 1993)]. In addition, the ability to score reliably an item that is
demonstrated on video does not imply that the clinician will achieve similar
reliability when directly examining the patient.
Secondly, this was the largest study to date. A broad spectrum of patients
was studied - some had stroke mimics, many were old, and some were confused or
aphasic. Unlike studies in which stable stroke patients were used, and the observers
were thus expecting to find neurological symptoms or signs (Shinar et al., 1985;
Gelmers et al., 1988; Brott et al., 1989a; Lindley et al., 1993; Dewey et al., 1999),
the present study selected patients who presented with the undifferentiated clinical
syndrome ofbrain attack. This minimised bias.
Thirdly, a wide range of observers participated in this study. Clinical
experience differed, and the first language of two observers was not English.
Previous studies used highly trained stroke neurologists (Shinar et al., 1985; Gelmers
et al., 1988), or the signs were demonstrated to the less experienced members of the
team by a stroke neurologist (Brott et al., 1989a). Two studies by the same clinicians
(Dewey et al., 1999; Dewey et al., 2001) compared trained research nurses to a
neurologist.
Fourthly, items of history were tested. Just two other studies tested the
history (Tomasello et al., 1982; Shinar et al., 1985), although one study only
reported the crude index of agreement (Tomasello et al., 1982).
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These strengths - which aim to replicate real-life, hence provide a realistic
impression of reliability - might be expected to diminish agreement. The final
strength of the study is that we attempted to explore some of the reasons for clinical
disagreements, which has not previously been performed in the field of stroke.
9.5.2 Comparison with other studies
History
The two earlier studies reported generally disappointing reliability for the
neurological history [it is not possible to directly compare the findings of Tomasello
et al (1982)]. Table 9.11 shows that in Shinar et al's (1985) study, kappa values
were poor to fair for the four items of history that could be compared directly. In the
present study, agreement was much better (despite - or perhaps because of - the
difference in observers' experience in the two studies).
Neurological examination
Our results are in broad agreement with the other studies (Table 9.11), and
reinforce the general finding of moderate to good reliability for the component parts
of the NIHSS. Like Lindley et al (1993), we found that confusion was an unreliable
sign. Unlike Shinar et al (1985), we found that hand weakness was reliable.
Diagnostic formulation
The reliability of the clinical diagnosis of stroke has not been tested before
(Goldstein & Matchar, 1994). Reassuringly, we found that this achieved good
agreement. In common with Lindley et al (1993) and Dewey et al (2001), we found
that the OCSP classification overall was moderately reliable (k 0.58, 0.54 and 0.42-
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0.58, respectively). The categories of POCS, LACS and TACS achieved better
reliability than PACS, and we also observed an improvement in k when an
experienced pair of observers was compared to a pair containing an inexperienced
observer.
9.5.3 Limitations of the study
There are some limitations of the present study. Although we aimed to see
patients as promptly as possible, the median time from symptom onset to evaluation
by the first observer was rather long (25 hours). The patient sample was not
consecutive, and we were unable to allocate examining pairs in the exact order listed
in the random number sheet. Despite this, there was no systematic bias in patient
exclusion or allocation.
Examiners were able to see patients within 30 minutes of each other, thereby
limiting changes in patient state, but even within this short time, important
fluctuations did occur (in at least three patients). Despite an examination time of 15
to 20 minutes, when patients were examined closely together, fatigue was a problem
(two patients refused to allow a second assessment). These difficulties would have
reduced agreement between examiners.
9.5.4 Limitations of the kappa statistic
The k statistic, although widely used, has been criticised (Maclure & Willett,
1987; Brennan & Silman, 1992; Byrt et al., 1993). When there are more than two
categories (e.g., the four OCSP subtypes), the opportunities for disagreement
increase, and the k value decreases (Brennan & Silman, 1992) (e.g. the overall k for
the OCSP classification was lower than the individual categories). In this situation,
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use of the intraclass correlation coefficient may be preferable (Maclure & Willett,
1987).
k is affected in complex ways by the prevalence of abnormality amongst the
subjects observed, and by observer bias. Very low (or high) prevalence results in
high levels of expected agreement, and consequently the k value is often low despite
near perfect agreement (Brennan & Silman, 1992). This was seen in the present
study for the items of whether signs affect both sides of the body, and whether the
lesion was in the brainstem. Observer bias, in this sense a systematic difference
between two observers in the way questions are answered, influences agreement.
Bias was seen in the present study - one examiner consistently scored the onset as
'exactly known' when it was actually unknown (as the examiner was unable to
provide the exact time). Bias is a form of disagreement with important practical
implications, but it is not separately identified by k. Statistical methods to adjust for
bias and prevalence have been proposed (Byrt et al., 1993), but have not become
widely accepted.
It can be difficult to compare k values between different studies, and within
studies. A significance test for a k value can be calculated, but this merely states the
likelihood that the result did not arise by chance - and chance has already been
eliminated from the value, making a p-value trivial in comparison to the actual k
(Cohen, 1960). Finally, although formulae are available to compare two independent
k values (Cohen, 1960), these have not become standard, so it is difficult to quantify
differences between k.
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9.5.5 Implications of the study
The present study found that certain components of the clinical assessment
achieved good or better reliability (summarised in Table 9.12). As these items
proved reliable when assessed by inexperienced students, doctors with a primary
language other than English, and in a broad range of (often difficult) patients, it can
be concluded that these items are reliable in everyday clinical practice. Little
additional training beyond medical qualification would be required to ensure
competence with such items. The present study also found that certain components
of the assessment had poor reliability, and performance was not improved under any
of the conditions tested. These questions and signs, despite any possible validity, are
probably useless in clinical practice (Table 9.12).
Our results have important implications for training. The reliability of a
substantial proportion of the clinical assessment could probably be improved. We
observed that increased clinical experience in our examiners led to better reliability
in our study, particularly for the examination. However, it would be wrong to simply
target the neurological examination for additional training, as reliability depends on
knowing the patient's history (allowing hypotheses to be tested) (Vogel, 1992;
Hansen et al., 1994). A reasonable strategy would be to provide less experienced
observers with detailed rules or guidelines for the interpretation of the information
obtained. Such guidelines have been demonstrated to improve reliability for the
diagnosis of transient ischaemic attack (Koudstaal et al., 1989) and the NIHSS
(Lyden et al., 1994). This may improve the confidence of examiners, which was
shown in the present study to be crucial to achieving good reliability.
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We observed that reliability was no worse for patients who presented within
six hours, and were examined earlier, than for patients who presented after six hours.
However, most patients admitted within six hours were actually assessed at around
24 hours after symptoms onset; only 11 patients presented and were assessed within
six hours, too few to draw meaningful conclusions about the reliability of the
assessment of the 'hyperacute' patient.
The determination of time of symptom onset has crucial implications for
acute stroke. Although good agreement was reached that an exact time of onset
could be determined, in fewer than 50% of patients did the examiners actually agree
on the precise time. Whether the patient woke from sleep with the deficit, or whether
symptoms had improved since onset, achieved only modest agreement. At present,
the only factor shown to be significant in determining eligibility for thrombolysis is
time from symptom onset, yet our evidence suggests that this can not be determined
reliably.
9.6 Summary
• This study has identified the reliable parts of the clinical assessment of
patients with brain attack
• Many of the items with only moderate agreement could probably be
improved with training
• Confidence improves reliability
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Recommendations for further research:
• We need more studies of patients who present within six hours of
symptom onset
• We need to explore ways of improving reliability of time of onset - or
alternate strategies to determine eligibility for thrombolysis.
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Table 9.1 Interpretation ofthe kappa statistic




0.61-0.80 Good or substantial
0.81-1.00 Very good
After Brennan and Silman (1992)
Table 9.2 Generalfeatures ofpatients recruited into the reliability study (n=98)
Feature Number (%/IQR*)
Median age (IQR*): 78.6 years (69.3-85.7)
Male gender: 44/98 (45%)
Final diagnosis of mimic 24/98 (24%)
Known cognitive impairment/confusion on examination 39/98 (40%)
Aphasia 37/98 (38%)
Median time from symptom onset to presentation (JQR):+ 4.8 hours (1.9-13.3)
Median delay between presentation to hospital and
evaluation by research team (IQR):f 25.3 hours (16.3-49.7)
Median time between commencement of first and second


















* IQR - interquartile range
f time of onset details were unknown in 4 patients, and there were 3 inpatient brain attacks
(hence time ofpresentation to ARU not appropriate),
f JH was the medical student
241
Table 9.3 Reliability ofthe assessment ofvascular risk factors
Item Kappa value 95 % Confidence Intervals
Hypertension 0.47 0.32-0.62
Smoker within 12 months 0.69 0.55-0.83
Ischaemic heart disease 0.64 0.50-0.78
Atrial fibrillation 0.54 0.38-0.70
Peripheral vascular disease 0.44 0.27-0.62
Diabetes mellitus 0.65 0.45-0.84
Past history of a focal neurological deficit 0.51 0.36-0.66
Table 9.4 Reliability of the assessment ofthe history ofthe presenting complaint
Item Kappa value 95% Confidence Intervals
An exact time of onset can be determined 0.63 0.47-0.78
The patient woke from sleep with deficit 0.55 0.40-0.69
The patient can recall what he/she was doing
at time of onset 0.37 0.20-0.53
Improvement since onset 0.54 0.39-0.68
Symptoms are now stable 0.59 0.42-0.77
Patient well in the week before onset 0.40 0.24-0.57
A definite history of focal neurological deficit 0.59 0.42-0.75
Hemianopia/quadrantanopia 0.63 0.47-0.79
Loss of speech/language 0.64 0.50-0.77
Loss of sensation 0.62 0.48-0.76
Loss of power 0.59 0.44-0.75
Headache 0.65 0.51-0.79
The symptoms affect the:
Left side 0.62 0.48-0.76
Right side 0.56 0.42-0.71
Both sides 0.43 0.23-0.63
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Table 9.5 Reliability ofthe physical examination
Item Kappa value 95 % Confidence Intervals
The patient is alert 0.70 0.52-0.89
The patient is drowsy 0.74 0.53-0.94
The patient is unconscious 1.00 1.00-1.00
The patient is confused 0.45 0.28-0.62
Arm weakness 0.65 0.49-0.80
Hand weakness 0.72 0.59-0.86
Face weakness 0.50 0.34-0.67
Leg weakness 0.57 0.41-0.73
The patient could walk 0.62 0.47-0.76
Visual loss 0.46 0.28-0.64
Dysarthria 0.41 0.25-0.58
Dysphasia 0.66 0.51-0.80
Sensory disturbance 0.49 0.34-0.65
Visual neglect 0.41 0.25-0.58
Sensory neglect 0.59 0.45-0.73
Other form of neglect 0.34 0.16-0.51
The signs affect the:
Left side 0.74 0.61-0.88
Right side 0.69 0.54-0.83
Both sides 0.19 -0.40-0.77
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Table 9.6 Reliability ofthe diagnosticformulation
Item Kappa value 95% Confidence Intervals
The patient has had a stroke 0.77 0.60-0.93
The lesion affects the:
Left side of the brain 0.90 0.79-1.00








Table 9.7 The impact ofexperience on the reliability ofthe clinical assessment
Kappa value for pairing:
Item Student-Doctor Doctor-Doctor
Vascular risk factors
Peripheral vascular disease 0.38 0.53
Past history of focal deficit 0.46 0.59
History of presenting complaint
Patient woke from sleep with the deficit 0.55 0.53
Patient can recall what he/she was doing at time
of onset 0.33 0.40
Patient was well in the last week 0.37 0.44
Examination
The patient is confused 0.38 0.53
Face weakness 0.41 0.61
Visual loss 0.35 0.60
Dysarthria 0.40 0.41
Visual neglect 0.23 0.64
Other form of neglect 0.33 0.33
Diagnostic formulation
OCSP classification 0.38 0.70
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Table 9.8 The impact oftime to presentation on the reliability ofthe clinical assessment
Kappa value for patients presenting:
Item Within 6 hours After 6 hours
Vascular risk factors
Peripheral vascular disease 0.46 0.42
Past history of focal deficit 0.56 0.44
History of presenting complaint
Patient woke from sleep with the deficit 0.59 0.50
Patient can recall what he/she was doing
at time of onset 0.45 0.26
Patient was well in the last week 0.46 0.34
Examination
The patient is confused 0.52 0.30
Face weakness 0.42 0.62
Visual loss 0.55 0.32
Dysarthria 0.47 0.32
Visual neglect 0.40 0.41
Other form of neglect 0.36 0.30
Diagnostic formulation
OCSP classification 0.58 0.54
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Table 9.9 Impact of the examiners' level of confidence on the reliability of the clinical
assessment
Kappa value when confidence was:
Item High Low
History items n=47 pairs n=48 pairs
Peripheral vascular disease 0.51 0.27
Past history of focal deficit 0.71 0.32
Patient woke from sleep with the deficit 0.80 0.31
Patient can recall what he/she was doing at onset 0.26 0.24
Patient was well in the last week 0.33 0.36
Examination items n=60 pairs n=36pairs
The patient is confused 0.41 0.44
Face weakness 0.67 0.31
Visual loss 0.52 0.35
Dysarthria 0.45 0.36
Visual neglect 0.49 0.24
Other form of neglect 0.24 0.45
Diagnostic formulation n=42 pairs n=52 pairs
OCSP classification 0.68 0.45
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Item becomes 'no' Original results
Vascular risk factors
Peripheral vascular disease 0.31 0.44
Past history of focal deficit 0.51 0.51
History of presenting complaint
Patient woke from sleep with the deficit 0.59 0.55
Patient can recall what he/she was doing at onset 0.55 0.37
Patient was well in the last week 0.40 0.40
Definite history of focal neurological deficit 0.62 0.59
Examination
The patient is confused 0.40 0.45
Visual loss 0.46 0.46
Sensory disturbance 0.45 0.49
Visual neglect 0.13 0.41
Sensory neglect 0.59 0.59
Other form of neglect 0.21 0.34
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Table 9.12 Summary ofthe reliability of the clinical assessment




An exact time of onset could be determined







Diagnosticformulation Stroke or mimic
Side of brain lesion
Could be
improved: History Other vascular risk factors







Diagnostic formulation OCSP classification
Unreliable: History Patient can recall what he/she was doing at
time of onset
Patient was well in the last week
Examination Confusion
Neglect (other than sensory & visual)
Dysarthria
* Although k was good, less than 50% ofpatients had the same time recorded
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Chapter 10 : A predictive model to distinguish stroke from
non-stroke using clinical features
10.1 Introduction
This chapter will attempt to draw together the findings of earlier chapters to
discover if certain clinical features independently predict the diagnosis, and whether
these could be put to clinical use in a simple tool. I will use the multivariable
statistical technique of logistic regression to develop a tool to assist in the diagnosis.
Careful attention to the basic methodological principles of model building - which
shall be covered in some detail - is critical to ensuring that potentially useful models
are generated.
10.2 Aims
(1) To use multivariable logistic regression to determine which clinical
factors independently predict the diagnosis of stroke (or mimic)
(2) To develop predictive models, using clinical data available at the bedside,
to distinguish between stroke and mimic in patients presenting with brain attack
(3) To develop simple clinical guidelines to assist the less experienced
clinician in the assessment of patients with brain attack
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10.3 Methods
10.3.1 Predictive models: ensuring methodological quality
I chose to develop predictive models using logistic regression for two
reasons. Firstly, there is considerable 'in-house' experience of prognostic modelling
using multiple logistic regression analysis (Counsell & Dennis, 2001), and therefore
clinical and statistical support were available. Secondly, this is an accepted and valid
method of distilling a vast amount of data into something smaller and clinically
useful (Braitman & Davidoff, 1996; Laupacis et al., 1997). Many authors have
proposed methodological standards for predictive modelling using logistic
regression, which I have summarised in Table 10.1. I have attempted to conform to
these standards wherever possible.
10.3.2 Patient selection
Inception cohort
The inception cohort was assembled from patients who entered the brain
attack study. As described in Chapter 7, consecutive patients who presented with
symptoms of brain attack - apparently focal neurological dysfunction of apparently
abrupt onset - were recruited to the study. A standard clinical assessment was
performed by one of four stroke research fellows, and the data obtained were entered
onto a standard data form.
In the brain attack study, there were 350 presentations by 336 patients. By
convention, the entry point for predictive modelling is defined as the time that the
patient first entered the study (so I excluded the 14 recurrent events).
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Referral pattern
This was described in detail in Chapter 7, but the essential points are that the
study was situated in a medium-sized urban teaching hospital with an acute stroke
unit and an academic interest in stroke medicine (although not a tertiary referral
centre for stroke). The hospital has an Acute Receiving Unit (ARU), which receives
all medical emergencies from the north of Edinburgh. Patients were referred directly
to the research fellows by ARU staff. ARU and ward admission registers were
inspected daily, and potentially eligible patients were assessed to achieve full case
ascertainment.
10.3.3 Definition of outcome events
The aim of the model was to predict the diagnosis in patients presenting with
symptoms of brain attack. The outcome event was the final diagnosis as determined
by the expert panel. Logistic regression works best when the outcome variable is a
binary event (e.g. stroke or not) (Laupacis et al., 1997), so the six diagnostic
categories were dichotomised. 'Thrombolysis-eligible' strokes (meaning that, if all
else were favourable, the clinician would be prepared to consider thrombolysis for
that patient) were patients with a definite or probable stroke or transient ischaemic
attack (TIA). Mimics were patients with a definite non-stroke or a plausible
alternative diagnosis for a clinical syndrome thought to be a possible stroke.
The issue of TIAs deserves clarification. I included patients with TIA,
although they are often excluded from prognostic models [e.g. Baird et al (2001)].
This was because: (1) it would be inconsistent (and not clinically sensible) to exclude
patients after they had already entered the study, and (2) patients who have
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symptoms of brain attack are 'thrombolysis-eligible'. At present there is no reliable
way to determine those whose symptoms will persist (i.e. stroke), and those whose
symptoms will resolve by 24 hours (i.e. TIA).
'Outcome' (i.e. the final diagnosis) was assessed blind to the prediction of the
model. The panel was unaware of the variables that were used to generate the model
(although it is plausible that they used some of the variables to make their decisions).
The two categories for logistic regression analysis were pre-specified, transparent,
and clinically sensible.
10.3.4 Selection of variables
Data reduction
The number of variables used in multiple logistic regression analysis must be
carefully controlled to produce reliable models (Concato et al, 1993; Harrell, Jr. et
al., 1996). Too many variables entered into a model can result in overfitting of the
model to the dataset (Concato et al., 1993), which severely limits its generalisability.
The critical factor is not just the absolute number of variables entered into the model,
but rather the ratio of the number of outcome events to the number of variables
entered [the events per variable (EPV)]. Empirical research has shown that an EPV
of 10 or more, for the less frequent outcome event, is required to avoid producing
unreliable models (Peduzzi et al., 1996). For example, in a study of 100 patients, in
which 70 have a stroke and 30 a mimic, the maximum number of variables that
should be entered (to produce a reliable model) is three.
In the brain attack study, 135 individual items of data (variables) were
collected for each patient (see data collection form, Appendix 2). Thus considerable
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data reduction was required before performing the statistical analyses. The methods
used to eliminate variables should be clinically sensible and not based on univariate
comparisons between single variables and the outcome of interest, as this can give
rise to spurious associations (Harrell, Jr. et al., 1996). I therefore used several
criteria that were independent of the outcome to eliminate variables. These were:
(1) variables with too much missing data (arbitrarily defined as missing in
more than 30 patients, or lower if the event rate was low) as this
suggested they were not easy to collect;
(2) variables in which the event rate was low (defined as less than 30);
(3) variables in which the reliability was moderate or poor (as defined by the
kappa obtained in the reliability study, Chapter 9);
(4) variables that I considered to be clinically irrelevant, and
(5) variables that duplicated others.
I was also able to combine several variables to create composite variables.
Where possible, data were dichotomised to make the models as simple as possible
(Harrell, Jr. et al., 1996).
Data quality - what to do with 'unknowns'
Variables in which there was a large amount of missing data were discarded.
However, it would have introduced major bias to discard patients in whom data was
unassessable (Norris et al., 2000). The strategy used to deal with missing data was
that if an item were 'unassessable', it was assumed to be absent. For example, if the
presence or absence of a vascular risk factor could not be determined at the bedside,
then the clinician would have to assume that it was absent; likewise, when examining
a patient, if sensation could not be tested (because the patient was unconscious), then
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the clinician would assume that there was no impairment. This is a conservative
approach that places value on items that are definitely known to be present, and - for
diagnostic purposes - reflects clinical reality.
10.3.5 Generation of the models
Sample size
The sample size needs to be adequate to ensure statistical validity. For
logistic regression analyses, the key issue is not the overall sample size, but the
number of outcome events (of the least common event) (Concato et al., 1993). The
problem of overfitting can be minimised by conforming to the 10 EPV rule
(discussed above). An additional problem is that of underfitting, where there are too
few outcome events which reduces the power of the model to detect important
associations such that important variables are omitted erroneously [equivalent to a
type II error (Concato et al., 1993)]. Before this study commenced, it was estimated
that a sample size of 300 - 400, which would include about 100 mimics, would allow
a simple model to be developed using 10 variables.
Statistical techniques
As the outcome event was binary (stroke or mimic), forward stepwise
multiple logistic regression was used to develop the predictive model. In this method
the computer identifies the predictor variable that has the strongest association with
the outcome, and enters it first (Counsell & Dennis, 2001). The variables not
included in the model are then re-analysed, and the one that explains the largest
amount of remaining variability is entered next. This process occurs until all of the
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predictor variables associated with the outcome have been included in the model
(those remaining are not significantly associated with the outcome). In addition,
after each new variable has been added to the model, the variables already in the
model are re-examined to see if they still have a significant association with the
outcome - if not they are removed from the model.
Multiple regression can give rise to spurious results if all variables are simply
entered into the model. This is because variables that are highly correlated with each
other may cancel each other out so that neither appears to be a significant predictor
of outcome - this is called collinearity (Concato et al., 1993). Collinearity can be
minimised by choosing only the most clinically relevant (among similar) variables
for inclusion in the model (Concato et al., 1993), and by using stepwise regression
methods (Counsell & Dennis, 2001).
Translating the predictive model into a clinically useful tool
The intended audiencefor the predictive model
I envisaged three possible audiences:
(1) A stroke or neurology registrar who may need to make the final decision
on thrombolysis for a patient. This clinician would be capable of
performing a thorough history and examination, and be familiar with the
OCSP classification and NIHSS. A model aimed at this clinician could
include some complex tasks.
(2) An emergency room doctor who needs to decide whether to fast-track the
patient to CT, to call in someone more senior (possibly out-of-hours), or
get a bed ready on the stroke ward. This clinician would be expected to
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be able to perform a limited neurological examination, and a model would
have to be simple to be useful.
(3) An ambulance paramedic or triage nurse in ARU who needs to identify a
possible stroke that should be seen promptly by someone with more
experience. A model would need to be very simple and brief.
What should the model achieve?
In each situation, the needs for a predictive tool will vary. In the first
scenario, the neurology or stroke doctor must make a decision that entails major risk
to the patient. The clinician would want to be very sure that the diagnosis was
stroke; I have arbitrarily defined an acceptable positive predictive value (PPV) of
95% (i.e. 19 out of every 20 predictions of stroke will actually have a stroke).
In the second situation, the risks of an incorrect diagnosis are less - the
patient has an urgent scan (which costs money) and a senior colleague is called in
unnecessarily. Here, it would be acceptable to lower the threshold to increase the
number of true strokes identified, at the expense of an increased false positive rate.
A reasonable PPV would be 85% (an arbitrary decision).
In the third situation, the risks to the patient of an incorrect initial diagnosis of
stroke are almost negligible, but the risk of a missing a true stroke becomes
important. Here, an ideal model should identify all potential stroke patients, at the
expense of low specificity. A PPV of 75% would be acceptable.
I therefore developed a different model for each of the above scenarios. It
was necessary to define the variables for inclusion in each model according to the




All analyses were performed in SPSS for Windows (version 10.0.5, ®SPSS
Inc. 1999). The outcome of interest was defined as stroke (coded as one, with mimic
coded as zero), all but two predictor variables were dichotomous (with a positive
response coded as one, negative response coded as zero). The models were
developed using forward stepwise selection, with entry criteria defined as p<0.05 and
removal criteria defined as p>0.10 for the significance level of the likelihood-ratio
test. Where required, 95% confidence intervals for the odds ratios were calculated.
10.3.6 Evaluation of the model
The computer-produced model comes complete with its own set of statistics
that measure the 'goodness of fit' of the model to the dataset (these vary according to
each computer package, as there is no consensus among statisticians about which
index is most appropriate (Concato et al., 1993)). These include the Hosmer and
Lemeshow test, which provides a %2 statistic and significance test, and a model
summary with a calculated r-square statistic that measures the proportion of the
variation explained by the model. However, these mathematical estimates do not
necessarily provide an indication of how accurate the model's predictions are likely
to be (Concato et al., 1993; Hall & Round, 1994).
There are several approaches to assessing the performance or accuracy of a
predictive model (Altman & Royston, 2000). It should be remembered that although
the outcome event is either present or absent (in binary terms, one or zero), the model
provides a predicted probability of the outcome event occurring, which lies between
the extremes of zero and one. Thus, one may compare observed and predicted
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outcomes for groups of patients (calibration) or individuals (accuracy scores). The
model should be able to distinguish between patients who do or do not experience
the outcome event (discrimination). It is also important to compare a model's
performance with clinicians' informal judgement, if it is to be used in clinical
practice (Counsell & Dennis, 2001).
Calibration
Calibration refers to the degree of bias of model predictions for groups of
patients, and can be estimated by plotting calibration curves (Diamond, 1992;
Harrell, Jr. et al., 1996). To derive the curves, I ordered the dataset by ascending
predictions of outcome and then divided it into 10 equal groups (where possible,
depending on the data). For each group, I plotted the mean observed outcome
against the mean predicted outcome. A model is well calibrated if, within each
decile, the proportion of patients predicted to have an event and the proportion
observed to have done so is the same (i.e. the calibration curve follows a 45° line).
Discrimination
Discrimination is the ability of the model to differentiate between patients
who do and do not experience the outcome, and was measured using the area under
the receiver operating characteristic (ROC) curve. This method compares random
pairs of patients, one with the outcome event (i.e. stroke) and one without (i.e.
mimic), to determine if a higher probability is assigned to the patient with stroke than
to the one with a mimic (Hanley & McNeil, 1982; Swets, 1988; Justice et al., 1999).
The area under the curve (AUC) ranges from 0.5 (no discrimination) to 1.0 (perfect
discrimination); the value can be interpreted as the 'percentage correct': for example,
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when the value is 0.82, this means that the model correctly predicts the outcome 82%
of the time (Swets, 1988). I constructed ROC curves and calculated the area under
the curve for each model using the data obtained from each logistic regression
analysis.
Comparison with clinical judgement
The accuracy of the models' predictions was compared with the research
fellow's final clinical diagnosis and end of bed assessment, the ARU referral
diagnosis and the general practitioner's diagnosis. The sensitivity and specificity for
each clinical diagnosis were determined in Chapter 7. The single point representing
sensitivity by 1-specificity for each clinical diagnosis was plotted on the appropriate
ROC curve, and compared with the model's curve. If the clinical diagnosis lay to the
left of the curve, the clinical diagnosis was more accurate; if the clinical diagnosis
lay to the right of the curve, it was less accurate.
10.4 Results
10.4.1 Baseline characteristics
Three hundred and thirty-six patients were included in the present study,
which included the initial presentation of consecutive patients who presented with
symptoms of brain attack. After the expert panel meeting, the final diagnosis was
determined to be a 'thrombolysis-eligible' stroke (hereafter referred to as stroke) in
234 patients, and a mimic in 102 patients. Following the 10 EPV rule (Peduzzi et al.,




The process of reducing variables proved to be challenging. Variables were
initially excluded according to the methods outlined (see Table 10.2). Data such as
side of the lesion, and time-related information (such as were the symptoms getting
worse) were excluded, and where clinically relevant, composite variables were
created from related items of data (see Table 10.3). The OCSP category was
simplified to whether a classification was possible (on clinical grounds). Unknown
or unassessable responses, which ranged from one (peripheral vascular disease) to 22
(sensory disturbance), were altered as described in the methods section.
This left 36 variables, still too many to produce a reliable model. However,
all seemed clinically plausible explanatory variables. At this point, I examined the
univariate analyses to assist me to reduce the variables even further. I was able to
eliminate age, gender, past history of stroke, and presence of migraine, epilepsy,
malignancy or psychological disturbance as none were significant predictors of the
final diagnosis. I excluded vascular risk factors, because as a group they did not
significantly predict diagnosis. Individually, certain conditions were strong
predictors (e.g. peripheral vascular disease), but occurred infrequently.
The three models
I was left with 16 variables. Further refinement of variable selection
depended on the intended audience for the model. For nurses and emergency
department doctors, I created models with few variables, as I considered that these
clinicians would not be capable of collecting every item of information (e.g. the
OCSP classification). However, for the stroke/neurology registrar, I created complex
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models with more variables as I considered that the stroke/neurology registrar ought
to be able to determine the answer to all questions.
I verified my own impressions by conducting an informal poll of five
emergency nurses, five medical senior house officers in the Acute Receiving Unit,
three stroke registrars (two with a neurology background, one with a general medical
background) and two stroke consultants. I asked each person to indicate whether
he/she thought a clinician in his/her category would be capable of determining the
response to 16 clinical variables. The consensus of all responses is provided in
Table 10.4, and the results were used to inform each model.
Model aimed at a stroke or neurology registrar. The variables chosen
represented one more than the maximal number allowed (11) (see Table 10.5). I was
able to remove the individual elements of the neurological examination, replacing
these with the NIHSS. I arbitrarily divided NIHSS into four categories, as the
relationship between NIHSS and diagnosis was not linear (with NIHSS = 0 as the
reference group).
Model aimed at an emergency department doctor. For this model, I removed
the NIHSS and OCSP variables, and used the individual components of the
neurological examination (see Table 10.6). I removed 'known cognitive
impairment' as I assumed this might not always be possible to collect immediately
by a junior doctor.
Model aimed at nursing staffor paramedics. For this model, I simplified the
variables even further, so that only a few key items need be collected (see Table
10.7). I added in the variable of 'abnormal verbal output' as this did not require the
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operator to discrimination between aphasia and dysarthria, merely to decide whether
verbal output was completely normal.
Description of clinical features
The patients for this model have been described in detail in Chapter 7. The
frequencies of the variables used for the analyses are detailed in Tables 10.5 - 10.7,
10.4.2 Generation of the models
Model aimed at a stroke or neurology registrar
This was the most complex model. It included several composite variables
that accounted for a vast amount of the physical examination: abnormal vascular
findings included measurement of blood pressure and pulse, auscultation of the heart
and palpation for peripheral pulses, and abnormal signs in other systems included an
assessment of the respiratory, abdominal locomotor and skin systems. The NIHSS
score summarises the neurological examination, and the ability to sub-classify the
patient's signs into one of four OCSP categories requires skill and knowledge.
Eight factors were demonstrated to independently predict the diagnosis (see
Table 10.8). A definite history of focal neurological symptoms, an exact onset of
symptoms, and absence of cognitive impairment (NB the odds ratio was less than
one, which predicted a mimic if cognitive impairment was present) predicted a
stroke. Abnormal vascular findings, absence of abnormalities in other systems and
increasing NIHSS score (particularly greater than 10) on examination predicted a
diagnosis of stroke. In the diagnostic formulation a stroke was favoured when an
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OCSP classification was possible and the signs could be lateralised to one side of the
brain.
Model aimed at an emergency department doctor
The simpler model aimed at doctors with little additional training in stroke
medicine consisted of five factors, all of which suggested a diagnosis of stroke (see
Table 10.9). In the history, a definite history of focal neurological symptoms, and an
exact onset were independently predictive. Arm weakness, abnormal vascular
findings and the ability to determine the side of the brain that was affected predicted
a stroke. Neither aphasia nor abnormal verbal output was independently predictive.
Model aimed at nursing staff or paramedics.
The simplest model, designed for nurses or paramedics, contained four items
(see Table 10.10). A diagnosis of stroke was predicted if there was a definite history
of focal neurological symptoms, an exact onset could be determined, there was
demonstrable arm weakness and verbal output was abnormal.
10.4.3 Evaluation of the models
Once generated, the key questions were how well did the models perform,
and was there any penalty for simplicity? The logistic regression program in SPSS
generated statistics that provide an overall assessment of performance. These have
been provided for the three models in Table 10.11. The Hosmer and Lemeshow test
is a goodness-of-fit test that the model adequately fits the data. When the
significance is low (<0.05), the model does not fit the data. The model summary
attempts to provide a measure of the proportion of variation that is explained by the
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model (equivalent to the r-square statistic in linear regression). The smaller the
deviance, and the greater the pseudo r-square values, the better the fit.
All models adequately fitted the dataset (Hosmer and Lemeshow test
significance >0.05). As the models became simpler there was a reduction in
goodness-of-fit and accuracy. The stroke registrar model had a pseudo r-square of
0.51 and correctly classified 83% of cases, whilst the nurse/paramedic model had a
pseudo r-square of 0.39 and classified 79% of cases correctly.
Calibration
The calibration curves for the three models are provided in Figure 10.1.
These show that the predictive models were well calibrated, with the point estimates
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Figure 10.1 Calibration curves for the three models
Upper left - stroke/neurology registrar model; upper right - emergency doctor model; lower
left - nurse/paramedic model. The dotted 45° line represents perfect calibration
Discrimination
The ROC curves for the three models are provided in Figures 10.2. The
stroke/neurology registrar model had the greatest area under the curve (AUC 0.87,
95% CI 0.83 - 0.91), suggesting that it predicted much better than chance. Both the
emergency department doctor model (AUC 0.85, 95%CI 0.80 - 0.90) and the
nurse/paramedic model (AUC 0.82, 95% CI 0.77 - 0.87) also predicted better than
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chance, although not as well as well as the more complex stroke registrar model
(statistical tests for the difference in area under the ROC curves were unavailable).
Stroke/neurology registrar model Emergency doctor model
1 - Specificity 1 - Specificity
Nurse/paramedic model
1 - Specificity
Figure 10.2 ROC curves for the three models
Upper left - stroke/neurology registrar model; upper right - emergency doctor model; lower
left - nurse/paramedic model. The dotted line marks area under the curve of 0.5 (no
discrimination). AUC: area under the curve (with 95% confidence intervals)
10.4.4 Could the models be used clinically?
The apparent usefulness of a model depends on more factors than its
goodness of fit, calibration and discrimination. An important factor is how often the
model can predict that an outcome is either very likely or very unlikely (i.e. the
majority of its probabilities lie closer to one or zero, rather than around the middle)
(Weir et al, 2001). As can be seen in Table 10.12, over 3A of the predictions of the
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stroke registrar model were in the very likely/unlikely range. 90% of those who had
a stroke had predicted probabilities greater than 0.75. The nurse or paramedic model
proved less helpful, with 43% of predictions between 0.25 and 0.75.
Each model's performance according to defined criteria
Model aimed at the stroke or neurology registrar
I envisaged that the stroke or neurology registrar might be the last clinician
separating the patient from a needle containing thrombolysis. The utmost
importance is that treatment is given to patients likely to benefit, and withheld from
mimics. I previously argued that a positive predictive value (PPV) of 95% would be
necessary for a model in this situation.
To achieve a PPV of 95%, the model aimed at a stroke or neurology registrar
selected patients with a probability of stroke of 0.90 or more. 106/336 patients were
identified as being strokes, of which 101 were actually strokes and 5 were mimics.
The sensitivity was 43%, but specificity was 95%, and the likelihood ratio (LR) for
the model using this cut-off was 8.8 (95% CI 3.7 - 21.0).
Model aimed at the emergency department doctor
The emergency department doctor is unlikely to be expert in the nuances of
the neurological examination, so the model needed to be simpler. The costs of an
incorrect diagnosis are less, but it would still be important to be accurate. I
arbitrarily defined a PPV of 85% as desirable.
To achieve this PPV, the model designed for the emergency physician
selected patients with a probability of stroke of 0.62 or more. This identified
238/336 patients as strokes, of which 202 were actually strokes and 36 were mimics.
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In this scenario, the model's sensitivity was 86% and specificity was 65%. The LR
at a cut-off of 0.62 was 2.5 (95% CI 1.9-3.2).
Could this simpler model work as well for the stroke or neurology registrar?
Using a probability cut-off of greater than 0.90 to achieve a 95% PPV, the simpler
model identified 93/336 patients as strokes, of which 88 were strokes and 5 were
mimics. The LR was 7.7 (95% CI 3.2 - 18.3), sensitivity 38%, and specificity 95%.
Model aimed at the emergency nurse or paramedic
Here the nurse or paramedic should identify as many strokes as possible.
Using a cut-off of greater than 0.10 probability identified 232/234 strokes, but also
90/102 mimics. A cut-off of 0.30 identified 229 strokes and 72 mimics, and a higher
cut-off of 0.4 identified 223 strokes and 58 mimics. One could argue about the ideal
cut-off, but if one chose a probability of 0.30, the model had a sensitivity of 98%,
specificity of 29%, and PPV of 76%. The LR was only 1.4 (95% CI 1.2 - 1.6).
At the other end of the spectrum, imposing a cut-off for this model of greater
than 0.90 identified 81 patients, 76 strokes and 5 mimics. This very simple model of
4 variables achieved a LR of 6.6 (95% CI 2.8 - 15.9), a PPV of 94%, sensitivity 33%
and specificity of 95%.
Comparison of model's predictive ability versus clinician's assessment
A comparison of the model's performance with clinical judgement was
obtained by plotting the sensitivity and 1-specificity for each clinician (this provides
a 'snap-shot' of accuracy) on the respective ROC curve. There were insufficient data
to allow a comparison of nursing staff or paramedics to the model designed for this
setting. The results for general practitioners (sensitivity 95%, specificity 15%) and
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acute receiving unit doctors (sensitivity 88%, specificity 49%) were plotted on the
ROC curve for the model designed for use by emergency department doctors with
little additional training (Figure 10.3). In both cases, the model performed better
than clinical judgement (the point for each clinician was closer to 0.5).
1 - Specificity
Figure 10.3 Accuracy of general practitioner and acute receiving unit doctor compared
with the model designedfor use by an emergency department doctor
When the points are to the right of the curve, the model is more accurate
I compared the stroke research fellow's end-of-bed assessment and final
clinical diagnosis against the model designed for use by a stroke or neurology
registrar (Figure 10.4). The model performed better than the end-of-bed assessment
(sensitivity 90%, specificity 43%), but not as well as the final clinical diagnosis
(made after a detailed history and examination, sensitivity 86%, specificity 83%).
The accuracy after the research fellow had taken a history (sensitivity 93%,




Figure 10.4 Accuracy of research fellow's end-of-bed assessment and final clinical
diagnosis compared with the model designedfor use by a stroke or neurology registrar
When the points are to the right of the curve, the model is more accurate
10.5 Discussion
10.5.1 Strengths of the present study
The study followed rigorous methodological criteria to ensure quality
(Peduzzi et al., 1996; Harrell, Jr. et al., 1996; Braitman & Davidoff, 1996; Laupacis
et al., 1997). The patient sample was well defined, the entry criteria were simple and
clinically relevant, and there were no restrictions. The data were collected
prospectively. Sample size was adequate to allow 10 variables to be entered into
each model without risking overfitting; variable selection was driven by clinical
common sense (in particular choosing variables with demonstrated good reliability).
Finally, the models were evaluated using several different robust methods.
Three models of varying complexity were produced, intended for three
different clinical scenarios. Accuracy was demonstrated for all models, and they
performed adequately in their intended clinical situation. The simplest model, aimed
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at nurses or paramedics, consisted of four variables, yet performed almost as well as
the more complicated models. The model designed for the emergency physician,
with limited in-depth knowledge of stroke medicine or neurology, contained just five
variables. This model was shown to be more accurate than clinical judgement by
ARU senior house officers.
The model designed for the stroke or neurology registrar contained eight
variables. Two of these variables required a reasonable degree of diagnostic skill,
but not in excess of skills expected of trainees in stroke medicine (personal
communication Dr M Dennis). As anticipated, this complex model was the most
accurate overall. It was reassuring to see that the variables included in each model
showed a logical hierarchy - with each more complex model adding to the variables
of the earlier model.
This study was unique. To my knowledge, only three multivariable models
of the acute diagnosis of stroke have been reported (Allen, 1983a; Libman et al.,
1995b; Mielke & Hennerici, 2001). None were adequate. One study was only
available in abstract form (Mielke & Hennerici, 2001). The multivariable model
reported by Allen (1983a) used discriminant function analysis to identify
independently predictive factors that could separate haemorrhage from infarct.
Libman and colleagues (1995b) entered 12 variables into a logistic regression model
(there were 78 mimics in this study) and identified decreased level of consciousness
as independently predictive of a mimic, and a history of angina as predictive of a
stroke. In the present study, vascular risk factors were not significant on univariate
analysis, and reduced consciousness was not significantly associated with diagnosis
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in the multivariable models (probably because other markers of severity were more
powerful predictors).
It is surprising that there has been little interest in the clinical diagnosis of
stroke. In contrast, there have been many studies that have attempted to determine
prognosis after stroke (Counsell & Dennis, 2001). A consistent finding is that the
prediction of outcome is largely affected by factors that reflect initial stroke severity
- implying that late survival and functional improvement may only be achieved by
reducing the initial severity of stroke (Ebrahim & Harwood, 1999b). Thrombolysis
is the most promising treatment available to reduce the initial severity of ischaemic
stroke (Wardlaw et al., 2001a). Simple bedside clinical tools to aid the diagnosis
could improve accuracy, confidence and speed of the initial assessment, thus
increasing the number ofpatients who might receive thrombolysis.
10.5.2 Limitations
Limitations of models in general
Prognostic models are frequently published but rarely used to inform clinical
decisions (Wyatt & Altman, 1995). Although logistic regression is widely available
(and easy to perform), researchers need to understand the methodology behind the
statistical technique to ensure good quality, clinically useful models are produced
(Concato et al., 1993; Wyatt & Altman, 1995; Laupacis et al., 1997; Counsell &
Dennis, 2001; Bagley et al., 2001). A recent systematic review of prognostic models
for acute stroke (Counsell & Dennis, 2001) documented poor quality in most of the
identified studies. None of 83 models met all quality criteria. Small sample sizes
were a particular problem (only 28/83 studies met or exceeded the 10 EPV rule).
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Cut-offs for variables were often chosen to fit the data, rather than make clinical
sense [e.g. a recent prognostic model used DWI lesion volume of 14.1ml as the key
cut-off (Baird et al., 2001)]. Yet models can be useful if they are methodologically
sound, clinically credible and simple to perform (Wyatt & Altman, 1995; Ebrahim &
Harwood, 1999c).
An alternate method of analysis that could have been used instead of logistic
regression is recursive partitioning analysis (Cook & Goldman, 1984). This
technique builds a tree in which the patient populations are split into smaller and
smaller categories based on response to each variable [and was recently used to
create the 'Canadian CT head rule for patients with minor head injury' (Stiell et al.,
2001)]. It has appeal because of its similarity with the way clinicians make decisions
(Cook & Goldman, 1984; Marshall, 2001). However it has been criticised as an
extreme form of 'data dredging' in which the model fits perfectly with the training
dataset but lacks any generalisability and clinical sense (Marshall, 2001)
[additionally, it requires complex software and expertise that were unavailable to
me].
Limitations of this study
There are limitations of this study. I entered 11 variables, one more than was
recommended, because I was unable to sensibly eliminate a further variable. The
sample size was relatively small, so it is possible that the models may have missed
important associations due to lack of power. The patient sample was probably older
and milder than other reported hospital cohorts (although our sample may be more
realistic than other highly selected series). It could be argued that the simplification
of the final diagnosis from seven into two binary categories was arbitrary, but I
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attempted to keep the classification clinically relevant (and the simplification
occurred before any analyses were performed). Internal validation of the models is
notoriously unreliable; even though the models were all highly accurate, this does not
imply that the models can be generalised to other cohorts of patients (Braitman &
Davidoff, 1996) (and suggests that they may be overfitted to the dataset).
The recommended method to avoid these problems is to validate predictive
models on an unrelated, external dataset (Harrell, Jr. et al., 1996; Laupacis et al.,
1997; Justice et al., 1999). I considered doing this using three independent datasets
that were available to me (the Lothian Stroke Register, the International Stroke Trial,
and the Oxfordshire Community Stroke Project). Unfortunately, all were unsuitable,
as they contained almost no details of patients with mimics. As the inception point
for most observational studies and stroke registers is when stroke is diagnosed, I
suspect that future external validation of my models will require a specific,
prospective study. Until then, the models I have generated cannot be considered
ready for clinical use (Sackett et al., 1985d; Laupacis et al., 1997).
10.5.3 Implications of the study
Clinical guidelines
Using multivariable statistical techniques, I have demonstrated that there are
several clinical factors that independently predict the likely diagnosis of patients
presenting with brain attack. Some items carry greater weight than others, and some
predict that a mimic is more likely than a stroke. I have summarised these factors
into a clinical guideline for the diagnosis of brain attack (Table 10.13).
275
Guidelines such as these, which have been rigorously developed, provide an
'evidence base' for the clinical methods that a senior stroke physician uses in the
assessment of the patient with brain attack. It is clear that a good proportion of
patients (in many cases the majority) present to hospital promptly; however, few
receive promising treatments such as thrombolysis within the narrow therapeutic
time window. The delay that a patient experiences is often waiting for clinical
assessment and brain imaging. Our focus must now turn to methods of accelerating
the patient's passage from the emergency department door to the acute stroke unit,
via the CT or MRI scanner.
Education and training of junior staff
The first clinicians that a patient with brain attack is likely to encounter in
hospital are nurses and junior doctors. Patients with acute neurological conditions
can be daunting for an inexperienced clinician. It may be difficult for a junior doctor
to arrange an urgent brain scan or consultation with a senior doctor when he/she is
lacking in confidence. With better knowledge of the key features that reliably
distinguish stroke from mimic, a junior doctor's assessment can be brief but more
focussed and assured.
The results of the present study have important implications for senior
doctors in how they train junior staff. The key items of the history have been
highlighted. The important components of the physical examination should be
tailored to the needs of the junior doctor. I believe that both the NIHSS and OCSP
classification are of great benefit in the assessment of patients with brain attack, and
should be taught to trainees in stroke or neurology.
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Further work is necessary
Whilst the logistic regression analysis has identified independent variables
that predict the diagnosis, there is still much work required before the models could
be put to clinical use. It would not be worthwhile attempting to create a clinical tool
without first validating the existing model on an external dataset. Assuming this, it is
clear that a predictive model must be simple to be attractive to clinicians (who dislike
complex, mathematical prediction rules that require a calculator (Ebrahim &
Harwood, 1999c), or having to carefully measure the volume of a lesion seen on
brain imaging). The clinical tool could be developed as a simple checklist, with a
tick or cross to be entered against each variable, and a minimum number of ticks to
diagnose stroke. For example, the nurse/paramedic model might require two or three
questions to be ticked to satisfy criteria for a diagnosis of stroke.
An alternative would be to take advantage of the relative weightings of each
variable (its coefficient in the logistic regression model) to construct a simple score.
Extending the above example, the coefficients for arm weakness and focal
neurological symptoms are around two, the coefficient for an exact time of onset is
near one, and for the sake of simplicity, the coefficient for abnormal verbal output
could be rounded up to one. Thus, there are a total of six points possible, and a
diagnosis of stroke might require four or more points. Obviously the complexity of
such a system would increase with more variables in the model, and mathematical
calculations would be required to determine the appropriate number of
points/questions to use as a cut-off for the tool. Whether it would ever be used - or
just quickly forgotten (Wyatt & Altman, 1995) - is another matter.
277
10.6 Summary
• I have used rigorous methods to develop a clinically sensible predictive
model to differentiate stroke from mimic at the bedside
• Three items of history, three items of examination, and two items of
diagnostic formulation are the key clinical factors that can aid bedside
diagnosis
• I have developed several models, ranging from very simple to complex.
These appear to have good accuracy, and could potentially be of benefit
to less experienced junior staff (and their patients). The simple items
could easily be taught to junior staff. Including all the complex items of
examination and assessment does not greatly increase accuracy, which is
acceptable for most situations
• Clinical algorithms may improve junior doctors' confidence and hence
accelerate the patient's progress through emergency department to the
acute stroke unit (via the scanner)
Recommendations for further research:
• External validation of these models is required before they can be used in
practice or developed further
• More studies are required on the reliability of the clinical assessment
(particularly those factors not examined in our reliability study, and using
nurses or paramedics)
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Table 10.1 Minimum methodological requirementsfor studies using predictive models
• An inception cohort was assembled with patients identified at a uniform point, and
adequately described
• The referral pattern was adequately described
• The outcome event was clearly defined, clinically important, and assessed blind to any
predictions of outcome made by the model
• Predictive variables were clinically sensible and collected prospectively
• The statistical technique used to determine which predictive variables were independent
was clearly stated
• Appropriate measures, in particular sufficient events per variable, were taken to avoid
overfitting of the model to the dataset.
• The model was validated (internally and externally)
Adaptedfrom (Sackett et al., 1985d; Concato et al., 1993; Wyatt & Altman, 1995; Harrell,
Jr. et al., 1996; Braitman & Davidoff 1996; Laupacis et al., 1997)
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Table 10.2 Variables excludedfrom brain attack training dataset
Variable Reason (number where appropriate)
1. Primary referral source Uncertain relevance
2. Who made the referral Uncertain relevance
3. The referring diagnosis Uncertain relevance
4. GP diagnosis Uncertain relevance
5. Diagnosis before assessment Not appropriate
6. Diagnosis after history Not appropriate
7. Diagnosis after examination Not appropriate
8. Primary source of history Uncertain relevance
9. Secondary source of history Uncertain relevance
10. Had previous focal deficit resolved
before symptoms onset?
Too much missing data (205)
11. Nature of previous deficit Too many alternatives make data analysis
difficult
12. Patient woke from sleep with deficit Too much missing data (94)
13. Patient can recall what he/she was
doing at time of onset
Poor reliability
14. Symptoms were stable at assessment Uncertain relevance
15. Evolution to maximal deficit Too much missing data (105)
16. Are the symptoms getting worse? Poor reliability
17. Was patient well in last week Poor reliability
18. Symptom side Uncertain relevance
19. Other symptoms Text field only
20. Lost consciousness Too much missing data (20) with a low event
rate (50)
21. Vomited Too much missing data (15) with a low event
rate (43)
22. Headache Too much missing data (35)
23. Seizure Too much missing data (16) with a low event
rate (26)
24. Pulse Uncertain relevance
25. Diastolic BP Poor reliability - may not be as reliable as
Systolic BP
26. Temperature Uncertain relevance
27. Oxygen saturation Not always available at the bedside
28. Cervical bruits Uncertain relevance
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Variable Reason (number where appropriate)
29. Cardiac failure Too few events (16)
30. Co-morbid condition Uncertain relevance (Field was intended to
explore difficulties in making diagnosis)
31. Glasgow coma score May be unreliable in presence of
aphasia/dysarthria
32. Presence of confusion Poor reliability
33. Visual inattention Too much missing data (25) with a low event
rate (42)
34. Eye deviation Too few events (24)
35. Nystagmus Too few events (23)
36. 3rd, 4th. 6th cranial nerve palsies Too few events (10)
37. Hand weakness Too much missing data (30)
38. Dysarthria Poor reliability
39. Cerebellar signs Poor reliability
40. Reflex asymmetry Poor reliability
41. Plantar response Moderate or poor reliability
42. Any important tests available Not appropriate
43. Did the patient fulfil FAST criteria? Not appropriate
44. No lateralisable signs Too few events (26), and some redundancy
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Table 10.3 Composite variables
Composite variable Components
• Inconsistencies Inconsistency in time of onset, evolution of symptoms,
presence or absence of major symptoms
• One of migraine, epilepsy,
malignancy or psychological
disturbance
Low frequency of individual items
• One or more vascular risk
factor
Hypertension, smoking (past or present), ischaemic
heart disease, diabetes, atrial fibrillation, peripheral
vascular disease (intermittent claudication/prior
surgery)
• Brainstem symptoms Visual loss, diplopia, vertigo, loss of balance, other
brainstem symptoms
• Motor symptoms Loss of power or function of the face, arm, hand or leg
• Sensory symptoms Loss of feeling or altered sensation of the face, arm,
hand, or leg
• Abnormal vascular findings Systolic blood pressure > 150 mmHg, clinical atrial
fibrillation, valvular heart disease or absent peripheral
pulses
• One or more abnormalities in
other systems
Abnormal signs of the respiratory, abdominal or other
(e.g., skin) systems
• Neurological signs Sign recorded for each side was reduced to presence or
absence of appropriate sign (e.g., from left hemianopia
and normal right visual field to 'hemianopia')
• Aphasia Used NIHSS question 11
• Face weakness Used NIHSS question 4
• Neglect Used NIHSS question 13
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Table 10.4 Capabilities ofthe different clinicians who diagnose stroke
Stroke / Emergency Emergency
neurology department nurse /
Clinical variable registrar doctor paramedic
History items
1. Known cognitive impairment y X X
2. Exact time of onset could be determined y y y
3. Definite history of focal neurological
symptoms
y y y
4. Motor symptoms y y y
Examination items
5. One or more abnormal vascular findings y y X
6. One or more abnormalities in other
systems
y X X
7. Normal level of consciousness y y y
8. No neurological signs y y X
9. Aphasia y y X
10. Abnormal verbal output y y y
11. Arm weakness y y y
12. Leg weakness y y y
13. NIHSS y X X
Diagnosticformulation
14. Signs lateralise to left or right side of
brain
y y X
15. Neurological deficits consistent with
symptoms
y ? X
16. An OCSP classification was possible y X X
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Table 10.5 Variables included in the stroke/neurology registrar dataset, and
characteristics ofthe patients
Clinical variable Stroke (%) Mimic (%) Total (%>)
History items
1. Known cognitive impairment 27 (12) 27 (27) 54 (16)
2. Exact time of onset could be
determined 179 (77) 57 (56) 236 (70)
3. Definite history of focal neurological
symptoms 227 (97) 69 (68) 296 (88)
4. Motor symptoms 177 (76) 42 (41) 219 (65)
Examination items
5. One or more abnormal vascular
findings 188 (80) 71 (70) 258 (77)
6. One or more abnormalities in other
systems 71 (30) 48 (47) 119 (35)
7. Normal level of consciousness 167 (71) 73 (72) 240 (71)
8. NIHSS category:
0 18 (78) 29 (28) 47 (14)
1-4 87 (37) 40 (39) 127 (38)
5-10 59 (25) 17 (17) 76 (23)
>10 70 (30) 16 (16) 86 (26)
Diagnostic formulation
9. Signs lateralise to left or right side of
brain 196 (84) 39 (38) 235 (70)
10. Neurological deficits consistent with
symptoms 202 (86) 61 (60) 263 (78)
An OCSP classification could be made 212 (91) 45 (44) 257 (77)
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Table 10.6 Variables included in the emergency department doctor dataset, and
characteristics ofthe patients
Clinical variable Stroke (%) Mimic (%) Total (%)
History items
1. Exact time of onset could be
determined 179 (77) 57 (56) 236 (70)
2. Definite history of focal neurological
symptoms 227 (97) 69 (68) 296 (88)
3. Motor symptoms 177 (76) 42 (41) 219 (65)
Examination items
4. One or more abnormal vascular
findings 188 (80) 71 (70) 258 (77)
5. Normal level of consciousness 167 (71) 73 (72) 240 (71)
6. No neurological signs 12 (5) 33 (32) 45 (13)
7. Aphasia 88 (38) 33 (32) 121 (36)
8. Arm weakness 158 (68) 25 (25) 183 (55)
9. Leg weakness 125 (53) 25 (25) 150 (45)
Diagnosticformulation
10. Signs lateralise to left or right side of
brain 196 (84) 39 (38) 235 (70)
11. Neurological deficits consistent with
symptoms 202 (86) 61 (60) 263 (78)
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Table 10.7 Variables included in the nurse orparamedic dataset, and characteristics ofthe
patients
Clinical variable Stroke (%) Mimic (%) Total (%)
History items
1. Exact time of onset could be
determined 179 (77) 57 (56) 236 (70)
2. Definite history of focal neurological
symptoms 227 (97) 69 (68) 296 (88)
3. Motor symptoms 177 (76) 42 (41) 219 (65)
Examination items
4. Normal level of consciousness 167 (71) 73 (72) 240 (71)
5. Abnormal verbal output 143 (61) 41 (40) 121 (36)
6. Arm weakness 158 (68) 25 (25) 183 (55)
7. Leg weakness 125 (53) 25 (25) 150 (45)
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Table 10.8 Logistic regression model for stroke/neurology registrars to predict the
diagnosis ofbrain attack
95% C.I.
Variable Coefficient Odds Ratio Lower Upper
1. Constant -3.324 0.036
2. Known cognitive impairment -1.118 0.327 0.140 0.763
3. An exact onset could be determined 0.952 2.590 1.303 5.151
4. Definite history of focal
neurological symptoms 1.975 7.207 2.482 20.927
5. Any abnormal vascular findings* 0.934 2.544 1.277 5.068
6. Abnormal findings in any other
system1 -0.824 0.439 0.227 0.847
7. NIHSS = 0*
NIHSS 1-4 0.651 1.917 0.702 5.230
NIHSS 5-10 1.145 3.144 1.025 9.645
NIHSS >10 1.979 7.233 2.176 24.047
8. The signs could be lateralised to the
left or right side of the brain 0.707 2.027 0.921 4.462
9. OCSP classification was possible 1.627 5.090 2.421 10.701
The model gives a predicted probability of stroke (ranging from 0—1. The mathematical
equation uses the coefficientfor each variable plus the constant to calculate the probability.
* systolic blood pressure > 150 mmHg, atrial fibrillation, valvular heart disease, and/or
absent peripheral pulses
f respiratory, abdominal or other abnormal signs
j:NlHSS=0 was entered as the reference group (therefore it does not have a coefficient)
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Table 10.9 Logistic regression model for emergency department doctors to predict the
diagnosis ofbrain attack
95% C.I.
Variable Coefficient Odds Ratio Lower Upper
1. Constant -3.830 0.022
2. An exact onset could be determined 1.006 2.736 1.466 5.105
3. Definite history of focal
neurological symptoms 2.179 8.838 3.310 23.596
4. Any abnormal vascular findings* 0.984 2.676 1.390 5.151
5. Arm weakness 1.384 3.989 2.104 7.564
6. The signs could be lateralised to the
left or right side of the brain 1.159 3.187 1.680 6.044
The model gives a predicted probability of stroke (ranging from 0—1. The mathematical
equation uses the coefficientfor each variable plus the constant to calculate the probability.
* systolic blood pressure > 150 mmHg, atrial fibrillation, valvular heart disease, and/or
absent peripheral pulses
Table 10.10 Logistic regression modelfor nurses or paramedics to predict the diagnosis of
brain attack
95% C.L
Variable Coefficient Odds Ratio Lower Upper
1. Constant -3.080 0.062
2. An exact onset could be determined 1.047 2.670 1.475 4.832
3. Definite history of focal
neurological symptoms 2.483 11.471 4.540 28.986
4. Abnormal verbal output 0.595 1.814 1.006 3.269
5. Arm weakness 1.637 6.066 3.387 10.863
The model gives a predicted probability of stroke (ranging from 0 — 1. The mathematical
equation uses the coefficientfor each variable plus the constant to calculate the probability.
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Table 10.12 Predictions in the very likely (or unlikely) range
Predicted probabilities (number of patients)
Model Below 0.25* (%) Above 0.75f (%) Total (%)
Stroke registrar 51 (15.2) 210 (62.5) 261 (77.7)
Emergency doctor 37 (11.0) 192 (57.1) 229 (68.2)
Nurse/paramedic 30 (8.9) 162 (48.2) 192 (57.1)
*there were 102 mimics in total
f there were 234 strokes in total
Table 10.13 Proposed clinical guidelines for the diagnosis ofbrain attack
Suggests the likely
Clinical Item Importance* diagnosis is:
History
• Definite history of focal neurological symptoms
• An exact onset of symptoms can be determined
• Known cognitive impairment
Examination
• Any abnormal vascular findings








• Signs can be lateralised to the right/left brain
• Signs can be placed in an OCSP category














CAN IMAGING IMPROVE THE DIAGNOSIS AND
MANAGEMENT OF BRAIN ATTACK?
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Chapter 11 : The impact of routine brain imaging in patients
with brain attack
11.1 Introduction
This chapter explores the results of routine brain imaging in the series of
patients with brain attack, whose clinical features have been described in Section II
of this thesis. Here I will integrate the clinical features, imaging findings and the
final diagnosis. The emphasis is on imaging that was performed as part of routine
clinical care ('advanced' magnetic resonance imaging will be considered in later
chapters). Where relevant, brief case histories and scans will be provided to illustrate
some of the difficulties in diagnosis.
11.2 Aims
(1) To describe the results of routine brain imaging in patients with brain
attack
(2) To assess the influence of routine imaging on the final diagnosis, and in
particular, if imaging helped to resolve clinical uncertainties
(3) To define the limitations of routine brain imaging
(4) To determine the sensitivity and specificity of routine brain imaging for
the detection of an acute stroke lesion
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11.3 Methods
11.3.1 Definition of 'routine brain imaging'
'Routine brain imaging' refers to that which was performed as part of normal
clinical care of the patient with brain attack. For most, this was an unenhanced
computed tomogram (CT) of the brain. Some patients had magnetic resonance
imaging of the brain (with or without CT). A routine MR brain scan consisted of
structural imaging only (diffusion-weighted and perfusion imaging were not
performed).
The Western General Hospital has an additional MR scan devoted to
research. During the latter part of the present study, some patients underwent
advanced MR imaging in the research scanner - with or without CT - as part of an
imaging study (to be presented in later chapters). I have used the results of the
structural imaging in patients who only had MR, and just the CT results in patients
who had both CT and MR, in the present study.
'Routine' also implied that the timing of the scan was unaffected by any
research requirements. For most patients, the research fellow provided written
advice to the referring team, but the decision to act on this advice, and the urgency of
any action, was left to the referring team. However, the research fellow could
arrange urgent scanning for patients that were assessed in the acute receiving unit
(ARU) at the time of admission if clinically indicated.
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11.3.2 Patients
Consecutive patients who presented to the Western General Hospital with
'brain attack' (apparently focal brain dysfunction of apparently abrupt onset) were
recruited. The clinician made a bedside diagnosis (which in almost all cases was
made blind to the imaging results) of non-stroke or definite, probable or possible
stroke. No definitions for the distinction between definite, probable, and possible
were provided. Full details of the methodology of the brain attack study are provided
in Chapter 7.
11.3.3 Scan interpretation
All brain scans received a routine formal report from one of four consultant
neuroradiologists. The scans were retrieved for later review at the expert panel
meetings (see Figure 11.1). The study neuroradiologist (Professor J.M.Wardlaw)
has a sub-specialty interest in the imaging of stroke, and given that she was often
aware of additional clinical information, and could therefore give a more informed
interpretation of the scan, her opinion prevailed if there was a clash with the official
report. When JMW was absent from the meeting, the clinicians still inspected the
scans, but the routine formal report was considered final.
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Figure 11.1 Professor J.M. Wardlaw reviewing scans at an expert panel meeting
At the expert panel meetings, scan findings were recorded on a data form (see
Appendix 4), and were summarised into one of four categories, then recorded on the
final diagnosis data sheet (see Appendix 5). Scans were categorised as (i) a relevant
acute stroke lesion - which could be infarct or haemorrhage, (ii) no relevant lesion -
the scan could be normal, or show irrelevant abnormalities such as periventricular
lucencies or atrophy, (iii) old stroke pathology, or (iv) a relevant non-stroke lesion.
Signs of infarction on CT brain imaging were established infarcts, defined as a
wedge-shaped or rounded hypodensity within recognised vascular territory, or early
ischaemic changes, defined as a loss of tissue density and/or swelling. The
abnormality had to be appropriate to the symptoms to be classed as relevant. If
several lesions were present, the lesion that explained the patient's presentation took
precedence (i.e. if there were both old stroke lesions and an acute infarct, the scan
was classed as showing acute stroke pathology).
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Infarcts were further classified according to the anatomical site of the lesion
(but not the size). Haemorrhages were classified according to likely aetiology based
on location and appearance of the lesion.
11.3.4 Final diagnosis
The final consensus diagnosis was made by a panel of experts, as described
in Chapter 7.3 (see also Figure 7.1). The expert panel met after the patient had
been discharged. The panel's final consensus diagnosis was based on an independent
review of all available clinical and investigational data. Patients were classed as
definite stroke, probable stroke, possible stroke, definite transient ischaemic attack
(TIA), possible TIA or definite non-stroke (as before, see Chapter 7.3). A relevant
stroke lesion on brain imaging was not required for a definite stroke diagnosis.
11.3.5 Statistics
The imaging results were described in patients with brain attack. Patients
were further divided into groups based on the brain scan result, and clinical features
were compared. I used the OCSP classification and NIHSS score as descriptors of
the severity of the stroke syndrome.
The value of the brain scan to resolve bedside uncertainty was assessed, by
comparing the certainty of the final consensus diagnosis - made in knowledge of the
brain imaging results - with the initial bedside diagnosis. Patients were divided into
bedside diagnosis of definite, probable, possible stroke and non-stroke. The final
consensus diagnosis was simplified by incorporating definite TIA with definite
stroke, and possible TIA with possible stroke.
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Accuracy parameters for the detection of a stroke lesion by brain imaging
were determined against the final consensus diagnosis (which was dichotomised to
'thrombolysis-eligible stroke' or mimic, using the same definitions as earlier
chapters). I calculated point estimates (with 95% confidence intervals) for the
sensitivity, specificity, positive predictive value and likelihood ratio, and compared
these with the research fellow's bedside diagnosis. Differences in observed
proportions were calculated (and statistical significance assumed if the 95%
confidence intervals for the difference did not cross zero).
As the data were not Normally distributed, non-parametric tests were used to
assess for significant relationships (%2 or Fisher's exact tests for categorical data,
Mann-Whitney U test for continuous data).
Statistical packages
Data analyses were performed using Microsoft Excel (version 97 SR-2,
®Microsoft Corporation 1997), Confidence Interval Analysis (version 2.0.0, ®Trevor
Bryant 2000) and SPSS for Windows (version 10.0.5, ®SPSS Inc. 1999).
11.4 Results
11.4.1 General characteristics
350 patient-episodes of brain attack were recruited into the study. 299 (85%)
episodes received a brain scan as part of routine clinical care. The 51 patient-
episodes that were not scanned shall be discussed separately (see below).
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The nature of the brain scan
275/299 (92%) patients had a CT, and 24/299 (8%) had a MR brain scan. 33
patients received both CT and MR, and 23 patients received a second CT scan (as
part of routine care), but only the results from the first CT scan will be reported in
the present study. Contrast was given for the CT brain scan on 21 occasions, but it
provided no additional diagnostic information.
Scan reports
The study neuroradiologist (JMW) was present at the meeting and provided a
'dynamic' opinion (i.e. she received a more informed clinical history, and the
clinicians could ask questions) for 150/299 (50.2%) scans.
Timing of the scan
The time from presentation to scanning is shown in Figure 11.2. 107/299
(35.8%) patient-episodes were scanned on the same day as admission, and 238/299
(79.6%) were scanned within the first 48 hours of admission. Of the 24 patients
whose brain imaging was MRI, 17 (70.8%) were scanned on the same day as
presentation (reflecting their participation in a research study). Precise details of
who arranged the scan, and whether it was performed urgently, were unavailable.
During the study period, 99 patients were seen within three hours of presentation to
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Figure 11.2 Delayfrom presentation to brain imaging in the brain attack study
(n=299 episodes)
Clinical features of patients who were scanned
The general features of the 287 patients (299 patient-episodes) who were
scanned are detailed in Table 11.1. The median age was 76 years, and the median
time from symptom onset to presentation was five hours (although most were not
seen by the research team until a day later). The final diagnosis was a definite or
probable vascular event in 76% of events.
The specific clinical features of patients are provided in Table 11.2. A
definite history of focal neurological symptoms was present in 91%, motor
symptoms in 66% and normal conscious level in 71%. The median NIHSS was 5.0,
19% had a total anterior circulation syndrome, and 17% could not be assigned an
OCSP classification. Almost 60% of patients who received a brain scan had a past
history of a focal neurological deficit. Of these 105 patients, symptoms had
completely resolved in 60 (57%, with details unknown for a further eight patients).
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11.4.2 The patients who were not scanned
49 patients - 51 (15%) patient-episodes of brain attack - did not receive a
brain scan during the hospital admission. Two patients had diagnostic imaging of the
spine (rather than the brain).
Clinical features of patients not scanned
Patients not scanned were older than those scanned (median age 80 years vs.
76 years, p=0.01, Mann-Whitney U, see Table 11.1). Table 11.2 shows that patients
not scanned in hospital were more likely to have cognitive impairment (29% vs 14%
in those scanned, p<0.01, %), less likely to have speech problems (28% vs 49% in
those scanned, p<0.01, %), and had a lower NIHSS score (median 2.0 vs 5.0 in those
scanned, p=0.01, Mann-Whitney U). In addition, 61% of those who were not
scanned could not be assigned an OCSP classification, compared with 17% of those
who were scanned (p<0.01, % ).
55% of patients not scanned received a final diagnosis of definite non-stroke.
14 patients (27%) were diagnosed as possible stroke, there were three (6%) definite
TIAs and two (4%) probable strokes. Four patients (8%) were diagnosed as definite
stroke but did not receive a scan, as follows:
• PH018, an 86 year old, developed profound right-sided weakness at
6am. On examination at 8.30am, the patient was deeply unconscious
with fixed and dilated pupils (NIHSS 37). He died at 12.10pm that day.
• PHI07 presented in a similar but less dramatic fashion. On examination
two hours after symptom onset she was drowsy, had a right hemiplegia
(with head and eye deviation to the left), and NIHSS 30. The patient
died later that day.
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• PH096 was aged 98 and previously dependent on family for basic care.
She presented with aphasia and right hemiparesis, NIHSS 26, and was
not expected to live (but did, and was later transferred to a nursing
home).
• PH030 presented with left-sided weakness and poor co-ordination. On
examination he had an ataxic hemiparesis pattern of lacunar deficit
(NIHSS 3). Symptoms rapidly resolved (within three days).
Causes of stroke mimic
There were 109 mimics recruited into the brain attack study. 67/109 (61.5%)
received a brain scan, and 42 (39.5%) were not scanned. The causes of stroke
mimic, subdivided by whether the patient had a brain scan, are provided in Figure
11.3. Some conditions did not require a brain scan: 100% of patients with a cord
lesion; 90% of those with syncope, and 75% of those with dementia were not
scanned in the present study. Conversely, all of those with space occupying lesions
and functional disorders, 86% of those with vestibular disorders, and even 2/3 of
those with migraine or mononeuropathy were scanned. In the absence of brain
imaging, the final consensus diagnosis of a stroke mimic was determined by the
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Figure 11.3 Causes of stroke mimics (n=109), subdivided by whether the patient was
scanned
Stroke mimicking condition listed in order offrequency (number ofepisodes in parentheses).
Light grey bar represents the proportion without a brain scan, dark grey bar represents the
proportion with a brain scan (number in each bar is the percentage).
11.4.3 Scan results in patients with brain attack
A brain scan was performed in 299 patient-episodes. The scan showed a
relevant acute stroke lesion in 127/299 (42.5%), a non-stroke lesion in 11/299
(3.7%), previous stroke pathology in 56/299 (18.7%), and no relevant pathology in
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Figure 11.4 Results ofroutine brain scans in the brain attack study (n=299)
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A key factor in the interpretation of the scan may be the time after symptom
onset that brain imaging was performed. I have plotted histograms of the
approximate time from onset of symptoms to scanning (measured in days, as I did
not have the exact time of scanning available), subdivided by scan result, in Figure
11.5. Overall, 97/299 scans were performed within 24 hours of symptom onset
(230/299 patients were admitted within 24 hours of onset). For scans that showed:
an acute stroke lesion, the median time from symptom onset to imaging was 1.1 days
(interquartile range [IQR] 0.2-2.0 days); no relevant pathology, 1.2 days (IQR 0.5-
2.2 days); old stroke pathology, 1.3 days (IQR 0.5-3.5 days), and non-stroke lesion
(n=l 1), median time was 1.8 days (IQR 1.2-5.6 days).
acute stroke lesion
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Figure 11.5 Histograms of approximate time from onset of symptoms to scanning,
subdivided by scan result
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In the following four sections I shall discuss the findings of the brain scans,
grouping patients by their scan result (acute stroke lesion, no relevant pathology, old
stroke pathology, non-stroke lesion). The clinical features of the patients, and their
final consensus diagnosis will be presented, to provide a clear description of the
nature of the brain imaging results in patients with brain attack.
Acute stroke lesion
An acute stroke lesion was seen in 127 patients who received a brain scan.
Table 11.3 shows that patients who had a relevant stroke lesion on CT had greater
stroke severity (measured by NIHSS and OCSP) than patients with other scan
findings. Only 5 patients had an NIHSS of zero, indicating no or very mild deficit
(e.g. a 'cortical hand'). A large proportion (37%) of patients with an acute stroke
lesion was scanned within 24 hours of onset of symptoms.
Infarcts
The scan showed an acute infarct in 108/127 (85%) of patients. Of the 42
patients with an infarct who were scanned within 24 hours of symptom onset, early
ischaemic changes were seen in 25 (60%) of these patients. Early ischaemic changes
were seen in two of 35 patients scanned 24-48 hours after onset, and in none of the
31 patients scanned after 48 hours from symptom onset.
The likelihood of seeing an infarct depended on stroke severity. Figure 11.6
shows that 41% of those with an infarct had an NIHSS score greater than 10.
Similarly, those classed as TACS made up 35% of patients with an infarct (Figure
11.7). Of all patient-episodes that were scanned (n=299), a relevant stroke lesion
was observed in 57/81 (70%) of those with NIHSS > 10 (13 of 57 were bleeds), and
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47/57 (83%) of those classed as TACS (9 of 47 were bleeds). At the other end of the
severity spectrum, a relevant stroke lesion was observed in 7/34 (21%) of those with
NIHSS = 0, and 23/57 (40%) of those classed as LACS (see Tables 11.4 & 11.5).
NIHSS=0 NIHSS 1-4 NIHSS 5-10 NIHSS>10
NIHSS score
Figure 11.6 Higher NIHSS scores were associated with a greater proportion of infarcts
seen on brain imaging
t? 40
TACS PACS LACS POCS
OCSP classification
Figure 11.7 The OCSP classification also influenced the likelihood ofseeing an infarct on
brain imaging
The OCSP classification and the site ofthe infarct
Details of the site of the infarct were tabulated against the research fellow's
clinical classification for the 108 patients with a relevant ischaemic lesion on
imaging (see Table 11.6). The site of the infarct was divided into broad anatomical
305
territories (middle [MCA], anterior [ACA] and posterior [PCA] cerebral artery
territory, borderzone, striatocapsular, lacunar and brain stem location). Overall, the
clinical classification matched the infarct location in 88/108 (81%) patients. 33/38
(87%) patients classed as a TACS had an MCA infarct, and one patient had a
striatocapsular infarct; 18/21 (86%) classed as a LACS had a lacunar infarct; 23/28
(82%) patients classed as PACS had MCA, ACA, borderzone or striatocapsular
infarcts, and 13/17 (76%) patients classed as POCS had either a brainstem or PCA
infarct. PCA infarcts caused difficulty in clinical classification (only 7/15 correctly
classified as POCS); and striatocapsular infarcts produced a variety of clinical
syndromes - 3/5 were PACS, with one TACS and one LACS.
Haemorrhages
The scan revealed haemorrhage in 19 patients (15%). Compared to patients
with infarcts (108, 85%), those with bleeds were more likely to have reduced level of
consciousness (63.2% vs 35.2%) or a total anterior circulation syndrome (47.4% vs
35.2%, p<0.05 for both, x2)- There was a non-significant trend for patients with
haemorrhage to present to hospital earlier (median 3.0 hours vs 4.2 hours), and have
a higher NIHSS (median 12 vs 7 for patients with an infarct). Scan features
indicated that the likely underlying mechanism for the haemorrhage was amyloid
angiopathy in 12 patients, and hypertension in 6 (in the remaining patient, it was
unclear whether the bleeding was into an infarct or a primary intracerebral
haemorrhage).
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The final consensus diagnosis in patients with an acute stroke lesion
122/127 (96.0%) patients with an acute stroke lesion received a final
diagnosis of stroke. There were five patients whose CT scan showed a relevant
infarct, yet the final consensus diagnosis was not stroke, as follows:
• PHI 13 presented at 0.63 hours after symptom onset. When assessed by
the research fellow (at 7 hours), the signs suggested a TACS (NIHSS 11),
but symptoms fully resolved by 24 hours, thus the final diagnosis was
TIA.
• PH165 presented at 3.5 hours with speech loss and right arm weakness,
but when examined several days later symptoms had resolved. CT
showed a left middle cerebral artery territory infarct. Final diagnosis was
TIA.
• PHI29 presented at 8.25 hours with left sided face, arm and leg motor and
sensory disturbance, but symptoms resolved fully - final diagnosis was
TIA.
• PHI 84 presented with aphasia and right arm and leg weakness (exact
onset unclear), but fully resolved within a day of admission, thus
diagnosed as TIA.
• PH234, a 66 year old man, was found lying on the floor in the late
afternoon. He was last seen by his wife four hours earlier (and had been
drinking alcohol with friends in the intervening time). On arrival at ARU,
he was drowsy and smelt of alcohol. There was dysphasia and a
moderate right hemiparesis. He was fast-tracked to scanning as a
potential candidate for thrombolysis, but whilst under observation his
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deficit improved, and by the following morning he had returned to
normal. The bedside diagnosis was alcohol intoxication, but the CT
showed clear early ischaemic changes in the left middle cerebral artery
territory (figure 11.8). Thus the final consensus diagnosis was possible
TIA.
Figure 11.8 A patient with early ischaemic changes on CT suggesting an infarct, but a
final clinical diagnosis ofpossible TIA
CT brain performed 5 hours 22 minutes after symptom onset demonstrates early ischaemic
changes with loss ofgrey-white definition around the basal ganglia (arrows).
No relevant lesion
There was no relevant lesion seen on the brain scan in 105 patients (35%).
Patients without a relevant brain scan lesion had milder stroke severity than patients
with a brain scan lesion (see Table 11.3). Median NIHSS was three, and 20 patients
(19%) had NIHSS = 0 (when compared with all other scan categories, the difference
in NIHSS score was significant, p<0.01, Mann-Whitney U).
Scan findings
The scan was completely normal in 54/105 (51.4%). In the remainder, there
were abnormalities such as atrophy (34 scans, 32.4%), periventricular lucencies (21
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scans, 20%) or an unrelated lesion (5 scans, 4.8%). The unrelated lesions included
developmental cysts, basal ganglia calcification, basilar artery ectasia, and a pituitary
tumour. The majority of patients had CT brain scans (n=275), but a few had MR
scans (n=24). The imaging modality had no influence on the frequency of normal
scans, although numbers were small (35.2% for CT, 33.3% for MR, p=0.85, %).
Thefinal consensus diagnosis in those with 'normal' scans
The consensus panel's final diagnosis was non-stroke for 20 patient-episodes
(including six patients with seizure, three with sepsis, three with functional
symptoms, two with Bell's palsy, and one each with confusion, hepatic
encephalopathy, syncope, migraine, subarachnoid haemorrhage [diagnosed by
angiogram] and transient global amnesia). The final diagnosis was stroke in 55/105
(52.4%) patients with no relevant lesion on brain imaging. Four patients were
classified as TACS yet had normal scans, as follows:
• PH058, a 47 year man, presented at 45 minutes with aphasia, mild right
sided weakness and right hemianopia. When seen at 1.3 hours, NIHSS
was eight (low for a TACS). The CT was performed urgently, and was
normal. Symptoms resolved completely within 24 hours, and the final
diagnosis was definite TIA.
• PHI98, a 99 year old woman, presented at 3.6 hours and was examined at
4.5 hours. There was a dense left hemiparesis, neglect and reduced
consciousness (NIHSS 11). CT at 6 hours was normal (as was the MR,
see Figure 13.10). Despite this, the final diagnosis was definite stroke.
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• PH285 presented at 5.25 hours with a moderate left hemiparesis, neglect
and visual loss (NIHSS was eight when seen at 5.5 hours). CT on the
same day was normal. The final diagnosis was definite stroke.
• PH337 presented at 7.25 hours with weakness of the left arm, dowsiness
and confusion. She was not examined until the following day, when there
was a left hemianopia, moderate hemiparesis and neglect (NIHSS 11). A
CT brain on the day of presentation was normal, as was a repeat scan
several days later - when symptoms were still present (see Figure 11.9).
The final diagnosis in this patient was probable stroke.
Figure 11.9 A patient with a total anterior circulation syndrome (TACS) with two normal
CT scans
On the left is the normal CT brain that was performed on same day as symptom onset, and
on the right is the repeat CT brain 12 weeks later (still normal)
Old stroke pathology
56 scans (18.7%) showed evidence of old stroke pathology as the only
abnormality. 39/56 (71%) gave a history of a focal neurological deficit in the past.
The clinical features of these patients were similar to patients whose scans showed
no relevant pathology (Table 11.3). Median NIHSS was four - lower than patients
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with an acute stroke or non-stroke lesion. Only four patients (7%) were classed as
TACS.
Old stroke pathology was also observed in those with a relevant stroke lesion.
22/108 (20%) patients with an infarct had old lesion, as did 4/19 (21%) patients with
a haemorrhage (all four had bleeds thought to be typical of amyloid angiopathy).
The final consensus diagnosis in those with old stroke pathology
36/56 (64%) patients with old stroke pathology as the only abnormality
received a final consensus diagnosis of stroke. 7/56 (12.5%) were diagnosed as non-
stroke. Three had seizures, two sepsis, one had acute confusion, and one had
hypoglycaemia; all presented with focal neurological signs, so presumably the old
stroke signs were 'unmasked' by these conditions.
Non-stroke lesion
11 scans (3.7%) demonstrated a relevant non-stroke lesion that accounted for
the patient's presentation. These patients' clinical features resembled those of
patients who were found to have an acute stroke lesion: the median NIHSS was six,
all had neurological signs, with a large proportion (91%) suggesting cortical
involvement (TACS or PACS classification). No lacunar syndromes were observed.
The final consensus diagnosis in patients with a non-stroke lesion
10 patients received a final diagnosis of non-stroke, and one patient was
given a final diagnosis of probable stroke, as follows:
• Nine patients had brain tumours - six were glioblastoma multiforme, two
were metastases, and one was a meningioma
• One patient had a large subdural haematoma
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• One patient received a final diagnosis of probable stroke. PH084, a 55
year old woman, presented with headache, left sided weakness and
parasthesiae that had started the previous night. Over the last year, she
had experienced similar symptoms (which had been called migrainous
hemiplegia). On examination, there was a mild left hemiparesis and
sensory loss, and clear cerebellar findings on the left (NIHSS 6, OCSP
classification POCS). The MR brain scan (Figure 11.10) showed a
solitary high signal lesion on T2 in the right pons (but no other signs of
demyelination). Cerebrospinal fluid was normal, oligoclonal bands were
not detected, and visual evoked responses were normal. The
thrombophilia screen was negative, but antinuclear antibodies were
positive (1 in 640 titre, anticentromere pattern). The diagnosis was
difficult in this patient, but the consensus panel opinion was probable
stroke as there was insufficient evidence to diagnose demyelination.
Figure 11.10 A patient with a solitary lesion in the pons on MR: what is the final
diagnosis?
The T2 axial image through the pons (left) demonstrates a solitary high signal lesion
(arrow), thought to be most consistent with demyelination. There were no other lesions.
Scan 11 months later (right) shows almost complete disappearance of the lesion.
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Overall, positive scans were seen in only 10/37 (27%) patients with a final
consensus diagnosis of definite non-stroke.
11.4.4 The value of brain imaging to resolve bedside uncertainty
In this section, I will examine how brain imaging helped to resolve
uncertainties in the bedside diagnosis of brain attack (in the 299 patient-episodes that
had brain imaging). At the completion of the clinical assessment, the research fellow
made a bedside diagnosis, which was blind to imaging results. The patient then had
a brain scan, which showed either a relevant acute lesion (an infarct, haemorrhage or
a non-stroke lesion) or no acute lesion (old stroke pathology, irrelevant pathology or
completely normal scan). At a later time, an independent panel of experts recorded
the final consensus diagnosis. Comparing the bedside diagnosis with the final
consensus diagnosis provided an insight into the value of routine brain imaging.
Of the 299 patient-episodes that received a brain scan, the bedside diagnosis
was definite stroke in 145 (48.5%), probable stroke in 71 (23.7%), possible stroke in
53 (17.7%) and non-stroke in 30 (10.0%). The relationship between bedside
diagnosis and imaging findings is detailed in Table 11.7. The proportion of patients
with any relevant lesion decreased as bedside certainty decreased (from 64% in those
with a definite stroke to 19% of those with a possible stroke), and the proportion of
patients with no relevant lesion increased (from 35% of patients with definite stroke
to 81% patients with possible stroke). This trend was significant (p<0.01, % test for
trend).
The final consensus diagnosis (grouped into four categories by combining
TIA and stroke) has been tabulated against the clinical diagnosis in Table 11.8. Of
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the 299 patient-episodes, the final consensus diagnosis was definite stroke in 196
(66%), probable stroke in 32 (11%), possible stroke in 34 (11%), and non-stroke in
37 (12%). Compared with the bedside diagnosis, it was therefore possible for the
final consensus diagnosis to become more certain, remain the same, become less
certain, or change completely (from stroke to non-stroke or vice versa). In the
following sections, I shall describe the effect of the scan result on the certainty of the
final consensus diagnosis, for each of the four bedside diagnostic categories.
I have divided the clinical diagnostic categories into whether a relevant lesion
was seen (which may have been a stroke or non-stroke lesion), and determined the
effect of the scan findings on the certainty of the final diagnosis in Table 11.9.
A bedside diagnosis of definite stroke
Table 11.9 shows that of the 145 patients thought to have a definite stroke
after the bedside assessment, imaging influenced the final consensus diagnosis in
nine patients (6%). In the other 136/145 (94%) patient-episodes, the certainty of the
final diagnosis matched the bedside diagnosis. 45 patients had no lesion seen on
imaging, but the final diagnosis remained definite stroke.
The impact of imaging on the final diagnosis was as follows:
• Two patients thought to have definite stroke after the bedside assessment
had a malignant glioma on brain imaging, thus the diagnosis changed
from definite stroke to non-stroke in two patients.
• The final diagnosis became less certain in six patients who had no
relevant lesion on brain imaging
• The final diagnosis became less certain in one patient who had early
ischaemic changes on CT (PH234, see Figure 11.8). This patient
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improved rapidly over several hours, and was probably intoxicated. The
finding of an abnormality on imaging reduced the panel's certainty that
this event was a non-stroke.
A bedside diagnosis of probable stroke
Of the 71 patients with a bedside diagnosis of probable stroke, imaging
influenced the final consensus diagnosis in 59/71 (83%). In 12/71 (17%) episodes,
the final diagnosis matched the bedside diagnosis (see Table 11.8 & 11.9).
The impact of imaging for those with probable stroke after bedside
assessment was as follows:
• Certainty increased in 46 patient-episodes. The scan showed a lesion in
24, but no lesion was seen in 22 patient-episodes.
• Certainty reduced in the nine patients with no relevant lesion seen on
imaging.
• The diagnosis changed in four patients. Three had brain tumours seen on
brain scan (glioma, metastases, and meningioma). One patient [PH282]
had a normal scan. This patient presented with poor co-ordination on a
background of flu-like symptoms, and had mild cerebellar signs on
examination. He had prominent respiratory findings, and a chest x-ray
was abnormal. The final diagnosis was chest infection.
A bedside diagnosis of possible stroke (the uncertain category)
Of the 53 patients with a bedside diagnosis of possible stroke, the least
certain diagnosis, imaging influenced the final consensus diagnosis in 38/53 (72%)
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of episodes. In 15/53 (28%), the final consensus diagnosis matched the bedside
diagnosis (see Table 11.8 & 11.9). The impact of imaging was as follows:
• In 25 episodes the final diagnosis became more certain
• In 13 the final diagnosis changed from stroke to non-stroke
• When a lesion was seen on brain imaging, the final diagnosis always
changed. However, absence of a lesion on imaging was less helpful, with
15 patients remaining in the same uncertain category.
• Overall, where the clinical diagnosis was uncertain, a lesion was seen on
imaging in only 10/53 (19%) patients.
A bedside diagnosis of non-stroke
Of the 30 patients with a bedside diagnosis of non-stroke, imaging influenced
the final consensus diagnosis in 12/30 (40%) of episodes. In 18/30 (60%), the final
consensus diagnosis matched the bedside diagnosis (see Table 11.8 & 11.9). The
impact of imaging was as follows:
• In two patients, the bedside diagnosis was changed to a definite stroke
based on an abnormal scan. For example, PH076 presented with a
subacute history of confusion, on a background of known dementia. The
general practitioner thought he had visual inattention. On examination,
the patient was drowsy, perseverated to commands, but there were no
convincing focal signs. The clinical diagnosis was non-stroke, but the CT
scan showed a left parietal haemorrhage (see Figure 11.11).
• In two patients, the bedside diagnosis was changed to a definite stroke
based on clinical findings (the scan showed no acute lesion). For
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example, PH260 presented following a seizure, and was found to have
right-sided weakness and aphasia. There was a background of recurrent
similar presentations following a left middle cerebral artery territory
infarct one year earlier. The bedside diagnosis was seizure. Although the
CT showed evidence of the old lesion, and no new pathology, the final
diagnosis was definite stroke as her clinical course failed to improve.
• Three patients' final diagnosis was possible TIA, as the symptoms lasted
less than 24 hours. Although the symptoms were non-specific, and the
brain imaging was normal, there were no other investigation results to
confirm the clinical diagnosis.
• Five patients with a bedside diagnosis of non-stroke were changed to a
final diagnosis of possible stroke. Two of the presentations were with
dizziness, one was seizure, one was drowsiness, and one was possibly
functional. All eight patients had normal brain scans, but other
investigations failed to confirm another cause for the presentation.
Figure 11.11 A patient with known dementia presented with an acute confusional state -
the imaging changed the diagnosis
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Arrow points to a subacute left parietal haematoma (probably secondary to cerebral
amyloid angiopathy)
11.4.5 What is the accuracy of routine brain imaging?
The accuracy of brain imaging in this cohort of patients can be assessed by
comparing imaging findings with the final consensus diagnosis. However, this has
several major problems: the final diagnosis was based in part on the findings of the
brain scan, and a normal brain scan may be seen in up to 50% of cerebral infarcts yet
is still helpful (as it rules out haemorrhage). In the present study of 299 patient-
episodes that were scanned, I dichotomised the scan findings to either a relevant
stroke lesion or no relevant stroke lesion (which included a non-stroke lesion, old
stroke pathology or normal scan). I dichotomised the diagnosis to 'thrombolysis-
eligible' stroke (n=232) or mimic (n=67) to maintain consistency with earlier
chapters.
Routine brain imaging showed a sensitivity of 54% (95% CI 48-61),
specificity of 99% (95% CI 92-100) and likelihood ratio of 36 (95% CI 5-256) for
the detection of a relevant stroke lesion (see Table 11.10). The accuracy (i.e.
correctly showed a stroke lesion for stroke diagnoses, and no stroke lesion for
mimics) was 64% (95% CI 59-69). Compared with the research fellow's bedside
diagnosis, the specificity of imaging was significantly better (16% difference [95%
CI 7-24]). However, sensitivity was significantly worse (31% difference [95% CI
23-39]), as was accuracy (20% difference [95% CI 14-27]).
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11.5 Discussion
The diagnosis of brain attack can often be challenging, as highlighted by
many of the clinical vignettes provided. Imaging identified a small proportion of
non-strokes - only space occupying lesions (3% of the total), but these were equally
distributed amongst the bedside definite strokes and less definite strokes. When
present, a relevant lesion on imaging sealed the diagnosis of stroke (or changed the
diagnosis completely) and was thus very useful.
The strengths of the present study are that it used an unselected cohort of
patients, so that it reflected routine clinical management of patients with brain attack.
This allowed a realistic assessment of the findings of imaging, and their impact on
the diagnosis in this setting. Previous studies have often used highly selected patient
samples to establish the value of imaging [such as excluding haemorrhage, e.g.(Al-
Buhairi et al., 1998), selecting middle cerebral artery infarcts, e.g. (Lev et al., 1999)
or thrombolysis recipients (Scott et al., 1999)]. Even a study of 1,191 'unselected'
patients referred for CT (Sotaniemi et al., 1990) reported a mean age of 46 years for
the patients scanned, suggesting considerable selection bias. The present study
specifically recruited all patients with brain attack, including those with mimics and
possible strokes, which has not been done in earlier studies.
Despite methodological difficulties in determining accuracy parameters, the
present study found that routine scanning had a sensitivity of 54% for the detection
of stroke lesions. This was very similar to other reports, such as 64% for Sotaniemi
et al (1990), and 55% for Sandercock et al (1985a) (combining infarcts and
haemorrhages). Other studies have demonstrated sensitivity for detection of
ischaemic stroke ranging from 49% [in mild stroke and TIA (Koudstaal et al., 1992)]
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to 75% [for early ischaemic changes in thrombolysis recipients (Barber et al., 2000)].
The present study was also able to calculate the specificity and likelihood ratio of
imaging. Identification of a relevant stroke lesion helped to confirm that the clinical
syndrome was a stroke; using Sackett et al's (1985b) nomogram for diagnostic tests,
assuming a 70% pre-test probability of stroke, a positive CT scan increases the post-
test probability to 99%.
11.5.1 Limitations of this study
Although this study aimed to reflect 'real life', there are some important
caveats to our findings. Our cohort was older, and stroke severity milder, as we
included all patients (including those with possible stroke, who tended to have milder
symptoms). As the likelihood of observing a relevant lesion was related to severity,
our findings may have underestimated the true value of scanning.
We are fortunate to have a friendly and efficient radiology service at our
hospital, hence the proportion of scans performed within 48 hours [as per National
Clinical Guidelines for Stroke (Intercollegiate Working Party for Stroke, 2002)] was
higher than in other UK centres (Ebrahim & Redfern, 1999). Scan times may well
have been influenced by the stroke research fellow's assessment.
All brain scans were interpreted by a neuroradiologist, and over half received
a second opinion by a neuroradiologist with a special interest in stroke (who was not
blind to the clinical details). The services of a neuroradiologist - let alone one with a
particular expertise in the imaging of stroke - would not be available in many
centres, and possibly provided us with an over-optimistic view of the value of
scanning. For example, early ischaemic changes were identified in 24/41 patients
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with infarcts who were scanned within 24 hours. A less expert radiologist may not
have 'seen' these early changes, thus reducing the sensitivity of the early scan from
60% to 29%.
As noted earlier, it is difficult to determine the accuracy of brain imaging, as
it plays a large part in determining the final diagnosis. To minimise this problem, I
focussed on the value of imaging in resolving clinical or bedside uncertainty (rather
than presenting the results of brain imaging for each final consensus diagnostic
category). The accuracy figures presented, however, may be an overestimation due
to the bias generated by using imaging to inform the gold standard diagnosis.
Finally, 51 patient-episodes of brain attack were not scanned. Usually this
was for legitimate reasons - those with stroke died soon after admission, or
symptoms resolved promptly; and brain imaging in many of those with a non-stroke
condition would not have been helpful (e.g. spinal cord lesions, syncope). However,
diagnostic certainty could have been improved if these patients were scanned.
11.5.2 Implications of the study
The role of clinical assessment
Brain imaging was very helpful when a lesion was present, but not so useful
when no lesion was observed. In contrast, the stroke research fellow's bedside
diagnosis achieved almost equivalent sensitivity and specificity, leading to better
overall accuracy than brain imaging. It is a mistake to believe that better (and more)
imaging would obviate the need for adequate training in clinical assessment.
Clinical certainty clearly influenced the likelihood of observing a relevant
lesion on scan. When the clinician made a diagnosis of definite stroke, the scan was
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four times more likely to show a relevant stroke lesion, and 1/3 as likely to show a
non-stroke lesion than when the diagnosis was possible stroke. When the clinical
diagnosis was certain, the final diagnosis rarely changed. However, when the
clinician was unsure, imaging proved to be very helpful.
The OCSP classification and NIHSS severity score were both associated with
scan findings. As the NIHSS increased (reflecting greater severity of signs), the scan
was more likely to show a relevant stroke lesion. This is in agreement with others
who have shown that NIHSS also correlates with the size of the infarct (Brott et al.,
1989b; Tomsick et al., 1996; Johnston et al., 2000). The OCSP classification was
also associated with the presence of a relevant stroke lesion in all patients with brain
attack. In addition, for those with infarcts, it was shown that the OCSP classification
predicted the likely site of infarction. This finding is consistent with those of several
larger studies (Al-Buhairi et al., 1998; Mead et al., 2000), which also demonstrated
an association between lesion size and OCSP classification (not possible in the
present study). Like Mead and colleagues (2000), we noted that the patient with a
posterior cerebral artery or striatocapsular infarct posed particular difficulties for
clinical classification.
There are limitations of routine imaging
This study has shown that imaging is extremely helpful, when a lesion is
present. The problem was that quite often imaging did not show a lesion: 35% of
patients with a final diagnosis of definite stroke, and 88% of those with probable
stroke. When the bedside diagnosis was certain, absence of a lesion on imaging did
not greatly affect the final diagnosis, but when the bedside diagnosis was uncertain -
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precisely the time that imaging should help - no lesion was seen in 43/53 (81%)
patients. Of these 43, the final diagnosis was definite or probable stroke in 15 (35%).
Bedside diagnosis was most difficult in patients with milder symptoms and
signs. Although patients with milder severity have better prognosis (Bamford et al.,
1991; Adams, Jr. et al., 1999), and are less likely to be considered for a risky
treatment such as thrombolysis, a correct diagnosis is still very important. Issues
such as driving, fitness for work or life insurance, and secondary prevention all
depend on a correct diagnosis. Unfortunately, this limitation of the bedside diagnosis
is also a weakness of routine imaging.
The usefulness of imaging is highly dependent on the skill of the radiologist.
This was demonstrated in the present study by the high rate of early ischaemic
changes noted in patients undergoing imaging within 24 hours of onset. Early
ischaemic changes can be very difficult to detect (Hand & Wardlaw, 2001), and their
reliability is poor (particularly when the image is viewed by a clinician or general
radiologist) (Wardlaw et al., 1999; Grotta et al., 1999). As noted, most other stroke
centres in the UK would be unlikely to have a neuroradiologist with expertise in
stroke at its disposal. The results we have obtained probably represent the 'best-case
scenario' for routine (CT) imaging.
How might advanced MR help?
Advanced MR imaging (i.e. diffusion- and perfusion-weighted imaging)
could solve many of the problems of conventional scanning. As discussed in detail
in Chapter 6, the advantages that MR appears to offer include:
• Positive identification of ischaemic lesions within minutes of symptom
onset, with lesions appearing bright on diffusion-weighted imaging
323
• Better sensitivity for smaller lesions, and lesions in the posterior fossa
• The ability to discriminate new lesions from old, which is of particular
benefit in patients with a past history of stroke who may present with a
mimic such as seizure or metabolic disturbance that resembles a new
ischaemic event
• Better reliability for lesion detection (thus less dependence on the skill of
the operator)
• Better overall sensitivity thus greater use in predicting outcome and
guiding management decisions in the acute phase
However, as discussed in Chapter 6, our knowledge of the usefulness of MR
imaging is based on small studies of highly selected patients. Would advanced MR
be ofbenefit in brain attack? The remainder of this thesis will explore the issue.
11.6 Summary
• Imaging is vitally important for the discrimination of haemorrhage from
infarct in patients with stroke
• In patients with brain attack, routine imaging can identify a small number
of stroke mimics (space-occupying lesions), but many patients with a
mimic will have an essentially normal scan (and thus diagnosis depends
on clinical skills)
• The likelihood of seeing a relevant abnormality on imaging is associated
with the severity of clinical findings.
• Routine brain imaging is often normal, particularly in situations where the
bedside diagnosis is uncertain, and where the clinical features are mild
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• The operator dependence of CT imaging may have been underestimated
Recommendations for further research:
• Advanced MR imaging may solve many of the problems of CT imaging,
and should be tested in an unselected brain attack cohort
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Table 11.1 Generalfeatures ofpatients in the brain attack study
Brain scan performed No brain scan
n=299 episodes, n=51 episodes,
Feature n=287patients n=49 patients P*
Median age (IQR)+ 75.92 yrs (66.3-82.0) 80.30 yrs (75.5-87.0) .014
Male genderf 143 (49.8%) 20 (40.8%) .244
Median time from onset
to presentation (IQR): 5.0 hrs (2.1-15.5) 3.75 hrs (1.6-10.8) .686
Number presenting
within 6 hours:* 158 (52.8%) 34 (66.7%) .067
Median time from onset
to examination (IQR): 25.5 hrs (21.0-51.1) 26.0 hrs (15.5-48.3) .195
Final diagnosis of event: <.001
Definite stroke 182 (60.9%) 4 (7.8%)
Probable stroke 32 (10.7%) 2 (3.9%)
Definite TIA 14 (4.7%) 3 (5.9%)
Possible stroke/TIA 34 (11.4%) 14 (27.4%)
Definite non-stroke 37 (12.4%) 28 (54.9%)
*
- p value determined by Mann-Whitney Utest or y2 test as appropriate
f - refers to the number ofpatients
/ - incomplete numbers, as inpatient strokes were not included
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Table 11.2 Clinical features ofpatients in the brain attack study (subdivided by whether a
brain scan was performed)
Brain scan performed No brain scan
n=299 episodes, n=51 episodes,
Feature n=287patients n=49 patients P*
History
Past history of stroke1 * 105 (59.7%) 24 (42.6%) .092
Cognitive impairment11 40 (14.4%) 14 (28.6%) .014
Definite focal neurological deficit 271 (90.6%) 36 (70.6%) <001
Exact onset 213 (71.2%) 34 (66.7%) .508
Motor symptoms 197 (65.9%) 28 (54.9%) .130
Sensory symptoms 69 (23.1%) 9 (17.6%) .389
Loss of speech 147 (49.2%) 14 (27.5%) .004
Examination
Normal conscious state 213 (71.2%) 36 (70.6%) .925
Abnormalities in other systems 100 (33.4%) 22 (43.1%) .179
Confusion* 76 (35.5%) 16 (38.1%) .750
Atrial fibrillation 65 (21.7%) 7 (13.7%) .191
Median NIHSS (IQR) 5.0 (2.0-11.0) 2.0 (0.0-5.0) <001
Clinical classification:5 <001
TACS 57 (19.1%) 3 (5.9%)
PACS 93 (31.1%) 15 (29.4%)
LACS 57 (19.1%) 2 (3.9%)
POCS 42 (14.0%) 0 (0%)
Unsure/No signs 50 (16.7%) 31 (60.8%)
*
-p value determined by Mann-Whitney Utest or •/ test as appropriate
f - refers to the number ofpatients
/ - denominator incomplete as some items were unassessable
§ - OCSP clinical classification (Bamford et al., 1991). TACS: total anterior circulation
























































































Table 11.4 Imaging findings in patients scanned, subdivided by NIHSS score (n=299)
Imaging findings
Relevant lesion No relevant lesion
Stroke Non-stroke Old stroke No relevant
NIHSS group: n lesion lesion pathology pathology
NIHSS = 0 34 7 (21%) 0 (0%) 7 (21%) 20 (59%)
NIHSS 1-4 109 32 (29%) 1 (0.9%) 26 (24%) 50 (46%)
NIHSS 5-10 75 31 (41%) 7 (9.3%) 16 (21.3%) 21 (28%)
NIHSS >10 81 57 (70%) 3 (3.7%) 7 (8.6%) 14 (17%)
Note: p<0.001 for association between NIHSS and scan finding (Mann-Whitney U, using
NIHSS as a continuous variable)
Table 11.5 Imaging findings in patients scanned, subdivided by OCSP classification
(n=299)
Imaging findings
Relevant lesion No relevant lesion
OCSP Stroke Non-stroke Old stroke No relevant
classification: n lesion lesion pathology pathology
TACS 57 47 (83%) 2 (3.5%) 4 (7.0%) 4 (7.0%)
PACS 93 32 (34%) 7 (7.5%) 29 (31%) 25 (27%)
LACS 57 23 (40%) 0 (0%) 8 (14%) 26 (46%)
POCS 42 17 (41%) 1 (2.4%) 6 (14%) 18 (43%)
Unsure 50 8 (16%) 1 (2.0%) 9 (18%) 32 (64%)
Note: p<0.001 for association between OCSP and scan finding (fi test)
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Table 11.6 Does the OCSP classification predict the site of the infarct? (n=108 patients
with a relevant infarct)
Clinical syndrome
TACS PACS LACS POCS Unsure
Infarcted territory (n=38) (n=28) (n=21) (n=17) (n=4)
MCA territory 33 16 1 3 1
ACA territory 1
PCA territory 3 4 7 1
Borderzone 3
Striatocapsular 1 3 1
Lacunar 1 18 1
Brainstem 1 1 6 2
Numbers in bold indicate an appropriate clinical syndrome/infarct combination
Table 11.7 The bedside diagnosis of brain attack, and imaging findings for each category
(n=299)
Imaging findings
Relevant lesion No relevant lesion
Bedside Stroke Non-stroke Old stroke No relevant
diagnosis n lesion lesion pathology pathology
Definite stroke 145 92 (63%) 2 (1.3%) 13 (9.0%) 38 (26%,)
Probable stroke 71 25 (35%) 3 (4.2%) 20 (28%) 24 (34%)
Possible stroke 53 8 (15%) 2 (3.8%) 14 (26%) 29 (55%)
Non-stroke 30 2 (6.7%) 4 (1.3%) 9 (30%) 15 (50%)
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Definite stroke 136 6 1 2 145
Probable stroke 46 12 9 4 71
Possible stroke 13 12 15 13 53
Non-stroke 2 2 8 18 30
Total 196 32 34 37 299















Definite stroke Yes (n-=94) — 91 (97%) 1 (1%) 2 (2%)
(n=145) No (n--51) - 45 (88%) 6 (12%) 0 (0%)
Probable stroke Yes (n =28) 24 (86%) 1 (4%) 0 (0%) 3 (11%)
(n=71) No (n=-43) 22 (51%) 11 (26%) 9 (21%) 1 (2%)
Possible stroke Yes (n =10) 9 (90%) 0 (0%) - 1 (10%)
(n=53) No (n=-43) 16 (37%) 15 (35%) - 12 (28%)
Non-stroke Yes (n -=6) - 4 (67%) 0 (0%) 2 (33%)
(n=30) No (n=-24) - 14 (58%) 8 (33%) 2 (8%)
* went from stroke to non-stroke or vice-versa
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Sensitivity 86% (81-89) 54% (48-61)
Specificity 83% (74-89) 99% (92-100)
Positive predictive value 92% (87-95) 99% (96-100)
Negative predictive value 72% (64-79) 38% (31-46)
Accuracy 85% (80-88) 64% (59-69)
Likelihood ratio 4.9 (3.3-7.4) 36.4 (5-256)
NB Diagnosis dichotomised to 'thrombolysis-eligible' stroke or mimic
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Chapter 12 : The feasibility of performing advanced MR brain
imaging in patients with brain attack
12.1 Introduction
There are clear limitations to CT scanning, and many apparent benefits to MR
scanning patients with brain attack. Some authorities now call for advanced MR to
be the initial investigation of choice for acute stroke (Hacke & Warach, 2000), yet
reading the many published reports of small, highly selected patient groups suggests
that this may not be very practical. Is advanced MR the solution to all of our
problems? To answer this question, one needs to assess the potential risks and the
benefits in a cohort of patients that reflect real life. This chapter will examine the
difficulties of scanning patients - the potential risks.
12.2 Aims
(1) To determine if it were possible to perform advanced MR as the initial
imaging assessment of acute stroke in a broad patient group
(2) To determine if there were any potential problems with safety in MR





Consecutive patients who presented to the Western General Hospital with
brain attack were eligible for the present study. However, we were unable to scan all
potential patients with brain attack, and had to impose two additional criteria. First,
the research fellow must have assessed the patient within 24 hours of symptom onset
(we wanted to concentrate on acute stroke). Second, the research fellow's clinical
diagnosis must have been probable or definite stroke (as we wanted to focus on the
patients with a high likelihood of acute stroke).
Initial assessment
We attempted to perform MR scanning as the initial brain imaging modality
in all patients eligible for the study. If MR scanning was not possible, the reasons
were recorded. A Brain Attack data form (see Appendix 2) was completed for
eligible patients until the Brain Attack study closed in May 2001. Thereafter,
patients who underwent MR scanning had a complete assessment (including brain
attack data form), but patients who could not be scanned had a limited assessment
(brain attack data forms were not filled out). This was because after May, one
research fellow (PJH) performed all patient assessments.
12.3.2 Scanning
Patients were scanned at the Scottish Higher Education Funding Council
Brain Imaging Research Centre, which is situated in the Department of Clinical
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Neurosciences, Western General Hospital. The study had almost unrestricted access
- during working hours - to the centre's 1.5 Tesla GE Signa Echoplanar MR scanner
(see Figure 12.1). Patients must lie supine in the tunnel, with their heads enclosed in
a coil (Figure 12.2 shows the head coil, with the patient about to be taken into the
'tunnel'. Vision is possible through the small mirror).
Figure 12.1 The research
scanner at WGH
Scanning protocol
All patients received a scan sequence that consisted of: a gradient echo
sequence (sensitive to old and fresh blood), diffusion-weighted imaging, perfusion
imaging (using the dynamic bolus tracking method, which required rapid intravenous
injection of 20ml gadolinium), and T2 axial images. This sequence took
approximately 20 minutes. In addition, certain selected patients received magnetic
resonance angiography of the Circle of Willis, and diffusion-tensor imaging. The
longer sequence could take up to 40 minutes.
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Figure 12.2 The MR head coil is a close fit (left), and observation of the 'patient' once in
the scanner can be difficult. [The 'patient' is the author].
The rationale behind the sequences chosen, and the scan results, will be
discussed in detail in the following two chapters.
Patient monitoring
To monitor for any potential safety problems, a member of the research team
(PJH, AMR [Post-doctoral fellow] or JH [medical student]) was present with the
patient in the scanner. A data form (see Appendix 9) was filled out for each patient.
Prior to scanning, the observer made an overall assessment of the patient's risk of
complications, noted whether x-ray of orbits were required (and why), and repeated
the NIHSS if there had been a delay of greater than one hour since initially
performed. During the scan, the patient's pulse and oxygen saturation were recorded
every 5 minutes (we did not record blood pressure as this would require an
automated cuff, which can be distressing to patients). The requirement for any form
of intervention, and premature termination of the scan were also noted.
The pulse oximeter module of Odam Maglife (MR compatible) multi-modal
monitoring device measured arterial oxygen saturation (SaCh) non-invasively via a
finger probe. This provided a continuous signal (from readings every 8 seconds) that
was displayed in the scanner, so that motion or magnetic field artefact could be
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recorded by the observer. Hypoxia was defined as a fall in SaC>2 to 90% or less,
sustained for at least one minute.
Interventions were divided into three categories. Medical intervention might
require administration of a drug, nursing intervention could include providing
suction, oxygen or other nursing procedure, and reassurance had to include physical
contact with the patient (not just verbal reassurance, which can be provided by the
radiographers from outside the scanning room).
12.3.3 Ethics and consent
The chairman of the local ethics committee of the Western General Hospital
approved the study. Where possible, consent to participate in the study was obtained
from the patient. When obtaining consent from the patient was impossible, assent
was obtained from a relative before the patient was scanned.
12.3.4 Statistics
Statistical analyses
The present study used key measures of stroke severity - the OCSP
classification, and NIHSS score - and a limited number of other items of clinical
assessment to compare different groups of patients. Data were analysed with




Data analyses were performed using Microsoft Excel (version 97 SR-2,
^Microsoft Corporation 1997) and SPSS for Windows (version 10.0.5, aSPSS Inc.
1999).
12.4 Results
Consecutive patient recruitment commenced on 9 Jan 2001 and completed on
3 Oct 2001. During the 34 week period, 138 presentations by 136 patients were
recruited to the study. Two patients presented twice during the study period. [N.B.
The results ofthe MR scans will be presented in Chapters 13 & 14.]
12.4.1 General Features
Table 12.1 shows the general features of all presentations included in the
study (with the same features from the entire brain attack study cohort presented for
comparison). Consistent with the eligibility criteria for the study, the delay between
onset of symptoms and evaluation was considerably shorter in the present study.
Thus, patients' symptoms were also more severe, and fewer had normal conscious
level or NIHSS of zero (compared with overall figures for the brain attack study).
Patients were eligible for MR scanning if the clinician felt that acute stroke
was the likely explanation for the brain attack. The final diagnosis was stroke or TIA
in 89%, with a few additional patients diagnosed as non-stroke or possible stroke
(Table 12.1).
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12.4.2 Patients not scanned
Of 138 consecutive patients who were eligible for MR scanning during the
study period, 53 (38%) could not be scanned. 27 entered the Brain Attack study, but
26 were seen after the Brain Attack study had stopped (thus details of this group
were often incomplete). There were two patients who re-presented. Both were
scanned on one occasion (but not the other).
Clinical features
The clinical features of patients who were not scanned are detailed in Table
12.2. Compared with those who were scanned, patients not scanned were
significantly older (median age 77 years vs 74 years, p=0.03, Mann-Whitney U) and
had signs of a more severe stroke (median NIHSS 11 vs 5, p=0.03, Mann-Whitney
U). The oldest patient who could not be scanned was 97.0 years. Patients not
scanned were also drowsy (57% vs 32%, p=0.01, %2) and less likely to have an exact
time of onset of symptoms (64% vs 86%, p=0.01, %2)-
Reasons eligible patients were not scanned
There were several major reasons for eligible patients not to be scanned
(Figure 12.3). The most frequent cause was that the patient was medically unstable
(15 patients, or 11.0% of the consecutive series of 138 patients). In 9/15, the patient
was too confused to be able to lie down flat and comply with the MR scan. In the
remainder, the patient's condition was too poor to justify the MR scan (e.g. Glasgow
Coma Score of eight, acute pulmonary oedema with oxygen saturation of 60%). 10
patients (7.4% of the consecutive series) were not scanned as they presented after
working hours, and by the morning (when I came to recruit them) symptoms had
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resolved. Despite open access to the scanner, it was unavailable to scan nine
patients. This was because of a scheduled service day for one patient, and








C/l to scanning (n=6)
Refused consent (n=3)




0.0 2.0 4.0 6.0 8.0 10.0
% of consecutive sample (n=53 not scanned)
12.0
Figure 12.3 Reasons eligible patients were not scanned (see textfor details)
Six patients had a contraindication to MR scanning - pacemaker in four,
recent surgery (with metal abdominal sutures still present), and a prosthetic mitral
valve (N.B. this is not a definite contraindication to MR scanning, and it was later
established that this patient would have been safe to scan). Three patients refused
consent for scanning on the grounds of claustrophobia. Four patients were fast-
tracked to the CT scanner for thrombolysis (it would have been unethical to deny
these patients the opportunity of thrombolysis, as the time to undertake MR would
have placed them beyond the six hour time window of the third International Stroke
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Trial). Four patients - a conservative estimate - were missed as the research fellow
was away; and the 'other' category consisted of the patient who had already been
scanned who re-presented, and another patient who was missed because the research
fellow was too busy that day.
Patients who could not be scanned with MR underwent an unenhanced CT
brain. All were able to tolerate the CT.
12.4.3 Patients scanned
Clinical features
The features of patients who were scanned are provided in Table 12.2. The
research fellow evaluated 34/85 (40%) patients within six hours of onset. Over one
third of patients awoke with symptoms (27/85). Patients who were scanned had
milder strokes than those who could not be scanned: NIHSS scores were
significantly lower, and there were fewer patients with an OCSP classification of
TACS (14% vs 23%). The oldest patient scanned was 98.7 years.
Preliminary observations
Risk ofcomplications
15/85 (18%) patients were judged to be at high risk of complications before
scanning commenced. The features of these 'high risk' patients are detailed in Table
12.3. High risk patients had more severe neurological signs (median NIHSS 20 vs
median NIHSS 4.0 for those at low risk, p<0.01, Mann-Whitney U); were more
likely to be drowsy (60% vs 10%, p<0.01, %), and all but three had other medical
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issues - such as respiratory problems, recent surgery or poor hearing - that could
potentially make scanning more difficult.
X-ray orbits
Departmental protocol required X-ray orbits to rule out metallic foreign body
if the patient was unable to do so. 11 patients (13%) required orbit x-rays before MR
scanning (four were aphasic, two had reduced level of consciousness, and five had
prior exposure to metal). This caused a delay estimated at 20-30 minutes (precise
details unavailable). All X-rays were normal.
Settling time
Patients required a settling time of 10 minutes (median, IQR 7-17 minutes)
from when they entered the MR scanner until scanning actually commenced. During
this time, the patient was given a detailed explanation of the procedure. There was
no significant association between length of settling time and NIHSS score
(Spearman rho test), presence of confusion (Mann-Whitney U), level of
consciousness (Mann-Whitney U), or presence of aphasia (Mann-Whitney U).
12.4.4 Observations during scanning
Oxygen saturation
Monitoring
We attempted to monitor all 85 patients, but were successful in only 61
(72%). Failure to monitor was usually because the patient was unable to keep the
finger probe in place (due to confusion, or aphasia), or the signal was weak or
unreliable (due to irregular pulse, or poor tissue perfusion). A comparison of
342
relevant clinical features in those that could and could not be monitored is provided
in Table 12.4. The only significant difference between the two groups was that
those who could not be monitored had shorter duration scans, which was almost
certainly a consequence of the inability to monitor them (rather than a cause). As
can be seen, many features - such as age, NIHSS, frequency of confusion, reduced
level of consciousness and atrial fibrillation - were slightly higher in the non-
monitored patients. As numbers were small, differences were not significant.
Hypoxia
11/61 (18%) patients had at least one episode of hypoxia - Sa02 < 90% for at
least one minute - during MR scanning. The lowest recorded saturation was 74%.
Table 12.5 details the features of patients whose oxygen saturation was successfully
monitored. Patients who had episodes of hypoxia were slightly older, but shared
similar stroke severity to those without hypoxia. All patients had a similar oxygen
saturation when measured in the acute receiving unit, but by the time the patient
commenced MR scanning, the saturation had fallen to 94% in those who went on to
experience episodes of hypoxia (non-significantly lower than those who did not
develop hypoxia). The duration of scanning was longer for patients who experienced
hypoxia (median 32 minutes vs median 25 minutes), which may have been an
important factor. No observed associations were significant, due to the small
numbers of patients involved.
Premature termination of scans
85 patients agreed to undergo MR scanning, but 17 (20%) could not complete
the full scanning sequence. The most frequent reason for early termination was
343
patient claustrophobia (10 patients). Four scans were halted because the observer
was concerned that the patient was medically unwell. The median duration of the
scan for those who terminated prematurely was 23 minutes, whilst it was 25.5
minutes for those who completed the full sequence (p=0.07, Mann-Whitney U). In
four patients, termination occurred very early (before any imaging data were
obtained). Most patients could tolerate around 20 minutes in the MR scanner.
Where insufficient imaging data were obtained during the MR (four patients),
an unenhanced CT brain scan was performed without difficulty.
Interventions required
Some form of intervention was required in 27 patients (32%). In most (21)
this was physical reassurance (which varied from a brief pat to the patient
desperately clinging onto the observer's hand for the entire sequence!), but in six
patients nursing intervention was required (oxygen given to two patients, assistance
with vomiting in four patients).
Table 12.6 shows that patients who required intervention during the scan
(compared with those who did not) were more likely to have a severe stroke (median
NIHSS 8 vs 4.5, p<0.01, Mann-Whitney U) or aphasia (44% vs 22%, p=0.04, %2). In
addition, there were non-significant trends for those requiring intervention to be
older, more confused or have reduced conscious state. Patients who required
intervention were far more likely to terminate the scan prematurely (56% vs 3%,
p<0.01,x2).
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Was the preliminary prediction of high risk accurate?
Patients judged to be at high risk of complications (for whatever reasons)
before scanning commenced proved to be less tolerant of scanning than those judged
to be at low risk (see Table 12.7). High risk patients were significantly more likely
to require intervention during the scan, and to terminate the scan prematurely than
low risk patients (p<0.01 for both, Fisher's Exact). However, hypoxia was twice as
frequent in the patients where there was no clinical suspicion of risk (not significant).
When compared with those who could be monitored, patients who could not
be monitored were also more likely to require physical intervention (63% vs 20%,
p<0.01, x ), and less likely to tolerate the full scanning sequence (scan completed in
58% non-monitored vs 89% monitored, p<0.01, Fisher's Exact).
12.5 Discussion
The biggest limitation of MR scanning, at least in this country, is its scarcity.
Few stroke consultants (8%) have unrestricted access to MR, and most (85%) scan
fewer than 10% of their stroke patients (Ebrahim & Redfern, 1999). The present
study had unrestricted access to a state-of-the-art MR scanner during working hours,
thus the results provide a realistic assessment of the number of acute stroke patients
who could be scanned successfully, and the problems likely to be encountered.
Of 138 consecutive patients with acute stroke (symptoms less than 24 hours
duration), we were able to start scanning in only 85 (62%). The major reason for the
inability to scan patients was that they were medically unstable. When scanned,
'unwell' patients - those with major strokes, reduced conscious level, or co-existing
medical problems - proved to be at greater risk for developing hypoxic episodes,
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requiring intervention, or terminating the scan prematurely. Our scanned cohort,
therefore, had strokes at the milder end of the spectrum.
Once in the scanner, the major problems we encountered were claustrophobia
and the requirement for long scanning times. Claustrophobia was an issue in 9.4%
(95% CI 5.6-15.5%) of our consecutive sample, a higher frequency than that reported
in other patient groups undergoing MR (who were stable) (Flaherty & Hoskinson,
1989; Avrahami, 1990; Dantendorfer et al., 1991; Saiji et al., 1998). Inspection of
Figures 12.2 & 12.3 provides a graphic illustration of why claustrophobia can be a
problem (as it was for the author on his first scan). The duration of the MR - 20
minutes in a confined, noisy environment - made it difficult to successfully image
acutely unwell stroke patients who may be anxious, distressed, confused or unable to
communicate. In contrast, the CT scan takes less than five minutes, is less confined
and is quieter.
Monitoring patients undergoing MR was difficult. Figure 12.3 shows that
only the patient's legs are in direct view of the radiographers - patients could vomit,
aspirate or even have a seizure undetected. By having a trained observer present in
the room, we were able to detect that patients frequently became distressed and
required physical reassurance. Less frequently, patients required nursing care, or
developed hypoxia. Many patients - possibly the 'sickest' - could not have their
saturations measured, because of poor peripheral perfusion, tachyarrhythmia,
restlessness or confusion. The signal obtained from the toe was unusable in most of
our patients, particularly the old (because of poor perfusion, weaker signal, or even
very thick nails).
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12.5.1 Comparison with other studies
How do our data compare with other studies? It is difficult to know. A
systematic review of advanced MR imaging in stroke (Keir & Wardlaw, 2000) found
that only 6/47 studies of diffusion-weighted imaging (DWI) gave details of patient
inclusions and exclusions, and no studies of DWI or perfusion imaging provided
details of patient tolerability. When numbers are provided, the impression obtained
is that MR imaging is possible in only a handful of patients. Examples include a
German study titled the 'feasibility and practicality of MR imaging' (Schellinger et
al., 2000) that recruited 64 patients within 12 hrs of symptom onset over 2 years.
During this time, the authors estimated that 1200 patients were seen per year (i.e.
<3% were scanned), yet claimed that MR was practical and feasible. Baird et al's
(2001) prognostic model included only 66 patients out of a possible 347 scanned
over a five year period (i.e. they scanned just over one patient per week for five
years). The current trial of intravenous desmotoplase (a thrombolytic agent) aims to
recruit patients within eight hours of onset, on the basis of MR abnormalities. As of
February 2002, 30 patients had been enrolled, whilst 2,463 had been screened
(personal communication, DIAS trial co-ordinators).
Of course it is difficult to directly compare these studies with the present one.
The desmotoplase trial requires patients to have a perfusion-diffusion mismatch to be
eligible for enrolment; so this (or the eight-hour time window) could be the reason
for the low recruitment rate. Schellinger et al's study excluded patients aged over
85, and selected only those with a definite stroke. Baird et al's study was
retrospective, and excluded patients with TIA and mimic. Almost certainly, many
patients would have been excluded from these studies because their scans were of
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insufficient quality. Overall, these studies suggest that scanning is possible in a few
specially selected patients (without spelling out what these selection criteria are).
The present study demonstrated that MR imaging was possible and yielded
usable results in 81/138 (59%) of a truly consecutive and prospective sample. These
patients came direct from our Acute Receiving Unit to the MR scanner. Of course, it
would be possible to sedate patients, but this would require considerable extra
resources (more staff, anaesthetic equipment, etc) and would delay time to treatment.
If patients who were not scanned due to medical problems, claustrophobia and the
like could be anaesthetised, all but around 5% - those with absolute MR
contraindications - could potentially be scanned.
12.5.2 Limitations of the study
The limitations of the present study are that complete clinical data were
unavailable for 26/53 patients who were not scanned. For most of these patients
(19), details were estimated from the patient's notes. The NIHSS was unavailable
for 20 patients. This may have resulted in some inaccuracy of the data for patients
not scanned.
We measured SaC>2 non-invasively by finger probe. It is possible that
movement or magnetic field artefact affected measurements, although the observer
was able to view the tracings on the monitor. To be certain that the changes we
observed were due to acute stroke rather than another factor (e.g. ageing), it would
have been ideal to recruit a series of age-matched controls. Unfortunately, this was
beyond the scope of the present study, but is the subject of a current study by my
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colleague Dr A.Rowat. Preliminary data suggest that hypoxia is infrequently
observed in healthy older adults (personal communication, Dr A.Rowat).
It could be argued that our scanning protocol was part of a research project,
and thus far longer than a 'clinical' protocol. As we discovered, patients tolerate
shorter scanning sequences much better, so our long scanning time may have
artificially increased the frequency of complications. Whilst it is certainly true that a
more targeted scanning sequence (e.g. just DWI) would be quicker, the problem is
deciding which sequence to use. For example, dropping perfusion means that the
presence of a mismatch cannot be determined; dropping the gradient echo may make
diagnosis of acute haemorrhage unreliable difficult, and dropping the T2 axial image
makes it difficult to diagnose mimics such as acute demyelination. At this time, the
ideal minimum sequence has not yet been established.
12.5.3 Implications of the study
Scanning acute stroke patients is a challenge
There is little doubt that MR scanning patients with acute stroke is
challenging. One in three patients, who had generally mild strokes, required some
form of intervention, and one in five patients could not complete the full scanning
sequence. Patients are at risk of hypoxia, vomiting and aspiration, yet it is difficult
to directly observe patients, and non-invasive monitoring may not work (in those at
greatest risk of complications). Our experience would suggest that it is important to
have a trained nurse (a sensible doctor would also suffice!) present in the scanner
with the patient.
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Is MR scanning dangerous in stroke patients?
This study provides insufficient data to state that MR scanning is dangerous
in acute stroke patients, but it does point to the need for caution. The fact that
patients must lay supine and motionless for around 25 minutes suggests an increased
risk of aspiration. We observed that 18% of our patients had at least one episode of
oxygen desaturation to 90% or less, although we did not determine the clinical
significance of this. We avoided scanning patients who appeared 'too sick' - others
might scan equivalent patients and that could cause harm. Further research is
warranted ifMR scanning is to become routine.
How might the number of patients be increased?
The number of patients eligible for MR could be increased substantially.
14% of patients (overall) were not scanned because they presented out of hours, and
by the following morning, symptoms had resolved or the patient was no longer
eligible for the study (greater than 24 hours after symptom onset). These patients
could be scanned if the MR was always operational; and perhaps half could be
scanned if the MR remained operational until 7pm (to catch patients presenting
between 4pm and 6pm).
5.8% of patients were not scanned because the research fellow was absent, or
the patient was taken directly to CT (fast-tracked) for thrombolysis. With more
training and increased experience of dealing with acute stroke patients, the system
would inevitably speed up, and could cope with the absence of key personnel.
Hence, MR would still be possible if thrombolysis were being considered, or if one
member of the team was away.
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Once the patient is within the MR, scanning time must be kept as brief as
possible (and no more than 30 minutes unless the patient is particularly well) to
maximise the chance of a complete and uninterrupted scan. By following these
measures, it may be possible to scan 75-85% of consecutive patients.
There will still be patients who cannot or should not be (MR) scanned
However, there will always be patients who cannot be scanned
(claustrophobia, contraindication, scanner down for servicing). It is important to
note that all 'un-scannable' patients could have a CT without incident - CT is clearly
a vastly more practicable technology for patients with acute stroke.
There are also patients who should not be scanned with MR in the acute
phase of stroke. The clinician was able to predict who was at high risk of
complications with accuracy: these were patients with severe stroke, reduced level of
consciousness, or co-existing medical conditions (particularly respiratory problems).
These warning signs predicted the need for intervention during, or early termination
of the scan. It is possible to identify inappropriate candidates for MR before the scan
commences, but the concern is that hypoxia was seen more frequently in patients
who were not judged to be at high risk of complications. Our experience would
suggest that acute stroke patients should be observed within the scanner.
12.6 Summary
• 62% of a consecutive series of patients could be MR scanned within 24
hours of symptom onset
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• The reasons for not scanning patients were divided between 'operational'
issues (outside scanning time, researcher absent, etc) and 'patient' issues
(medically unwell, refused consent, etc.)
• With organisational change, possibly 85% of patients could be scanned
• 33% of patients scanned required some form of intervention, and 20%
could not complete the full sequence. These complications were
frequently predicted by the clinician before the scanner, and were more
likely in patients with severe strokes or when the scan was prolonged
• 20% of patients experienced episodes of hypoxia during the scan. Apart
from association with more severe stroke, this was not predictable
• MR entails a small, but probably not inconsequential, risk to patients from
hypoxia, aspiration and delay to treatment
Recommendations for further research:
• A study to specifically address the safety issues of MR scanning is
required; this might involve monitoring more elderly controls, and a
larger number of patients with stroke, so that the age, severity and
comorbidity can be examined more closely
• Further studies should determine the optimum scanning sequences, and
the benefits of MR in less selected cohorts of patients with acute stroke
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Table 12.1 Features ofpatients recruited into thefeasibility study
All patients in
MR Feasibility study Brain Attack study
Feature Number (%) Number (%)
Median age (IQR) 76 years (67-82) 76 years (67-83)
Male gender 61 (44%) 163 (49%)
Median delay from symptom onset to
evaluation (IQR) 8 hours (3-19) 26 hours (13-51)
Hypertension 74 (54%) 159 (49%)
Ischaemic heart disease 36 (26%) 100 (31%)
Normal conscious level 81 (59%) 227 (68%)
Median NIHSS (IQR)* 6.0 (4-11) 4.0 (2-10)
NIHSS group*:
NIHSS = 0 4 (3%) 47 (13%)
NIHSS 1-4 44 (37%) 134 (38%)
NIHSS 5-10 37 (31%) 82 (23%)
NIHSS >10 33 (28%) 87 (25%)
OCSP classification
TACS 24 (17%) 60 (17%)
PACS 49 (36%) 108 (31%)
LACS 44 (32%) 59 (17%)
POCS 10 (7%) 42 (12%)
Unknown 11 (8%) 81 (23%)
Final diagnosis:
Definite or probable stroke 112 (81%) 220 (63%)
TIA 11 (8%) 17 (5%)
Possible stroke or TIA 6 (4%) 48 (14%)
Non-stroke 9 (7%) 65 (19%)
* 20 in feasibility study without NIHSS scores
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Table 12.2 Clinical features of eligible patients who could and could not undergo MR
scanning
Patients NOT scanned Patients scanned
Feature Number (%) Number (%) P*
Median age (IQR) 77.3 years (71-86) 74.1 years (63-81) .025
Male gender 20 (38%) 43 (51%) .140
Median delay from symptom
onset to evaluation (IQR) 6 hours (3-15) 12 hours (3-22) .073
Hypertension 25 (47%) 49 (58%) .230
Ischaemic heart disease 13 (25%) 23 (27%) .742
Exact onset of symptoms 34 (64%) 73 (86%) .006
Woke from sleep with symptoms 10 (22%) 27 (36%) .114
Normal conscious level 23 (43%) 58 (68%) .007
Median NIHSS (IQR)f 11.0 (4-20.5) 5.0 (3.5-8.5) .027
OCSP classification .490
TACS 12 (23%) 12 (14%)
PACS 16 (30%) 33 (39%)
LACS 16 (30%) 28 (33%)
POCS 3 (6%) 7 (8%)
Unknown 6 (11%) 5 (6%)
* significance determined by Mann-Whitney U test (for continuous variables) andy2 test (for
categorical variables).
| 20 in not scanned group without NIHSS scores
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state OCSP NIHSS Other issue(s)
188 90 Alert PACS 8 Neck OA; poor level of function after
prior strokes
217 89 Drowsy TACS 27 —
230 80 Drowsy TACS 21 Recent surgery (TURP)
247 88 Drowsy TACS 27 -
257 74 Drowsy TACS 28 Known COAD
284 91 Drowsy LACS 7 Very frail, poor hearing and vision
305 78 Drowsy TACS 23 Recent hospitalisation with prostatic
problems
328 79 Drowsy LACS 8 Known COAD
351 80 Drowsy TACS 20 Other medical problems (on steroids,
very frail skin, at risk of pressure
sores)
362 80 Alert PACS 17 --
371 78 Drowsy TACS 25 History of alcohol abuse
385 76 Alert PACS 13 Known COAD, required 02
387 77 Alert PACS 9 Required 02, swallowing problems
391 86 Alert TACS 23 Required 02
395 71 Alert POCS 4 Vomited before scan
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Table 12.4 Characteristics of patients who had Sa02 recorded successfully (n=61) and
those who did not (n=24).
Sa02 recordings No Sa02 recordings
possible (n=61) possible (n=24)
Feature Number (%) Number (%) P*
Median age (IQR) 73 years (61-82) 77 years (71-81) .441
Irregular pulse 13 (22) 6 (26) .725
Confusion 10 (24) 5 (36) .411
Decreased conscious level 11 (18) 5 (21) .766
Aphasia 18 (30) 7 (30) .975
Median NIHSS (IQR) 5.0 (3-9) 6.0 (4-9) .356
TACS 9 (15) 3 (13) .788
Median scan time (IQR) 27 mins (20-42) 21 mins (16-30) .026
Median Sa02 in ARU (IQR) 97% (95-98) 96% (95-98) .542
* significance determined by Mann-Whitney U test (for continuous variables) andf test (for
categorical variables).
Table 12.5 Characteristics of patients who had successful Sa02 recordings during
scanning (n=61), subdivided into those who had at least one episode of hypoxia (n=ll)
and those who did not (n=50).
Episode(s) of hypoxia hyP0X'a
Feature (n=ll) (n=50) P*
Median age (IQR) 75 years (63-82) 72 years (58-82) .488
Median Sa02 in ARU (IQR) 96.5% (95-98) 97.0% (95-98) .794
Sa02 at start of scanning (IQR) 94.0% (93-97) 96.0% (95-98) .125
Median scan time (IQR) 32 mins (15-48) 25 mins (20-39) .789
Decreased conscious level 1 (8%) 10 (20%) .670
Median NIHSS (IQR) 5.0 (3-9) 5.0 (3-9) .858
* significance determined by Mann-Whitney U test for all except conscious level - Fisher's
Exact test.
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Table 12.6 Characteristics ofpatients who required intervention, and those who did not,
during MR scanning
Intervention required No intervention
Feature (n=27) (n=58) P*
Median age (IQR) 78 years (67-85) 72 years (60-81) .106
Median NIHSS (IQR) 8.0 (4-17) 5.0 (3-9) .002
Median scan time (IQR) 25 mins (16-35) 25 mins (20-39) .162
Confusion 7 (26%) 9 (16%) .253
Aphasia 12 (44%) 13 (22%) .038
Decreased conscious level 7 (26%) 9 (16%) .253
Premature termination of scan 15 (56%) 2 (3%) <.001
* significance determined by Mann-Whitney U test (for continuous variables) andy2 test (for
categorical variables).
Table 12.7 The clinical prediction of the patient's risk of complications during MR
scanning
'High risk' n=15 'Low risk' n=70 P*
Episodes of hypoxia 1 (10%) 10 (20%) .673
Premature termination of scan 7 (47%) 10 (14%) .009
Intervention required 10 (67%) 17 (24%) .004
* significance determined by Fisher's Exact test.
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Chapter 13 : Magnetic resonance brain imaging and the
diagnosis of brain attack
13.1 Introduction
This chapter explores the benefits of magnetic resonance (MR) brain imaging
in the diagnosis of brain attack. The findings, particularly of the gradient echo
(GRE), diffusion-weighted (DWI) and perfusion (PI) sequences will be described in
a study of 96 consecutive patients with brain attack. Emphasis will be placed on the
results of MR in patients with ischaemic stroke, and how the features seen on MR
correlated with baseline clinical features. The impact of the MR on the clinical
diagnosis will be explored.
13.2 Aims
(1) To describe the MR findings in patients with brain attack
(2) To correlate imaging findings with baseline clinical features
(3) To determine the sensitivity and specificity for structural and advanced
MRI
(4) To describe how advanced MR imaging - particularly diffusion-weighted





The present study recruited consecutive patients who presented to the
Western General Hospital with symptoms of brain attack. The clinician must have
considered that acute stroke was the likely diagnosis for the brain attack, and the
patient must have been assessed by the clinician within 24 hours of symptom onset
(defined as time symptoms were first noted). Entry criteria were almost identical to
the study of feasibility of MR (although the present study recruited for a longer
time); and the general methods to ensure case ascertainment were as described for
the clinical studies (see Section II, Chapter 7).
There were two 'target' patient groups. The highest priority was assigned to
patients who presented with symptoms of cortical stroke within 12 hours of onset.
These patients received a longer initial imaging assessment, and were scanned
sequentially over three months (to study the pathophysiology of the ischaemic
penumbra). Patients with symptoms of brainstem or subcortical stroke, or cortical
stroke beyond 12 hours, were assigned a lower priority. These patients received a
shorter imaging assessment, and were scanned once. [NB. This thesis will not
address the role ofadvanced imaging in the study ofstroke pathophysiology].




One research fellow (PJH) recruited and assessed all patients. A detailed
baseline clinical assessment was performed, and a Brain Attack data form was
completed for each patient (see Appendix 2). Prior to scanning, the conscious level
was assessed again and the National Institute of Health Stroke Scale (NIHSS)
repeated if there had been a delay of one hour or more since initially performed.
Investigations
The research fellow organised MR brain imaging for each patient, and
arranged for a Doppler ultrasound examination of the extracranial carotid and
vertebral vessels either at the same visit or subsequently. Routine blood tests were
performed in each patient. Additional investigations (e.g. echocardiogram) were
performed at the discretion of the responsible clinician.
If possible, each patient was to receive a computed tomography (CT) brain
scan shortly before or after the MR. However, the CT was not always immediately
available (because it was often very busy). If the patient were unwell, or had
difficulty coping with the MR, I returned the patient to the ward without a CT, as
safety and comfort for the patient was paramount.
Final diagnosis
The final diagnosis of the event was determined by consensus of a panel of
experts (as described in Chapters 7 &11). Meetings were conducted when sufficient
experts were available (minimum four clinicians, of whom two were consultants,
from a pool of five consultants and three registrars). The research fellow presented
the clinical details, and the neuroradiologist (JMW) reviewed the CT scan, structural
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MR and DWI. The panel assigned each patient to one of five diagnostic categories
(definite, probable and possible stroke, definite transient ischaemic attack (TIA) and
non-stroke). The details were recorded on the final diagnosis data form (see
Appendix 5).
Influence of advanced imaging on the diagnosis sub-study
The present study aimed to determine the impact of brain imaging on the
clinician's diagnosis, by assessing the clinician's certainty at each 'level' of the
diagnostic process - after the clinical assessment, after CT brain imaging, after
structural MR brain imaging, and after the DWI. All patients who successfully
underwent MR scanning were studied, but only those who had contemporaneous CT
and MR could be compared.
The study was performed at the same time as the consensus panel meetings.
Clinicians were asked to complete a data sheet for each patient (see Appendix 10),
which consisted of a series of lines. Each line was a visual analogue scale ranging
from 0-100%. The clinician placed a tick on the line to indicate the level of certainty
after each level of the diagnostic process was presented (i.e. history, examination,
CT, structural MR, and finally the DWI). A score of 0% indicated that the clinician
was certain the diagnosis was non-stroke. A score of 100% indicated complete
certainty for the diagnosis of stroke (see Appendix 10). Only after the individual
clinicians had scored their data sheets (at each level) did I ask the group to make a
consensus diagnosis.
To reflect real life, the score was cumulative - each successive diagnostic
level was added to the last - so we tested the additional effect of MR (rather than
361
MR as the only imaging modality). This was a pragmatic decision, as there was
insufficient time and enthusiasm to show the scans multiple times.
Later, a single observer measured the marks on the data sheet to convert these
to a numeric score.
13.3.2 Scanning
Patients were scanned using a 1.5 Tesla GE Signa Echoplanar MR scanner
(see Figure 12.1) specifically dedicated to research. The study had unrestricted
access to the scanner during working hours (with an arrangement that stroke patients
took priority over all other patients).
Patients were escorted from the Acute Receiving Unit (ARU) or ward to the
scanner by members of the research team. The patient was briefly re-assessed by a
radiographer to ensure that there was no contraindication to scanning. If necessary,
orbits were x-rayed to exclude metallic foreign bodies. The radiographer provided a
detailed explanation of the procedure, fitted earplugs and ensured the comfort of the
patient before scanning commenced.
MR brain imaging sequences
Patients who presented with symptoms of cortical ischaemia within 12 hours
received the following image sequences: axial diffusion-weighted image (DWI),
20x5mm slices with 1mm slice gap [40 second scan time]; gradient echo (GRE),
20x5mm slices with 1.5mm slice gap [3mins 2secs]; diffusion-tensor images (DTI),
15x5mm slices with 1mm slice gap, repeated ten times [10 x 40 sec]; perfusion
imaging (PI), 15x5mm slices with 1 mm slice gap [lmin 26secs]; T2 fast spin echo
axial images (T2FSE), 30x5mm slices with no gap [3min 22secs], and magnetic
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resonance angiography of the circle of Willis (MRA), approximately 116x1.8mm
slices with no gap [6min 34secs], Total sequence time: 21 minutes 44 seconds.
Patients with cortical symptoms beyond 12 hours, brainstem or subcortical
symptoms received the following sequences: GRE, 20x5mm slices with 1.5mm slice
gap [3min 2secs]; DWI, 20x5mm slices with 1mm slice gap, repeated twice [2 x 40
sec]; PI, 15x5mm slices with 1 mm slice gap [lmin 26secs], and T2FSE, 30x5mm
slices with no gap [3min 22secs], Total sequence time: 9 minutes 10 seconds.
If the research fellow felt that a high priority patient was too unwell to
tolerate the full sequence, a briefer sequence that substituted two 40 second DWI
sequences for the ten 40 second DTI sequences was performed. The order of
sequences was critical - it ensured that the key data (the DWI) were obtained first,
and if necessary the MRA could be abandoned. Ensuring patient comfort and safety
took precedence at all times.
Rationalefor sequences
The long scanning time incorporated many different sequences. The GRE
sequence is exquisitely sensitive to both acute and chronic haemorrhage (see Section
I, Chapter 6), which is important ifMR is to replace CT. Both DWI and T2 FSE are
required to help determine the age of a lesion, and confirm whether the lesion is
ischaemic. PI was chosen to document blood flow to the affected area, and to
establish if a mismatch existed. The MRA sequence could identify occluded vessels.
The only image sequence not in current clinical use - DTI - was chosen for a sub-
study that examined the response of brain tissue to ischaemia (in a series of patients
with cortical stroke). DTI allows the assessment of both the amount and direction of
water diffusion - anisotropy - which may be altered by ischaemia (Pierpaoli et al.,
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1996). The complex pathophysiology of stroke recovery will not be discussed in this
thesis.
13.3.3 Image processing and analysis
After scanning, hard copies of the DWI, GRE, T2FSE and MRA were printed
onto photographic film, and were available for immediate inspection and reporting.
For the DWI images, only qualitative reports were possible (i.e. lesion
present/absent, lesion small/large, area affected). Perfusion images were not printed
off, as the quality of the raw images produced by the MR machine are relatively
poor. Thus, more detailed analysis of the PI and DWI images (for example lesion
volume measurement) required computer-assisted image processing.
The key issue of blinding
Lack of blinding is a major shortcoming of many studies of advanced MR
brain imaging (Keir & Wardlaw, 2000). It is difficult to be convinced of the role of
imaging when the same clinician recruited the patients, reported the scans, analysed
the images, and performed the follow-up assessment. Such a study would not
provide objective assessment of the relationships between clinical severity an
imaging appearance, or functional outcome and imaging. To minimise these
potential biases, we undertook the following steps:
• The clinician (PJH) was blind to the PI data and to measurements on DWI
• The neuroradiologist (JMW) reported the scans independently, blind to the
symptoms (this was done separately to the final diagnosis team meetings,
where the images were reviewed with the clinicians)
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• PI and DWI lesions were identified and outlined for measurement by JMW
blind to all other details (and the DWI and PI were done separately and blind
to each other)
• The actual measurement of PI and DWI lesion volume and apparent diffusion
coefficient (ADC) were performed on computer by a scientist blind to all
baseline and follow-up data clinical data, and the DWI and PI were done
separately and independently
• The presence of a mismatch between DWI and PI lesions was determined by
the neuroradiologist blind to all clinical details
Determining DWI lesion volume and the ADC
This was performed by CSR (PhD candidate) under supervision by JMW.
After scanning, the data were saved onto disc and transferred to a UNIX workstation
to allow processing. The images were realigned to each other and motion and patient
movement artefact was corrected using software developed in-house (by Dr Mark
Bastin, medical physicist). At this point (which could take up to 30 minutes per
scan), the images were ready for analysis.
DWI lesion volume was determined using ANALYZE™ (Version 7.5, Mayo
Clinic, Rochester USA) software. The DWI map (with lesions showing as white
blobs) was inspected, and regions of interest were outlined manually. The computer
software then calculated volume (area of the lesion multiplied by slice thickness).
ADC, a measure of the actual amount of water diffusion, was also determined by
ANALYZE™. A contralateral region of interest in normal tissue was highlighted on
the DWI map, and both it and the ischaemic lesion were traced onto the ADC map.
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The computer calculated the mean ADC in both regions of interest. Thus the
ADC value obtained was relative to the contralateral (normal) tissue.
The assessment of PI parameters
The PI sequence consisted of a rapid intravenous injection of gadolinium,
followed by repeated scans of the entire brain every 2.5 seconds for 85 seconds
(generating 34 time points) which 'tracked' the passage of the tracer agent through
the brain. The raw data were exported from the scanner as a DICOM file to a Sun-
UNIX workstation for further processing, which was performed by Dr Paul Armitage
(Medical Physicist). The first step was to correct for motion artefact, using software
developed in-house, and align the scans with each other and the DWI image (as
above). The critical importance of correcting for movement artefact (and thus the





Figure 13.1 Patient movement artefact can overestimate the perfusion abnormality
The dark blue area (arrows) appears more extensive in the upper row of images with no
motion correction. Patient's right is on the left side ofthe page.
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The next step in processing was to convert the images to a display of tissue
contrast agent concentration (rather than the loss of signal produced by the contrast).
This was done automatically using an equation that relates the drop in signal to the
signal of the tissue before contrast was given. Once this was performed, the
concentration of contrast in each of the 34 slices (for every voxel of brain tissue) was
plotted on a concentration versus time graph. A 'gamma variant curve' was fitted to
the graphs: cerebral blood volume (CBV) was estimated as the area under the gamma
variant curve; mean transit time (MTT) roughly equated to the width of the curve,
and cerebral blood flow was determined by dividing CBV by MTT. An arterial input
function was not calculated (see Section I, Chapter 6 for further explanation). Thus
the PI parameters were all relative measurements: the lesion was compared with
contralateral normal tissue.
Colour CBF and MTT maps were produced and printed for each patient. The
neuroradiologist (JMW), blind to clinical details, examined the PI maps in two
sittings. The first reading was to identify whether a mismatch between perfusion and
diffusion was present (to be discussed in Chapter 14). Both PI maps were coded as
normal (no perfusion abnormality), focal area of reduced flow consistent with acute
ischaemia, or focal area of increased flow/hyperaemia. The second reading,
performed blind to the DWI scan result, was to outline the focal regions of abnormal
perfusion on the maps, so that lesion volume could be determined semi-automatically




Descriptive statistics were used to test the significance of associations and
correlations. The data were initially checked for a Normal distribution, which was
present only for ADC values. Parametric statistical tests were used for ADC values,
but all other data were analysed with standard non-parametric tests. I used the
NIHSS and Oxfordshire Community Stroke Project (OCSP) classification as the
main markers of stroke severity.
Accuracy ofMR imaging
To determine sensitivity and specificity consistent with earlier chapters, I
reduced the final diagnostic categories to 'thrombolysis-eligible' stroke (i.e. definite
stroke or TIA or probable stroke) or mimic (i.e. definite non-stroke or possible stroke
with a plausible non-stroke explanation for the clinical features). The scan findings
were dichotomised to relevant stroke lesion (either infarct or haemorrhage) or no
acute stroke lesion (normal, non-stroke lesion, old pathology, or atrophy). 95%
confidence intervals were determined for the accuracy parameters.
The impact of imaging on the diagnosis
I analysed the data obtained from the clinicians' diagnostic certainty data
sheets in several ways (as no single method adequately summarised the results). (1)1
plotted a series of line graphs. There was one graph per clinician, with each line on
the graph representing an individual patient for which the clinician made a decision.
The y-axis represented the percentage certainty, and the x-axis represented the
decision nodes (clinical assessment, CT, structural MR and DWI). The graphs
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provided an overall picture of how certainty changed, and whether there were any
clear trends within and between clinicians. Unusual or outlying patients were
identified and described.
(2) I determined the magnitude of change in certainty on moving between
each imaging modality (CT, structural MR and DWI). A score of 50% was deemed
to be complete uncertainty, and any movement away from this (in either direction)
was an increase in certainty (i.e. a 40% increase in certainty could mean going from
50% to 90% certain, or from 50% to 10% certain). For every patient, the raw score
at each node was changed to a certainty figure by subtracting the score from 50 and
ignoring the direction sign (so that a patient's raw score of 36% became 14%, the
same as a patient starting with a score of 64%). [This made certainty for a non-
stroke equal to certainty for a stroke]. The change in certainty was simply the
difference in certainty between clinical assessment and CT, CT and structural MR,
and structural MR and DWI. A change in certainly could be either positive (became
more certain) or negative (became less certain). Mean certainties at each decision
node were calculated for every individual patient (using the scores of all clinicians
who assessed that patient), for every clinician (using all patients that the clinician
assessed), and then for all patients (ignoring the fact that patients had been assessed
by different groups of clinicians). The change in certainty was analysed using two
way ANOVA (adjusting for patients and clinicians).
(3) To give another view of the data, I determined the frequency diagnostic
certainty increased, remained the same or reduced for each clinician, and the number
of times that each clinician was 100% certain after each imaging modality.
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(4) The interaction between severity of stroke and utility of brain imaging
was analysed by dividing patients into OCSP subtypes, and four NIHSS categories
(NIHSS 0, 1-4, 5-10, >10), and determining mean change in certainty (with 95%
confidence intervals) from the clinical assessment to the completion of imaging.
The impact of imaging on lesion localisation
The accuracy of the research fellow's clinical prediction of lesion localisation
was compared to the location shown by DWI (in patients with ischaemic or
haemorrhagic stroke who had a visible DWI lesion). The OCSP classification was
used as the clinical predictor of lesion location. DWI lesions were divided into
cortical, large subcortical (e.g. striatocapsular infarct), small subcortical (a 'lacunar
infarct' as described by the neuroradiologist) and brainstem. Haemorrhages were
divided into subcortical (small or large) and cortical. To be classed as a correct
clinical prediction, patients with a TACS or PACS must have had a cortical or large
subcortical lesion, patients with a LACS must have had a small subcortical lesion,
and patients with POCS must have had a brainstem lesion or cortical infarct affecting
the occipital lobe(s).
Statistical packages
Data analyses were performed using Microsoft Excel (version 97 SR-2,
®Microsoft Corporation 1997), Confidence Interval Analysis (version 2.0.0, ®Trevor
Bryant 2000) and SPSS for Windows (version 10.0.5, °SPSS Inc. 1999). Two-way
ANOVA was performed using the general linear model function of SPSS, entering
certainty as the dependent, and clinicians and patients as fixed variables, to
determine change accompanying each new piece of information.
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13.4 Results
The study commenced recruitment on 19 September 2000, and completed
recruitment on 7 November 2001 (with a break in recruitment from 14/11/00 -
7/1/01 for conferences and holidays). During this time, 96 patients were recruited
(no patients were recruited more than once). [NB. The present study recmited an
additional 11 patients compared with the feasibility study (Chapter 12), as it
recruited for a longer period of time].
13.4.1 General Features
Patient demographics
Table 13.1 & 2 give details of the general recruitment and demographics of
the 96 patients recruited. The median age of the patient group was 74 years. 54%
were seen by the research fellow within 12 hours of onset (median time 9.3 hours),
and most were scanned within 13 hours of symptom onset. 37/96 (39%) patients
reported a past history of a focal neurological deficit, which had completely resolved
in 23 patients. Only three patients were unable to walk prior to the stroke.
Vascular risk factors were common in this cohort: 58% of patients were
present or past smokers, 57% reported a history of hypertension, 25% had ischaemic
heart disease, and 25% had known atrial fibrillation.
Clinical features of the brain attack
The clinical features of the event that led to recruitment are detailed in Table
13.3. A time of onset was estimated for 13 patients (13%), and a further 34 patients
(35%) first noticed symptoms on waking. When a patient awoke from sleep with the
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deficit, the median time that the patient was last known to be normal was 7.75 hours
earlier (IQR 4.4 - 10.8 hours).
Almost 75% of brain attacks involved motor symptoms, and around 50%
caused speech disturbance. On examination, 20% of patients were confused, and
20% had reduced consciousness. The median NIHSS score for the cohort was 5
(IQR 3 - 9). 40% were classed as partial anterior circulation syndrome (PACS),
31% lacunar syndrome (LACS), and 14% total anterior circulation syndrome
(TACS).
Final diagnosis
The final diagnosis was definite or probable stroke in 85/96 (88%) of patients
recruited, TIA in 3/96 (3%), possible stroke in 3/96 (3%) and definite non-stroke in
5/96 (5%) (see Table 13.4 & Figure 13.2).
definite stroke
Figure 13.2 Final diagnosis ofpatients in MR study
13.4.2 Scanning details
37 patients (39%) presented with symptoms of cortical stroke within 12 hours
of onset. These high priority patients received the longer scanning sequences
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(median scan time 39 minutes, IQR 26-48mins). The remaining 59 patients (62%)
received the shorter duration scan sequence (median scan time 21 minutes, IQR 17-
26.5mins).
The distribution of time to scanning for the 96 patients is illustrated in Figure
13.3. Four patients were scanned after 48 hours. Although not strictly eligible, these
patients were scanned, as they were willing to participate, and could still provide
useful data.
30
n=7 n=21 n=15 n=28 n=!7 n=4
0-3 hrs 3-6 hrs 6-12 hrs 12-24 hrs 24-48 hrs >48 hrs
Time (hours) between onset and MR
Figure 13.3 Timefrom symptom onset to scanning (n=92 patients scanned)
Aborted scans
Four patients aborted the scan (due to claustrophobia) before any useful data
could be obtained. A further 15 patients could not complete the full imaging
protocol (13 were undergoing the longer DTI sequence), although useful DWI and PI
data were obtained. 9/37 patients invited to undergo sequential scanning refused
after the first scan.
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Scan quality
The earliest and briefest images - DWI and GRE - were less affected by
movement artefact. Later and longer sequences - T2FSE and MRA - were more
likely to be degraded by patient movement (see Figure 13.4 and also Figure 13.28).
The neuroradiologist (JMW) was able to provide a qualitative report on all scans.
Figure 13.4 Patient movement artefact degraded the T2FSE sequence (see alsofig 13.28)
PH387: Patient presented with a left PACS, MR at 29 hours 30 minutes after onset. T2FSE
(left image) is degraded by movement artefact making the hyperintense left MCA infarct
more difficult to see (arrows), but the DWI (right) shows an obvious hyperintensity.
Scan quality was of critical importance for the successful computerised
processing of images. DWI lesion volume could not be calculated for six patients,
although JMW was able to determine a rough lesion volume by estimating the area
of the lesion on the photographic film and multiplying this by the number of slices
involved. The ADC could not be calculated for 10 patients, as the data from the MR
scanner had become corrupted (thus preventing further analysis). This could not be
remedied. PI parameters could not be determined in 22 patients: the patient was
unable to tolerate the sequence (n=7), the data was corrupted (n=7), or the sequence
was not performed because the lesion identified on MR was not ischaemic (n=8).
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13.4.3 MR brain imaging and the detection of stroke mimics
Five patients were diagnosed as definite non-stroke. Two patients [PH250,
PH372] had a brain tumour (meningioma and metastasis); in these patients the
diagnosis was confirmed by the brain imaging (the lesion was also visible on CT in
the patient who had both CT and MR). One patient's symptoms were due to a
seizure [PH360], one was due to decompensation unmasking previous stroke signs
[PH364], and one was thought to be functional [PH378]. In these three cases, the
brain imaging (including DWI) showed no acute lesion. Although the diagnosis was
based on the history and examination, it was useful to note that the DWI was
negative.
Three patients received a final diagnosis of possible stroke. Two patients
[PH222, PH397] presented with symptoms of vestibular disturbance, and all MR
sequences failed to disclose an acute lesion. Reaching a consensus final diagnosis
was difficult, as some members of the panel were happy to label this as peripheral,
but others felt that ischaemia could not be excluded. The other patient [PH388]
presented with slurred speech and unsteadiness. On examination, she was confused,
dysarthric and unsteady. There was a background of moderately severe cognitive
impairment. MR imaging showed atrophy, leukoaraiosis and old petechial
haemorrhages, but no acute lesion on DWI. A urinary tract infection was suspected,
but there was no laboratory proof of this, so the consensus diagnosis was possible
stroke.
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13.4.4 The detection of haemorrhage with advanced MR
Acute intracerebral haemorrhage
Five patients with acute ICH were scanned with MR before CT (see Figure
13.5). Two patients were scanned within a few hours of symptom onset - both
presented with a severe clinical syndrome (TACS, NIHSS 22 & 23). The other three
patients were scanned greater than 12 hours after symptom onset, and had milder
features (classed as PACS, LACS and unsure; NIHSS 12, 3 and 7).
There were several typical features of acute haemorrhage seen on MR. The
GRE scan showed an ovoid mass lesion with hypointense (black) margins; the
presence of hypointensity was more obvious in patients scanned later. The DWI
scan showed a hyperintense (white) lesion, a similar appearance to ischaemia.
However, areas of intense hypointensity could often be seen in the lesion on DWI (at
the periphery of the lesion when scanned in the first few hours), and the ovoid shape
was not the typical wedge shape of an ischaemic lesion. The T2 images (only shown
for PH236) were difficult, as the hypointense lines at the rim of the lesion were often
not present. In contrast, the CT was very obvious in each case (see Figure 13.5).
PH391; MR scan performed at 2 hours 27 minutes following symptom onset. The left image
is the gradient echo, middle image is the DWI (large arrows point to the hypointense
serpiginous lines often seen), right image is the CT (2 hours 35 minutes).
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PH243: MR scan performed at 3 hours 24 minutes. The left image is the gradient echo,
middle image is the DWI, and right image is the CT (at 3 hours 38 minutes)
PH236/ MR scan performed at 12 hours 53 minutes. Left image is the gradient echo, middle
image is the DWI and right image is the T2FSE.
PH284: MR scan performed at 15 hours 3 minutes. The left image is the gradient echo,
middle image is the DWI, and right image is the CT (15 hours 13 minutes).
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PH265: MR scan performed at 25 hours. The left image is the gradient echo, middle image is
the DWI, and right image is the CT (25 hours 15 minutes).
Figure 13.5 The appearance of acute intracerebral haemorrhage on MR in the five
patients scanned
Haemorrhagic transformation ofan infarct
The MR scans identified haemorrhagic transformation of an infarct in three
patients, all ofwhom were scanned after 12 hours (see Figure 13.6). The appearance
of haemorrhage was characteristic, but not as obvious to the untrained observer as
the CT (see PH352, figure 13.6). The neuroradiologist considered that patient
PH352's lesion was haemorrhagic transformation because there were two lesions (in
the caudate and lentiform nucleus) which appeared diffusely petechial with no mass
effect.
PH352: Patient presented with a left TACS. MR performed at 19 hours 45 minutes shows a
right striatocapsular infarct with haemorrhagic transformation (left image is the GRE,
middle image the DWI). CT 1 hour later (right image) shows the same.
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PII3 87. Same patient as figure 13.3. Patient presented with a left PACS. MR at 29 hours 30
minutes after onset shows a left middle cerebral artery territory infarct with haemorrhagic
PH257: Patient presented with a L TACS at 2 hours 10 minutes, entered into IST-3
(unknown whether patient received placebo or thrombolysis). MR at 16 hours 36 minutes;
DWI (left) showed an extensive hemispheric hyperintensity, and GRE sequence (right)
showed extensive haemorrhagic transformation at the edges of the lesion.
Figure 13.6 Haemorrhagic transformation seen on MR
Remote haemorrhage
Old discrete haemorrhages
31/92 patients scanned (34%) had evidence of old discrete stroke pathology.
20 patients gave a history of a previous focal neurological deficit (18 patients who
had a past history of a focal deficit had no evidence of old stroke pathology on MR).
The GRE sequence demonstrated that for 4 of 31 patients (13%, 95% CI 5-39%), the
old lesion had actually been a primary intracerebral haemorrhage (PICH). The scans
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of several patients [PH222, PH393, PH382] are provided in Figure 13.7: the CT
showed an old slit-like lesion in the basal ganglia, whilst the GRE sequence showed
blood breakdown products demonstrating that the stroke had been a PICH.
PH222: CT on left shows old basal ganglia stroke (arrow), MR on right shows that this event
was a primary intracerebral haemorrhage (large arrow) and a few microbleeds (small
arrows)
PII3 82. This patient presented with a briefepisode of right-sided weakness, GP commenced
aspirin. Re-presented several months later with new symptoms - MR shows old bleed
(arrow)
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PH393: This patient presented with a weak left hand, but had a history ofmultiple events in
the past. CT (left) shows an old stroke (large arrow) and basal ganglia calcification (thin
arrows). GRE (right) shows a rim ofhaemosiderin around the old stroke, confirming that it
was a bleed (large arrow).
Figure 13.7 The gradient echo sequence detected old stroke events that were actually
haemorrhages
Microbleeds
Ten patients exhibited old microbleeds, seen on the GRE image as small,
hypointense (i.e. black) punctate lesions (see Figures 13.7 & 8). The frequency in
this cohort was therefore 10.9%, with 95% confidence intervals extending from 6.0%
to 18.9%. The MR showed an acute infarct in four patients, a PICH in two, and no
acute lesion in four (but all had atrophy and or periventricular lucencies). Four of 10
patients had a history of known cognitive impairment, and five had a past history of
stroke. The presenting symptoms ranged from mild to severe (NIHSS range 1-23,
median 7.5).
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Figure 13.8 Microbleeds seen on the gradient echo MR sequence
This patient presented with an acute PICH (see Figure 13.4), lower extremity of the PICH is
marked by large arrow. Small arrows denote microbleeds.
13.4.5 MR brain imaging of ischaemic stroke
82 patients had presumed ischaemic stroke. Of the original 96 patient study
cohort, four patients could not tolerate the MR scan, five patients had a definite non-
stroke, and five patients had a PICH. The final diagnosis determined by the
consensus panel (which was made after viewing the MR) was definite stroke (n=66),
probable stroke (n=10), definite TIA (n=3) and possible stroke (n=3). In the
following sections I shall describe the findings of advanced MR in the group of
patients with definite, probable and possible cerebral ischaemia.
The DWI scan
A hyperintense (or white) lesion was visible on DWI sequence in 64/82
(78%, 95% CI 68-86%) patients. Figure 13.9 shows that a visible DWI lesion was
present in 62 (94%) of those with a final diagnosis of definite stroke, and two (67%)
of those with definite TIA. All patients with a final diagnosis of probable or possible
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Final diagnosis
Figure 13.9 Proportion in each diagnostic category with a visible lesion on DWI scan
(n=82)
Normal D WI scans
There were 18 (22%) patients with a normal DWI scan: four received a final
diagnosis of definite stroke, one received a final diagnosis of transient ischaemic
attack, ten were diagnosed as probable stroke, and three as possible stroke. The
clinical features of those with and without a visible DWI lesion are compared in
Table 13.5. The major differences were that patients without a visible lesion were
more likely to have brainstem symptoms, an OCSP classification of posterior
circulation syndrome, lower NIHSS scores, and signs suggesting brainstem
involvement (p<0.02 for all). In addition, patients with no lesion on DWI were
scanned later than those with a DWI lesion (median 22 hours vs 10 hours, p=0.06),
but this may have reflected later recruitment of patients with brainstem or milder
strokes.
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To further investigate the reasons for normal DWI scans, I excluded those
with a brainstem lesion (n=8) and reanalysed the data. There was still a significant
difference in NIHSS score (median 6.5 for those with a lesion, 3.5 for those with no
lesion, p=0.02), and a non-significant trend for those with a DWI lesion to be
scanned earlier (median time 9.5 hours vs 22 hours, p=0.12). Those with a visible
DWI lesion were more likely to have a cortical syndrome (TACS or PACS) than a
lacunar syndrome (61% vs 31%), whilst the reverse was true for those with no visible
DWI lesion (33% cortical vs 42% lacunar, p=0.01 for the difference between groups,
x2)-
When those with a final diagnosis of possible stroke or transient ischaemic
attack (n=4) were excluded, results were also similar: patients with no visible lesion
had a milder clinical syndrome, and the lesion was more likely to be subcortical or
brainstem in location.
One patient [PHI98] had clinical features of a total anterior circulation
syndrome yet had a normal DWI scan. This 98 year old woman woke with
symptoms at 8.30am (last normal at 4.30am). On examination, she was mildly
drowsy, had a left hemiparesis and gross neglect (NIHSS 11). She was scanned 5
hours and 34 minutes after onset of symptoms (9 hours 34 minutes since last
normal). Figure 13.10 shows the normal DWI scan, and an MRA that demonstrated
an occluded right middle cerebral artery.
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Figure 13.10 A patient with a clinical TACS and an appropriate middle cerebral artery
occlusion yet a normal DWI
PHI 98: This patient presented with a right TACS (NIHSS 11). MR performed at 5 hours 34
minutes. DWI sequences (left and middle images) showed no evidence of an ischaemic
lesion, but the MRA (right image) showed an occluded right middle cerebral artery (arrow).
Did lesion volume correlate with stroke severity?
DWI lesion volume data were available for all 82 patients. The median
lesion volume was 0.85mL (IQR 0.1-7.6mL), and the mean lesion volume was
14.3mL. Data were dominated by the 18 patients with no visible lesion (volume
therefore OmL), which may have affected the strength of the relationships. Analyses
were therefore performed on the whole group, and the subgroup of patients with a
lesion.
(1) NIHSS: In Figure 13.11, I have plotted the data for all patients with
presumed ischaemic stroke (n=82). There was a significant correlation between
lesion volume measured on DWI and stroke severity measured by the NIHSS
(correlation coefficient, rs 0.55, p<0.01, Spearman's rho). After excluding the
patients with no lesion, the association remained significant in the subgroup (rs 0.51,
p<0.01, Spearman's rho).
(2) OCSP classification: There was a clear relationship between OCSP
classification and DWI lesion volume, with highest volumes observed in those with
TACS (see Table 13.6), and lowest in those with POCS (p<0.01, Kruskal-Wallis).
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In the subgroup with a visible DWI lesion, the relationship remained highly
significant, although lacunar strokes had the lowest lesion volumes (p<0.01, Kruskal-
Wallis).
200
NIHSS score ? ^ ^ ^ ^/ = 0.35, rs = 0.55, p<0.001
Figure 13.11 Scatterplot ofNIHSS versus lesion volume on DWI (with regression line)
Each point represents a single patient; the straight line represents the line offit (determined
by linear regression) and the surrounding lines represent the 95% confidence intervals for
the line offit. r is the proportion of the variability explained by the relationship (i.e. 35%),
rs is the Spearman correlation coefficient
Apparent Diffusion Coefficient (ADC)
A relative ADC value was calculated for 52 patients. It was not possible to
determine ADC in 20 patients with no or very small lesions (due to partial volume
effects and other technical reasons pertaining to small lesions), and in 10 patients due
to other technical reasons (corrupted data). Of the 52, the final diagnosis was
definite stroke in 50 and TIA in two patients. The distributions of age, gender, time
to scanning, NIHSS, and OCSP classification were similar to the whole group of 82
patients.
Figure 13.12 shows a significant inverse relationship between NIHSS and
ADC (correlation coefficient, rs -0.35, p=0.01, Spearman's rho). The mean ADCr
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(with 95% confidence intervals) for the four OCSP categories is shown in Figure
13.13. Overall, there was no significant relationship between mean ADC and OCSP
subtype (p=0.08, one-way analysis of variance), and inspection of the graph shows
that the mean ADC was actually lower for LACS than for PACS. Patients with a
TACS did have a lower mean ADC than PACS, LACS and POCS combined (mean
ADC 0.66 vs 0.78, p=0.02, Two-sample t test).
NIHSS score 2 n ; a /o ?c n m
r = 0.14, rs = -0.35, p = 0.01
Figure 13.12 The relationship between ADCr and stroke severity as defined by NIHSS
Each point represents a single patient; the straight line represents the line offit (determined
by linear regression) and the surrounding lines represent the 95% confidence intervals for
the line offit. r2 is the proportion of the variability explained by the relationship (i.e. 14%),
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Figure 13.13 The relationship between ADCr and OCSP classification
As the data were Normally distributed (p=0.20, Kolmogorov-Smirnov testfor normality) the
mean ADCr (with 95% CI) for each OCSP subtype is presented.
Did ADC correlate with DWI lesion volume?
The relationship between ADC and DWI lesion volume is shown in a
scatterplot of the 52patients with a measurable ADC (Figure 13.14). There was a
trend for larger DWI lesion volumes to be associated with lower ADC, but this was a
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Figure 13.14 The relationship between ADC and DWI lesion volume
Each point represents a single patient; the straight line represents the line offit (determined
by linear regression) and the surrounding lines represent the 95% confidence intervals for
the line offit. r2 is the proportion of the variability explained by the relationship (i.e. 5%), rs
is the Spearman correlation coefficient
PI parameters
Maps of mean transit time (MTT) and cerebral blood flow (CBF) were
available for 68/82 (83%) patients. No PI data were obtained in 14 patients due to
patient inability to tolerate the sequence (n=7), or corrupted data that prevented
further analysis (n=7). Of the 68, the final diagnosis was definite or probable stroke
in 62 (91%), TIA in 3 (4%), and possible stroke in 3 (4%).
The difficulty of interpreting PI maps
PI maps (read with the DWI scans) were coded as no perfusion lesion, focal
area of reduced flow consistent with acute ischaemia, or focal area of increased
flow/hyperaemia. On the first reading of the PI maps (to determine if a mismatch
existed), 23/68 (34%) patients had no PI lesion. On the second reading of the PI
maps (to mark the perfusion abnormality so that measurement of lesion volume
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could be performed), 27 patients were thought to have had no PI lesion (see Table
13.7). This gave a kappa value of 0.81 (very good) for the intra-observer reliability
of the detection of a PI lesion.
When it came to measuring PI lesion volume, there were 41 patients with a
visible PI abnormality (four fewer than after the first inspection). However, a lesion
could not be measured in 8/41 (20%) patients. This was because the PI abnormality
was in an old stroke lesion (three patients, see Figure 13.15), was too small or
patchy to measure (three patients, see Figure 13.16), or was hyperaemia (two
patients, see Figure 13.17). Although hyperaemia is an abnormality of perfusion, it
is not a deficit of perfusion that could be used to determine mismatch.
Visual examination of the MTT and CBF maps yielded slightly different
results - it was possible to have a lesion present on one map but not the other (see
Table 13.8). When there was disparity in the size of the lesion seen on the two
forms of PI, the MTT map was invariably larger (see Figure 13.18). Of the 33
patients with a measurable lesion, the MTT map was positive in 29 of 33 scans
(88%), the CBF map was positive in 24/33 scans (73%), and 20/33 (61%) patients
had lesions on both MTT and CBF maps.
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Figure 13.15 Difficulties ofmeasuring a PI abnormality: old stroke lesions
PH260: This patient presented with aphasia and right sided weakness (NIHSS 7). There was
a past history ofa left middle cerebral artery infarct, and the differential diagnosis was
between a seizure or a new ischaemic lesion. The DWI scans (upper row) showed subtle
hyperintensity (white arrow) at the margin of the old lesion (black arrow). The CBF maps
(lower row) showed a focal area ofreducedflow (arrows) to the region corresponding with
the old lesion. Whatpart of the reducedflow was new?
Figure 13.16 Difficulties ofmeasuring a perfusion lesion: small lesions
PH394: This patient presented with rightface, arm and leg weakness (NIHSS 5). MR at
3.8hours. The DWI scans (upper row of images) show a left thalamic lacunar lesion
(arrow). The CBF (middle row) and MTT (lower row) images show a small region of
perfusion abnormality matching the diffusion lesion, but too difficult to draw round and
measure.
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Figure 13.17 Difficulties measuring the PI deficit: hyperaemia
PH387: This patient presented with global aphasia (NIHSS 9). MR at 29.5 hours. The DWI
scan (upper row of images) shows a bright ischaemic lesion in the superior branch of the left
middle cerebral artery (arrow). The CBF map (middle row) shows a focal area of increased
flow (arrows, seen as red) in the same distribution as the DWI abnormality, consistent with
hyperaemia and said to be evidence ofreperfusion. The MTT maps (lower row) are not as
obvious, but also show afocal area ofreduced transit. At follow-up, modified Rankin score
was two.
Figure 13.18 Disparity between the size ofthe perfusion deficit on MTT and CBF maps
PH276: This patientpresented with aphasia and weakness of the rightface (NIHSS 6). MR
at 21.2hours. DWI (top row of images) shows a large left middle cerebral artery distribution
hyperintense lesion. The CBF maps (middle row) show a moderate sizedfocal area of
reducedflow consistent with acute ischaemia. The MTT maps (lower row of images) show a
much larger area ofreducedflow.
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No PI lesion
23/68 (34% 95% CI 24-46%) patients with ischaemic stroke had no perfusion
deficit (defined as no lesion observed on both MTT and CBF maps on the first
inspection). The features of patients with and without a visible perfusion
abnormality are detailed in Table 13.9. The major differences were that patients
without a PI lesion were scanned much later (24 hours vs 9 hours, p<0.01, Mann-
Whiney U), had milder strokes (e.g. median NIHSS 4 vs 7, p<0.01, Mann-Whiney
U) and more often had a lacunar (61% vs 16%, p<0.01, %2) or brainstem syndrome
(22% vs 4%, p=0.03, %2). DWI lesion volume was significantly higher in those with
a perfusion abnormality (median 4.7mL vs 0.2mL, p<0.01, Mann-Whiney U). The
final diagnosis was more likely to be a probable than definite stroke in those without
a visible PI lesion.
How often was there a PI lesion in patients with no DWI lesion?
18 patients with cerebral ischaemia had no visible lesion on DWI. 14
received perfusion imaging (unsuccessful or abandoned in the remainder). Of the 14,
the clinical classification was POCS in five, LACS in four, and PACS in two (three
were unknown). Nine of the 14 had no PI lesion. The final diagnosis was probable
stroke in six, possible stroke in one and definite stroke in two. Five patients with no
DWI lesion had a visible PI lesion; the final diagnosis was definite TIA in one,
probable stroke in two, and possible stroke in two (both patients had symptoms of
vertigo).
Did lesion volume correlate with stroke severity?
PI lesion volumes were calculated in all 68 patients. The 35 scans with no
measurable perfusion abnormality were given a zero volume. On MTT maps, 39
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(55%) patients had no lesion, so the median lesion volume was OmL, mean 49.2mL.
Of those with a measurable lesion (29 patients), median lesion volume was 66.2mL
and mean 107.3mL. On CBF maps, 44 patients had no lesion, so the median lesion
volume was also OmL, mean 23.3mL. Of the 24 with a measurable lesion, median
lesion volume was 35.4mL and mean 66.OmL. There was a strong correlation
between MTT and CBF lesion volume (rs 0.70, p<0.01, Spearman's, see Figure
13.19).
MTT vol mL , „
r =0.69, rs=0.70, p<0.01
Figure 13.19 Correlation between lesion volume on CBF and MTT maps
Each point represents a single patient; the straight line represents the line offit (determined
by linear regression) and the surrounding lines represent the 95% confidence intervals for
the line offit. r is the proportion of the variability explained by the relationship (i.e. 69%),
rs is the Spearman correlation coefficient
(1) MTT and NIHSS: There was a significant relationship between MTT
lesion volume and stroke severity (measured by the NIHSS) in all 68 patients (rs
0.46, p<0.01, Spearman's, see Figure 13.20). The relationship remained significant
if only those with a measurable lesion were included (n=29, rs 0.45, p=0.02,
Spearman's).
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r2=0.45, rs=0.46, p<0.01
Figure 13.20 The relationship between MTT lesion volume and NIHSS (all patients,
n=68)
Each point represents a single patient; the straight line represents the line offit (determined
by linear regression) and the surrounding lines represent the 95% confidence intervals for
the line offit. r2 is the proportion of the variability explained by the relationship, rs is the
Spearman correlation coefficient
(2) CBF and NIHSS: A significant relationship was also observed when CBF
was used as the measure of perfusion. Figure 13.21 shows the relationship for all
patients (n=68, rs 0.46, p<0.01, Spearman's). The relationship was also significant
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r =0.54, rs=0.46, p<0.01
Figure 13.21 The relationship between CBF lesion volume and NIHSS (all patients, n=68)
Each point represents a single patient; the straight line represents the line offit (determined
by linear regression) and the surrounding lines represent the 95% confidence intervals for
the line offit. r2 is the proportion of the variability explained by the relationship, rs is the
Spearman correlation coefficient
Lesion volume on PI and the OCSP clinical classification were associated
(see Table 13.10), with higher volumes observed for TACS than PACS, LACS and
POCS (p<0.01, Kruskal-Wallis).
Which correlated better with stroke severity: PI or DWI?
There was a clear relationship between lesion volume on DWI and PI scans
(rs 0.63, p<0.01, Spearman's, see Figure 13.22). Larger DWI lesions were
associated with larger lesions seen on the MTT map, but at lower DWI lesion
volumes the association was not as clear (small DWI lesions could have an MTT
lesion of up to lOOmL). The relationship between MTT lesion volume and NIHSS,
and between DWI lesion volume NIHSS, is shown in an overlay scatterplot (Figure
13.23). For the 68 patients who had both PI and DWI imaging, the DWI lesion




150 200 250 300
MTT lesion volume (mL) ? _. ^ „
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Figure 13.22 The relationship between DWI lesion volume and PI lesion volume (on
MTT))
Each point represents a single patient; the straight line represents the line offit (determined
by linear regression) and the surrounding lines represent the 95% confidence intervals for
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Figure 13.23 How did DWI lesion volume and PI lesion volume compare?
NIHSS-DWIrs = 0.69, NIHSS-MTT rs = 0.46
Each point represents a single patient; the lines represent line offit for DWI and MTT
(determined by linear regression). rs is the Spearman correlation coefficient
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13.4.6 The accuracy of MR brain imaging compared to the final consensus
panel diagnosis
MR data were obtained in 92 patients. All patients had structural imaging
(gradient echo and T2 images), but one patient [PH372] did not have DWI (the
structural imaging showed a brain tumour, so other sequences were performed
instead of the DWI).
A CT brain scan was performed in addition to the MR for 62/92 (66%)
patients. The CT was performed after the MR in 40/62 (median time between scans
0.8 hours, mean 7.0 hours), and before the MR in 22/62 (median time between scans
1.1 hours, mean 6.2 hours).
The sensitivity and specificity of structural and advanced MR
To assess accuracy parameters consistently with earlier chapters (Chapters
7,8 & 11), the final diagnosis was dichotomised to 'thrombolysis-eligible' stroke
(definite stroke, TIA or probable stroke, n=84) or mimic (definite non-stroke or
possible stroke with a plausible non-stroke explanation, n=8). The measure of
imaging accuracy was whether a relevant stroke lesion was seen (which assumed that
a negative scan was unhelpful). The expert panel had seen all brain scans when the
final diagnosis was made.
I have tabulated sensitivity, specificity, positive and negative predictive value
and overall accuracy for the CT brain, structural MR and DWI scan in Table 13.11.
As the final diagnosis was strongly influenced by the imaging findings, no patients
with a mimic were found to have a relevant stroke lesion, thus the likelihood ratio
(not shown on the table) for all imaging was infinity, and the specificity and positive
predictive value were also 100%. However, the sensitivity of CT and structural MR
398
was 43% (i.e. a relevant stroke lesion was shown by imaging in less than half of
those with a stroke), and the overall accuracy was 48%. In contrast, the sensitivity of
the DWI sequence was almost double that of the CT and the structural MR (82%),
and overall accuracy was 84%.
When (and how) did DWI help?
The DWI image showed a relevant stroke lesion for 69 patients with a
'thrombolysis-eligible' stroke (sensitivity 82%), whilst the structural MR showed a
relevant lesion for 36 patients (sensitivity 43%). The nature of the lesion seen on
DWI in the 33 patients with a normal T2 is shown in Figure 13.24. The most
frequent type of lesion was lacunar (13 patients, 39%, see Figure 13.25), followed
by several discrete lesions in the middle cerebral artery territory (6 patients, 18%, see
Figure 13.26) and an individual small lesion in middle cerebral artery territory (6
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Figure 13.24 Location of the lesion seen on DWI when structural imaging was normal
(n=33)
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Figure 13.25The DWI scan clearly showed lacunar infarcts
PH300: MR at 14 hours 24 minutes. T2 image (left) showed several old lacunar lesions and
a subtle right thalamic/external capsule lesion (arrows), but there was no way of telling that
this was the recent lesion. DWI (right) showed an obvious right hyperintensity (arrow).
Figure 13.26 The DWI scan showed scattered lesions throughout the middle cerebral
territory (not seen on structural MR)
PH354: Presented with a left PACS. MR at 4 hours 49 minutes. T2 image (left) showed
several old lesions in both hemispheres, whilst DWI (middle and right) showed several
scattered high signal lesions in borderzone territory (arrows).
Figure 13.27 The DWI scan showed a small cortical lesion (not seen on structural MR)
PH393 (same patient as in figure 13.7). Patient presented with a weak left hand. MR at 6.5
hours. T2 image (left) shows leukoariosis and old stroke lesions (not shown), whilst the DWI
(right) showed an obvious right parietal hyperintensity (arrow).
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In addition, the DWI was coded as helpful for 19 patients where the structural
imaging also showed an ischaemic lesion. In 11 patients (58%) the DWI confirmed
that a subtle lesion seen on the T2 image was a relevant infarct (see Figure 13.28).
In four patients (21%), the DWI identified the one acute lesion amongst several older
lesions (see Figure 13.29). In the remainder, the DWI was helpful because it
showed several lesions (n=2), confirmed that a haemorrhagic lesion was actually
haemorrhagic transformation of an underlying infarct (n=l), and showed a smaller
lesion than seen on the T2 image (which one might interpret as that reperfusion had
occurred).
Figure 13.28 The DWI scan confirmed that a subtle abnormality seen on T2 was an acute
infarct
PH384: Presented with a right PACS (NIHSS 5). MR at 2hours 49 minutes. T2 image (left,
badly degraded by movement artefact) showed a possible area of increased signal in right
parietal region (arrow), whilst the DWI (middle and right images) showed an obvious
hyperintensity (arrows).
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Figure 13.29 The DWIscan identified an acute lesion amongst several lesions seen on T2
PH246; Presented with left LACS (NIHSS 6). MR performed at 26 hours. The T2 image (left)
showed several high signal lesions (arrows), whilst the DWI (right) showed a single left
frontal hyperintense lesion (arrow)
The DWI scan was of no additional benefit in the identification of
haemorrhage (n=5). When the DWI was normal (21 of 91 patients who had DWI), it
was often difficult to know whether this had been helpful. For those considered to be
a definite non-stroke who had DWI performed (n=4), a normal DWI scan was
reassuring. For the three patients with a final consensus panel diagnosis of possible
stroke, the normal DWI was of little benefit. The DWI was normal in one patient
with a definite TIA (imaged shortly after symptoms resolved completely). The
clinical features were considered strong enough evidence to classify four patients as
definite stroke (one with TACS, three with LACS), and 10 patients as probable
stroke (four with POCS, three with PACS, one with LACS and two unsure), despite
the absence of a DWI lesion.
13.4.7 The impact of advanced imaging on the clinician's diagnosis
91 patients were available for analysis (four aborted the MR due to
claustrophobia, one patient did not have DWI). The 62 patients who had a
contemporaneous CT formed the main analysis group, as data were available for all
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four levels of the diagnostic process (clinical diagnosis, diagnosis after CT, diagnosis
after structural MR, diagnosis after DWI).
There were four clinicians present at the meeting for 11/62 patients (18%),
five were present for 27 patients (44%), six present for 14 patients (23%), and seven
clinicians present for 10 patients (16%). Clinicians provided an opinion on an
average of 42 patients (range 30-58).
Diagnostic certainty
I have plotted percentage certainty at the four levels of the diagnostic process
for each clinician, with each line representing a patient, in Figure 13.30. Several
trends can be distinguished: (1) clinicians were certain about the diagnosis for the
majority of patients after the clinical assessment; (2) the CT scan appeared to
improve certainty more than either form of MR for most patients; (3) for a small
number of patients, the DWI scan increased certainty (for stroke and non-stroke); (4)
some clinicians (e.g. clinician six) appeared to rely on imaging more than others (e.g.
clinician four), and (5) there were many common patients (some are marked by study
number in each graph) who had almost identical lines by each consultant.
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Clinician 1 (n=58)
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Figure 13.30 Impact of brain imaging on diagnostic certainty for all clinicians (only













Common patients: the outliers
The mean diagnostic certainty for patients with a final diagnosis of definite
stroke was 89.4% after the clinical assessment, and increased to 97.5% after all the
imaging. These patients were in the top part of the graph for each clinician. Yet
there were some 'outliers' (marked by study number in each graph). Inspection
reveals that these patients had almost identical lines for each consultant. PH250
presented with abrupt onset of left-sided weakness (NIHSS 8 on examination), but
also had known lung carcinoma. CT showed a solitary high-density lesion, possibly
a metastasis, possibly a meningioma. MR confirmed that the lesion was a
meningioma. The clinicians were uncertain after the clinical assessment, but
convinced after the CT that the diagnosis was non-stroke.
PH360 presented after a probable seizure, with a subtle (and questionable)
focal deficit. Most clinicians felt that stroke was possible based on the clinical
assessment. The nomial CT was a little helpful, but the normal DWI was far more
helpful in reducing the certainty that this event had been a stroke. PH364 presented
with worsening of neurological deficit from a previous stroke; there had also been
symptoms suggesting a chest infection. The CT showed old stroke lesions, but the
DWI was normal. Most clinicians were reassured by this, and certainty of a non-
stroke cause for symptoms increased.
PH373 presented with progressive neurological impairment, and lacked
typical risk factors for stroke. However, CT showed early ischaemic changes, as did
the structural MR and DWI. Clinicians 1 & 7 were around 25% certain after the
clinical assessment, whilst clinicians 3 & 8 were around 66%, with certainty
improving markedly after the CT for two, and after the MR for the remainder.
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PHI45 presented with speech impairment. The previous night, she had a
typical migraine accompanied by visual impairment. On examination, she was
confused, and had slight hesitancy of speech (NIHSS 1). The CT suggested subtle
early ischaemic changes in the left insular cortex, which was confirmed by both
structural MR and DWI. Again, clinicians were uncertain after the clinical
assessment, but convinced after the imaging (although some clinicians were more
convinced by the CT [e.g. clinician 2], and others by the MR [e.g. clinician 4]).
There were 10 patients with mean certainty of less than 70% after the clinical
assessment. After imaging, there was a major change in certainty for six patients
(three towards a diagnosis of stroke, three towards non-stroke). The mean change in
certainty for all ten patients was 21.8%.
Overall change in certainty with each imaging modality
Table 13.12 displays several measures of how imaging changed diagnostic
certainty for the 62 patients who had CT, structural MR and DWI. As anticipated
from visual inspection of the line graphs (Figure 13.30), CT had the greatest impact
on certainty, although the overall effect was modest (3.7%). For 90% of patients, the
CT increased mean certainty. The structural MR conferred a small change in
certainty compared with the CT (1.1%), but for almost 20% of patients mean
certainty was unchanged, and for an equal number of patients, certainty actually
reduced. The addition of DWI changed mean certainty by 2.0%, although the range
was large. For 18% of patients, the DWI made the clinicians less certain, and for
16% of patients the DWI did not change certainty.
Two-way ANOVA tests for the mean change in certainty between clinical
assessment to CT, CT to structural MR, and structural MR to DWI showed that the
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mean variation in certainty for patients was significant (p<0.01 for each test). There
was less variation in certainty for clinicians (p>0.12 for each test), although clinician
two had the greatest mean change in certainty after CT (5.2%), and clinician six had
the greatest change in certainty after MR (2.4% for structural MR, 4.4% for DWI).
Clinician four found DWI the least useful (0.3% change in certainty).
How often were clinicians 100% certain of the diagnosis?
Imaging had a major effect on the number of times clinicians were 100%
certain that the diagnosis was stroke, as shown in Table 13.13. After the clinical
assessment, clinicians (with two exceptions) were completely certain for only a few
patients. After the CT was presented, certainty of 100% increased to between 15-
20% of patients. After the DWI scan, most clinicians were 100% certain of the
diagnosis for 60-70% of the patients. The exceptions were clinicians 4 and 8, who
were convinced by the history more often than the others; and clinician 7, who was
rarely 100% convinced about any patient.
Stroke severity and the impact of imaging on certainty
The impact of imaging on diagnostic certainty when patients were divided by
measures of stroke severity was assessed for all 87 patients who had DWI MR (and
received a final diagnosis of definite, probable, or possible stroke). As this analysis
included patients who did not have CT, the results do not show the additional benefit
of DWI over CT.
When divided into OCSP categories (see Figure 13.31), imaging had the
greatest overall effect on certainty in those with a classification of PACS (mean
increase of 9.1%, from 87.8 to 96.9% certain). When divided into NIHSS categories,
imaging had the greatest effect on certainty in those with NIHSS 1-4 (mean increase
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of 6.7%, from 85.3 to 91.9% certain). There were only four patients with NIHSS of
zero, hence confidence intervals were very wide. Those with NIHSS >10 had a
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Figure 13.31 Stroke severity and the impact of imaging on diagnostic certainty
Includes all patients with a final diagnosis of stroke who underwent MR with DWI (n=87).
The mean change in certainty from clinical assessment to after the DWI is charted on the Y
axis, with OCSP classification on the left halfof the Xaxis, NIHSS category on the right half
ofthe axis. Each bar represents the percentage change (plus 95% confidence intervals).
Did clinical lesion localisation agree with the DWI scan?
Although it increased overall certainty for the diagnosis of stroke, the DWI
scan disagreed with the clinical prediction of lesion localisation in some cases. 69
patients with a visible DWI lesion and a diagnosis of stroke (haemorrhage or infarct)
were analysed. Figure 13.32 demonstrates the number of patients with cortical,
large subcortical, lacunar or brainstem lesions on DWI, divided by OCSP
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classification. Of the 12 patients classed as TACS clinically, all had an appropriate
lesion (one had a striatocapsular infarct). Of those classed as a PACS, 2/32 (6%)
were shown to have had a lacunar infarct by DWI. 7/21 (33%) patients clinically
labelled as lacunar stroke turned out to have a cortical lesion. All four patients
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Clinical prediction of the nature of the lesion (OCSP classification)
Figure 13.32 How often was clinical lesion location proved to be wrong by the DWI scan?
The X-axis is the clinical prediction ofwhere the lesion is, based on the OCSP classification.
The Y axis is the number ofpatients with a lesion seen on imaging, with the actual imaging
result divided into four categories. The clear finding is that 1/3 of those classed as lacunar
syndromes actually had a cortical lesion.
Thus, the DWI scan identified an incorrect clinical classification in 9/69
patients (13%, 95% CI 7-23%). Wrong clinical classifications were most commonly
seen with patients thought to have had a LACS, and rarely seen in those thought to
have had a cortical syndrome (TACS or PACS).
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13.5 Discussion
The present study recruited 96 consecutive patients with features of brain
attack. 30% were scanned within 6 hours of symptom onset, 96% within 48 hours.
Some of the principal findings of this study - the high frequency of normal DWI and
PI scans, the difficulty of detecting acute haemorrhage, and the small overall impact
of MR on diagnostic certainty - are at odds with many earlier studies. Until now,
published reports have concentrated on highly selected patients with severe strokes;
the present study selected a broader range of patients and so included milder strokes.
If the clinician is to determine the potential of advanced imaging in the 'real world',
data from a wide variety of studies are needed.
13.5.1 Is it possible to incorporate advanced imaging techniques into routine
clinical practice?
In Chapter 12, it was established that MR could be difficult for patients,
particularly those with major stroke or co-existing medical conditions. An important
finding was that scanning time should be kept to a minimum. However, even our
briefest scanning protocol kept the patient in the magnet for 21 minutes (median),
even though the sequence time (usually the only figure provided in published
reports) was 9 minutes and 10 seconds.
Could the protocol be shortened?
It is possible to reduce scanning time by dropping sequences, but apart from
changing the DTI (20 minutes) to DWI (1-2 minutes), it is not obvious which other
sequences to drop. Much depends on the impact of sequences on patient
management, which shall be considered in the following chapter. For diagnosis, the
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key sequences were the gradient echo and diffusion-weighted images, but neither
provides good structural detail. The sensitivity of the T2 image, which does provide
good structural and anatomical detail, was no better than CT. Could it be dropped?
This would make ageing of ischaemic lesions far more difficult, and risk missing
tumours, pituitary lesions, leukoaraiosis, atrophy, and abnormalities of
bones/orbits/sinuses altogether.
Extensive processing times
Although the MR produces DWI images on photographic film, these are not
generally suitable for quantitative analysis. The PI images from the scanner are
unsuitable even for visual inspection. If measurement of DWI lesion size, ADC, or
PI parameters is important, then extra processing time needs to be allowed. This can
limit the usefulness of advanced MR in the acute assessment of stroke (Baird &
Warach, 1998).
Despite automated systems designed to analyse images directly from the
scanner, we found that DWI lesion volume could not be measured in 6 patients, ADC
in 10 patients, and PI parameters in 7 patients because of technical reasons. For all
the PI and DWI images, a neuroradiologist needed to trace the boundaries of the
lesion to allow the 'automated' program to run. The image processing time was long
- up to several hours per patient - but important, as illustrated by the exaggerated
size of the perfusion deficit when patient movement was not corrected (Figure 13.1).
Our physicist estimates that a more streamlined procedure could be performed for
clinical purposes, but this would still take around 15-30 minutes per patient (personal
communication, Dr Paul Armitage).
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For the diagnosis of ischaemic stroke in the present study, extensive post¬
processing of the MR data to generate measures of perfusion conferred no additional
benefit. Fewer than half of our patient sample had a lesion on either measure of PI.
Even when present, perfusion abnormalities showed no better correlation with stroke
severity than the DWI. However, PI may have potential use for the management of
acute ischaemic stroke, which shall be considered in the next chapter.
13.5.2 The diagnosis of brain attack
Despite the claims for MR to be the first line imaging investigation in acute
stroke (Lovblad et al., 1998; Prichard & Grossman, 1999; Warach, 2001a), this is
one of only two studies that have prospectively scanned an unselected sample of
patients presenting with stroke-like symptoms (although in the study of Perkins et al
(2001), patients routinely underwent CT brain "within minutes of arrival at the
Emergency Department" so patients with bleeds or tumours were not recruited to
actually determine whether this is true).
The detection of haemorrhage
Acute intracerebral haemorrhage
The present study recruited five patients with an acute ICH. The MR
characteristics of acute haemorrhage (see Figure 13.4) were present consistently, but
the changes seen were often subtle (in comparison to the obvious appearance on CT).
The GRE sequence was the most sensitive image sequence, yet it is not a routine part
of the MR evaluation of patients with acute stroke. The appearance of acute
haemorrhage on DWI was confusing - it appeared as a white blob, just like
ischaemia. With experience, the appearances become obvious (i.e. the black
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[hypointense] serpiginous lines at the margin due to paramagnetic effects and the
overall shape), but it is instructive to note that the first patient scanned with a
hyperacute ICH [PH243] completely flummoxed two experienced neuroradiologists
and me!
Our small series of patients support the findings of Patel et al (1996) and
Schellinger et al (1999), but do not confirm the latter's claim that MRI is as reliable
as CT. More work is required before this claim can be accepted. Our experience
would suggest that clinicians and radiologists will need training to become familiar
with the MR appearances of haemorrhage.
Remote haemorrhage
The GRE sequence also revealed that 13% of old stroke lesions were actually
haemorrhages, and 11% of all patients had cerebral microbleeds. Prior studies have
shown that clinically silent microbleeds occur in 6% of healthy elderly subjects
(Roob et al., 1999), up to 26% of patients with previous ischaemic stroke (Kwa et
al., 1998) and up to 66% of patients with ICH (Roob et al., 2000). Histopathologic
analysis of the regions seen on GRE as microbleeds (in patients with ICH) confirmed
that are deposits of haemosiderin due to bleeding-prone microangiopathy (Fazekas et
al., 1999).
The increased sensitivity of MR to both old ICH and microbleeds has
implications for the management of acute ischaemic stroke. A past history of ICH is
a contraindication to thrombolytic therapy, although as many as 13% of patients
could be inadvertently treated if CT alone is used. The risk of intracranial
haemorrhage from thrombolysis in patients with microbleeds is not known (Tong et
al., 1999), although there has been a recent report of haemorrhage at the site of a
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microbleed following intra-arterial thrombolysis (Kidwell et al., 2002). Similarly,
the complication risk of oral anticoagulants in patients with microbleeds is unknown.
TIAs and non-strokes
Five patients whose final diagnosis was non-stroke were scanned. The two
patients with brain tumours were easily identified by the structural MR, and the
remaining three patients had normal DWI scans. This supports the findings of
Chapter 7: the diagnosis of many stroke mimics is based on clinical features, not
imaging findings. We observed no false positive DWI scans [as has been reported
for partial status epilepticus (Lansberg et al., 1999), transient global amnesia (Strupp
et al., 1998), hypoglycaemia (Hasegawa et al., 1996) and cerebral venous thrombosis
(Doege et al., 2001)]. Interestingly, two patients who presented with vertigo and
normal DWI scans had a posterior fossa perfusion deficit. The final diagnosis was
possible stroke.
Three patients' deficit resolved completely within 24 hours. These patients
were scanned at approximately two, four and nine hours after symptom onset (one
patient's symptoms had resolved by the time of scanning). Two patients showed a
small lacunar hyperintensity on DWI, and the DWI was normal for the other patient
(although the PI scan was abnormal). Several studies have shown that DWI lesions
may be seen in up to 48% of patients with TIA (Kidwell et al., 1999; Engelter et al.,
1999), particularly when the TIA is prolonged. Thus it appears unlikely that DWI
can distinguish between stroke and TIA.
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Acute ischaemic stroke
The clear superiority of DWI was demonstrated in the present study:
sensitivity of DWI was almost twice that of structural MR and CT. The DWI
sequence was well tolerated, and forgiving of patient movement - interpretable
images were obtained for all patients who had it. Another advantage of the DWI
sequence is that ischaemic lesions are usually obvious. Others have shown that the
identification of ischaemia on DWI is more reliable than on CT (Urbach et al., 2000;
Fiebach et al., 2001); Lansberg and colleagues (2000a) found that the image
interpreter felt lesions were more conspicuous with DWI and so had greater
confidence in reporting.
The sensitivity of DWI in the present study (83%) was lower than most
previous studies [e.g. 95% (Perkins et al., 2001), 98% (Oppenheim et al., 2000a),
100% (Urbach et al., 2000)]. The likely explanation for this observation is that our
patient cohort was milder than other studies, and hence DWI is less effective at
detecting small lesions than large cortical lesions. Previous studies selected few
patients, often just those with major hemispheric ischaemia, and the mean NIHSS is
usually much higher [11.8 in one study (Lansberg et al., 2000b) and 15.5 in another
(Tong et al., 1998), compared with our mean NIHSS of 7.0],
This theory is further supported by a comparison of the present study with
that of van Everdingen et al (1998). The latter study, selected because it provided
more clinical details than most, recruited 42 patients with hemispheric ischaemia (see
Table 13.14). The mean/median NIHSS scores were not provided. Lesion location
was lacunar in six patients (14%) cortical or large subcortical in 32 patients (76%),
and no lesion was seen in four patients (10%). Mean lesion volume was higher,
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ADC was lower, and the correlation between stroke severity (NIHSS) and lesion
volume was stronger in van Everdingen's study than in the present study. Further
work is needed to confirm our finding that a change in case-mix towards milder
severity results in weaker associations between DWI and stroke.
13.5.3 The normal DWI scan
21/87 (24%) patients with features of brain attack, and no evidence of
haemorrhage on imaging, had no discernible lesion on DWI. Despite this, 14 - over
60% - were considered by the panel of experts to have had a probable or definite
stroke.
Do other studies report normal (false negative) DWI scans?
The many optimistic reports of 100% sensitivity of DWI (Gonzalez et al.,
1999; Urbach et al., 2000) have been tempered by increasing evidence that false
negative DWI findings in acute stroke are not rare. Ay et al (1999b) found a normal
DWI in 17 of 772 patients (2% false negative rate), Oppenheim et al (2000b) eight of
139 patients (6%), Sunshine et al (2001) seven of 62 patients (11%) scanned within
six hours of onset, and Lovblad et al (1998) 18 of 151 patients (12%). False negative
DWI was more common in brainstem strokes, very small lesions, and those imaged
early. The present study had the highest ever reported frequency of false negative
DWI scans (18/82, 22%).
Sunshine et al (2001) reported that all seven of their patients with a normal
DWI had abnormal PI scans. All patients were scanned within six hours of symptom
onset. Of the patients in the present cohort with normal DWI who had PI (14), an
abnormality was seen on either MTT or CBF maps in five patients (and no
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abnormality was seen in the remaining nine patients). PI was often negative in
patients who were scanned late, had mild symptoms or brainstem strokes - precisely
the patients that were more likely to have a negative DWI scan. Only three of our 14
patients with normal DWI were scanned within six hours of symptoms onset (two
had no PI lesion, and one patient had a PI lesion), so it is possible that these patients
were scanned too late for a PI deficit to still be present. This all seems to suggest
that PI is useful only in the first few hours, and for patients with more severe,
hemispheric strokes.
Why did the present study find so many normal DWI scans?
Was our scanner not sensitive enough?
We used a state of the art, 1.5 tesla MR unit, DWI images were acquired
using echoplanar imaging, using standard techniques, and each image comprised 20
slices of 5mm thickness with 1 mm gap between slices. It is possible that very small
lesions (less than 1mm) were missed, and that brainstem lesions were obscured by
magnetic susceptibility artefact.
Were patients scanned too early?
Other reports have suggested that false-negative DWI is more likely in the
first three to six hours after stroke (Lefkowitz et al., 1999; Oppenheim et al., 2000b;
Sunshine et al., 2001). This has been explained on the basis that early lesions may
not have had hypoperfusion of sufficient severity or duration to result in cell
membrane pump failure (which is thought to cause the DWI hyperintensity). If
scanned serially, the very early patient will eventually show a lesion on DWI (Tong
et al., 1998; Lefkowitz et al., 1999; Oppenheim et al., 2000b).
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However, 13 of our 18 patients with no DWI lesion were scanned after 12
hours. Perhaps the theory that tissue destined for infarction passes through a phase
resulting in increased signal on DWI does not apply to all patients. It may be
possible that there are several pathways from tissue ischaemia to eventual necrosis,
and not all of them result in a bright lesion on DWI. It may be possible that the
belief that a bright DWI lesion is caused by cell membrane pump failure is actually
wrong - definitive proof for the basis of the diffusion abnormality has not yet been
established (Yuh et ai, 1999). Or perhaps, in patients with milder symptoms, tissue
does not reach the membrane failure phase until after 24 hours. This would suggest
the possibility that restoring blood flow might help such patients much later than is
currently believed. Data from the present study could help to stimulate further
investigation into the pathophysiology of cerebral ischaemia.
Was the ADC a more sensitive marker of ischaemia?
Calculating the ADC allows a precise determination of the rate of water
diffusion in and out of cells. Lefkowitz et al (1999) found - in two patients with an
initially normal DWI scan - that the ADC was reduced in the area of the eventual
lesion, suggesting that there may be a certain ADC threshold for lesions to become
obvious on DWI scan. This is an interesting concept, and in future studies we plan to
examine the ADC values of regions of tissue with abnormal perfusion but no DWI
lesion. At present, calculating an ADC is a time-consuming process, and it should be
noted that over half of our patients with no DWI lesion also had no PI lesion, which
would make it almost impossible to determine a region of interest for ADC
calculation at the time the patient presents.
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13.5.4 The clinical impact of advanced imaging
We attempted to determine whether the improved sensitivity of advanced
imaging translated into clinical benefit. Three other groups have examined this
issue. Lansberg et al (2000a) showed that observer's confidence in identifying acute
lesions was greater using DWI than conventional MR; presumably this increased
confidence may impact on the clinician's further investigations and management.
Lutsep et al (1997), in a retrospective review of 103 patients, found that DWI
was superior to standard MR in eight patients. The DWI detected a lesion not seen
on T2 in six patients (two were shown to have a thalamic lacunar infarct, a different
vascular territory to the clinical localisation); and in two, the DWI distinguished new
from old lesions. Albers and colleagues (2000a) found that DWI helped to clarify
the age of the lesion in eight, and demonstrated multiple lesions (suggesting an
embolic source) in five of 40 consecutive patients. The DWI altered clinical lesion
localisation in seven patients (18%): three were thought to have had lacunar strokes
but the DWI showed cortical lesions, three were thought to have had small cortical
lesions but the DWI showed a lacunar lesion, and one patient thought to have had a
brainstem stroke had a cortical lesion on DWI.
In the present study, DWI altered lesion localisation in 13% (primarily
identifying cortical lesions when the clinical classification was lacunar). DWI did
not alter the vascular territory in any of our patients. We also observed that the DWI
could distinguish new lesions from old, and multiple lesions suggesting an embolic
source, in a handful of patients. This has clear implications for the subsequent
investigation and management of the patient.
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The impact on diagnostic certainty
Although making a correct diagnosis is the first aim of the stroke clinician,
and is the rationale for brain imaging, this is the first study to ascertain the impact of
MR on clinician's diagnostic certainty. We designed the study to determine the
additional benefit of MR over and above CT. We showed that across all patients and
clinicians, brain imaging makes a small (but significant) increase in certainty. The
CT scan, when performed first, provides the greatest amount of diagnostic
information for the clinician. This reflects the fact that for most patients, the
diagnosis is almost certain after the clinical assessment alone.
However, DWI was most helpful for the 'difficult' patients: those in whom
the clinician was unsure of the diagnosis, and patients with milder strokes. In a small
number of patients, DWI can make a large difference in certainty. Overall, the
clinician achieves 100% certainty for around 20% of patients with CT, but almost
60% of patients with DWI.
13.5.5 Limitations of the study
There were limitations to the present study. Patients in our sample were
relatively mild (median NIHSS 5), old (median age 74.4), and had a high frequency
of co-existing medical problems. Our cohort was probably rather different to the
types of patients admitted to an academic German (or North American) neurologist-
led stroke unit that seem to be reported in the literature [e.g. (Schellinger et al.,
2000)]. Our study may have found a higher impact of DWI by including milder
stroke patients, because in studies of mainly severe stroke patients, the CT is more
likely to show an abnormality, so reducing the value of a positive DWI. On the other
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hand, our study found more normal DWI and PI scans, and weaker relationships
between imaging and clinical features. To understand this promising diagnostic test
better, it is important that MR is tested on a broad range ofpatients (Powers, 2000).
This study aimed to, and probably succeeded in recruiting a broader spectrum
of patients than other studies reported to date. However, due to funding limitations
we were unable to recruit consecutive patients with brain attack - patients included
were those with a clinical diagnosis of probable or definite stroke. Thus, there was
selection bias in the patients who were recruited to this study, and this could have
influenced the findings (in particular, the sensitivity and utility of DWI).
Although 96 patients were recruited (and 92 patients were scanned), our
sample size was still small. It would have been preferable to include more non-
strokes and haemorrhages to strengthen our observations, but resources were limited.
Despite recruiting and scanning 82 patients with cerebral ischaemia, numbers for the
analysis of calculated parameters (ADC, PI, DWI lesion volume) were diminished
for various technical reasons. However, our sample size was considerably larger
than most previous studies (Keir & Wardlaw, 2000).
Another limitation was that the final diagnosis was made after the panel of
experts had reviewed the CT scan (where there was one), structural MR and DWI
with the neuroradiologist. There was thus the potential for bias. If the clinicians
were convinced that DWI was always abnormal in ischaemic stroke, a positive study
would increase the probability of a positive diagnosis, and so increase the apparent
sensitivity of DWI. This is a problem that has been noted by others (Lovblad et al.,
1998), but in the absence of a true gold standard for the diagnosis of stroke
(D'Olhaberriague et al., 1996), it is difficult to avoid this bias.
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13.6 Summary
• In a less selected and probably milder patient group than other reports, we
found advanced MR provided a small additional amount of clinically
helpful information over and above CT. In a handful of patients, DWI
had a major impact on diagnostic certainty, however for most patients the
CT was adequate.
• A surprisingly large number of ischaemic events had no DWI corollary;
this raises questions about the sensitivity of DWI, and what it is believed
to represent.
• The MR appearance of acute haemorrhage is distinctive but subtle, and
could easily be missed by unfamiliar observers
• The MR appearance of old haemorrhage, best seen on the gradient echo
sequence, can provide information not available on the CT that has
implications for risky treatments such as thrombolysis or anticoagulation.
• For most non-strokes, the MR is likely to be normal - the diagnosis
remains a clinical one
• Extensive image processing to determine DWI lesion volume, ADC and
PI parameters is of limited benefit in the diagnosis of brain attack.
Recommendations for further research:
• The role of MR in patient management needs to be assessed
• We need to determine the ideal imaging protocol
• There should be large, methodologically-sound studies of the reliability of
detecting acute haemorrhage on MRI
425
• We need further investigation into the causes of a normal DWI, and the
sequence of pathophysiological changes as shown by PI and DWI and
structural MR
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Table 13.1 General recruitment details
MR study patients (n=96)
Median age (IQR) 74.4 years (65.1-81.4 yrs)
Male gender 48 (50%)
Median time from onset to examination
(IQR) 9.3 hours (3.1-20.6 hrs)
Onset to examination:
Within 12 hours 52 (54%)
Greater than 12 hours 44 (46%)
Median time from onset to MR (IQR) 13.2 hours (5.2-22.6 hrs)
Table 13.2 Patient demographics in MR study
MR study patients (n=96)
Past history of stroke 37 (39%)
Prior level of function:
Walked independently 93 (97%)




Ischaemic heart disease 24 (25%)
Diabetes 6 (6%)
Atrial fibrillation 24 (25%)
Peripheral vascular disease 15 (16%)
Table 13.3 Clinicalfeatures ofMR study patients
MR study patients (n=96)
Exact onset known* 83 (87%)
Woke from sleep with deficit* 34 (35%)
Nature of symptoms:
Visual loss 12 (13%)
Brainstem symptoms+ 12 (13%)
Speech disturbance 52 (54%)
Sensory symptoms 28 (29%)
Motor symptoms 71 (74%)
Median systolic blood pressure (IQR) 155mmHg (144-178mmHg)
Atrial fibrillation 20 (21%)
Confusion* 16 (20%)
Reduced conscious state 20 (21%)











* exact onset defined as time symptoms first noted (time ofwaking ifawoke with symptoms)
f brainstem symptoms were vertigo, diplopia, or unsteadiness
/confusion was assessable in 79/96patients
Table 13.4 Final diagnosis ofpatients in MR study
Final diagnosis MR study patients
Definite stroke 75 (78%)
Probable stroke 10 (10%)
Definite TIA 3 (3%)
Probable stroke 3 (3%)
Non-stroke 5 (5%)
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Table 13.5 Clinicalfeatures of those with and without a visible lesion on DWI.
Visible lesion on DWI No visible lesion on
(n=64) DWI (n= 8)
Feature Number %) Number %) P*
Median time from onset to 10 hours 4.9-20) 22 hours 6.5-26) .062
MR scanner (IQR)
Median age (IQR) 77 years 67-82) 70 years 62-80) .292
Past history of stroke 27 42) 7 39) .802
Exact onset 56 88) 14 78) .449
Woke from sleep with deficit 22 34) 7 39) .569
Symptoms:
Visual 8 13) 1 6) .676
Speech 38 59) 8 44) .259
Brainstem 5 8) 6 33) .012
Sensory 21 33) 3 17) .183
Motor 52 81) 8 44) .005
Confusion+ 11 28) 3 21) .739
Decreased conscious level 14 22) 2 11) .502
Median NIHSS (IQR) 6.0 4-9) 3.0 1-4) <.001
OCSP classification: <.001
TACS 10 16) 1 6)
PACS 31 48) 3 17)
LACS 19 30) 5 28)
POCS 4 6) 6 33)
Unsure 0 0) 3 17)
Brain side affected:* <.001
Left 37 58) 6 33)
Right 25 39) 4 22)
Brainstem 2 3) 6 33)
* significance determined by Mann-Whitney U test (for continuous variables) andf test or
Fisher's Exact test (for categorical variables)
f confusion not determined in 28 patients
/ side ofbrain affected could not be determined in two patients with no visible lesion
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Table 13.6 OCSP classification and DWI lesion volume
Subgroup with visible
OCSP classification All patients (n=82) DWI lesion (n=64)
TACS (n) 11 10
Mean (mL) 67.3 74.0
Median (mL) 21.0 22.9
Range (mL) 0-269.7 0.9-269.7
PACS (n) 34 31
Mean (mL) 11.7 12.8
Median (mL) 4.9 5.1
Range (mL) 0-68.4 0.1-68.4
LACS (n) 24 19
Mean (mL) 0.8 1.0
Median (mL) 0.4 0.5
Range (mL) 0-5.5 0 1 y\
POCS (n) 10 4
Mean (mL) 1.7 4.3
Median (mL) 0 2.6
Range (mL) 0-11.5 0.4-11.5




P value* <0.001 <0.001
* significancefor the relationship determined by Kruskal-Wallis test
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Table 13.7 Reliability of the observation that there was no relevant PI lesion on either
MTT or CBF maps *
1st reading:
2nd reading: No PI lesion PI Lesion present Total
No PI lesion 22 5 27
PI lesion present 1 40 41
Total 23 45 68
Kappa 0.81 for intra-rater reliability (95% CI
* Observer viewed the PI maps with the DWI
Table 13.8 The two measures ofcerebral perfusion often disagreed
MTT maps:
CBF maps: No lesion Lesion present Total
No lesion 8 9 17
Lesion present 4 20 24
Total 12 29 41
In 8 patients, although a lesion was visible, it could not be measured (see text)
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Table 13.9 Clinicalfeatures ofthose with and without a visible lesion on either PI image
Visible lesion on PI No visible lesion on
(n=45) PI (n=23)
Feature Number (%) Number (%) P*
Median time onset-MR (IQR) 8.9 hours (4.4-19.8) 24.7 hrs (13.5-30.5) .004
Median age (IQR) 74 years (68-80) 72 years (58-82) .851
Past history of stroke 19 (42) 9 (39) .806
Exact onset 38 (84) 20 (87) .782
Woke from sleep with deficit 17 (38) 5 (22) .333
Symptoms:
Visual 7 (16) 1 (4) .250
Speech 26 (58) 9 (39) .145
Brainstem 6 (13) 4 (17) .724
Sensory 12 (27) 10 (44) .161
Motor 34 (76) 16 (70) .596
Decreased conscious level 11 (24) 1 (4) .048
Median NIHSS (IQR) 7.0 (4-9) 4.0 (2-5) .001
OCSP classification: <.001
TACS 8 (18) 0 (0)
PACS 24 (53) 3 (13)
LACS 7 (16) 14 (61)
POCS 4 (9) 5 (22)
Brain side affected:+ .040
Left 28 (62) 7 (30)
Right 14 (31) 10 (44)
Brainstem 2 (4) 5 (22)
Final diagnosis: .029
Definite stroke 40 (89%) 14 (61%)
Probable stroke 2 (4%) 6 (26%)
TIA 1 (2%) 2 (9%)
Possible stroke 2 (4%) 1 (4%)
No DWI lesion present 5 (11) 9 (39) .007
Median DWI lesion volume 4.7 (0.8-12.6) 0.2 (0-0.5) <.001
(mL)
* significance determined by Mann-Whitney U test (for continuous variables) andf test or
Fisher's Exact test (for categorical variables)
f side ofbrain affected could not be determined in two patients with no visible lesion
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Table 13.10 OCSP classification and PI lesion volume
OCSP classification MTT maps (n=68) CBF maps (n=68)
TACS (n=8)
Mean (mL) 189 140
Median (mL) 226 123
Range (mL) 0-359 0-342
PACS (n=27)
Mean (mL) 45 14
Median (mL) 0.6 0
Range (mL) 0-258 0-101
LACS (n=21)
Mean (mL) 9.4 1.6
Median (mL) 0 0
Range (mL) 0-103 0-18
POCS (n=9)
Mean (mL) 18 5.6
Median (mL) 0 0
Range (mL) 0-135 0-37
P value* <0.001 <0.001
* significancefor the relationship determined by Kruskal-Wallis test
Table 13.11 Accuracy of CT, structural MR and DWI brain imaging for the detection ofa
relevant stroke lesion
CT brain (n=62)* Structural MR (n=92) DWI (n=91)+
Feature (95% CI) (95% CI) (95% CI)
Sensitivity 43% (31-56) 43% (33-54) 82% (73-89)
Specificity 100% (57-100) 100% (68-100) 100% (65-100)
PPV 100% (86-100) 100% (90-100) 100% (95-100)
NPV 14% (6-28) 14% (7-26) 32% (16-53)
Accuracy 48% (36-60) 48% (38-58) 84% (75-90)
* 62 patients had both CT and MR at the same time
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Table 13.13 How often clinicians were 100% certain in their diagnosis
Number of times clinician was 100% certain that the diagnosis
was stroke, after:
Clinical
Clinician (n)* assessment CT Structural MR DWI
1 82 1 (1%) 12 (15%) 23 (28%) 52 (63%)
2 64 3 (5%) 20 (31%) 33 (52%) 47 (73%)
3 54 3 (6%) 10 (19%) 16 (30%) 38 (70%)
4 40 1 (18%) 11 (28%) 18 (45%) 24 (60%)
5 41 3 (7%) 8 (20%) 8 (20%) 22 (54%)
6 84 0 (0%) 7 (8%) 20 (24%) 60 (71%)
7 52 2 (4%) 2 (4%) 2 (4%) 4 (8%)
8 63 13 (21%) 12 (19%) 23 (37%) 41 (65%)
* number ofpatients for whom each clinician made a diagnosis
Table 13.14 DWIfor the detection of ischaemic stroke: a
study and that ofvan Everdingen et al.
comparison between the present
van Everdingen et al Present study
Number of patients 42 82






Cortical/large subcortical 32 (76%) 48 (59%)
Lacunar 6 (14%) 14(17%)
Brainstem 0 (0%) 2 (2%)
No lesion 4 (10%) 18 (22%)
Sensitivity of DWI 90% 83%
Mean DWI lesion volume (range) 33mL (0-200) 14.3mL (0-269.7)
Mean ADCr in lesion 0.73 0.80*
Spearman rho correlation between initial
NIHSS and DWI lesion volume (rs) 0.63 0.55f
* ADCr not measured in 10patients, those with no DWI lesion (18) allocated ADCr of 1.00
f this figure includes all 82 patients
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Chapter 14 : Can MR assist in patient management?
14.1 Introduction
In this final chapter I shall examine how MR may assist the clinician in the
management of a patient with brain attack. The first half is devoted to the potential
of diffusion-weighted and perfusion imaging in acute ischaemic stroke: could these
techniques be used to define the onset of symptoms, predict outcome, or select
appropriate patients for treatment? In the second half of the chapter I will examine
the additional impact of structural MR and DWI on current patient management.
14.2 Aims
(1) To determine if MR imaging parameters could be used as a surrogate
marker of the time from symptom onset.
(2) To determine if the features seen on diffusion imaging might predict
outcome from acute ischaemic stroke (and so guide treatment)
A) Does DWI lesion volume predict outcome?
B) Can a recently proposed predictive model for stroke recovery that
incorporates DWI lesion volume be independently validated?
(3) How often does a DWI-PI mismatch occur; if absent, why; if present, did
it predict a worse outcome?





The analyses contained in this chapter were performed on patients recruited
into the brain imaging study described in Chapter 13. Procedures for determining
patient eligibility, the clinical assessment, performance of other investigations, and
determining the final diagnosis were exactly the same as already described.
Assessment of outcome
Outcome was assessed by modified Rankin Score (mRS) determined at (no
sooner than) three months. Death was coded as mRS 6. After ascertaining that the
patient was still alive (by hospital records and contact with the general practitioner),
the majority of patients were followed-up by telephone. Patients who agreed to
undergo sequential imaging were assessed at their final out-patient visit by the
research fellow (PJH).
14.3.2 Scanning
The MR sequences were described in the last chapter. Patients received
structural imaging - a gradient echo (GRE) and T2 sequence - and 'advanced'
imaging - diffusion-weighted (DWI) and perfusion imaging (PI). The analysis of the
PI data used mean transit time (MTT) and cerebral blood flow (CBF) maps.
All patients were to undergo an ultrasound examination of the extracranial
carotid and vertebral arteries, either at the time of imaging or subsequently.
Methodology particular to the aims of this chapter will be covered below.
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The age of the DWI lesion
The neuroradiologist was asked to estimate the age of the lesion seen on
DWI. Lesions were categorised as no older than six hours, at least six hours but no
more than 12 hours old, and at least 12 hours old. The neuroradiologist judged the
age of a DWI lesion by its degree of brightness, how well-defined the margins of the
lesion were, and whether a lesion was present on the T2 image. The MR-based
estimation of lesion age was compared with the time of stroke onset given by the
patient.
The apparent diffusion coefficient (ADC) may provide information that could
determine age of the lesion. Several groups have analysed the timecourse of the
ADC after stroke (Lutsep et al., 1997; Schlaug et al., 1997; Schwamm et al., 1998;
Fiebach et al., 2002). Typically, relative ADC values are reduced at the time of the
first MR examination, and then continue to fall, reaching a nadir at 12-24 hours.
Thereafter, ADC values begin to rise, returning to normal by around four days. In
the present study, a scatterplot of ADC versus time was constructed, and a regression
line fitted to look for trends. Patients with outlying results were analysed
individually.
DWI parameters and outcome
The methods used to calculate DWI lesion volume and ADC were described
in Chapter 13. In the present study, univariate and multivariate analyses (see
Statistics, below) were performed to determine if DWI lesion volume or ADC was
capable of predicting outcome.
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Determining the presence of a DWI-PI mismatch
The measures of perfusion that were used in the present study were mean
transit time (MTT) and cerebral blood flow (CBF). The process of generating these
maps from the raw data was described in Chapter 13. The neuroradiologist
examined the PI maps at two sittings. At the first, the presence of a mismatch was
determined by visual inspection of the DWI and PI images. This was designed to
simulate the clinical requirement for a rapid decision to guide treatment (and will be
the primary analysis of mismatch in the present study).
MTT and CBF maps were analysed and coded separately. We defined
mismatch as a focal region of perfusion abnormality that appeared 20% or more
greater in volume than the DWI lesion. This is the same definition that has been
used by others (Warach et al., 2000; Schellinger et al., 2001). Images were coded as:
large mismatch present (PI>DWI in excess of 20%, including patients with no DWI
lesion); mismatch present (PI>DWI of about 20%); no mismatch - PI=DWI, and no
mismatch - PI<DWI (including patients with no PI lesion). The neuroradiologist
interpreted the images blind to all patient details.
A second reading was required to mark any visible focal areas of reduced
perfusion so that the PI lesion volumes could be measured on a computer workstation
(the same process as for measuring DWI lesion volume, described in Chapter 13).
The regions of interest were not marked at the same sitting as the determination of
mismatch because we wanted the latter to be as quick as possible (to be clinically
realistic). The data obtained from the formal lesion volume analysis were compared
with the qualitative visual inspection in a secondary analysis. The 'calculated
mismatch' (as opposed to the mismatch determined by visual inspection) was defined
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as a ratio of PI lesion volume: DWI lesion volume greater than or equal to 1.2. No
mismatch was divided into PI=DWI (ratio greater than 0.8 and less than 1.2) and
PI<DWI (ratio less than or equal to 0.8). Patients with a PI lesion but no DWI lesion
were arbitrarily assigned a DWI volume of l.OmL for calculation of the ratio.
Finally, the volume of perfusion abnormality greater than the diffusion abnormality
(thought to represent the ischaemic penumbra) was determined by subtracting DWI
lesion volume from the PI lesion (where a mismatch existed).
14.3.3 Influence of advanced imaging on current management strategies
sub-study
This sub-study aimed to determine how often - and why - MR imaging
changed patient management, compared with CT imaging. A panel of clinicians was
asked their opinion about a series of hypothetical management scenarios, using the
clinical details and imaging findings of patients recruited. A brief standardised
summary of the patient's clinical details was provided by the research fellow (PJH),
the brain scans were shown with any abnormality demonstrated by the
neuroradiologist (JMW), and the panel recorded their answers to six questions on a
data form (see Appendix 11). The presentation of the imaging followed the same
order for every patient: CT brain scan first, then structural MR, then DWI. CT
therefore served as the baseline against which changes were measured. Decisions
were cumulative, as the scans for each patient were viewed at the one setting.
It was decided to use hypothetical management scenarios, as relatively few
actual management decisions are made on the majority of patients. Most present
outside the time window for thrombolysis, most are in sinus rhythm and are not
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candidates for long-term anticoagulation, and most do not have a severe carotid
stenosis; thus the number of patients whose management could actually be
influenced by imaging is tiny. By using the basic clinical details of each patient (e.g.
sudden onset right sided weakness, TACS on examination), and asking the clinician
to assume that the other important factors were satisfied depending on the question
(e.g. presented at two hours, in atrial fibrillation etc), it was possible to use every
patient to determine how imaging might affect management.
The scenarios chosen (see Appendix 11) reflect the range of therapeutic
options available to the stroke physician. At present, acute management of the
patient with stroke may involve reversal of anticoagulation if a haemorrhage, or
treating ischaemic stroke with intravenous thrombolysis (either open-label, or as part
of a clinical trial). [NB. The Department of Clinical Neurosciences are conducting
the Third International Stroke Trial, a randomised controlled trial of intravenous
thrombolysis for ischaemic stroke (treatment may be given up to six hours from
onset)]. Secondary prevention of further stroke may involve consideration of long-
term anticoagulation, carotid endarterectomy or altering antiplatelet therapy.
To be eligible for the study, it was therefore necessary that the patient had
both CT and MR examinations. The patients were recruited to the MR imaging of
brain attack study, as was described in Chapter 13. The present study was
performed months after the consensus panel and influence of imaging on the
diagnosis meetings. To ensure that clinicians were blind to the patient's actual
identity, only patient number was used, and no identifying details were used in the
brief clinical detail given. Meetings were conducted when at least four clinicians
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Descriptive statistics were used to look for, and test the significance of,
relationships and correlations. The data were initially checked for a Normal
distribution. This was not present, so standard non-parametric tests were used
throughout. I used the NIHSS and Oxfordshire Community Stroke Project (OCSP)
classification as the main markers of stroke severity and type. Outcome was
dichotomised to 'good', mRS 0-2 (independent), or 'poor', mRS 3-6 (dependent or
dead).
Validation ofa proposed predictive modelfor stroke recovery that used DWI
lesion volume
Recently, a three item model for the prediction of outcome after stroke has
been proposed (Baird et al., 2001). Logistic regression identified three
independently predictive variables (DWI lesion volume, NIHSS score, and time from
onset to MR scanning), and recursive partitioning was used to categorise the three
variables (to provide optimum discrimination between good and poor recovery), and
assign points for each category. The total score was the sum of points for each
variable, and could range from zero to seven points. 0-2 points indicated a low
probability of recovery, 3-4 points a medium probability, and 5-7 points a high
probability of recovery (Baird et al., 2001).
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To validate the model, I performed a multivariable logistic regression
analysis using the same variables originally entered by Baird and colleagues (except
'participation in a drug trial', as this was not relevant in our cohort). I entered seven
variables to ensure that my model faithfully replicated that described by Baird et al,
even though this was in excess of the ideal events per variable rate [which indicated
that only three variables should have been entered in Baird et al's model to avoid
overfitting of the model to the dataset (Peduzzi et al., 1996)]. I was unable to
perform recursive partitioning to derive categories (and hence points) for the
variables selected in my model. Instead, I assigned points and a total score as
described in the three-item model, and tabulated the predicted and observed outcome
to determine if the model accurately predicted outcome in our patient cohort.
Mismatch
The neuroradiologist classified patients' scans based on visual inspection of
the MTT map and DWI scan (designed to replicate the clinical situation). Patients
either had a mismatch - where the PI lesion was greater than the DWI lesion (or
there was no DWI lesion), or had no mismatch - where the DWI lesion was equal to
or larger than the PI lesion (or there was no PI lesion). Standard non-parametric
statistical tests were used to assess the significance of differences between the two
groups. In addition, the results of visual inspection were compared with the
calculated lesion volume results to determine if there were differences between the
two methods.
The impact ofMR on patient management
Analyses were kept simple, as the main purpose of the study was descriptive.
The frequency of management changes in total, and the number of patients affected
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by management changes, was assessed for each clinician, and a mean calculated.
The nature of the management change, and the imaging findings that prompted the
change, were described.
Statistical packages
Data analyses were performed using Microsoft Excel (version 97 SR-2,
®Microsoft Corporation 1997), Confidence Interval Analysis (version 2.0.0, ®Trevor
Bryant 2000) and SPSS for Windows (version 10.0.5, ®SPSS Inc. 1999). Logistic
regression models were developed using forward stepwise selection of variables,




The analyses reported in this chapter were performed on patients recruited
into the brain attack imaging study (reported in the last chapter). 96 patients were
recruited in total. 82 patients had cerebral ischaemia, and were the subject of the
present analyses of determining time from symptom onset by lesion age, DWI
parameters and outcome, and the frequency and implications of a DWI-PI mismatch.
63 patients (of the 96) received CT at around the same time as MR, and were the
subjects of the analysis of the impact of imaging on patient management.
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Final diagnosis and outcome
The final diagnosis was definite or probable stroke in 85/96 (88%) of patients
recruited, TIA in 3/96 (3%), possible stroke in 3/96 (3%) and definite non-stroke in
5/96 (5%) (see Table 13.4).
Outcome data were available for all but one patient (this patient had no
telephone, no fixed address, and attempts to contact his mother and brother were
unsuccessful). At three months, 14/95 patients (15%) had died, 34/95 (36%) were
dependent (mRS 3-5), and 47/95 (49%) had a good outcome (mRS 0-2). 51% were
therefore dead or dependent (poor outcome).
14.4.2 Could MR be used as a surrogate marker for time of symptom onset?
Using DWI to estimate the age of the lesion
The age of the lesion based on its MR appearances was estimated in the 64
patients who had a visible lesion on DWI (if the scan were normal, it was not
possible to determine age of lesion). A precise time of onset was known for 35/64
patients (53%). Onset details were unclear in 29 patients: 21 (33% of the total)
awoke from sleep with the deficit, and 8 (13%) whose onset had to be estimated
(usually because the patient lived alone and was aphasic on presentation). The MR-
estimated age of the lesion was compared to the precisely known age of the lesion.
Table 14.1 shows the estimates of lesion age based on MR appearance
against the 'true' age (which has been split into three categories to facilitate
comparison). The MR estimate of age was correct in 17/35 patients (49%, 95% CI
33-64%). The positive predictive value of a MR-estimated age of less than six hours
was 4/8 (50%, 95% CI 22-79%), whilst it was 11/14 (79%, 95% CI 52-92%) for an
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MR-estimated age of greater than 12 hours. Only 4/11 patients (36%, 95% CI 15-
65%) who presented within six hours of onset had a correct estimation of lesion age
by MR. If dichotomised to age within six hours and greater than six hours - which
reflects possible clinical requirements - then the sensitivity of the MR assessment of
lesion age less than six hours was 36% (95% CI 15-65%), and the specificity was
83% (95% CI 64-93%).
To explore why the MR timing of lesion age differed from the 'true' age (the
precise time symptoms were first noted), the five extreme 'outliers' of Table 14.1 are
considered in more detail. Two patients [PH362, PH363] presented within six hours
but were classed as greater than twelve hours by MR appearances. PH362 presented
with a moderately severe clinical syndrome (classed as a PACS, NIHSS 17), and was
scanned at 5.7 hours. DWI lesion volume was 68mL, and the T2 images showed
increased signal, suggesting a lesion at least 12 hours old (see Figure 14.1). In
contrast, PH363 presented with a moderate syndrome (PACS, NIHSS 9). At 4.3
hours, the scan showed a smaller lesion volume of 5mL, but there was increased
signal on the T2 images (again suggesting older lesion age).
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Figure 14.1 The lesion appeared older than it was.
PH362; presented with a PACS, scanned at 5 hours 42 minutes. DWI image (left) shows a
mature hyperintensity in the left temporal region (with a second small right temporal
hyperintensity). T2 image (right, degraded by movement artefact) shows early increased
signal (arrow). Age of lesion estimated as greater than 12 hours.
Three patients [PH342, PH352, PH386] were scanned after 12 hours but the
lesion was classed as within six hours based on the MR appearances. PH342
presented with symptoms suggesting a lacunar stroke (NIHSS 5), the DWI lesion
measured 1.4mL, and the T2 images showed no increased signal. PH352 presented
with more severe symptoms suggesting a TACS (NIHSS 9), yet the DWI scan
showed a striatocapsular infarct with haemorrhagic transformation (see Figure 13.5).
PH386 presented with symptoms of a PACS (NIHSS 8) and was randomised into the
IST-3. By the time of scanning, the patient had improved significantly, and the DWI
showed a subtle lesion (0.4mL) that appeared much younger than it actually was (see
Figure 14.2).
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Figure 14.2 The lesion appeared younger than it was.
PH386.'77ns patient presented with a PACS and was randomised into 1ST-3 (unknown
whether placebo or thrombolysis was given). Scanned at 14 hours 35 minutes. DWI image
(left) shows a small increased signal lesion (arrow) corresponding to very subtle increased
signal on T2 (arrow, right image). Age oflesion estimated to be less than six hours.
Thus there were explanations for the individual variations seen, but no
uniform features that suggested why some lesions looked a different age on the scan
to their real age.
Was there a correlation between ADC and time from symptom onset to
scanning?
The relationship between time from symptom onset to scanning and ADC
was explored in 52 patients (see Figure 14.3). There was a suggestion of a 'J' curve,
with ADC values reaching a nadir at around 15-20 hours, then rising again. Clearly
numbers were too small to make any firm conclusions [and the latter part of the
curve (that actually dips down again) was composed of five patients who were
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Figure 14.3 The relationship between ADCr and timefrom symptom onset to scanning
Each point represents a single patient; the central curved line represents the line offit
(determined by cubic regression) and the surrounding lines represent the 95% confidence
intervals for the line offit.
Outliers (see textfor discussion): *PH398; fPH367; iPH274; §PH230; \PH257
There were several outlying patients who need further exploration to
understand the utility of ADC in timing the age of the lesion. Patient [PH398] had a
mean ADC of 1.16 in the lesion, yet was scanned 3 hours after symptoms onset. An
ADC greater than one suggests that diffusion in the affected area is actually greater
than in the opposite hemisphere, normal brain tissue. ADC >1 might be expected in
the subacute to chronic ischaemic lesions. PH398 had awoken at 7.30am, then
walked to his GP's surgery for a routine visit. Whilst in the waiting room he
developed left sided weakness and visual loss. In the acute receiving unit (ARU), he
had a gross left hemianopia, mild-moderate hemiparesis and neglect (NIHSS 7),
consistent with a posterior cerebral artery territory infarct. The early DWI scan is
shown in Figure 14.4. His neurological state deteriorated (NIHSS 13 the following
day), and a repeat DWI at 4 days showed a very obvious lesion. The other patient
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with an abnormally high ADC [PH367] was scanned at 4.5 hours, but had woken
with symptoms and was last completely intact 10.5 hours earlier. Her signs
suggested a right PACS (NIHSS 7).
Figure 14.4 A patient with an abnormally high ADC when scanned 3 hours after onset of
symptoms
DWI at 3 hours (left scan) showed a subtle hyperintense lesion in the right occipital lobe.
Repeat DWI at 4 days (right scan) showed an obvious hyperintensity involving occipital lobe
and cerebral peduncle.
Three patients had very low ADC despite being scanned soon after symptom
onset. Lowest ADC values usually occur 12 to 24 hours after symptom onset.
Patient [PH274] was scanned at 6 hours and 45 minutes, but had woken with the
deficit, and was last normal 9 hours earlier. Patient [PH230] was scanned at 13
hours; onset was precise, but the patient had suffered a major stroke (NIHSS 21).
Patient [PH257] was scanned 16.5 hours after symptom onset; whilst onset was
precise, the stroke was massive (NIHSS 28). Thus an extreme ADC value was often
seen in patients with an unclear time of onset or very severe stroke.
14.4.3 The DWI scan and outcome after ischaemic stroke
Analyses were performed on the 82 patients with ischaemic stroke, less one
patient in whom follow-up data were unavailable.
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Clinical predictors of outcome
There were several potent clinical predictors of outcome: NIHSS, OCSP
classification, reduced conscious level, age and cognitive impairment (p<0.03 for all)
(see Table 14.2). Increasing age, more severe stroke and prior dementia predicted a
poor outcome (modified Rankin score three to five or death).
DWI lesion volume and ADCr
Imaging features and outcome are detailed in Table 14.2. There was a non¬
significant trend for patients with poor outcomes to present to hospital and be
scanned earlier (p=0.11). 7/18 (39%) patients with no visible lesion on DWI had
poor functional outcome.
There was no statistically significant relationship between outcome and DWI
lesion volume, but inspection of Figure 14.5 demonstrates that those with poor
outcome tended to have larger lesions (but the overall relationship was dominated by
the preponderance of small DWI lesions). Even when those with no visible DWI
lesion were excluded, there was still no significant association between DWI lesion
volume and outcome - median lesion volume was 4.0mL (IQR 0.5-8.1) for those
with good outcome, and median lesion volume was 4.2mL (IQR 0.8-33.9) for those
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Figure 14.5 Box-and-whisker plot of DWI lesion volume subdivided by good outcome
(n=43) andpoor outcome (n=38)
The black horizontal line in each box represents the median, with the boxes representing the
interquartile range, and the whiskers represent the maximum. Outliers are recorded
individually (the two extreme outliers, both in the poor outcome category, are not pictured)
There was no relationship between ADCr and outcome in the 51 patients with
both ADCr and outcome data (Table 14.2). This group included only those with a
visible DWI abnormality (to permit the calculation of the ADCr).
Validation of the three-item model for the early prediction of stroke
recovery
The data from the present study were used to independently validate the
recently proposed 'three-item scale for the early prediction of stroke recovery' (Baird
et al., 2001). The clinical features of the present cohort differed from the training
dataset that developed the model (Boston patients). Our patients were slightly older
(mean age 72.3 years, vs 69.6 years for Boston patients), the frequency of heart
disease was lower (25% vs 46%), the NIHSS scores were lower (mean 7.0 vs 10.5),
time to scanning was longer (mean 15.7 hours vs 9.7 hours), and DWI lesion





not Normally distributed (and it would appear that neither were the Boston data),
statistical tests comparing means for the two groups would have produced spurious
results and were therefore not performed.]
Multivariable logistic regression analysis
Age, gender, history of hypertension, history of heart disease, time to
scanning, NIHSS score and DWI lesion volume were entered into the logistic
regression analysis. Age and NIHSS score were the only significant factors in the
model (see Table 14.3). With increasing age or stroke severity, the likelihood of a
good outcome diminished. The sensitivity of my model for the prediction of a good
outcome was 0.86, the specificity was 0.61, and overall accuracy of the model's
predictions was 0.74. The model fitted the dataset well (Hosmer and Lemeshow
statistic p=0.61). The other variables - including DWI lesion volume and time from
onset to scanning - provided no additional prognostic information and were
eliminated from the model.
Did the model accurately predict outcome in the present study?
Although multivariable analysis demonstrated that time and DWI lesion
volume were not independent predictors of outcome in the present study, the
accuracy of Baird et al's (2001) three-item scale was assessed by determining a score
for each patient (as indicated by Baird et al). 43 patients were assigned a high total
score (5-7 points). Baird et al's model predicted a 91% likelihood of good recovery,
but only 58% of our patients actually made a good recovery (Table 14.4). The
difference between predicted and observed recovery was significant (p<0.01,
Fisher's exact test).
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30 patients were assigned a medium total score (3-4 points), and - as
predicted - around half (57%) recovered. Only nine patients received a low total
score. Two (22%) recovered, compared with the predicted 7% recovery, but
confidence intervals were wide and the difference was not significant (p=0.60) due to
low numbers.
14.4.4 PI and outcome
68 patients had perfusion imaging, and functional outcome was assessed for
all but one patient. 40 patients had a good outcome, and 27 had a poor outcome.
There were 22 patients with no visible PI lesion; 14 of the 22 (64%) were
independent, and 8/22 (36%) were dead or dependent at follow-up (p=0.65, %2).
Median MTT lesion volume for those with a poor outcome was 0.6mL (IQR 0 -
134.1mL), and for those with a good outcome it was OmL (IQR 0 - 17.1mL)(p=0.08,
Mann-Whitney U). There was no significant difference in CBF lesion volume
between those with good and poor outcomes (median volume OmL for both, p=0.30,
Mann-Whitney U).
When patients with no visible PI lesion were excluded, the results became
clearer. There were 29 patients with a visible lesion on MTT maps. Median lesion
volume was 120mL for those who did poorly (n=14), and 20.5mL for the 15 who did
well (p=0.04, Mann-Whitney U). Clinically, median NIHSS was 11 in the poor
outcome group and 5 in the good outcome group (p<0.01, Mann-Whitney U).
Similarly, for the CBF maps (24 patients with a visible lesion), those with good
outcome (n=13) had lower median NIHSS (6 vs 11, p<0.01, Mann-Whitney U), but
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only a trend for lower median lesion volume (21mL vs 67mL, p=0.15, Mann-
Whitney U).
The presence of hyperaemia was detected in seven patients on the CBF map
(see Figure 13.17 in previous chapter for an example). Three were scanned within
six hours, one was scanned at seven hours, and the other three were scanned after 12
hours. Five of seven (71%) patients with hyperaemia had a good outcome.
14.4.5 Did DWI-PI mismatch predict outcome after ischaemic stroke?
It was not possible to determine the presence of a mismatch if there were no
DWI lesion and PI lesion. This combination occurred in eight patients using MTT
maps, and 11/68 patients using CBF maps (the two measures of perfusion used in
this study often conflicted, as described in the last chapter, Table 13.7).
Mismatch determined by visual inspection of the images
MTT maps
The neuroradiologist classified patients based on a brief visual inspection of
the MTT map and DWI scan (designed to replicate the clinical situation). Patients
either had a mismatch - where the PI lesion was greater than the DWI lesion (or
there was no DWI lesion), or had no mismatch - where the DWI lesion was equal to
or larger than the PI lesion (or there was no PI lesion).
Of the 60 classifiable patients using MTT maps, 25 (42%) had a mismatch,
and 35 (58%) did not. The clinical features of patients in the two categories are
detailed in Table 14.5. There were no significant differences between the two
groups, although there was a trend for patients with a mismatch to be scanned earlier,
have more severe strokes (higher NIHSS and more TACS), and larger DWI lesion
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volume. Outcome data were available for 59 /60 patients. As shown in Figure 14.6,
52% of those with a mismatch were either dead or dependent, whilst 32% of those
without a mismatch were dead or dependent at follow-up (p=0.13, x )• The presence













Figure 14.6 Outcome according to visual inspection of the DWI and MTT-PI scans (n=59)
Within the mismatch category were several subcategories. 16 patients had a
large mismatch, with the perfusion deficit considerably larger than the DWI lesion
(see Figure 14.7 - 14.9), In this group, median NIHSS was 8.0, and 9/16 (56%)
were dead or dependent at follow-up. Four patients were thought to have a smaller
mismatch (PI approximately 20% greater volume than DWI, see Figure 14.10):
median NIHSS 6.5, and 2/4 (50%) dead or dependent. Five patients had no visible
DWI lesion but had a PI abnormality (see Figure 14.11): median NIHSS 1.0, and 2/5
(40%) dead or dependent at follow-up.
Patients without a mismatch had either a matching perfusion and diffusion
deficit (n=13) or a perfusion lesion that was smaller than the DWI lesion (n=21).
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Those with a matching deficit (see Figure 14.12) had a median NIHSS of 7.0, and
3/13 (23%) were dead or dependent. Those with a smaller perfusion lesion (see
Figure 14.13) or no perfusion lesion (see Figure 14.14) had a median NIHSS of 4.0,
and at follow-up 8/21 (38%) were dead or dependent.
CBF maps
Of the 57 classifiable patients using CBF maps, only 10 (18%) had a
mismatch. The clinical features of this group are detailed in Table 14.6. There was
a non-significant trend for patients with a mismatch to be scanned earlier, have
higher NIHSS and fewer lacunar syndromes than patients without a mismatch.
Lesion volume on DWI was almost identical. Outcome data were available for 56/57
patients. 4/10 (40%) of those with a mismatch, and 19/46 (41.3%) of those without a
mismatch were dead or dependent at follow-up (p=0.94, Fisher's exact). The
presence of a mismatch with the CBF map did not predict outcome (odds ratio for a
poor outcome 0.9, 95% CI 0.2-3.8).
Disparity between the findings of the CBF and MTT maps was frequently
observed. In addition to the ten patients with a mismatch on CBF, there were 12
patients who had a mismatch on MTT maps (but not on CBF) - see Figures 14.8 &
14.9.
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Figure 14.7 A large PI-DWI mismatch
PH384: This patient presented with leftface and arm weakness and visual loss (NIHSS 5).
MR at 2.82 hours. DWI (upper row ofimages) shows a right temporal hyperintensity
(middle cerebral artery territory). CBF map (middle row) shows a moderately large focal
area ofreducedperfusion (blue) in the right temporal lobe. MTT map (lower row) shows an
extensive area ofreduced perfusion (red = delayed transit) in the right temporal and
parietal lobes. Both maps were classed as showing a mismatch (PI>DWI).
Figure 14.8 A large mismatch on MTT but small CBF lesion
PH399: This patient presented with left hemiplegia, hemianopia andprofound neglect
(NIHSS 15). MR at 4.43hours. DWI (top row of images) showed a right parietal
hyperintensity; CBF map (middle row) showed a matchingfocal area ofreducedflow, and
the MTT map (lower row) showed a much larger area ofdelayed transit.
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Figure 14.9 A large mismatch on MTT but no CBF lesion
PH305: This patient presented with a left TACS (NIHSS 23). MR at 2.5hours. DWI (upper
row of images) shows a large hyperintense lesion in left middle cerebral artery territory.
CBF maps (middle row) show slight reduction offlow in the same territory, but the MTT
maps (lower row) show marked delayed transit in a larger area than the corresponding DWI
lesion. Patient died on day 13.
Figure 14.10 A patient with a small mismatch (PI around 20% greater than DWI)
PHI88: This patient presented with right sided weakness (NIHSS 8). MR at 9 hours. The
DWI (upper row of images) shows a leftfrontal hyperintensity (arrows). The CBF maps
(middle row) show a slightly largerfocal area ofreducedflow (arrows, but the MTT maps
(lower row) are subtle.
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Figure 14.11 A patient with a visible PI lesion but no DWI lesion
PH293: This patient presented with a three hour episode ofaphasia, which resolvedjust
before imaging (at 3.9hours). The DWI scan and CBF map show no lesion, but the MTT
map shows a focal area of increased transit in the left temporal lobe consistent with acute
ischaemia
DWI rCBF rMTT
Figure 14.12 A patient with a matched PI and DWI deficit
PH367: This patient presented with left sided weakness and inattention (NIHSS 7). MR at
4.8 hours. DWI shows a hyperintense lesion in the distribution ofa branch of the right
middle cerebral artery. CBF map shows reducedflow matching the DWI lesion. The MTT
map shows possible increased transit throughout most of the right hemisphere
Figure 14.13 A patient with a smaller PI lesion than DWI lesion
PH257: This patient presented with aphasia, right hemianopia and hemiplegia (NIHSS 28).
MR at 16.6 hours. The DWI image shows extensive left hemispheric hyperintensity with
haemorrhagic transformation posteriorly (arrow). The PI maps show a much smaller area
offocal reduced bloodflow. The area ofhaemorrhagic transformation is seen as no flow on
PI (white arrows).
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Figure 14.14 A patient with no visible PI lesion
PH212: This patientpresented with mild right leg weakness and speech difficulties (NIHSS
3). MR at 4.1 hours. The DWI shows a small hyperintensity in the left frontal lobe. CBF and
MTT maps do not show an abnormality.
The influence of time
As the time from symptom onset to scanning increased, the likelihood of
observing a mismatch diminished. Using MTT maps, the proportion of patients with
a mismatch within six hours was 10/18 (56%); between six and twelve hours was 3/7
(43%); between 12 and 24 hours was 9/23 (39%), and after 24 hours was 3/14 (21%)
(see Figure 14.15). 8/13 (62%) patients who were scanned within 12 hours and had
a mismatch were dead or dependent at follow-up, whilst 3/12 (25%) patients who
presented at the same time but did not have a mismatch were dead or dependent at
follow-up (p=0.07, x2)-
I 40
44 57 59 77
0-6 hrs 6-12 hrs 12-24hrs >24 hrs
BM no mismatch
□mismatch
Time from symptom onset
Figure 14.15 The likelihood ofseeing a mismatch diminished as timefrom onset increased
60 classifiable patients using MTT maps, divided into mismatch or not on basis ofvisual
inspection
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The latest time that a mismatch was observed was in a patient scanned at 51.8
hours after symptom onset [PH307]. This 81 year old patient presented with right
hand weakness and speech loss, on examination the pulse was irregular, there was
aphasia and moderate right hemiparesis (NIHSS 11). The clinical classification was
PACS. The DWI (see Figure 14.16) showed a patchy left internal borderzone
ischaemic lesions, but the MTT maps showed a much larger perfusion deficit. At
three months, the patient needed considerable support from family (mRS 3).
Figure 14.16 The latest patient with a mismatch scanned in the study
PH307: This patient presented with (NIHSS 11). MR at 51.8 hours. The DWI image shows
patchy small hyperintense lesions in the internal borderzone region (arrows). The CBF map
showed no abnormality, but the MTT map shows a much largerfocal area ofreduced blood
flow (arrows) compared with the DWI.
The earliest patient with a mismatch in the study was scanned at 2.5 hours
after symptoms onset. This 77 year old presented with speech disturbance and
reduced consciousness, on examination, GCS was 11, there was global aphasia, a
right hemianopia and right hemiplegia (NIHSS 23). The clinical classification was
TACS. MRI brain showed an extensive infarct, with PI scans showing a large
mismatch (see Figure 14.9). The patient died 13 days after onset.
The influence of infarct location on the presence ofa mismatch
To determine whether a mismatch was mainly seen in those with cortical
rather than lacunar infarcts, patients were divided on the basis of the location and
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size of the infarct on the MR. Those with a brainstem infarct (n=2) or a normal
structural/DWI scan (n=18) were excluded. Patients with large subcortical lesions
were classed as non-lacunar infarcts, along with patients with cortical lesions.
Of the 15 patients with lacunar infarcts, 13 had successful PI scans. None
had a mismatch (using the MTT map). Of the 47 patients with non-lacunar
hemispheric infarcts, 39 had successful PI scans. 20 had a mismatch and 19 did not.
The difference in observed frequency of mismatch between the lacunar and non-
lacunar groups was significant, despite the small numbers involved (p<0.01, %2).
Median time to scanning was 14.4 hours for the lacunar infarct group, and 7.1 hours
for the non-lacunar group (although three of the lacunar infarct patients were scanned
within six hours).
Mismatch determined by careful measurement of lesion volumes
How did visual grading compare with measured volumes?
The neuroradiologist's visual classification of mismatch was compared to the
calculated ratios from measurement of DWI and PI lesion volume. Although the
initial visual classification included a distinction between those with a large and a
small mismatch, only four patients were classed as a small mismatch (so this
category was removed). Table 14.7 shows the comparison using the MTT map.
Clinically, the most important distinction would be to identify whether a mismatch
was present, and Table 14.7 shows that 25 patients were classed as having a
mismatch, and 19 actually had one according to volume measurements (76%
correct). 25 patients also had a 'true' mismatch, of whom 19 (76%) were classed as
mismatch after visual inspection. Table 14.8 shows the comparison using the CBF
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map. Here, 10 patients were classed as mismatch after visual inspection of the
images, of whom six had a mismatch when measured (60% correct). 19 patients had
a measured mismatch, but only six (32%) were actually classed as a mismatch by
visual inspection.
Features ofpatients with a calculated mismatch
The clinical and radiological features and outcome of patients with a
calculated mismatch are shown in Table 14.9 (for the MTT map) and Table 14.10
(for the CBF map). There was a trend (significant for the MTT map) for clinical
features to be more severe in those with a calculated mismatch, and the size of the
lesion on DWI and PI was significantly larger in those with mismatch (p<0.01 for
both CBF and MTT maps, Mann-Whitney U). However, even carefully measured
mismatch did not significantly predict outcome: for the MTT map, the odds ratio of a
poor outcome if mismatch was present was 1.7 (95% CI 0.6-4.9, p=0.45, x2), and 1.5
(95% CI 0.5-4.5, p=0.69, x) for the CBF map.
Size ofthe 'penumbra'
For patients with a mismatch, the region of perfusion abnormality larger than
the diffusion abnormality may represent the ischaemic penumbra. In our patients
with a mismatch, the volume of 'penumbra' ranged from 4.4mL to 236.5mL on MTT
maps (median 76.5mL, 25 patients), and from 3.4mL to 139.2mL on CBF maps
(median 30.7mL, 19 patients).
The relationship between outcome and size of the 'penumbra' for the MTT
map is illustrated in Figure 14.17. The median volume of penumbra in the patients
who did poorly was 133.3mL, and 54.9mL in those who did well (p=0.25, Mann-
Whitney U). For the CBF map (see Figure 14.17), the median volume was 33.2mL
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in the poor outcome group, and 22.7mL for the good outcome group (p=0.33, Mann-
Whitney U). Thus, outcome did not appear to be associated with size of the
'penumbra' in the present study.
Penumbra on MTT maps Penumbra on CBF
p=0.25 Mann-Whitney U p=0.33 Mann-Whitney U
poor good poor good
Functional outcome Functional outcome
Figure 14.17 The size of the 'penumbra' in those with a mismatch: did it predict outcome?
Box-and-whisker plot ofsize ofpenumbra for patients divided into good and poor functional
outcome
Exploring other factors that affect perfusion imaging: the importance of
carotid stenosis
Of the 82 patients with a final diagnosis of possible, probable or definite
cerebral ischaemia, 72 had a carotid doppler ultrasound examination. Six patients
had an ipsilateral carotid occlusion, and a further four patients had 60-99% ipsilateral
stenosis. To investigate whether carotid stenosis may have been associated with
absence of a perfusion deficit, I plotted the number of patients within 20% bands of
ipsilateral carotid stenosis, subdivided by whether a PI lesion was present (Figure
14.18). No significant relationship was observed (p=0.66, % ). An ipsilateral >60%
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Figure 14.18 The influence of an ipsilateral carotid stenosis on the presence of a visible
perfusion abnormality (n=55)
68 patients had PI data, but a carotid ultrasound was not performed in six, and the
symptoms referred to the brainstem or could not be localised in seven (hence any stenosis
could not be classed as ipsilateral)
An almost identical trend was seen when carotid stenosis was subdivided by
whether a mismatch was present (Figure 14.19). There was no significant
relationship (p=0.17, y£), but those with severe stenosis were more likely to have a
mismatch.
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Figure 14.19 The influence of an ipsilateral carotid stenosis on the presence of a DWI-PI
mismatch on MTT maps (n=52)
52 patients had all of: a carotid ultrasound, PI scanning, and either a PI or DWI lesion.
Ipsilateral refers to side of symptoms - when symptoms referred to the brainstem or could
not be localised, patients were excluded.
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14.4.6 What was the impact of advanced imaging on current management
strategies?
This sub-study examined how often - and why - MR imaging changed
patient management, compared with CT. 63 patients were recruited into the study
(one more than the influence of imaging on the diagnosis sub-study - an extra CT
scan was found). Within the group of 63 patients were four patients with a stroke
mimic (seizure, tumour, decompensation, and functional), four patients with primary
intracerebral haemorrhage, three patients with haemorrhagic transformation of an
infarct, and eight patients with microbleeds. 18/63 (29%) patients had a normal DWI
scan.
Five clinicians were present at the meetings when 46 patients were discussed,
and four clinicians (the minimum) were present when 17 patients were discussed.
An additional two clinicians attended a few meetings, but were excluded from the
analysis, as the number of patients an opinion was given for was too low (seven and
15). In total, there were 299 'patient-clinician episodes' (not all clinicians passed an
opinion about the same patient).
Clinicians varied in experience and training. Clinicians one and two were
academic consultants in stroke medicine, clinicians three and four were academic
consultants in neurology, clinician five was a stroke research fellow (commencing
geriatric training), and clinician six was a trainee in neurology (18 months before
training complete).
The CT was performed after the MR in 41/63 (median time between scans
0.8 hours, mean 7.0 hours, range 48.8 hours), and before the MR in 22/63 (median
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time between scans 1.1 hours, mean 6.2 hours, range 23.5 hours). Overall, 43/63 of
CT scans were performed within two hours before or after the MR scan.
How often did management change after the MR images?
MR brain imaging - both structural and DWI sequences - resulted in few
changes in management. Table 14.11 shows that, when averaged across all six
clinicians, MR resulted in a management change in eight of 49 patients (16%). In six
of the eight patients, the change occurred after the structural imaging.
There were clear differences between clinicians. Two found MR to be very
helpful (management altered in 26% and 22% of patients), although one placed more
emphasis on the DWI (management changed in 14%) than the other clinicians. Two
clinicians made few changes after MR imaging (management changed in 7% of
patients). There was no pattern observed as to whom found MR useful, in particular,
experience had no impact on whether the MR changed management.
On average, each clinician made 294 management decisions. 17 changes
were made after MR; 13 after the structural and 4 after the DWI images were shown.
Often a finding on MR resulted in a number of changes in one patient. The mean
number of changes per patient was 2.4 after structural imaging and 1.5 after DWI.
How did the results of the MR brain imaging change management?
Urgent reversal ofanticoagulation
Anticoagulation was reversed urgently for 24/299 (8%) patient-clinician
encounters after the CT. After structural MR, there were five management changes:
in two (one patient) an initial decision to reverse anticoagulation was changed after
the MR showed features suggesting a meningioma (rather than a bleed), and in two
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(one patient) the MR showed haemorrhagic transformation of an infarct, not seen on
the CT (which was performed 13 hours earlier). One clinician decided to reverse
anticoagulation urgently in one patient (whose MR showed old microbleeds only),
but then changed back to continuing with anticoagulation after the DWI showed an
acute lacunar infarct.
Intravenous thrombolysis
The two hypothetical questions asked whether the clinician would treat a
patient at two hours, and at four hours, with intravenous thrombolysis (either open-
label or as part of a randomised trial). Three clinicians (3, 4 & 6) would only ever
give thrombolysis as part of a randomised trial, and no clinicians would give open-
label thrombolysis for the patient presenting at four hours.
For the two-hour patient, there were 68 (23%) decisions to give open-label
thrombolysis, 176 (59%) decisions to randomise the patient to a trial, and 55 (18%)
decisions to withhold treatment after CT. Mostly, clinicians withheld treatment
because the symptoms were due to an intracerebral haemorrhage, or the symptoms
were not convincing enough (despite being asked to imagine that symptoms were of
severity to warrant treatment). For the four-hour patient, 243 (81%) decisions were
to randomise, and 56 (19%) decisions to withhold treatment.
After structural MR, there were 22 changes for the two-hour patient, and 16
changes for the four-hour patient. One clinician decided to change from trial to
open-label treatment for a two-hour patient (the structural MR showed atrophy only),
and a different clinician made the same decision for a four-hour patient (structural
MR was normal). Four decisions were made to change from open-label to trial, for
no discernible reason. The remaining 32 changed decisions were from treatment to
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nothing. The MR findings that resulted in these changes were: evidence of
haemorrhagic transformation (12 decisions in 2 patients); evidence of old
haemorrhagic stroke (12 decisions in 3 patients); microbleeds (5 decisions in 2
patients), and atrophy (3 decisions in 1 patient).
After the DWI scan, there were ten changes in management. Three decisions
were to do nothing, as the DWI was normal. One decision was to go from no
treatment to open label treatment as DWI showed a clear infarct in a two-hour
patient, and - in a separate patient - management was changed from no treatment to
trial as DWI showed an infarct in a four-hour patient. The five other management
decisions were to change from open-label treatment to participation in a trial, as the
DWI was normal or showed small lesions (one lacunar, two cortical).
Long term anticoagulation
Clinicians were asked if they would advise long-term anticoagulation for the
patient (if in atrial fibrillation). On the basis of the CT, 268 (90%) decisions were to
anticoagulate, and 31 (10%) to avoid anticoagulants. Patients with haemorrhage or
haemorrhagic transformation were those for whom anticoagulants were avoided, and
of these, one clinician altered management after structural MR imaging (as the CT
was uncertain whether the lesion was a tumour or a bleed, whilst structural MR was
clear that it was a meningioma).
Of those who initially decided to anticoagulate, 19 changed management after
the structural MR. The MR findings that resulted in the change were: old
haemorrhagic stroke (15 decisions in four patients); haemorrhagic transformation (2
decisions in 2 patients); microbleeds (1 decision) and leukoariosis (1 decision). After
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the DWI, one clinician changed management from anticoagulation to none, on the
basis of a normal DWI scan.
Carotid endarterectomy
221 (74%) decisions were to proceed with carotid endarterectomy (CEA) if
there was an ipsilateral 90% carotid stenosis, and 78 (26%) were against CEA, after
the CT had been performed. Clinicians decided not to proceed with CEA when the
patient had suffered a haemorrhage or posterior circulation event, and further
imaging did not change management. After structural MR, there were five
management changes, all against proceeding to CEA. Two patients had clear infarcts
in the posterior cerebral artery territory, and three patients had many old lesions
evident on the structural imaging (in two there was also evidence of old
haemorrhage).
DWI had the largest impact on CEA, with nine changes recorded. In all but
one, the changes were against proceeding with CEA. The DWI appearances in the
eight patients were: probable/possible posterior circulation vascular territory (7
decisions in 3 patients), and normal scan (1 decision). For one clinician, after
deciding against CEA after the structural imaging on the basis of an old
haemorrhage, the management was changed back to proceeding with CEA when the
DWI showed a small anterior circulation lacunar infarct.
Antiplatelet therapy
The final management scenario asked the clinician about antiplatelet therapy,
assuming that the patient were already on aspirin. There were 56 (19%) decisions to
continue with aspirin and 26 (9%) decisions to stop aspirin after the CT. Stopping
aspirin was observed in the four patients with a bleed (by five clinicians), in the
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patient with a meningioma (by five clinicians), and in one patient with haemorrhagic
transformation of an infarct (by one clinician) [NB not all the clinicians were present
for every patient]. Neither structural nor DWI MR changed these decisions. One
clinician had fixed views on aspirin: in 46/47 patients, aspirin was continued, in one
patient (with a haemorrhage) aspirin was stopped, and there were no changes after
further imaging.
Of the 217 (73%) decisions to intensify antiplatelet therapy, 13 were changed
after structural MR. Three clinicians stopped aspirin in one (different) patient each -
the structural MR showed old haemorrhage or microbleeds and no evidence of an
acute lesion. Ten decisions to change the patient back to aspirin were made - the
structural MR showed old haemorrhage (4 decisions in two patients), microbleeds (3
decisions in two patients), leukoariosis (two decisions in one patient), and
haemorrhagic transformation of an infarct (one decision). Only two decisions were
altered by the DWI: one clinician recommenced aspirin - structural MR showed
microbleeds, DWI showed an acute lacunar infarct, and one clinician went from
intensified antiplatelet therapy to aspirin when the DWI was normal.
14.5 Discussion
14.5.1 Is it possible to predict the 'age' of a lesion with advanced imaging?
The requirement for a known, precise time of onset is critical to the safe use
of thrombolysis. Yet 1 in 3 patients are excluded from treatment as time of symptom
onset is unknown (Barber et al., 2001a). Around 25 - 30% of patients wake from
sleep with stroke (International Stroke Trial Collaborative Group, 1997; Elliott,
1998), and in the remainder, onset cannot be determined because of speech or other
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problems (Barber et al., 2001a). MR imaging offers a potential solution to this
problem, because it is independent of the patient's ability to recall the onset of
symptoms.
In the present small study, a neuroradiologist with considerable experience in
stroke estimated the age of the lesion seen on DWI. The typical changes that occur
in the maturation of a DWI lesion were used as the basis for the judgement
(Koroshetz & Gonzalez, 1997). The assessment was quick and potentially widely
applicable. Using the patient's time of onset as the gold standard (in the subgroup
with very precise onset details) showed that there was a discrepancy between the
imaging findings and the patient's duration of symptoms.
Similar findings were observed when the ADC was examined. Although
others have suggested that this may be a useful marker of lesion age (Fiebach et al.,
2002), we did not observe this. ADC values varied significantly in our
heterogeneous population of patients, as has been noted in previous studies
(Schwamm et al., 1998; Fink et al., 2002). In addition, in most patients there is a
further fall in ADC, but the time that it reaches its nadir varies from a few hours to a
few days (Lutsep et al., 1997; Schwamm et al., 1998; Fiebach et al., 2002). Thus it
would be impossible to define threshold levels for ADC with which to age a lesion
accurately. As we demonstrated, an extreme ADC value probably indicates that
there is inconsistency in timing.
These findings, although on a small scale, have implications for hyperacute
treatments such as thrombolysis. The appearance of the DWI lesion, and the ADC,
may provide a more direct estimate of the degree of tissue damage than just relying
on time alone. It is clear that time and imaging parameters are measuring different
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things. Ideally, treatment should be guided by the degree of tissue damage, for
which time is a very crude estimate. These data suggest that some patients who
present early have severe damage, and thus may be unsuitable for thrombolysis even
within three hours, whilst other patients who presented later had milder damage, and
could be suitable for thrombolysis eight or even twelve hours after onset.
14.5.2 The prediction of outcome after stroke
The prediction of outcome after stroke has been the subject of much research,
and for obvious reasons: accurate prediction could help to guide management
decisions (Counsell & Dennis, 2001). For a treatment such as thrombolysis, it would
be ideal to be able to select only the patients likely to benefit, and exclude those who
are at high risk of complications and those who are likely to do well without
treatment. Such predictions would have to be based on clinical or investigative data
that can be obtained from the patient immediately on presentation (rather than at 24
hours, or one week, as was the focus of many previous studies, e.g. (Johnston et al.,
2002)).
There has been much interest in the potential of MR to predict outcome.
Several small studies demonstrated that there was a strong correlation between
baseline DWI lesion volume and outcome, with a higher lesion volume predicting a
worse prognosis (Lovblad et al., 1997; van Everdingen et al., 1998; Barber et al.,
1998; Beaulieu et al., 1999). More recently, two studies showed that DWI lesion
volume at baseline independently predicted outcome (Thijs et al., 2000; Baird et al.,
2001). In both studies, logistic regression was performed, and the other independent
474
predictors were age, NIHSS and delay to imaging (Thijs et al., 2000), and NIHSS
and time (Baird et al., 2001).
However, these two studies have been criticised for failing a number of
methodological standards (Hand et al., 2001; Counsell et al., 2001). The studies
were retrospective, the sample sizes were small, the patients were highly selected
(just hemispheric strokes), and the models violated key rules of logistic regression
[e.g. 12 variables were entered into the model when there were only 24 outcome
events (Thijs et al., 2000)]. We thus aimed to perform an external validation of
Baird and colleagues' (2001) three item scale.
In our own series of 82 patients, we found that the three stage model failed to
usefully predict outcome, particularly in those predicted to have a good outcome.
We found that DWI lesion volume provided no additional prognostic information -
either on univariate or multivariate analyses. In our sample of patients, the most
important predictors of outcome were age and NIHSS score.
Why did DWI lesion volume not predict outcome?
Not withstanding the methodological flaws of the models produced, probably
the major explanation for our findings is case-mix. Our patient sample was an
unselected group of patients who presented with brain attack. This reflects real-life.
We included patients who turned out to have had transient ischaemic attacks, and
possible strokes. Our patients were older, had more comorbidity, and had milder
stroke severity than the patients previously reported. The two previous studies had
major selection bias: only 66 patients from a potential 347 (19%) were selected for
Baird et al's study (2001), and Thijs et al (2000) excluded those with prestroke
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disability, lacunar subtype and normal DWI scans. Both identified patients
retrospectively.
The clear implication of the present study is that for patients with milder
stroke severity, or lacunar or brainstem strokes, imaging adds little to the prediction
of outcome over and above age and NIHSS score. The importance of the NIHSS has
been a consistent finding in many other studies (Muir et al., 1996; Adams, Jr. et al.,
1999; Uchino et al., 2001). An explanation for the discordance of results between
the present study and other imaging studies can be seen in Figure 14.20 [reproduced
from (Adams, Jr. et al., 1999)]. The mean baseline NIHSS of our cohort has been
plotted on the curve, along with that of Baird et al's study (it was not possible to
include Thijs et al's study). Our cohort is on part of the curve where the slope is very
steep, particularly if the curve for lacunar stroke is also included. Where the slope is
very steep, small changes in NIHSS can result in major changes to the likelihood of a
good outcome. It would be difficult for any factor to add to NIHSS in the prediction
of outcome. Conversely, Baird et al's cohort (and other similar studies) is further
down the curve. Lacunar strokes were excluded, and it can be seen that the slope
becomes less steep. Here, the relationship between NIHSS and outcome is not as
strong - small changes in NIHSS have less effect on outcome - and so it becomes
possible for other features like DWI lesion volume to add independent information.
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Baseline NtH Stroke Scale Score
Figure 14.20 The influence ofbaseline stroke severity on outcome
The Y axis plots the probability ofan excellent outcome, and the Xaxis plots baseline NIHSS
score. The straight line is the three month outcome for non-lacunar stroke, and the straight
line with dots is the three month outcome for lacunar stroke. The black arrow marks the
mean NIHSS in the present study, the grey arrow marks the mean NIHSS of Baird et al's
study. Reproducedfrom (Adams, Jr. et al., 1999).
Limitations of the study
The present study is subject to a number of limitations. In order to replicate
Baird et al's study, I contravened many of the unofficial rules of logistic regression.
However, as the aim was to validate an existing study (and they had contravened the
rules to produce their model), I felt this was acceptable. I used the modified Rankin
score as a measure of outcome, but it would have been desirable to combine this with
a measure of neurological deficit (such as a repeat NIHSS at 3 months) to determine
how much of the poor outcome was due to the stroke (Lyden & Hantson, 1998).
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14.5.3 The DWI-PI mismatch - what more does it tell us?
The combination of perfusion and diffusion-weighted imaging has also
attracted much interest as a predictive tool. It is thought that the region of perfusion
compromise that is larger than the region of abnormal diffusion (thought to represent
the ischaemic core of an infarct) is an approximation of the ischaemic penumbra -
tissue that should respond to reperfusion therapy. Thus, demonstration of a
mismatch might identify patients suitable for thrombolysis after three hours (Albers,
1999; Warach, 2002; Parsons et al., 2002). In the absence of treatment, lesion
growth is said to occur in patients with a mismatch (Tong et al., 1998; Barber et al.,
1998; Beaulieu et al., 1999)
Most of the previous studies have been subject to numerous methodological
problems (Keir & Wardlaw, 2000), principally selection bias. Despite the logical
attractiveness of such theories, questions remain. How often does a mismatch occur
in unselected patients? What is the implication of finding a mismatch? How feasible
is the process of determining a mismatch? There is currently a randomised
controlled clinical trial ['DIAS', Desmotoplase In Acute ischaemic Stroke] in
progress that aims to test a new thrombolytic agent, with entry to the trial based on
demonstration of a mismatch. We aimed to determine if such a trial was feasible in
our unit.
Practical difficulties of determining if a mismatch is present
We demonstrated that determining the presence of a mismatch is challenging.
The initial problem is the extensive processing of the data required to generate
perfusion maps, which has been the major limiting factor for widespread use of PI
(Baird & Warach, 1998). Now, PI packages are often available with the MR
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scanner, but these have limitations (Calamante et al., 2002). One of the most time
consuming aspects of post-processing is correction of motion artefact, but if this is
not performed, the volume of the lesion may be seriously over-estimated (see Figure
13.1).
The next problem is that there is no ideal single measure of perfusion. The
four different measures - mean transit time (MTT), time to peak (TTP), cerebral
blood volume (CBV) and cerebral blood flow (CBF) — have advantages and
disadvantages. TTP and MTT maps are most widely used, because the lesion
boundaries are more distinct (Parsons et al., 2001). In the present study, we found
the MTT maps far easier to read, and consequently visual inspection of the MTT map
more accurately defined a mismatch than did the CBF map. However, Parsons and
colleagues (2001) found that the CBF map most accurately defined tissue in the
mismatch region that was at risk of infarction (the MTT map overestimated the final
infarct size). In our study, there was often discordance between the two measures of
perfusion.
A method for overcoming the extensive processing required to calculate DWI
and PI lesions is to base decisions on a brief visual inspection of the DWI film and PI
maps. This is the basis for recruitment to the DIAS trial. We replicated this scenario
in the present study, but also calculated the actual lesion volumes. This required an
additional reading of the PI maps, which resulted in some changes to the initial
classification of the PI lesion. We demonstrated major differences in the nature of
the mismatch as identified by visual inspection and by lesion calculation, but it is by
no means clear which method is 'correct'. Our data suggests that in future,
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researchers should clearly specify what method of perfusion they used, how it was
processed and then analysed, so that the results can be interpretable.
A final problem was the difficulty of interpreting the PI maps, which was
highlighted in Chapter 13 (see Figures 13.15-13.18). PI maps can be difficult to
report when there are old stroke lesions, very small (particularly lacunar) lesions, and
even extracranial carotid stenosis (Neumann-Haefelin et al., 2000). Few studies to
date have mentioned these problems, possibly because the patients in these studies
have been so highly selected.
The significance of a 'mismatch'
A mismatch was observed in 42 % of patients on MTT maps, and 18% (by
visual inspection) to 33% (by calculation) of patients on the CBF map overall. This
is far less than the 75% suggested by others (Parsons et al., 2001), but ours was a
more heterogeneous group, and time to scanning varied. In patients scanned within
six hours, 56% had a mismatch (on MTT maps) and these patients did worse.
Overall, in our cohort, the presence of a mismatch did not predict outcome.
Our patients were not treated with thrombolysis, which may prevent lesion growth
and improve outcome in those with a mismatch (Parsons et al., 2002). We did not
perform further scans on the majority of patients, so we do not know whether the
ischaemic lesions in those with a mismatch enlarged, as is proposed. Our data would
suggest that in a milder cohort of patients scanned at later time intervals, the presence
of a mismatch is of little clinical value.
This data helps to define the place of diffusion and perfusion MRI. In
patients who present early, with symptoms of a severe stroke, the demonstration of a
mismatch may be of benefit in guiding further treatment.
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Limitations
The present study was subject to many limitations, some of which have been
highlighted above. Our sample size was small (though larger than many prior
studies). We measured outcome as the modified Rankin score, which may be
insensitive to subtle changes (but is arguably more relevant to the patient). To test
the underlying theories of the perfusion-diffusion mismatch, sequential scans were
required (but this was beyond the scope of this thesis, though is part of the
underlying study). There may well have been significant associations between lesion
growth and the presence of a mismatch, even though the clinical associations were
not significant [as was found in the original report by Barber et al (1998)]. It has
been proposed that quantifying the severity of the perfusion deficit better predicts the
proportion of the mismatch that is likely to go on to infarction (Neumann-Haefelin et
al., 1999). Whilst interesting, this offers little to the clinician who needs to make a
rapid decision at the bedside.
14.5.4 Do the results of advanced imaging change the clinician's
management?
Many have argued for widespread availability of advanced MR on the basis
that it provides far greater information about ischaemic lesions than CT (Prichard &
Grossman, 1999; Hacke & Warach, 2000; Warach, 2001b). MR - particularly the
DWI and GRE sequence - improves accuracy of the diagnosis of stroke, and can be
extremely helpful to the clinician in a handful of patients. Does this translate into
changes in patient management? Earlier studies have not addressed this directly.
Improved management is assumed to flow from the greater information that DWI
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shows about the stroke. For example, Albers et al (2000a) demonstrated that DWI
can show 'potentially clinically relevant findings' not seen on the CT which may
affect management - such as multiple lesions suggesting an embolic source, or
altered lesion location.
The present study is the first to directly assess the impact of structural MR
and DWI on patient management. A panel of clinicians of varying experience was
given a series of hypothetical management, and changes in management were
recorded. We demonstrated that MR altered management in 16% of patients (on
average). Surprisingly, the structural images altered management far more often than
the DWI.
MR had the greatest impact on the scenarios involving thrombolysis, where
the demonstration of any form of blood - haemorrhagic transformation, old primary
intracerebral haemorrhage, or microbleeds - on the gradient echo sequence resulted
in the clinician deciding against treatment. DWI had the greatest impact on the
endarterectomy scenario, where the clinician decided against recommending surgery
on seven occasions when the lesion localised to the posterior circulation. The results
obtained were highly consistent - similar changes were made by the clinicians on the
same patients.
Limitations of the study
The methodology of the study - a series of hypothetical scenarios that
required many assumptions - may be criticised as not being realistic. The evidence
obtained from this study is indirect, albeit closer to actual patient management than
earlier studies. The ideal methodology would be to use real patients, but this would
require enormous numbers. The aim was to assess how much MR influenced patient
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management (over and above CT), so the use of scenarios was an efficient way of
minimising individual patient factors and maximising the influence of imaging in
decision-making.
Other limitations of the present study include the variation in time between
CT and MR, and the clinicians' own biases. 32% of CT scans were obtained greater
than two hours earlier or later than the MR. In one patient, the CT (obtained 13
hours before the MR) showed early ischaemic changes, and the MR showed
haemorrhagic transformation; clinicians were happy to give thrombolysis after the
CT, but avoided it after the MR. The study was also hampered by clinicians' own
biases - evidenced by several who would only enter a patient into a trial of
thrombolysis (and the department itself is currently conducting a trial of
thrombolysis), and one clinician who did not believe that any antiplatelet agent was
superior to aspirin. I attempted to minimise the influence of bias by including many
clinicians from different backgrounds and with different levels of expertise. Despite
that, the findings probably represent a uniform approach to management that may or
may not be representative ofwider practice.
Finally, it would have been desirable to show the PI images, to assess the
impact of mismatch on clinician's decisions about thrombolysis. This was not
possible, as the extensive processing required to generate PI images meant they were
unavailable till after the study was complete. Additionally, given the departmental
bias towards a randomised trial of thrombolysis without imaging-based entry criteria,
it is doubtful that PI-DWI data would have altered decisions.
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What are the implications of the management sub-study?
Imaging is less important to management than clinicalfactors
Imaging probably has less relevance to management than it does for
diagnosis. Management of individual patients depends on many clinical factors
(such as: did the patient present within the time window, was the stroke severity
sufficient, was the patient's premorbid state good enough to consider surgery or
anticoagulation, etc.). In contrast, there are relatively few imaging factors that
influence management. CT alone is capable of detecting most of these, leaving little
extra benefit to be gained by MR. Hence, in the present study, MR caused a
management change in 104/1794 (6%) scenarios.
The impact of imaging varied for each clinician. I hypothesised that junior
doctors would find MR more useful than senior doctors, who are used to working
with CT. However, level of experience, and clinical background (neurology vs
stroke medicine), did not influence whether the clinician found MR useful. This has
resource implications: there is little use in performing extra imaging if the clinicians
will not act on the findings.
More research is needed
We observed that structural imaging resulted in 81/104 (78%) of the changes.
The major finding that prompted these changes was the demonstration of
haemorrhage on the GRE sequence, or leukoaraiosis on T2 sequence in a smaller
number of patients. The demonstration of a relevant lesion on DWI, or the absence
of a lesion on DWI, had little impact.
Many decisions to avoid proven treatments were made on the basis of
conjecture rather than evidence. Although leukoariosis on CT has been shown to
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independently predict cerebral haemorrhage complicating anticoagulation in those
with cerebral ischaemia 'of presumed arterial origin' in one trial (Gorter, 1999), the
importance of this factor in cerebral ischaemia secondary to atrial fibrillation, and
how CT findings relate to MR findings, has not been established. A recent case
report (Kidwell et al., 2002) suggested that microbleeds might be associated with
remote haemorrhage complicating thrombolysis, but called for a large prospective
study. There is an urgent need for more research into the influence of microbleeds,
old bleeds, and leukoariosis on the risks of thrombolysis and oral anticoagulants.
Why was little 'positive' use made ofthe MR?
There were 104 altered management decisions in the present study. 93
changes were 'negative' (i.e. the clinician decided not to give a treatment, randomise
the patient in a trial, or not intensify antiplatelet therapy). Only 11 'positive' changes
to management were made. Why did MR findings result in so few decisions to act
more aggressively?
One possible explanation is that despite MR imaging, clinicians may act on
the expectation that the scan will be negative: management decisions are made after
the clinical assessment and can only modified downward by subsequent imaging.
For example, any abnormality on CT - haemorrhage or major signs of ischaemia -
would prompt the clinician to avoid thrombolysis. In the present study, the few
patients with microbleeds or old haemorrhage on MR influenced management far
more than the larger number of patients with a negative DWI. If this is true,
clinicians will need to change their mind-sets away from CT if the full potential of
MR is to be realised.
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More complex imaging might restrict management choices
The present study has shown that the more complex the imaging, the less
likely it is that patients will receive risky treatments such as thrombolysis. In
addition, we found that only 56% of our patients who presented within six hours had
a DWI-PI mismatch. It may be desirable that trials impose entry criteria to ensure a
new drug is tested in a homogeneous population (Warach, 2002). However, it must
be recognised that this strategy increases the complexity of the requirements for the
trial, and dramatically restricts eligibility. Where evidence suggests that a treatment
is beneficial - thrombolysis for ischaemic stroke within three hours of onset
(Wardlaw et al., 2001a), anticoagulation for atrial fibrillation (Koudstaal, 2002) -
efforts ought to be directed towards ensuring every eligible patient receives
treatment.
14.6 Summary
• The present study selected a broader spectrum of patients, and therefore
provides useful data on the utility of MR in real life
• Imaging may provide a more direct estimate of the degree of tissue
damage than can be determined by using time from symptom onset
• The present study found that DWI lesion volume did not predict outcome,
and was unable to validate a simple predictive model proposed by others.
Imaging parameters probably have less prognostic influence in patients
with small cortical, lacunar or brainstem infarcts, than in those with large
hemispheric infarcts
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• Perfusion abnormalities are correlated with the baseline neurological
deficit and DWI appearance. On its own, PI does not provide additional
prognostic information
• In combination with DWI, PI does identify a subgroup of patients with
mismatch. These patients have larger DWI lesions, and more severe
neurological deficit. The presence of a mismatch did not predict outcome
in our cohort
• The determination of mismatch is currently technically difficult, and the
significance of the various perfusion parameters remain uncertain
• The additional impact of MR (over CT) in current management was
small. The MR resulted in a change in management for 16% of patients
(ranged from 7% to 26% of patients depending on the clinician). The
demonstration of blood on structural images had the greatest impact on
management. Usually, an abnormality seen on imaging stopped the
clinician from acting.
14.6.1 Recommendations for further research
• Further prospective studies of a broad selection of patients are required to
establish the role of MR in routine clinical practice
• More information on the association between time and imaging
parameters is required to determine how to combine these two measures
to ensure that patients benefit from thrombolysis
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• The best measure of perfusion needs to be determined, and clear criteria
established to identify a mismatch. If lesion volumes must be calculated,
then processing times needs to be reduced to make the process viable
• The pathophysiology of ischaemic stroke needs further exploration: what
does a mismatch signify, does the DWI lesion represent infarcted tissue,
what is the significance of a mismatch seen many hours after onset?
• Further research into the impact of advanced imaging on real
management ofpatients is required
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Table 14.1 Accuracy of determining the age of the lesion based on its MR appearances
(n=35*)
Precisely known onset
MR-estimated age of lesion 0-6 hours 6-12 hours >12 hours Total
Within 6 hours 4 1 8
6-12 hours 5 2 6 13
After 12 hours 2f 1 11 14
Total 11 4 20 35
* patients who did not wake with symptoms, and could give an exact time of onset. A DWI
lesion had to be present to allow an estimation oflesion age.
f 'extreme outliers' - see textfor explanation
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Table 14.2 Clinicalfeatures, DWI and outcome in MR study (n=81)
Functional outcome in the MR study
Factor Good (n=43) Poor (n=38) p+
Clinicalfeatures
Median age (years) (IQR) 69.8 (60.1-77.2) 80.0 (72.2-83.7) <.001
Median time (hrs) from onset of
symptoms to scanning (IQR) 14.6 (5.6-24.7) 9.4 (4.7-19.8) .107
Male gender 21 (49%) 20 (53%) .733
Cognitive impairment 3 (7%) 11 (29%) .009
Hypertension 23 (54%) 23 (61%) .798
Ischaemic heart disease 9 (21%) 11 (29%) .194
Past history of stroke 14 (33%) 19 (50%) .111
In atrial fibrillation 7 (16%) 11 (29%) .171
Median systolic blood pressure
(mmHg) (IQR) 155 (140-178) 164 (149-180) .233
Reduced conscious state 0 (0%) 16 (42%) <.001
Median NIHSS (IQR) 4.0 (3.0-7.0) 8.0 (5.0-12.0) <.001
OCSP classification:* .027
TACS 1 (2%) 10 (26%)
PACS 21 (49%) 13 (34%)
LACS 12 (28%) 11 (29%)
POCS 7 (16%) 3 (8%)
DWIfeatures
No visible DWI lesion 11 (26%) 7 (18%) .439
Median DWI lesion volume (mL) 0.6 (0.1-6.2) 1.6 (0.2-22.0) .222
(IQR)
ADC (IQR)11 0.76 (0.71-0.85) 0.75 (0.65-0.82) .342
* outcome was assessed by modified Rankin Score. Data not availablefor one patient
f significance determined by Mann-Whitney U test (for continuous variables) andf test (for
categorical variables).
f OCSP classification unknown in three patients
| ADC and outcome data availablefor 51 patients (29 good outcome, 22 poor outcome)
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Odds Ratio (95% CI)
0.94 (0.89-0.99)
0.83 (0.72-0.96)
Table 14.4 Predicted and observed outcome using the three-item scale
Baird et al (n=129)* Present study (n=81)
Three- Predicted Number % Number %
item total % recovered recovered recovered recovered
score recovery / total (95% CI) / total (95% CI) P+
0-2 7% 3/42 7 (0-15) 2/9 22 (3-60) 0.60
3-4 46% 21 / 40 53 (37-68) 17/30 57 (37-75) 0.45
5-7 91% 41 141 87 (77-97) 25/43 58(42-73) <0.001
* datafrom combined Boston and Melbourne patient groups (Baird et al., 2001)
f significance for the difference between predicted recovery by the logistic model and
observed recovery in Brain Attack series (determined by Fisher's exact test)
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Table 14.5 Features of patients according to whether mismatch present using visual
inspection ofMTT map (n=60)
Imaging category:
Factor Mismatch (n=25) No mismatch (n=35) P*
Median age (yrs) (IQR) 76.3 (69.1-80.7) 72.4 (60.1-81.9) .319
Time to scanner (hrs) (IQR) 8.9 (4.0-20.5) 14.6 (6.1-26.0) .142
Median NIHSS (IQR) 7.0 (3.5-10.0) 5.0 (4.0-8.0) .203
OCSP classification:1 .130
TACS 5 (20%) 3 (9%)
PACS 12 (48%) 15 (43%)
LACS 4 (16%) 14 (40%)
POCS 2 (8%) 3 (9%)
Median DWI lesion volume (mL)
(IQR) 5.0 (0.6-16.4) 0.9 (0.5-5.5) .179
Poor outcome1 13 (52%) 11 (32%) .129
* Significance determined by Mann-Whitney U test for continuous variables, and x test for
categorical variables
f OCSP classification could not be determinedfor two patients with PI>DWI
i Outcome data not availablefor one patient (who had no mismatch)
Table 14.6 Features of patients according to whether mismatch present using visual
inspection of the CBF map (n=57)
Imaging category:
Factor Mismatch (n=10) No mismatch (n=47) P*
Median age (yrs) (IQR) 76.9 (72.6-82.1) 74.2 (62.3-81.2) .390
Time to scanner (hrs) (IQR) 5.8 (3.0-16.6) 14.5 (5.6-24.7) .075
Median NIHSS (IQR) 7.0 (4.8-8.3) 5.0 (4.0-8.0) .506
OCSP classification:1 .119
TACS 1 (10%) 7 (15%)
PACS 16 (60%) 20 (43%)
LACS 1 (10%) 17 (36%)
POCS 1 (10%) 3 (6%)
Median DWI lesion volume (mL)
(IQR) 2.2 (0.1-11.0) 1.8 (0.5-7.5) .536
Poor outcome1 4 (40%) 19 (41%) .940
* Significance determined by Mann-Whitney U test for continuous variables, and y2 test or
Fisher's exact testfor categorical variables
f OCSP classification could not be determinedfor two patients with PI>DWI
f Outcome data not availablefor one patient (who had no mismatch)
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Table 14.7 The agreement between visual classification of mismatch and calculation of
lesion volumes using the MTT maps
Calculated lesion volumes:
Mismatch No Mismatch
Visual classification: PI>DWI PI=DWI PKDWI Total
Mismatch (PI > DWI) 19 0 6 25
No Mismatch:
PI=DWI 5 1 7 13
PI < DWI 1 1 20 22
Total 25 2 33 60
Table 14.8 The agreement between visual classification of mismatch and calculation of
lesion volumes using the CBF maps
Calculated lesion volumes:
Mismatch No Mismatch
Visual classification: PI>DWI PI=DWI PKDWI Total
Mismatch (PI > DWI) 6 0 4 10
No Mismatch:
PI=DWI 10 2 6 18
PI < DWI 3 2 24 29
Total 19 4 34 57
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Table 14.9 Features ofpatients according to whether a calculated mismatch was present
using the MTT map (n=60)
Calculated category:
Factor Mismatch (n=19) No mismatch (n=38) P*
Median age (yrs) (IQR) 77.6 (70.3-80.3) 72.4 (60.2-82.0) .333
Time to scanner (hrs) (IQR) 6.8 (4.2-18.2) 16.6 (7.1-26.0) .030
Median NIHSS (IQR) 7.0 (4.0-11.0) 5.0 (3.0-8.0) .021
OCSP classification:* .058
TACS 6 (24%) 2 (6%)
PACS 12 (48%) 15 (43%)
LACS 3 (12%) 15 (43%)
POCS 3 (12%) 2 (6%)
Median DWI lesion volume (mL)
(IQR) 6.5 (1.7-16.4) 0.6 (0.4-3.2) .001
Median CBF lesion volume (mL)
(IQR) 18.2 (0-56.8) 0 (0-0) <.001
Poor outcome* 12 (48%) 12 (35%) .326
* Significance determined by Mann-Whitney U test for continuous variables, and y2 test or
Fisher's exact testfor categorical variables
f OCSP classification could not be determinedfor two patients
t Outcome data not availablefor one patient (who had no mismatch)
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Table 14.10 Features ofpatients according to whether a calculated mismatch was present
using the CBF map (n=57)
Calculated category:
Factor Mismatch (n=19) No mismatch (n=38) P*
Median age (yrs) (IQR) 76.5 (69.8-79.4) 74.2 (62.5-82.1) .826
Time to scanner (hrs) (IQR) 6.3 (3.9-21.2) 14.6 (6.8-24.1) .176
Median NIHSS (IQR) 7.0 (4.0-11.0) 5.0 (3.0-8.0) .063
OCSP classification:1 .079
TACS 5 (26%) 3 (8%)
PACS 10 (53%) 16 (42%)
LACS 2 (11%) 16 (42%)
POCS 2 (11%) 2 (5%)
Median DWI lesion volume (mL)
(IQR) 8.3 (0.9-24.9) 0.9 (0.4-5.6) .001
Median MTT lesion volume (mL)
(IQR) 38.3 (18.2-101) 0 (0-0) <.001
Poor outcome* 9 (47%) 14 (38%) .492
* Significance determined by Mann-Whitney U test for continuous variables, and y2 test or
Fisher's exact testfor categorical variables
f OCSP classification could not be determinedfor one patients with no mismatch
/ Outcome data not availablefor one patient (who had no mismatch)
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Implications for clinical practice
Brain attack is a medical emergency. At the beginning of the 21st century,
there is a very promising treatment for acute ischaemic stroke - thrombolysis - and
many other therapeutic options for patients with any form of stroke - stroke unit
care, surgery for intracerebral haemorrhage, and aspirin. The challenge is to ensure
that all eligible patients receive the best care possible.
Patients who present to hospital with a brain attack comprise a heterogeneous
group of serious medical conditions - not all will have a cerebral infarct. This thesis
has demonstrated the key components of the clinical assessment that accurately
distinguish between stroke and mimic at the bedside. We identified the reliable
components of history and examination. Three streamlined models were produced,
which varied from a four item tool (designed for a nurse) to an eight item tool (for a
trainee or expert in neurology).
Evidence suggests that around 50% of patients currently arrive at hospital
within six hours of symptom onset, yet only a small fraction receives thrombolysis.
The major stumbling block appears to be the long delay from arrival to assessment
and investigation. The data gathered in this thesis could be used to improve the
clinical assessment of brain attack, by promoting a rapid confident clinical diagnosis,
and thus prompt referral for neuroimaging.
There is little doubt that imaging has an enormous contribution to make in the
diagnosis and management of acute stroke. Every patient with brain attack needs to
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be imaged; the question is what is the best imaging method for the individual
patient? CT is available, rapid and cheap. It demonstrates haemorrhage with
accuracy and reliability, and shows great potential for the diagnosis of hyperacute
ischaemia. Conversely, MR imaging is difficult, time consuming and unavailable to
the vast majority of patients. Yet MR has great potential in expanding our
understanding of the pathophysiology of acute ischaemia, and may be helpful for
clinical diagnosis and management.
This thesis has shown that MR is not yet ready to replace CT as the imaging
of choice for patients with brain attack. In a less selected - and more representative
patient sample - MR showed little extra advantage. However, in certain situations,
advanced brain imaging might be preferred: for the patient with an unclear diagnosis;
to identify if an old lesion were a haemorrhage; to distinguish a new lesion from old,
and possibly to help guide treatment in patients who present early with a major
stroke. For most, the CT scan remains the unquestioned 'cardiogram of the brain'
(Buchan, 2001). Given its ease, safety and availability, CT is likely to remain at the
forefront of patient assessment for some time.
Implications for research
I would hope that this work might stimulate further research into the clinical
assessment, with particular emphasis on the validity and reliability of symptoms and
signs in the first few hours. Simple clinical research has enormous potential to assist
in training less experienced doctors and nurses. The key questions that deserve
further attention are: (1) is it possible to identify the patient with a TIA on
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presentation; (2) how useful is the OCSP clinical classification in the first few hours,
and (3) can the models developed be validated in an independent dataset?
I have identified many imaging issues that require further clarification. Work
is currently underway to explore, in far greater detail, the safety of MR imaging
acute stroke patients. There is much more to be learnt about the pathophysiology of
acute stroke, and how this is represented on the MR scan. A larger study involving
severe patients may shed further light on such problems as the best measure of
abnormal perfusion, defining the ischaemic penumbra, and determining if there are
reliable (and practical) imaging methods for identifying viable brain tissue.
The experience of recruiting and scanning patients, analysing the data
obtained, and writing up this thesis has given me an excellent insight into why earlier
studies have been so small and highly selected. There is no doubt that patients are
difficult to scan with MR, and as stroke is a heterogeneous condition, there is often
great - and disappointing - variation in the results obtained. However, f think it is
important that all results are reported, not just those that best fit with an attractive
theory. More studies of MR should be performed prospectively, in diverse but
clearly described patient groups. Most importantly, one must not suspend one's
critical faculties when reading a paper on imaging!
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Appendices
Appendix 1: Medline Search Strategy
1. exp basal ganglia cerebrovascular disease/ or exp brain ischemia/ or exp carotid artery diseases/ or
exp cerebrovascular accident/ or exp intracranial arterial diseases/ or exp intracranial arteriovenous
malformations/ or exp "intracranial embolism and thrombosis"/ or exp intracranial hemorrhages/
or exp vasospasm, intracranial/ or exp vertebral artery dissection/ or Cerebrovascular disorders/
2. (strokeS or cva or cerebrovscS or cerebral vascular).tw.
3. ((cerebral or brain or vertebrobasilar) and (isch?emi$ or infarcts or thromboS or emboli$)).tw.
4. ((cerebral or brain or subarachnoid) and (haemorrhage or hemorrhage or haematoma or hematoma
or bleedS or aneurysm)).tw.
5. diagnosis/ or diagnosS.tw.
6. "diagnostic techniques and procedures"/
7. exp Neurologic Examination/ or diagnostic techniques, neurological/
8. physical examination/
9. exp medical history taking/
10. ((clinical or neurologic) adj5 (assessment or diagnosis or picture or investigation or information or






16. exp basal ganglia cerebrovascular disease/di or exp brain ischemia/di or exp carotid artery
diseases/di or exp cerebrovascular accident/di or exp intracranial arterial diseases/di or exp
intracranial arteriovenous malformations/di or exp "intracranial embolism and thrombosis'Vdi or
exp intracranial hemorrhages/di or exp vasospasm, intracranial/di or exp vertebral artery
dissection/di or Cerebrovascular disorders/di
17. 1 or 2 or 3 or 4
18. 15 and 17
19. 16 or 18
20. diagnosis, differential/
21. diagnostic errors/
22. false negative reactions/
23. false positive reactions/
24. observer variation/
25. "sensitivity and specificity"/
26. clinical competence/
27. reproducibility of results/
28. ((inter?rater or inter?observer) adj5 (reliability or variation)).tw.
29. (accurate adj5 (assessment or diagnosis or identification or differentiation or discrimination)).tw.
30. stroke?like.tw.
31. (true stroke or pseudostroke).tw.
32. mimic$.tw.
33. misdiagnosis.tw.
34. predictive value of tests/
35. or/20-34
36. 19 and 35
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Appendix 2: BRAIN ATTACK ASSESSMENT FORM
EXAMINER: PJH / JK / BL / other:
Study number
Patient's Phone number: ( ) WARD
Patient's GP & Clinic Phone Number:
1. TIMING
When did the patient arrive in ARLI (or hospital)? Date:
(Tts logged in by the nursing staff)







Primary referral source: ARU □ Other □ Comment
Who made the referral: Doctor □ Nurse □
The referring diagnosis: Stroke □ Non-stroke □ Unsure □
GP diagnosis: Stroke □ Non-stroke □ No diagnosis □ No GP letter □
Diagnosis before assessing the patient: Def. Str □ Prob. Str □ Poss. Str □ Non-stroke Q
(end of the bed assessment)
Diagnosis after taking the history: Def. Str □ Prob. Str □ Poss. Str □ Non-stroke Q
Diagnosis after the examination: Def. Str □ Prob. Str □ Poss. Str □ Non-stroke □
3. SOURCE OF HISTORY
Who/what was the PRIMARY (or major) source of □ Patient
history? □ GP Letter
□ Relative
□ Ambulance
□ Inpatient Medical Notes
□ Other





□ Inpatient Medical Notes
□ Other
Is there inconsistency or discrepancy between primary and secondary source for:
Time of onset of this event (>30 minutes difference)? □ Yes D No
Evolution of symptoms since onset of this event □ Yes □ No
Presence or absence of major symptoms (e.g. vomiting, LOC) □ Yes □ No
Ifyes for any of the above, please comment:
4. PAST HISTORY
Was the patient known to have cognitive impairment before this event? YQnD Unknown □
Was the patient able to walk independently before this event? Y PI N PI Unknown P
(without the aid of another person, but can use a stick or aid)
Study number Patient label
Does the patient have any of the following conditions: (tick any that apply)
□ Migraine Q Known malignancy
□ Epilepsy □ Psychological disturbance (requiring any treatment)
Is the patient a smoker (incl. given up <12 months)? Y □ N □ Unknown □
Is the patient an ex-smoker >12 months? Y □ N □ Unknown □
Is there a history of Ischaemic heart Disease (angina, AMI, CABG)? Y □ N □ Unknown □
Is there a history of hypertension? (including drug treatment at any time) Y □ N □ Unknown □
Is there a history of Diabetes Mellitus? (Including diet control) Y □ N □ Unknown □
Is there known Atrial Fibrillation? Y □ N □ Unknown □
Is there known peripheral vascular disease? (int claud or prior surgery) Y □ N □ Unknown □
Was there a history of focal neurological deficit in the past? Y □ N □ Unknown □
If yes, had it resolved completely before this event? Y □ N □ Unknown □
What was the deficit, if any? (tick those that apply)
Communication disorder □ Visual disorder □ Swallowing problem □
Motor deficit Q [Left □ Right □] Other □ Balance or co-ordination problems □
Comment:
5. HISTORY OF THIS EVENT
Can the exact time that symptoms were first noted be determined? (time that symptoms came on or patient awoke)
Yes □
No □>
If yes, onset was: Date: I / Time:
Did the patient wake from sleep with the deficit? Yes □ No Q
If yes, last time known to be normal / / Time:
If time that svmntnms ' ' Onset is not assessable e.o. unconscious - comment
first noted can not be □ The exact onset is unclear
determined, tick one: □ other
APPROX TIME OF ONSET
/ / time:
Yes □ No □
Minutes
(1 day = 1440mins)
Can the patient or relative recall exactly what the patient was doing at time of onset?
Are the symptoms now Ves I I ^"Evolution to maximal deficit took
stable? - | ^
No □ ►Are the symptoms still getting worse? Yes □ No O
Has there been any improvement in symptoms? Yes □ No □
Was the patient generally well in the week before these symptoms started?
If no, comment:
Yes O No O
Was there a definite history of focal neurological symptoms? Yes □ No □
If yes, tick any of the following that apply:
Visual loss □ Diplopia Q
Loss of balance □
Other brainstem symptoms □ Comment
Face:
Loss of feeling □
Loss of power Q
Loss of function □
Altered sensation □
Arm:
Loss of function of speech or language f~l
Vertigo □
Hand: Leg:
Loss of feeling □
Loss of power □
Loss of function □
Altered sensation Q
Loss of feeling □
Loss of power O
Loss of function □
Altered sensation □
Loss of feeling Q
Loss of power □
Loss of function □
Altered sensation □
The symptoms have affected left □, right □, both □ sides; Or there are no lateralising symptoms □
Any other symptoms?
Is the patient able to walk independent of another person at present? Yes □ No □ Unknown □
Study number Patient label
Has the patient lost consciousness (at any time since onset)?
Has the patient vomited (at any time since onset)?
Is there a definite history of headache during this event?
If history of headache, is it distressing to the patient?
If history of headache, tick any that apply
YD N □ U □
YD N □ U □
Yes O No Q Unknown D
Yes D No D
□ The headache commenced before the event
□ The headache started when the event started
□ The headache commenced after the event started
Has the patient had a seizure since symptom onset? Yes □ No □ Unknown □















Yes O No O Ifyes, Left Q Right □
Yes O No O Specify
Yes O No O Specify
SaQ2
i v-»o | | i ^ w | |
Yes □ No □ Ifyes, Left □ Right □
Abdomen:
Are there any other abnormal physical signs? Yes □ No □
If yes, comment:
Does the patient have an overwhelming co-morbid condition (making assessment difficult)? Yes □ No □
If yes, comment:
Conscious State: (Circle the most appropriate number that describes the level of consciousness)
Reaction Level Scale
..... Responds verbally, makes eye contact, obeys commands, responds to lightMentally responsive stjmu,atjon (touch) or stmng stimulation (loud verbal/shaking)
1 Alert. No delay in response
2 Drowsy or confused. Responds to light stimulation, but drowsy or disoriented in time, place or
person
3 Very drowsy or confused. Responds only to strong stimulation
Unconscious Test response to painful stimulation - sternal rub or nailbed pressure
4 Localises to site of pain, does not ward off pain
5 Withdraws from painful stimulus
6 Flexion to pain
7 Extension to pain
8 No response to pain
Glasqow Coma Score
Eye Opening: Best motor: Best verbal:
Never 1 None 1 None 1
To pain 2 Extend to pain 2 Noises only 2
To sound 3 Abnormal flexion to pain 3 Inappropriate 3
Spontaneously 4 Flexion to pain 4 Confused 4
Localises to pain 5 Normal 5
Normal 6
Study number Patient label
Confusion tests: Can you test for confusion?
□ No
□ Yes
□ The patient is unconscious
□ . If so, can the patient be engaged (followThe patient is aphas,c
your face)? Yes □ NoQ
□ Other
Do not attempt the tests for confusion - pass on to the neurological examination
Time? (nearest hour) Yes Q No Q
Is the patient oriented to: Day? Yes Q No O
Month? Yes Q No Q
Year? Yes Q No D
Can the patient state all 7 days of the week backwards, starting with Sunday? Yes □ No □
7. NEUROLOGICAL EXAMINATION
Signs are on Left □ Right □ Both/Bilateral signs Q; No Lateralising signs □; There are no signs Q
Legend for completing this section: Y=yes, N=no, U=unsure/unassessable. Tick one box for each question
Vision
Is there a LEFT hemianopia? Y □ N □ U □
If yes, is it partial Q, complete □
Is there LEFT visual inattention? Y □ N □ U □
Is there a RIGHT hemianopia? YQnDuD
If yes, is it partial □, complete □
Is there RIGHT visual inattention? Y □ N □ U □
Eve Movements
Are the eyes deviated to the left? Y □ N O U □
Is there nystagmus to the left? Y Q N □ U □
Is there LEFT lll/IVA/l nerve lesion? Y □ N □ U □
Are the eyes deviated to the right? Y □ N □ U □
Is there nystagmus to the right? YDnQuD
Is there right lll/IVA/l nerve lesion? YDnQuD
Speech & Language
Can patient point to the ceiling with unaffected side?
YD N□U□
Is verbal output: Normal Q Slow □
Slurred^ Unintelligible^ No verbal outputO
Face
Can patient lift LEFT eyebrow? Y □ N □ u □
Can patient lift RIGHT eyebrow? Y u N u u U
Is there asymmetry of the smile? Y □ N □ u □
Arm weakness L R Lea weakness L R
The arm does not drift □ □ The leg does not drift □ □
The arm drifts □ □ The leg drifts □ □
Unable to lift arm off bed □ □ Unable to lift leg off bed □ □
Unassessable □ □ Unassessable □ □
Hand weakness: fine finaer movements are:
LEFT: Normal Q Reduced □ UO
RIGHT: Normal □ Reduced □ U □
Cerebellar sians
There is finger-nose ataxia L: Y □ N O U □
out of proportion to weakness R: Y □ N □ U □
There is heel-shin ataxia out L: Y Q N □ U □
of proportion to weakness R: Y □ N □ U □
Sensory signs Reflexes
Is there LEFT sensory loss? yDnQuD Asymmetry of the biceps jerk? YDnQuD
Is there RIGHT sensory loss? Y □ N □ U □ Asymmetry of the knee jerk? YDnDuD
Visuospatial dysfunction
Is there sensory extinction?
Is the patient aware of the deficit?
Does the patient recognise his/her own hands?
Are there any other "parietal" signs:
Yes on L O Yes on R □; N □ U Q
NO on L □ NO on R □; Yes □ U □ ; No deficit □
YD N□U□
Study number Patient label
Plantar response
Left flexor Q Left extensor Q Left equivocal or mute O Unsure on left □
Right flexor □ Right extensor Q Right equivocal or mute Q Unsure on right Q
8. DIAGNOSTIC FORMULATION
Were any important tests (that helped the diagnosis) immediately available? Y Q N □
If yes. EGG □ Glucose □ Other
Are the neurological signs consistent with the symptoms? Y Q N □ No neurological signs □
Do the neurological deficits conform to a known vascular territory (e.g. aca, mca, pica) Y □ N □ No signsQ
Did the patient fulfil Newcastle
Newcastle FAST criteria:
FAST criteria for acute stroke (on admission)? Yes □ No LJ
GCS>5
+ one of
Facial weakness (unequal smile or obvious weakness)
Arm weakness (one arm drifts or falls rapidly) □
Speech problems (word finding difficulties or slurred speech) □
Diaanosis at end of assessment:
DEFINITE STROKE □ PROBABLE STROKE □ POSSIBLE STROKE □ NON-STROKE □
Specify:
Clinical Classification: NO SIGNS □
TACS □ PACS □ LACS □ POCS □ Unsure □





Any comments about the
form?
Comment:
How long did it take to see the patient?
How long did it take to fill out this form?
Minutes
Minutes
Study number Patient label








Alert - keenly responsive
Drowsy - arousable by minor stimulation to obey, answer, or respond
Stuporous - requires repeated stimulation to attend, or is obtunded and requires strong or painful stimulation to
make movements (not stereotyped)


















Patient is asked to open & close eyes, grip & release normal hand
0 Normal
2. Best Gaze 1
2
Partial gaze palsy - gaze is abnormal in one or both eyes, no forced deviationAotal gaze paresis
Forced deviation - or total gaze paresis not overcome by oculocephalic maneouvre














Minor - flattened nasolabial fold, asymmetry on smiling
Partial - total or near total paralysis of lower face
Complete - absent facial movement in upper and lower face on one or both sides
0
1
No drift - holds limb at 90 degrees for full 10 seconds







Some effort against gravity
No effort against gravity
No movement
Untestable
0 No drift - holds limb at 90 degrees for full 10 seconds







Some effort against gravity
No effort against gravity
No movement
Untestable
0 No drift - holds limb at 45 degrees for full 5 seconds







Some effort against gravity
No effort against gravity
No movement
Untestable
0 No drift - holds limb at 45 degrees for full 5 seconds







Some effort against gravity




9. Limb Ataxia 1
2
Present in 1 limb




Partial loss - patient feels pinprick is less sharp oris dull on affected side








Mild - moderate dysphasia obvious loss of fluency or comprehension, without significant limitation on ideas
expressed or form of expression. Makes conversation about provided material difficult or impossible, e.g.
examiner can identify picture or naming card from patient's response.
Severe dysphasia - all communication is through fragmentary expression; great need for inference, questioning,
and guessing by the listener who carries burden of communication. Examiner cannot identify materials provided
from patient response





Mild - moderate dysarthria - patient slurs some words, can be understood with some difficulty.








Partial neglect - Visual, tactile, auditory, spatial, or personal inattention or extinction to bilateral simultaneous
stimulation in one of the sensory modalities
Complete neglect - Profound hemi-inattention or hemi-inattention to more than one modality. Does not recognise
own hand or orients to only one side of space
Study number Patient label
Notes for completion of NIHSS:
Administer stroke scale items in the order listed. Record performance in each category after each subscale exam. Do not go back and
change scores. Follow directions provided for each exam technique. Scores should reflect what the patient does, not what the clinician
thinks the patient can do. The clinician should record answers while administering the exam and work quickly. Except where indicated,
the patient should not be coached (i.e., repeated requests to patient to make a special effort).
1a. Level of Consciousness: The investigator must choose a response, even if a full evaluation is prevented by such obstacles as an
endotracheal tube, language barrier, orotracheal trauma/bandages. A 3 is scored only if the patient makes no movement (other than
reflexive posturing) in response to noxious stimulation.
1b. LOC Questions: The patient is asked the month and his/her age. The answer must be correct - there is no partial credit for being
close. Aphasic and stuporous patients who do not comprehend the questions will score 2. Patients unable to speak because of
endotracheal intubation, orotracheal trauma, severe dysarthria from any cause, language barrier or any other problem not secondary to
aphasia are given a 1. It is important that only the initial answer be graded and that the examiner not "help" the patient with verbal or non¬
verbal cues.
1c. LOC Commands: The patient is asked to open and close the eyes and then to grip and release the non-paretic hand. Substitute
another one step command if the hands cannot be used. Credit is given if an unequivocal attempt is made but not completed due to
weakness. If the patient does not respond to command, the task should be demonstrated to them (pantomime) and score the result (i.e.,
follows none, one or two commands). Patients with trauma, amputation, or other physical impediments should be given suitable one-step
commands. Only the first attempt is scored.
2. Best Gaze: Only horizontal eye movements will be tested. Voluntary or reflexive (oculocephalic) eye movements will be scored but
caloric testing is not done. If the patient has a conjugate deviation of the eyes that can be overcome by voluntary or reflexive activity, the
score will be 1. If a patient has an isolated peripheral nerve paresis (CN III, IV or VI) score a 1. Gaze is testable in all aphasic patients.
Patients with ocular trauma, bandages, pre-existing blindness or other disorder of visual acuity or fields should be tested with reflexive
movements and a choice made by the investigator. Establishing eye contact and then moving about the patient from side to side will
occasionally clarify the presence of a partial gaze palsy.
3. Visual: Visual fields (upper and lower quadrants) are tested by confrontation, using finger counting or visual threat as appropriate.
Patient must be encouraged, but if they look at the side of the moving fingers appropriately, this can be scored as normal. If there is
unilateral blindness or enucleation, visual fields in the remaining eye are scored. Score 1 only if a clear-cut asymmetry, including
quadrantanopia is found. If patient is blind from any cause score 3. Double simultaneous stimulation is performed at this point. If there is
extinction patient receives a 1 and the results are used to answer question 11
4. Facial Palsy: Ask, or use pantomime to encourage the patient to show teeth or raise eyebrows and close eyes. Score symmetry of
grimace in response to noxious stimuli in the poorly responsive or non-comprehending patient. If facial trauma/bandages, orotracheal tube,
tape or other physical barrier obscures the face, these should be removed to the extent possible.
5-8. Motor Arm and Leg: The limb is placed in the appropriate position: extend the arms (palms down) 90 degrees (if sitting) or 45
degrees (if supine) and the leg 30 degrees (always tested supine). Drift is scored if the arm falls before 10 seconds or the leg before 5
seconds. The aphasic patient is encouraged using urgency in the voice and pantomime but not noxious stimulation. Each limb is tested in
turn, beginning with the non-paretic arm. Only in the case of amputation or joint fusion at the shoulder or hip may the score be "x" and the
examiner must clearly write the explanation for scoring as an "x."
9. Limb Ataxia: This item is aimed at finding evidence of a unilateral cerebellar lesion. Test with eyes open. In case of visual defect,
insure testing is done in intact visual field. The finger-nose-finger and heel-shin tests are performed on both sides, and ataxia is scored only
if present out of proportion to weakness. Ataxia is absent in the patient who cannot understand or is paralyzed. Only in the case of
amputation or joint fusion may the item be scored "9", and the examiner must clearly write the explanation for not scoring. In case of
blindness test by touching nose from extended arm position.
10. Sensory: Sensation or grimace to pin prick when tested, or withdrawal from noxious stimulus in the obtunded or aphasic patient. Only
sensory loss attributed to stroke is scored as abnormal and the examiner should test as many body areas [arms (not hands), legs, trunk,
face] as needed to accurately check for hemisensory loss. A score of 2, "severe or total," should only be given when a severe or total loss
of sensation can be clearly demonstrated. Stuporous and aphasic patients will therefore probably score 1 or 0. The patient with brain stem
stroke who has bilateral loss of sensation is scored 2. If the patient does not respond and is quadriplegic score 2. Patients in coma (item
1a=3) are arbitrarily given a 2 on this item.
11. Best Language: A great deal of information about comprehension will be obtained during the preceding sections of the examination.
The patient is asked to describe what is happening in the attached picture, to name the items on the attached naming sheet, and to read
from the attached list of sentences. Comprehension is judged from responses here as well as to all of the commands in the preceding
general neurological exam. If visual loss interferes with the tests, ask the patient to identify objects placed in the hand, repeat, and produce
speech. The intubated patient should be asked to write. The patient in coma (question 1a=3) will arbitrarily score 3 on this item. The
examiner must choose a score in the patient with stupor or limited cooperation but a score of 3 should be used only if the patient is mute
and follows no one step commands.
12. Dysarthria: If patient is thought to be normal an adequate sample of speech must be obtained by asking patient to read or repeat
words from the attached list. If the patient has severe aphasia, the clarity of articulation of spontaneous speech can be rated. Only if the
patient is intubated or has other physical barrier to producing speech, may the item be scored "9", and the examiner must clearly write an
explanation for not scoring. Do not tell the patient why he/she is being tested.
13. Extinction and Inattention (formerly Neglect): Sufficient information to identify neglect may be obtained during the prior testing. If
the patient has a severe visual loss preventing visual double simultaneous stimulation, and the cutaneous stimuli are normal, the score is
normal. If the patient has aphasia but does appear to attend to both sides, the score is normal. The presence of visual spatial neglect or
anosagnosia may also be taken as evidence of abnormality. Since the abnormality is scored only if present, the item is never untestable.
Appendix 3: Clinical Assessment Scales
The Glasgow Coma Score
Best motor response Points Eye opening Points Best verbal response Points
Normal 6 Spontaneously 4 Normal 5
Localises to pain 5 To sound 3 Confused 4
Flexes to pain 4 To pain 2 Inappropriate 3
Abnormal flexion to 3 Never I Noises only 2
pain
Extends to pain 2 None 1
None 1
The Reaction Level Scale
Score: Clinical State
1 Alert (no delay in response)
2 Drowsy or confused (responds to light stimulation, but drowsy or disoriented in time,
place or person)
3 Very drowsy or confused (responds only to strong stimulation)
4 Localises to site of pain, does not ward off pain
5 Withdraws from painful stimulus
6 Flexion to pain
7 Extension to pain
8 No response to pain
Oxfordshire Community Stroke Project (OCSP) stroke subtype
OCSP subtype Clinical features
TACS Total anterior
circulation syndrome
PA CS Partial anterior
circulation syndrome
LA CS Lacunar syndrome
POCS Posterior circulation
syndrome
Either (a) homonymous hemianopia, hemiparesis and higher
cerebral dysfunction (e.g. aphasia or neglect); or (b) drowsiness
plus hemiparesis and higher cerebral dysfunction
Two of three components of a TACS, higher cerebral dysfunction
alone, or restricted motor/sensory loss
Pure motor or pure sensory disturbance, sensory-motor
disturbance or ataxic hemiparesis. Motor/sensory signs must
involve at least two of face, arm and leg.
Ipsilateral cranial nerve palsy with contralateral motor/sensory
deficit, bilateral motor/sensory deficit, disorder of conjugate
gaze, cerebellar dysfunction, or isolated homonymous
hemianopia









Recent infarct on appropriate side
Recent haemorrhage on appropriate side
















Was the lesion seen only with
contrast?
Comment
Yes □ No □
Yes EH No I I
FURTHER CT SCAN
/ /Date of scan:
Did it provide any additional
information (over and above first
scan)?
If yes, please comment:


















Carotid Duplex performed during
admission?
Result:
Yes □ No □
Recent infarct on appropriate side □ Left ICA □ Normal
Recent haemorrhage on appropriate side □ □ Minor atheroma
Other lesion on appropriate side □ □ Stenosis %
Comment: Right ICA □ Normal
Old discrete lesion(s) □ □ Minor atheroma
Periventricular lucencies □ □ Stenosis %
Is there a documented vertebral
vessel abnormality?
Yes □ No □
Comment:
Were any other important imaging tests performed?
Detail:










ril □ msd □ pags □











3. HOW WAS THE DIAGNOSIS MADE? (tick one for each section only)
Demoaraohics & Historv:
□ Definite stroke/TIA □ Probable stroke/TIA □ Possible stroke/TIA □ Non-stroke
Examination:
□ Definitely compatible □ Probably compatible □ Possibly compatible
with stroke with stroke with stroke
□ Not compatible with a
stroke (non-stroke)
Imaaina:
□ Relevant stroke □ Relevant non- Q No relevant □ Previous stroke r—. cjone
lesion stroke lesion pathology seen pathology
4. COMMENTS
Appendix 6: Accuracy of clinical diagnosis of stroke - 2x2 tables
GP diagnosis
Final diagnosis





Clinical diagnosis Stroke Mimic
Stroke 190 54
Mimic 26 51
Research fellow's 'end ofbed' assessment
Final diagnosis
Clinical diagnosis Stroke Mimic
Stroke 216 62
Mimic 25 47
Research fellow's diagnosis after history only
Final diagnosis
Clinical diagnosis Stroke Mimic
Stroke 223 52
Mimic 18 57
Research fellow'sfinal clinical diagnosis
Final diagnosis
Clinical diagnosis Stroke Mimic
Stroke 206 19
Mimic 35 90
Appendix 7: THE INTERRATER RELIABILITY STUDY DATA FORM
When did the examiner see the patient?
Who gave the history? Patient □
HISTORY
Date: / / Start time:
Patient and relative Q Relative/other □
1. Does the patient have high blood pressure? Y □ N □ unknown □(including drug treatment at any time)
2. Is the patient a smoker? (including giving up <12 months ago) Y □ N □ unknown □
3. Does the patient have ischaemic heart disease? Y □ N □ unknown □
4. Does the patient have atrial fibrillation? Y □ N □ unknown □
5. Does the patient have peripheral vascular disease? Y □ N □ unknown □
6. Does the patient have diabetes? Y □ N □ unknown □
7. Does the patient have a history of focal neurological deficit before
this event?
Y □ N □ unknown □
HISTORY OF THIS EVENT
8. Can the exact time the symptoms were first noted be determined?
If yes, what was the exact time of onset?
9. Did the patient wake from sleep with the deficit?
If yes, what was the last time known to be normal?
10. Can the patient recall what they were doing at the time of onset?
11. Has there been any improvement since the onset of symptoms?
12. Are the symptoms now stable?
13. Has the patient been generally well in the week before the
symptoms started?
14. Is there a definite history of focal neurological deficit?
15. If yes, was there hemianopia/quadrantanopia;
was there loss of speech or language function;
was there sensory loss;
was there loss of power;
did the symptoms affect the left side;
did the symptoms affect the right side;
did the symptoms affect both sides?
16. Did the patient have a headache during the event?
17. How confident are you about the findings from the history?
YDN □
Y □ N □ unknown Q
Y D N □ unknown Q
Y D N □ unknown Q
YQnQ unknown Q
YDnD unknown I I
YQnQ unknown □
YGnD unknown □





Y □ N □ unknown □
high G] low GD
GENERAL EXAMINATION
18. Is the patient alert?* YDND
19. Is the patient drowsy? YDND
20. Is the patient unconscious? YDND
21. Is the patient confused? Y □ N □
NEUROLOGICAL EXAMINATION
22. Does the patient have arm weakness?
Does the patient have hand weakness
Does the patient have face weakness
Does the patient have leg weakness?
Is the patient able to walk?
Does the patient have visual loss?
Does the patient have speech problems (dysarthria)1
Does the patient have a language prob\em(dysphasiafi
Y □ N □ unexamin. □
Y □ N □ unexamin. Q
Y □ N □ unexamin. □
Y □ N □ unexamin. □
Y □ N □ unexamin. □
Y □ N □ unexamin. □
Y □ N □ unexamin. □
Y □ N □ unexamin. □
Does the patient have sensory disturbance? YDnQ unexamin. d
Does the patient have visual neglect? YGnQ unexamin. d
Does the patient have sensory neglect? Y EG N d unexamin. d
Does the patient have any other form of visio-spatial dysfunction (e.g. Y d N d unexamin. d
dressing apraxia)?
23. Is the right side affected? Y d N d
24. Is the left side affected? Y d N d
25. Are both sides affected? Y d N d
26. How confident are you about the results of the examination? high d low d
FINAL DIAGNOSIS
27. Do you think the patient has had a stroke? Y d N d
28. If yes, is there a left-sided brain lesion? Y d N d
29. is there a right-sided brain lesion? Y d N d
30. is there a brain-stem lesion? Y d N d
31. what OCSP-classification would you give this patient? TACS d PACS d
LACS □ POCS d
Unexamin. d
32. How confident are you about the final diagnosis? high d low d
Finish time:
INSTRUCTIONS
Observer one explains the proceedings and asks for the patient's consent in participating in the study e.g.: 'We are
doing research on the diagnostic tests we use in the hospital for people who we think might have had a stroke. To
make these tests more reliable we have to compare the results from different observers. I would like to ask you a few
questions and to do a few tests. My colleague will come to see you after me and will repeat some of the questions
and tests. Would you mind participating?'
Observer one and two do not communicate with each other during or in between assessments. Assessment forms
are put in a sealed envelope immediately after the assessment.
Circle your initials.
Circle which observer is 'one', the first to see the patient, and which one is 'two', the second to see the patient.
Note the date as DD/MM/YY
Note the times as on a 24 hour clock.
Score the answer by ticking the 'yes' or 'no' box (or 'unexaminable') for the examination. Score all the questions.
HISTORY
2. If the patient denies being a smoker but stopped less than 12 months ago, score this question as 'yes'.
HISTORY OF THE EVENT
8. When the symptoms were noticed when waking up, note the waking time as time of onset.
17. If your clinical impression was made with a high level of confidence score 'high'; if you were not confident
score 'low'.
GENERAL EXAMINATION
18. Judge this on observation and score 18, 19 or 20 as 'yes' when applicable and as 'no' when not. Score one




22. 'Able to walk' means without help from another person; walking aid may be used.
26. If your clinical impression was made with a high level of confidence score 'high'; if you were not confident
score 'low'.
31. If the patient has had a stroke a choice has to be made between TACS (total anterior circulation infarct),
PACS (partial anterior circulation infarct), LACS (lacunar infarct), POCS (posterior circulation infarct).
LACS: patients present with a pure motor or pure sensory stroke, sensor-motor stroke, ataxic hemiparesis
(cerebellar type ataxia with pyramidal signs), dysarthria clumsy had syndrome, or acute focal movement
disorders.
TACS: patients present a combination of new higher cerebral dysfunction (dysphasia, dyscalculia,
visiospatial disorder); homonymous visual field defect; and ipsilateral motor and/or sensory deficit of at
least two areas of face, arm and leg.
Impaired consciousness rendering testing impossible is interpreted as a deficit.
PACS: patients present with two of the three components of the TACS, higher cerebral dysfunction alone
or with motor/sensory deficit more restricted than those classified as LACS (confined to one limb, or to face
and hand but not the whole arm).
POCS: patients present with any of the following: ipsilateral cranial nerve palsy plus contralateral motor
and/or sensory deficit, bilateral motor/sensory deficit, disorder of conjugate eye movement, cerebellar
dysfunction without ipsilateral long-tract deficit (ataxic hemiparesis), or isolated homonymous visual field
defect.






Observer yes 31 10 7 48
1 no 6 26 2 34
unknown 4 3 8 15
Total 41 39 17 97
Smoker within 12 months
Count
Observer 2
yes no unknown Total
Observer yes 17 2 3 22
1 no 56 3 59
unknown 1 7 8 16












Totalyes no unknown yes no unknown
Observer yes 17 4 6 27 Observer yes 8 7 3 18
1 no 4 50 2 56 1 no 4 53 3 60
unknown 1 3 10 14 unknown 2 4 12 18




Totalyes no unknown yes no unknown
Observer yes 5 3 4 12 Observer yes 3 2 1 6
1 no 7 51 8 66 1 no 62 5 67
unknown 1 5 13 19 unknown 3 10 13
Total 13 59 25 97 Total 3 67 16 86
*This question was added after the study commenced
PHx focal neurological deficit
Count
Observer 2
yes no unknown Total
Observer yes 21 7 7 35
1 no 6 40 4 50
unknown 1 4 8 13
Total 28 51 19 98
History ofpresenting complaint




Observer yes 46 9 55
1 no 9 34 43
Total 55 43 98
The patient can recall what he/she was doing at onset
Count
The patient woke from sleep with deficit
Count
Observer 2
yes no unknown Total
Observer yes 15 5 1 21
1 no 5 39 6 50
unknown 3 7 16 26
Total 23 51 23 97





Totalyes no unknown yes no unknown
Observer yes 40 10 1 51 Observer yes 34 7 4 45
1 no 9 13 9 31 1 no 4 25 7 36
unknown 2 6 7 15 unknown 2 5 10 17
Total 51 29 17 97 Total 40 37 21 98
Symptoms now stable
Count





Totalyes no unknown yes no unknown
Observer yes 64 5 7 76 Observer yes 41 9 5 55
1 no 2 2 1 5 1 no 11 13 3 27
unknown 1 1 15 17 unknown 4 2 10 16
Total 67 8 23 98 Total 56 24 18 98










Symptoms affect the left side of the body
Count
Symptoms affect the right side of the body
Count





Totalyes no unknown yes no unknown
Observer yes 60 3 6 69 Observer yes 4 2 6
1 no 3 6 3 12 1 no 5 49 5 59
unknown 4 13 17 unknown 1 4 19 24




Totalyes no unknown yes no unknown
Observer yes 25 5 6 36 Observer yes 14 5 1 20
1 no 5 29 1 35 1 no 3 35 6 44
unknown 2 2 14 18 unknown 1 5 19 25




Totalyes no unknown yes no unknown
Observer yes 44 5 6 55 Observer yes 23 3 4 30
1 no 3 11 2 16 1 no 3 29 7 39
unknown 1 4 13 18 unknown 1 4 14 19




Totalyes no unknown yes no unknown
Observer yes 16 7 7 30 Observer yes 1 3 1 5
1 no 2 34 5 41 1 no 6 50 9 65
unknown 1 3 14 18 unknown 4 14 18





Observer yes 14 4 2 20
1 no 4 51 5 60
unknown 2 2 13 17
Total 20 57 20 97
Physical examination
The patient is alert
Count





Totalyes no yes no
Observer yes 75 7 82 Observer yes 10 1 11
1 no 2 14 16 1 no 5 82 87
Total 77 21 98 Total 15 83 98




Observer yes 4 4
1 no 94 94
Total 4 94 98
























Observer yes 11 10 4 25
1 no 4 50 5 59
unknown 2 3 7 12




Totalyes no unknown yes no unknown
Observer yes 51 7 1 59 Observer yes 51 5 2 58
1 no 9 29 38 1 no 5 32 37
unknown 1 1 unknown 2 1 3




Totalyes no unknown yes no unknown
Observer yes 29 9 1 39 Observer yes 41 10 1 52
1 no 13 43 1 57 1 no 10 32 42
unknown 1 1 2 unknown 1 2 3




Totalyes no unknown yes no unknown
Observer yes 27 9 36 Observer yes 12 5 2 19
1 no 5 42 3 50 1 no 7 56 3 66
unknown 1 3 6 10 unknown 4 5 4 13




Totalyes no unknown yes no unknown
Observer yes 19 15 1 35 Observer yes 27 9 36
1 no 10 41 4 55 1 no 7 51 58
unknown 2 6 8 unknown 1 3 4




Totalyes no unknown yes no unknown
Observer yes 21 9 2 32 Observer yes 3 4 8 15
1 no 8 42 1 51 1 no 5 47 4 56
unknown 5 4 6 15 unknown 2 9 16 27
Total 34 55 9 98 Total 10 60 28 98




Observer yes 12 2 5 19
t no 4 44 5 53
unknown 1 7 18 26
Total 17 53 28 98




Observer yes 35 8 43
1 no 7 48 55
Total 42 56 98
Observer 2
Totalves no unknown
Observer yes 2 4 3 9
t no 3 42 15 60
unknown 1 9 19 29
Total 6 55 37 98




Observer yes 32 7 39
1 no 5 54 59
Total 37 61 98




Observer yes 1 3 4
1 no 4 90 94
Total 5 93 98
Diagnostic formulation




Observer yes 76 3 79
1 no 4 15 19





Observer yes 28 4 32
1 no 3 41 44





Observer yes 37 2 39
1 no 2 35 37





Observer yes 2 2 4
1 no 3 68 71




TotalTACS PACS LACS POCS
Observer TACS 13 5 18
1 PACS 4 20 4 1 29
LACS 5 13 1 19
POCS 1 2 7 10
Total 18 32 17 9 76
Appendix 9: MR STUDY - IN-SCANNER DATA FORM
Study number_
1.TIMING
The date of this assessment Date: / / Comolication risks
Arrived at scanning suite Time: The patient's risk is: HIGH / LOW
Entered MR scanner Time: Comment:
Out of MR scanner Time:
Were Xray Orbits required? Yes Q No O If yes, why: □ Aphasic, □ Comatose, □ Metal work
2. PRE-SCAN EXAMINATION
Conscious State: (Circle the most appropriate number that describes the level of consciousness)
Reaction Level Scale
Mentally responsive Responds verbally, makes eye contact, obeys commands, responds to light
stimulation (touch) or strong stimulation (loud verbal/shaking)
1 Alert. No delay in response
2 Drowsy or confused. Responds to light stimulation, but drowsy/disoriented in time, place or person
3 Very drowsy or confused. Responds only to strong stimulation






Localises to site of pain, does not ward off pain
Withdraws from painful stimulus
Flexion to pain
Extension to pain







Best motor: Best verbal:
1 None 1 None
2 Extend to pain 2 Noises only
3 Abnormal flexion to pain 3 Inappropriate
4 Flexion to pain 4 Confused
Localises to pain 5 Normal
Normal 6
NIHSS: Same as at initial assessment? Yes □ No O
If NO, please complete NIHSS form
3. OBSERVATIONS WITHIN SCANNER
Time 0 =




Was any intervention required? No □ Yes □
If YES was it: □ Medical - detail:
□ Nursing - detail:
□ Reassurance - detail:
Did the patient ring the panic button? Yes O No □
Was the full scan completed? Yes □ No □





Any other problems in the scanner? No □ Yes 0
If yes, please detail:
Finish time:
Appendix 10: The CT-MR diagnosis study data form
CT -MR STUDY: FINAL DIAGNOSIS
PATIENT NUMBER: PII It O
Date of meeting: 2c 'n 'jt(
You are clinician:
(please tick)
RIL □ MSD □ PAGS □ C
BW □ Other:
<GM □ JK □ CLMS □ EK □
FINAL DIAGNOSIS
INSTRUCTIONS - Please put a cross on the line. If you are 100% sure the diagnosis is stroke/TIA, put a
cross at the left end: if you are 100% sure the diagnosis is non-stroke, put a cross at the right end A cross
through the middle point means you cannot be sure whether the diagnosis is stroke or non-stroke.
A. Your diagnosis on the basis of... HISTORY
Stroke/TIA | | I Non-stroke
B. Your diagnosis on the basts of... HISTORY & EXAMINATION
Stroke/TIA | | I Non-stroke
C. Your diagnosis on the basis of... HISTORY, EXAMINATION & CT SCAN □ No CT done
Stroke/TIA | I I Non-stroke
D. Your diagnosis on the basis of... HISTORY, EXAMINATION & MR
Stroke/TIA i_ _j Non-stroke
E, Your diagnosis on the basis of... HISTORY, EXAMINATION & DW1
Stroke/TIA |_ j Non-stroke
51 / 6i fV - In. U)fryC_
Appendix 11: The CT-MR management scenarios study data form
CT -MR STUDY: FINAL DIAGNOSIS







MSD u/ PAGS □ CPW □ GM □ JK □
HYPOTHETICAL MANAGEMENT SCENARIOS
A. ACUTE MANAGEMENT
1. If this patient were on warfarin for
AF, and INR was 3.3, would you
reverse the anticoagulation urgently?
2. tf this patient were 50 years okt,
otherwise well, and presented at 2
hours, would you?







After CT: After MR:
y
After DWI:
[vf Open label tPA t^TOpen label r-tPA □ Open label tPA









3. If this patient were 60 years old,
otherwise well, and presented at 4
hours, would you?
B. SECONDARY PREVENTION
1. If this patient is in AF, and has no
contraindications, would you
anticoagulate in the long term?
2. If this patient were male, fit and
well, made a good recovery from
stroke, and had a 90% ipsilateral
carotid stenosis, would you refer for
CEA?
After CT: After MR: After DW1:




□ Open label tPA
rtfCndomiseto




I yj r\dfKXHill5« lO
IST-3
QlTothirg






After CT: AWMR: AfterPWt:
Q^Yes 0 Yes □ res
□ No □ No □ No
After CT: After MR: After DWI:
3. If this patient were in sinus rhythm,
and already on aspirin, assuming
they make a good recovery from
stroke, would you?
□ Stop aspirin
□ Continue aspirin
□Intensify
antiplatelet therapy
{eg cloptdogrel)
F1 Stop aspirin
DZ^Qon tinue aspirin
Galntensify
antiplatelet therapy
(eg cfopidogrel)
□ Stop aspirin
Q^ontinue aspirin
□ Intensify
antiplatelet therapy
(eg clopidogref)
